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This chapter presents an overview of tuberculosis as a global and ancient pandemic. 
Specifically how the disease, and it’s aetiologic agent Mycobacterium tuberculosis, has 
influenced research and development in both medicine and infectious disease as 
a study topic, will be discussed. A summary of the core technologies or topics that 
underpin the research chapters of this thesis will be introduced here as well. These 
include the use of next generation sequencing technologies, the unique evolution of M. 
tuberculosis, the composition of the bacterial cell wall and associated secretion systems 
as well as the host response to M. tuberculosis.
A bRIEf HIsToRy of TubERcuLosIs
M. tuberculosis is the causative agent of tuberculosis, a major current global health 
problem. Tuberculosis is also an ancient disease with palaeopathological evidence 
dating back to the Neolithic period (~8000 BCE) (1). It is therefore safe to say that 
tuberculosis has plagued humans for centuries. This pathogen has been referred to 
by various names such as: King’s evil, consumption, phthisis, captain of these men of 
death, the white plague and played an important role in shaping modern society (2–4).
Ancient civilisations had to contend with infection by M. tuberculosis and naturally 
attempted to study the disease with the knowledge and world view of the time. While 
notable advancements were made in the 19th century, ancient scientists were able to 
rationalise remarkable characteristics of tuberculosis for the time period. The first 
appearance of M. tuberculosis in historical record dates back to the ancient Egyptian 
civilisation, where Egyptian mummies have been identified with Pott’s lesions (an 
extrapulmonary form of tuberculosis that affected the vertebrae, resulting in malfor-
mations of the spine) in approximately 2400 BC (5). While the Egyptians seemed to be 
aware of a fatal disease in their midst, there was little to no notable documentation 
of a tuberculosis-like disease in the papyrus that has survived to the modern age (6). 
Scholars first wrote about a disease resembling tuberculosis approximately 3000 years 
ago as evident by text discovered in modern day India and China (7). The disease is also 
mentioned in two books of the old testament, namely Leviticus 26:16 and Deuteronomy 
28:22. The ancient Greeks had a remarkable grasp on tuberculosis as an infectious 
and fatal disease as evident by their name for tuberculosis, namely phthisis (wasting 
away) also referred to as consumption or “tering”. This name for tuberculosis would be 
the dominant name until the 19th century. Below is the account of Hippocrates as he 
described tuberculosis in his book Of the epidemics as translated by Francis Adams (8).
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“The greatest and most dangerous disease, and the one that proved fatal to the great-
est number, was consumption. With many persons it commenced during the winter, 
and of these some were confined to bed, and others bore up on foot; the most of those 
died early in spring who were confined to bed; of the others, the cough left not a single 
person, but it became milder through the summer; during the autumn, all these were 
confined to bed, and many of them died, but in the greater number of cases the dis-
ease was long protracted. Most of these were suddenly attacked with these diseases, 
having frequent rigors, often continual and acute fevers; unseasonable, copious, and 
cold sweats throughout; great coldness, from which they had great difficulty in being 
restored to heat; the bowels variously constipated, and again immediately in a loose 
state, but towards the termination in all cases with violent looseness of the bowels; 
a determination downwards of all matters collected about the lungs; urine excessive, 
and not good, troublesome melting. The coughs throughout were frequent, and copious, 
digested, and liquid, but not brought up with much pain; and even when they had some 
slight pain, in all cases the purging of the matters about the lungs went on mildly. The 
fauces were not very irritable, nor were they troubled with any saltish humors; but there 
were viscid, white, liquid, frothy, and copious defluxions from the head. But by far the 
greatest mischief attending these and the other complaints, was the aversion to food, as 
has been described. For neither been described. For neither had they any relish for drink 
along with their food, but continued without thirst. There was heaviness of the body, 
disposition to coma, in most cases swelling, which ended in dropsy; they had rigors, and 
were delirious towards death.” - Hippocrates
It becomes apparent that Hippocrates had a firm grasp on the symptoms of tuberculosis 
and could recognise the afflicted by their symptoms, which were masterfully described. 
However, the method by which consumption was acquired was lost on Hippocrates, 
as he guessed a hereditary component. This was however not the only contribution 
to tuberculosis research made by the ancient Greeks. Both Isocrates and Aristotle 
were aware of the ability of tuberculosis to spread from one individual to another and 
touched upon the airborne infectious nature of tuberculosis.
“Why are those taken by phthisis, who are brought in contact with the sufferer, and not 
taken by such diseases as dropsy, fever and apoplexy, however close the contact with 
sufferers from this disease may be? Phthisis spoils the air and makes it dangerous, thus 
others become infected.” -Isocrates
“Why when one comes near consumptives, does one contract their disease? The reason 
is that the breath is bad and heavy, one breathes this pernicious air and takes in the 
disease because there is in the air something disease producing” -Aristotle
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The Roman empire added their contributions to tuberculosis research as well. The 
Romans were able to diagnose tuberculosis and even offered a cure to this ailment (9). 
Furthermore the Byzantine Roman empire were accurately able to describe pulmonary 
and glandular tuberculosis (10). Probably the greatest Roman impact on tuberculosis 
was the spread of the disease across the known world at the time. DNA evidence has 
emerged to show the spread of tuberculosis across three continents as Rome provided 
roads and infrastructure to connect the Mediterranean, Europe, Africa and Asia by 
trade routes and the famous Roman roads (11).
While some advancements were made in England and France after the Romans, the first 
major contribution to the study of Tuberculosis came in 1699 from Leiden University in 
the Dutch Republic. Francis Sylvius, a respected physician and anatomist, provided the 
first clear description of tubercles and their progression to lung abscesses and cavities 
in his thesis, Opera Medica (12). He also noted that these nodules found in consumptive 
patients resembled that of skin ulcers caused by scrofula, of which the infectious agent 
is Mycobacterium scrofulaceum. In another thesis, Praxeos medicae idea nova, Sylvius 
noted that phthisis is scrofula of the lung and thus drew a link between two distinct 
yet related diseases and their causative agents (13). The notion of tuberculosis as a 
pulmonary disease was rediscovered by Rene Theophile Hyacinthe Laennec, inventor 
of the stethoscope, in the early 19th century some 200 years after Francis Sylvius (14). 
Laennec’s greatest contribution came from the realisation that the tubercle formation 
seen in various organs originate from the same disease, namely tuberculosis and thus 
arguing for a renaming to phthisis. The invention of the stethoscope is a direct conse-
quence of Leannec’s aversion to placing his ear upon the chest of a young woman in 
order to listen to her heart (14). By use of the stethoscope, a tool born from Leannec’s 
modesty, he was able to diagnose patients with pulmonary tuberculosis. This was the 
first diagnosis method for tuberculosis before death. These discoveries contributed to 
his thesis, D’Auscultation Mediate, which is the first major body of work describing 
the pathology of tuberculosis as well as the physical signs of tuberculosis in living 
individuals (4).
The first scientific demonstration of the infectious nature of tuberculosis arose in 1865 
(15). The French military surgeon, Jean-Antoine Villemin, demonstrated the infectious 
nature of tuberculosis by inoculating a rabbit with liquid from a tubercle cavity which 
he removed from a patient who had succumbed to tuberculosis (16). He further dem-
onstrated transmission from cattle to rabbits as well as inter-rabbit transmission, how-
ever his findings were predominantly ignored at the time. Villemin however noted that 
infected rabbits were largely without symptoms with autopsy revealing the presence 
of infection (16). During the same period as Villemin’s demonstration, William Bud set 
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forth a hypothesis that tuberculosis is spread across communities by specific germs. 
In his letter to The Lancet, he lists multiple observations on tuberculosis among which 
it is noted that phthisis (tuberculosis) does not originate spontaneously, is a zymotic 
disease (implies that a causative agent is present) and is propagated from one person 
to another (17). The medical advancements in the 19th century on the diagnoses of tu-
berculosis were paralleled with major strides in microbiology. Unbeknownst to those 
studying the disease at the time, the late 19th century would merge the two fields and 
link microbes to disease through the ground-breaking work of Heinrich Robert Koch
In the 19th century, the medical community were thus aware that diseases like tuber-
culosis are infectious and communicable. In turn the scientific community was aware 
that microorganisms occur naturally in the environment and that these organisms do 
not spontaneously generate but are ever present. Spontaneous generation was officially 
disproven by Robert Koch in his work with Bacillus anthraxis during the development 
of the Koch postulates in 1877 (18). This directly resulted in the establishment of germ 
theory and its acceptance in the scientific community. A few years later, on 24 March 
1882, Robert Koch made another contribution to the understanding of infectious dis-
ease and delivered his famous presentation, Die Aetiologie der Tuberkulose. In this 
presentation, Koch demonstrated that Phthisis was caused by M. tuberculosis, by use 
of a systematic method for detecting the origin of infectious disease. This came to be 
known as the Koch postulates for determining infectious aetiology, which is to this day 
the standard for establishing an aetiology for an infectious disease (19). Although it was 
firmly established at this time that tuberculosis is caused by M. tuberculosis, there was 
no effective treatment against this ailment. Even Koch’s major invention of tuberculin 
proved to be ineffective. In fact, the first treatment that offered some progress was 
artificial pneumothorax. The move towards a tuberculosis vaccination began in 1908 
when Albert Calmette and Camille Guérin cultivated tubercle bacilli, obtained from the 
udder of a cow, at the Pasteur Institute in the city of Lille, France. During their attempts 
to cultivate the bacilli they counteracted the clumpy nature of mycobacteria by adding 
ox bile and observed that sub-culturing decreased the virulence of the bacilli. This 
bacilli was sub-cultured for 11 years until 1919 when Calmette and Guérin inoculated 
a Guinea pig and observed that no disease progression occurred (20). This built on 
the early work of Edward Jenner and marked the first vaccine, called Bacille Calmette 
Guérin (BCG), against tuberculosis. This vaccine is still a standard vaccination given 
in many countries shortly after birth. For the next few decades there were little to no 
major discoveries as the world recovered from world war 1. However a different major 
discovery was at hand which would revolutionise the world of medicine and kickstart 
tuberculosis research once again.
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On the third of September 1928 Professor Alexander Flemming found that one of his 
staphylococci cultures was contaminated with a fungus that inhibited the growth of the 
bacteria. This finding was refined later by Florey and Chain and the world was intro-
duced to penicillin, one of the first antibiotics produced by a microorganism. Wartime 
efforts saw a need for penicillin and mass production and distribution was achieved in 
1945. While penicillin was active against a multitude of pathogens, a major pathogen 
that remained viable in the presence of penicillin was tuberculosis. However, the 
first tuberculosis antibiotic was not far behind and early trials with a new antibiotic, 
streptomycin, were already successful at this time. Pioneering work by Albert Schatz, 
Elizabeth Bugie and Selman Waksman isolated Streptomycin from Streptomyces griseus 
in 1944. A total of 10g could be isolated, which was enough to test three guinea pigs 
(21–23). The initial trials were successful and a further 25 Guinea pigs were tested and 
cured after 49 days compared to the 24 control animals in 1945 (24). This sparked an 
antibiotic revolution in M. tuberculosis research with multiple first-line chemotherapies 
being developed between 1944 and 1960. For the first time in the history of tuberculosis, 
the pathogen was under control, or so it seemed. The patients treated with streptomy-
cin showed a very high relapse rate and only with the arrival of combination therapy 
tuberculosis patients could be really cured. In many ways the problem of tuberculosis 
was considered solved and public interest in this disease waned. Indeed a publication 
in the journal American Review of Tuberculosis and Pulmonary Diseases by Johannes Holm 
clearly illustrated the sentiment of the day, that tuberculosis is curable with the antibi-
otics at hand (25). This sentiment lasted approximately 20 years, which in the context 
of tuberculosis plaguing human kind is barely a blink of an eye.
The return of Tuberculosis to the forefront of public health threats was sparked by 
another infectious disease which started gaining notoriety in the 1980’s (26). The rise 
of Human Immunodeficiency Virus (HIV) and acquired immunodeficiency deficiency 
syndrome (AIDS) provided the catalyst for the resurgence of tuberculosis (27). Many 
individuals with latent tuberculosis were getting ill when their immune system was 
compromised by HIV/AIDS (28). Thus a large number of deaths around HIV and AIDS 
were not due to the virus its self but due to the absence of a functional immune sys-
tem. Infection by M. tuberculosis and HIV/AIDS is so intertwined that research into the 
synergy between these diseases is ongoing to this day. This resurgence of tuberculosis 
infections during the 1980’s to early 2000’s included large scale treatments of the popu-
lation with antibiotics (29). The increase in use of antibiotics resulted in the increase 
in antibiotic resistance to the point where many strains evolved resistance to first and 
second line antibiotics (30). Antibiotic resistance of M. tuberculosis threatens to revive 
this disease to the mortality rates observed before the use of chemotherapies and 
naturally interest and research into the disease increased dramatically.
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The late 1990’s and early 2000’s issued revived tuberculosis research. Major advance-
ments in molecular biology techniques were being developed, including high through-
put sequencing and proteomics. The technology stemming from the human genome 
project was pursued by the group of Stuart Cole at the Pasteur Institute in Paris, France 
resulting in the publication of the first M. tuberculosis genome in 1998 (31). This was 
the beginning of the molecular investigation and appreciation of M. tuberculosis as 
an unusual and puzzling organism. The secrets of the M. tuberculosis genome were 
unlocked, paving the way for major scientific advances. Here, I will limit myself to the 
ones that relevant to the topics of this thesis. The first is that M. tuberculosis seems to 
have, in comparison to other bacteria, a rather unusual genome variation and evolu-
tion. Of note was the presence of a large number of related genes with high Guanine 
and Cytosine (GC) content which were also highly repetitive and have undergone a 
clonal expansion in the genome resulting in a high genomic occupancy. These genes 
were later described as the pe/ppe genes, so denoted by a conserved proline-glutamic 
acid or proline-proline-glutamic acid in the protein coding sequence. These genes are 
unique to the mycobacteria, and certain sub-families are unique to the pathogenic 
mycobacteria. Furthermore, no plasmids were found in the genome as well as what 
seems to be a complete lack of recent homologous gene transfer. With the inclusion of 
more genomic sequences it also became apparent that M. tuberculosis has a regional 
restriction where strains can be grouped by geographical location.
The second major point from the genomic revolution was the identification of a new 
protein secretion system, named the type VII secretion system in accordance with the 
nomenclature used in the Gram-negative bacteria (32). A handful of these secretion 
systems, also called ESX, are present in M. tuberculosis. This system was shown to be 
linked to the highly repetitive pe/ppe genes and responsible for secreting their protein 
products (33). Sequencing of the non-pathogenic M. smegmatis genome revealed that 
they were highly abundant only in pathogenic mycobacteria and the two major sub-
families of these proteins, i.e. the PE-PGRS and PPE-MPTR proteins, were not present 
in M. smegmatis. In addition, two members of the type VII secretion system, namely 
ESX-2 and ESX-5, are not present in this saprophyte either (34). Protein secretion sys-
tems allow bacteria to interact with their environment. The presence of unique systems 
in the pathogenic mycobacteria and this discrepancy between a major pathogen and 
a non-pathogenic counterpart is therefore a major topic of investigation. It was later 
found by Abdallah et al that the PE-PGRS and PPE-MPTR proteins are secreted by the 
ESX-5 system (33). The picture of M. tuberculosis type VII secretion was starting to take 
shape at this point where a unique method of secretion has developed to secrete a large 
family of unique proteins. These factors should assist the bacterium in one way or 
another to either cause disease or survive within its environment. While many theories 
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surrounding the role of these proteins have been proposed, none of them have as of 
yet been accepted as a definitive function (35). The main problem is simply the large 
number of members in the PE-PGRS and PPE-MPTR protein families. In addition, these 
genes and their protein products have peculiar characteristics that make their analysis 
complicated, including very high GC content of their genes, which makes them prob-
lematic for standard Illumina sequencing, and a very high amount of glycine residues, 
which is also challenging for proteomics and structural analysis. The function of PE/
PPE proteins, and by extension the PE-PGRS/PPE-MPTR proteins, is therefore largely 
unknown. It is however hypothesised that these proteins play an important role in the 
modulation of the host response either by direct interaction with host processes or by 
interacting with the immune system. Indeed, some PE-PGRS proteins from M. mari-
num have been implicated in virulence and granuloma formation (36), while others 
mediate host cell apoptosis, cytokine secretion and induction of necrosis (37,38). In 
2018 Ates et al discovered that secretion of these proteins were controlled by a single 
protein, PPE38. To add to the confusion, deletion of this protein occurs naturally in a 
number of circulating isolates, including the highly virulent Beijing strains (39). This 
called into question how important these proteins were to M. tuberculosis and forms the 
basis of the major investigations of this thesis.
sHoTGuN GENoMIcs AND PRoTEoMIcs
In this thesis, genomics; proteomics and a combination of the two, known as prote-
ogenomics, have been implemented in multiple projects. These techniques form a 
central theme in the work presented here and each of these technologies will be briefly 
discussed in this section.
DNA forms the basis of all living organisms and acts as the storage for all structural 
and functional information of a cell. The central dogma of molecular biology dictates 
how information is processed in a living organism. The central dogma states that the 
primary information flow in a cell starts at DNA which is transcribed to RNA which in 
turn is translated to proteins. It is possible for RNA to be reverse transcribed to DNA, 
however once RNA has been translated to proteins the information is committed. Each 
step of the central dogma has associated regulatory mechanisms which increase in 
complexity as information moves from DNA to proteins. Genomics and proteomics has 
revolutionised the biological sciences by allowing unprecedented insight into cellular 
physiology at the molecular level. The field of genomics is concerned with studying the 
total genetic make up of a given organism, which provides information on evolution 
and traits of that organism. Proteomics is concerned with studying how the genetic ma-
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terial is used to react to the environment and drive cellular function. Figure 1 serves to 
illustrate the importance of viewing a system within the correct context. There clearly 
exists a disparity between the genetic material and the proteins they encode. The 
genome may thus not provide the best surrogate for the function of the proteins and 
vice versa. To investigate the genome and proteome on a systems or high-throughput 
level, shotgun techniques are currently favoured. The shotgun sequencing technique 
minimises the initial complexity by breaking the DNA strands or proteins into smaller 
components, namely 100 bp reads or peptides. These are subsequently sequenced and 
reassembled by aligning the fragments to a reference. In the following paragraphs 
we will briefly describe shotgun genome sequencing and proteomics as well as the 
benefits of combining these two technologies in a cross-platform approach.
Genomics
Illumina sequencing is currently leading the genome sequencing market due to the 
high quality reads and high sequencing capacities which cannot yet be matched by 
long read sequencing technologies. However the contigs that are formed by short 
reads tend to fail in regions with duplicated genes or repetitive elements. This is es-
pecially problematic in the pe/ppe genes which are clonal expansions of one another 
and contain highly repetitive elements and are often discarded from analysis for this 
reason. Shotgun sequencing data can be analysed either through reference assembly, 
de novo assembly or a combination of the two can be used when called for. Reference 
assembly or reference mapping relies on a known reference sequence that has often 
been generated and completed by de novo assembly. Multiple paired or unpaired reads 
can align and the more reads that align the greater the confidence of variant calls in 
that region. The advantage of reference assembly is that variants that depend on a 
figure 1: The strengths and weaknesses of genomics and proteomics.
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“parent” genome can be detected, such as single nucleotide polymorphisms, deletions, 
insertions, etc (Figure 2, top left). The disadvantage of using a reference sequence is 
that alignment can fail in highly repetitive regions. In addition, reference assembly 
suffers from the so called reference bias. As reference sequences are often arbitrary, a 
single reference might not be indicative of all organisms from that species. Therefore 
features such as novel genes or genetic sequences cannot be detected and form part 
of the “dark genome”. De novo assembly is used when a reference is not available or to 
detect features such as insertions which cannot be detected by reference assembly. 
In de novo assembly reads are aligned based on their overlapping base pairs to form 
contigs and overlapping contigs are aligned to form consensus sequences (Figure 2, 
top right). While de novo assembly can generate large consensus sequences it is rare to 
assemble a full genome completely with short read sequencing. The gaps between con-
tigs are subsequently filled with low throughput techniques such as Sanger sequenc-
ing. As mentioned problematic regions can occur during reference alignment and the 
breakpoints are rarely clear-cut. With single nucleotide polymorphisms this does not 
pose a problem with enough coverage, however with structural variation unresolved 
breakpoints are problematic. To increase resolution, unmapped reads as well as aligned 
figure 2: Reference (top left) and de novo (top right) assembly algorithms. In this thesis a combina-
tion approach (bottom) was used to resolve problematic regions and gain base pair resolution on 
genomic break points.
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reads flanking the structural variation site can be extracted, aligned and combined to 
create a consensus sequence (Figure 2, bottom). This reduces ambiguity and increases 
the resolution of breakpoints. This demonstrates the flexibility within the analysis of 
a genome to gain a variety of information without the need for additional sequencing.
Proteomics
The genome is the blueprint of the cell and contains all the information to create 
the structural and functional processes of the cell. While de novo peptide assembly 
can be done, the technology is not yet mature and most proteomics studies still rely 
on database search strategies. While DNA is made up of four fundamental building 
blocks, proteins are much more complex molecules that can be built from 20 different 
amino acids. Thus the processes involved in shotgun proteomics are not universally 
applicable. As per example, if a protein has few or no trypsin sites, this protein will 
not be detected by tandem mass spectrometry. This can be mitigated by additional 
proteases or complementary studies, but often the problem persists and total coverage 
cannot be guaranteed. Due to this and a multitude of other reasons the peptide spectral 
matches achieved by proteomics have a much lower efficiency (~35-45%) than genome 
alignment scores (95%-98%). Nonetheless a standard workflow for shotgun proteomics 
has been consolidated as shown in figure 3.
figure 3: The label-free proteomics sample preparation workflow.
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Briefly, total proteins are extracted from cells and the disulfide bonds are reduced and 
irreversibly alkylated. This creates a stable, soluble, unfolded protein which exposes 
all the amino acids to a protease. The irreversible alkylation of the S-H groups found 
in cysteine with iodoacetamide causes the formation of carboxyamidomethylcysteine 
which in turn causes a cysteine mass shift from 103.01 Da to 160.03 Da. This mass shift 
has to be accounted for and included in the database search algorithms. Reduction and 
alkylation is followed by digestion of the linear proteins to peptides by a protease. In 
the majority of cases, trypsin can be used which will proteolytically cleave at lysine 
and arginine. If needed, additional enzymes can be added to increase sequencing ef-
ficiency. The peptides are separated by reverse phase chromatography on C18-silica 
to reduce the complexity of samples that enter the mass spectrometer. As the Thermo 
Scientific range of mass spectrometers were used in this study, the rest of this over-
view will be in line with their machines. It is important to note that other vendors 
may offer other options and other technologies in this space. Molecules that are able 
to ionise will enter the mass spectrometer filtered for neutral as they pass past the 
active beam guide to reduce noise. Ions enter the quadrupole mass filter for precursor 
ion selection. Selected ions are moved to the ion routing multipole, which performs 
high energy collisional dissociation to fragment precursor ions. These fragmented ions 
are focussed in the C-trap and sent to the orbitrap mass analyser for high resolution 
identification. This process is repeated every 3 seconds until the chromatography has 
concluded. This outputs mass/charge data that is matched to theoretical spectra which 
has been generated from a six frame translation of a reference genome. The peptide 
false discovery rates are computed and proteins are assembled following the principles 
of parsimony. This yields expression data which can be compared using statistical 
techniques depending on the type of experiment done.
Mass spectrometry-based proteomics identifies and assigns abundance on an atomic 
basis. This allows for powerful labelling techniques which greatly increase both the 
accuracy and the types of experiments that can be performed. Label-free proteomics is 
commonly used for differential expression as modern data analytics techniques along 
with high resolution mass spectrometry provide adequate accuracy for analysis. In this 
technique two conditions are analysed separately and their profiles are combined in 
the data analysis steps. The number and complexity of each processing step detailed in 
Figure 4 increases the technical variability in the experimental setup which decreases 
the accuracy (Figure 4). However, label-free experiments require no special reagents 
and yield the greatest number of identifications compared to labelled techniques. 
Chemical labelling of the peptides can be done using tandem mass tags or iTraq labels. 
These tags are either added at the protein level to find protease sites or at the peptide 
level for highly accurate quantification. This is achieved by decreasing variability but 
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requires additional fragmentation for optimal sequencing which decreases the num-
ber of proteins that can be identified through increase in cycle times (Figure 4). Finally 
metabolic labelling is the most accurate as the proteomes of organisms are labelled 
prior to experimentation. Thus the majority of variability is biological as all samples 
are processed together. Additional techniques such as protein turnover and protein 
synthesis can be tracked using metabolic labels as well. This approach increases the 
complexity of the sample analysed and halves the identification rate. Dynamic exclu-
sion will prevent repeated sequencing of the same precursor, but with SILAC labels, 
there are two separate precursors for the same proteins.
Most studies utilising proteomics are concerned with detection as well as abundance of 
proteins. However, many more advanced processes can be studies using proteomics as 
the core technology. These include localisation studies such as localisation of organelle 
proteins by isotope tagging (LOPIT), detecting proteases using terminal amine isotopic 
labelling of substrates (TAILS), post-translational modifications (PTM), protein turn-
over, complex formation and more. Proteomics is thus a powerful and rapidly expand-
ing technique which is likely to form the basis of more technologies in the near future.
figure 4: Techniques and basic workflow available in quantitative mass spectrometry namely, label 
free (left), chemical labelling with isobaric tags (middle) and metabolic labelling with heavy lysine 
and arginine (right).




If the genome is a list of all the instruments then the proteome is the orchestra.-R. 
Simpson.
This quote elegantly described how genomics and proteomics is utilised by cells in their 
system wide biology. It also illustrates that one is dependent upon the other. Proteoge-
nomics combines genome sequencing and proteomics to gain the maximum amount of 
information from a cell. Specifically, proteogenomics is often used to identify hidden 
and unique features in a non-model organism’s genome and proteome which would be 
unachievable using either genomics or proteomics alone. These include novel proteins 
and protein isoforms, allele abundance, organism-specific mutations and gene fusions 
(Figure 5). Proteogenomics is studied by sequencing a target organism and identify-
ing variation from the reference or assembling a new consensus genome. The open 
reading frames are found and translated in six frames to create an organism-specific 
proteome. This proteome is used as the template for theoretical spectra during mass 
spectrometry database searches. It is also possible to identify the variants as compared 
to the reference and concatenate the new altered amino sequence to an existing pro-
tein reference. The altered sequences can be retrieved with a unique ID for database 
searches without and will not significantly affecting the false discovery rate (40).
figure 5: Combination of genomics and proteomics can be done computationally in order to detect 
unique or novel genetic elements such as gene fusions.
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The omics technologies are clearly powerful and can be used in creative ways to in-
vestigate the systems biology of an organism that has not been possible until recently.
EVoLuTIoN of MycobAcTERIuM TubERcuLosIs.
The genus mycobacteria consists of approximately 170 species of which most are sap-
rophytic (41). A number of these saprophytic mycobacteria can cause disease under 
optimal circumstances such as an immunocompromised host, but are either free-living 
microbes or adapted to a specific animal host, such as M. marinum, M. abscessus or M. 
avium. These are typically referred to as non-tuberculosis mycobacteria (NTM’s) and 
distinct from the human-adapted mycobacterial species known as the M. tuberculosis 
complex (MTBC). The MTBC contains the major human pathogens such as M. tubercu-
losis and M. leprae which have no external reservoir and are dependent on a host for 
survival and propagation. These mycobacteria likely arose through clonal expansion 
of a smooth tubercle bacilli progenitor (42). The MTBC can be further sub-divided into 
the human-adapted strains and the animal-adapted strains, where the animal adapted 
strains likely branched off from M. africanum.
Transition from environmental saprophyte to human pathogen
The evolution of soil or free-living mycobacteria to those dependent on mammalian 
hosts may have been a sequential phenomenon. A current hypothesis proposed by 
Neyrolles et al and discussed further by Gagneux et al is the emergence of pathogenic 
mycobacteria through predation of ancestral mycobacteria by free-living protozoa (43). 
In this scenario, organisms such as amoeba would feed on bacteria, however certain 
bacteria would survive and utilise the intracellular environment as a source of nutri-
ents. This has been indicated by experimentation where multiple NTM strains are able 
to not only survive internalisation by Acanthamoeba, but actively multiply and increase 
in virulence with each passage (44,45). It is further suggested that through the sharing 
of genetic material between free-living and mycobacteria within a transition state, the 
ability to survive internalisation by these protozoa was transferred. Indeed a genomic 
island found in M. avium is responsible for the ability of this mycobacteria to survive 
within human macrophages as well as Acanthamoeba (46). This specific genomic island 
is unique to M. avium and likely originates from environmental proteobacteria (44).
It is tempting to speculate that a chain of events could occur where early ancestors 
to pathogenic mycobacteria were preyed upon by protozoa and through horizontal 
gene transfer acquired the ability to survive predation and thrive within the intracel-
lular environment. The more these bacteria multiplied, the more they adapted to an 
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intracellular lifestyle and eventually gained the ability to survive within more complex 
organisms such as fish (M. marinum), birds (M. avium), amphibians (M. xenopi) and 
mammals (M. tuberculosis, M. leprae, M. bovis).
Absence of horizontal gene transfer in the MTbc
While the sharing of DNA between individuals may have given rise to the pathogenic 
mycobacteria, this ability was not maintained in the MTBC. The lack of horizontal gene 
transfer has important consequences for the evolution of bacteria. This is illustrated 
by the difference between vertical (parent to child) evolution and lateral (horizontal 
gene transfer) evolution (Figure 6). Vertical asexual evolution, as occurs in bacteria, 
is the movement of DNA through cloning from parent to child. Thus any changes that 
occur are on a small scale through mutation of the genome. Alternatively, horizontal 
gene transfer is the movement of DNA between organisms and is facilitated by either 
transformation, conjugation or transduction (Figure 6). This allows organisms within 
a niche to share DNA and thus functionality in its entirety. Through a combination of 
vertical evolution and horizontal gene transfer, bacterial organisms can acquire new 
genetic traits in a de novo fashion while remaining nimble in a dynamic environment 
figure 6: Evolution through reproduction. Vertical evolution transfers genetic information from a 
parent to child. This can occur through meiosis and chromosome cross over in eukaryotes (top 
left) or through clonal reproduction as seen in prokaryotes (top right). Genetic material can also 
be shared between organisms and is named horizontal gene transfer (bottom). Horizontal gene 
transfer is mediated through three main processes, namely conjugation, phage transduction or the 
uptake of free DNA.
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through lateral DNA sharing. The acquisition of a number of bacterial traits have 
been attributed to horizontal gene transfer. Examples include traits such as antibiotic 
resistance (47), novel metabolic pathways (48), pathogenesis (49), translation (50) and 
more. DNA sharing is an important mechanism that introduces a significant amount of 
variation into the genome and is a cornerstone of evolution in the absence of sexual re-
production. Indeed the MTBC has undergone a clonal expansion to give rise to multiple 
strains of M. tuberculosis. In turn, these strains have further diversified in a restricted 
capacity to give rise to clades which are restricted by geographical location or adapted 
to animals. Interestingly, the lack of horizontal gene transfer is only found within 
the MTBC and the NTM’s are still able to share DNA between different species. In M. 
tuberculosis the ESX-1 type VII secretion system has a major role in pathogenesis and 
the ESX-4 system is likely inactive. However the same systems are used for horizontal 
gene transfer between M. smegmatis and genetically distinct organisms (51) as well as 
receiving DNA (52). It is thus clear that at least some of the horizontal gene transfer ele-
ments have been repurposed for pathogenesis in the MTBC while still active in NTMs.
Without horizontal gene transfer, the mechanisms available to the MTBC to evolve are 
limited to parent to child evolution, which is less efficient when there is no crossing 
of chromosomes as seen in sexual reproduction. Effectively, evolution in the MTBC 
is limited to the DNA currently present within the bacteria. Thus changes can occur 
through mutations such as single nucleotide polymorphisms, deletions or duplications 
but acquiring novel genes and therefore novel functions are either not possible or 
the process surrounding it is not currently known. This is solved by horizontal gene 
transfer in other organisms. Nevertheless, M. tuberculosis is capable of surviving the 
host response and has seemingly adapted to the host directly as evidenced by the 
geographic restrictions of different clades primarily detected through conserved dele-
tions. Single nucleotide polymorphisms also play a prominent role in the evolution of 
M. tuberculosis, specifically in the acquisition of drug resistance (53–56), through the 
use of an error prone polymerase (57). In this thesis we also discuss the use of gene fu-
sions as an additional mechanisms of evolution which allows for the de novo biogenesis 
of genes in the absence of horizontal gene transfer (58).
The lack of horizontal gene transfer in M. tuberculosis is a fascinating topic with im-
portant implications to the continued evolution of M. tuberculosis. Indeed the loss of 
horizontal gene transfer likely resulted as a transition from NTM to MTBC where there 
are little to no other bacteria present in the same niche and bacterial processes can 
be compensated for by the host. This is seen in intracellular symbiotes, such as mito-
chondria, where the bacteria loses most of its genome and functionality and provides 
the host with a dedicated process. Perhaps the loss of horizontal gene transfer in the 
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MTBC would not have occurred if these organisms were not obligate pathogens, and 
are therefore not as restricted in their evolution or pathogenicity as it may seem.
bAcTERIAL cELL wALLs
Bacterial species can be divided into two broad categories based on their cell wall, 
namely Gram-positive and Gram-negative bacteria. This nomenclature is given based 
on the so-called Gram stain developed by Hans Christian Gram. Through the Gram 
stain, the physical properties of a bacterial cell wall can be described. Gram-positive 
bacteria will retain crystal violet dye due to a thick peptidoglycan layer. Gram-negative 
bacteria do not retain the dye, due to the thin peptidoglycan layer, and are only visual-
ized by a pink counterstain (59). The Gram-positive cell wall contains an inner phos-
pholipid membrane that divides the cytosol from a thin periplasmic layer. The thick 
peptidoglycan layer also contains teichoic and lipoteichoic acids that act as chelating 
agents and are further connected by D-D transpeptidase to form a rigid cell wall (Figure 
7A, top left). In contrast to the Gram-positive cell wall, the Gram-negative cell wall 
has two lipid bilayers. The inner membrane is followed by a large periplasmic space 
which contains the thin peptidoglycan layer. This is followed by the outer membrane 
which has lipopolysaccharides on the surface (Figure 7, bottom). The mycobacteria 
figure 7: Composition of bacterial cell walls, including Gram-positive (top left), Mycobacterial cell 
wall (top right) and Gram-negative (bottom).
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phylogenetically belong to the high GC Gram-positive bacteria, however these bacteria 
have characteristics belonging to the Gram-negative bacteria. The M. tuberculosis cell 
envelope has a cytoplasmic phospholipid membrane as well as a thin peptidoglycan 
layer, similar to the Gram-negatives. This is followed by a unique arabinogalactan layer 
and a mycolic acids layer, which is capped by surface lipids and a capsule like structure 
(Figure 7, top right). Because the composition of the second membrane is unique and 
because mycobacteria phylogenetically belong to high GC Gram-positive bacteria we 
have to conclude that the evolution of this second membrane was independent and 
therefore an example of convergent evolution.
From the cell wall composition, it becomes apparent that the needs of the Gram-positive 
and Gram-negative bacteria for protein secretion are radically different. Specifically, 
the Gram-positive bacteria only have one hydrophobic phospholipid membrane and 
thus has a lower barrier for protein secretion. The Gram-negative bacteria have a dual 
layer phospholipid membrane which unsurprisingly requires specialised systems to 
secrete proteins to the outer membrane. The mycobacteria have a diderm cell envelope 
and therefore require a specialized protein secretion system. As the inner membrane 
is present in all living organisms, the systems in place to secrete proteins across this 
membrane is highly conserved and shared across all organisms, including M. tuber-
culosis. These are namely the general secretory pathway (Sec) and twin arginine path-
way (Tat) and are responsible for secreting unfolded and (partially) folded proteins, 
respectively (Figure 8A). The Sec system can be further split into the SecB-dependent 
pathway, the signal recognition particle (SRP) pathway and in some organisms the 
SecA2 pathway, where the SecB-dependent pathway secretes proteins to the periplasm 
and the SRP pathway deposits proteins in the plasma membrane (Figure 8B).
figure 8: Schematic representation and basic functionality of the conserved sec (left) and tat (right) 
secretion systems. The sec and tat system facilitates transport across the inner cell membrane if two 
membranes are present. The sec system secretes unfolded proteins while the tat system is able to 
secrete folded proteins.
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As mentioned, Gram-negative bacteria require specialised secretion systems to trans-
port proteins to the outer membrane. There are currently 9 known secretion systems 
found in the Gram-negative bacteria to suit this purpose, named Type I secretion 
system (T1SS) to type IX secretion system (T9SS) with the T4SS found in both Gram-
positive and negative bacteria (60). Of these systems, the majority spans the inner and 
outer membrane, the exception is the T5SS which is only found on the outer membrane 
(Figure 9). Both the T5SS and the T2SS rely on the sec/tat secretion system to mediate 
secretion while the rest of the systems utilise a single step mechanism. Each of the 
systems are clearly structurally distinct, reflective of their function in the cell. Finally 
the T3SS and T4SS are able to interact with another cell by spanning the inner and 
outer membrane and injecting substrates into a host cell. T8SS forms the extracellular 
nucleation-precipitation pathway and is suggested to be involved in the production of 
adhesive fibres on the surface of pathogenic bacteria. These fibres are likely used for 
interaction with the host or biofilm formation (61,62). The T9SS also known as the Por 
secretion system is involved in gliding motility by secretion of cell surface motility 
adhesins (63). The composition of the bacterial cell wall clearly has a major effect 
on evolution of the secretion systems based on the physical requirements. Multiple 
specialised secretion systems evolved in the Gram-negative bacteria to compensate for 
the secondary outer membrane. The mycobacterial cell wall is unique, as it does not 
fall within the Gram-positive or negative category. The cell wall is best described as a 
Gram-positive cell wall with some Gram-negative traits such as an outer cell envelope 
figure 9: Composition and basic functionality of the secretion systems in the Gram-negative bacte-
ria. The secretion systems are designated type I secretion system (T1SS) to type IX secretion system 
(T9SS). T1SS, T2SS, T3SS, T4SS and T9SS spans the inner and outer membrane.
30
(64). The mycobacteria therefore require specialised systems to facilitate the move-
ment of proteins across the membrane. While outer membrane proteins are present 
in the mycobacteria, the method by which proteins are secreted to the extracellular 
milieu is still unknown. The type VII secretion system is a specialised secretion system 
first identified in the mycobacteria which may fulfil this role and is further discussed 
below.
Type VII secretion systems
The type VII secretion system was first discovered in the mycobacteria and after this 
discovery, variants of this system have been identified in other Gram-positive bacteria 
as well (65). This secretion system consists of a maximum of five loci and this number 
varies by species. The loci are named ESX1 to ESX-5 and are clonal expansions of each 
other where ESX-4 was likely the original system and ESX-2 and ESX-5 the most recent 
(66). This results in each system sharing specific core components as well as variable 
components across the homologs in the same genome. Each type VII loci is thus ca-
pable of a different function in the mycobacteria, depending on the species as well as 
the system (Figure 10).
The core components are comprised of the ESX conserved components (Ecc) ranging 
from EccA to EccD and MycP, with EccE present in all ESX systems except ESX-4, and 
MycP (32). Other non-secretory and non-conserved components include the ESX-spe-
cific proteins (ESP) and finally secreted components which are either small proteins 
such as EsxA and EsxB and the PE/PPE proteins (32). The secreted proteins of this 
system can also be seen as the effectors of the secretion system. This genetic basis of 
the T7SS has provided the first picture of how the secretion machinery would operate 
in M. tuberculosis. Importantly, this secretion system facilitates secretion through the 
inner membrane with an unknown mechanism secreting proteins through the second-
ary capsule layer. To consolidate this picture of the T7SS crystal structures of the ESX-5 
and ESX-3 systems have been resolved recently (67–69). Through these endeavours a 
clearer picture of the Type VII secretion system, based on the conserved components, 
has emerged. In the current view, EccC is the pore and operates the active transport 
of effectors across the membrane by hydrolysing ATP. This hydrolysis is mediated by 
ATPase domains which undergo a conformational change in response to a substrate 
binding and opening the pore and allowing secretion (67).
Of the five type VII secretion systems, only ESX-1, -3 and 5 have known functionality. 
ESX-1 is responsible for secreting the major virulence factors ESAT-6 and CFP-10 and 
has been implicated in multiple aspects of pathogenesis and is the subject of multiple 
studies (70–75). ESX-3 is involved in nutrient uptake, specifically iron and heme uptake 
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(76,77). The most relevant to this thesis is the ESX-5 system, which is only found within 
the pathogenic mycobacteria; ESX-5 is essential for growth, is involved in carbon up-
take and secretes a family of unique proteins named the PE/PPE proteins (33,39,78).
The PE/PPE proteins
While the ESAT-6 and CFP-10 proteins are the most well-studied virulence factors of the 
type VII secretion system, this thesis focuses on the less well-studied PE/PPE proteins 
secreted by ESX-5. The PE/PPE proteins are characterised by an N-terminal containing 
a proline-glutamic acid motif (PE) or a proline-proline-glutamic acid motif (PPE). These 
protein families as a whole are found within both pathogenic and non-pathogenic my-
cobacteria. Members of the PE/PPE protein family can be separated into sub-groups 
that are restricted to either the pathogenic or non-pathogenic mycboacteria (79). The 
figure 10: Current known structure of the T7SS. This structure is extrapolated from the T7SS found 
in M. xenopi. The T7SS is further divided into 5 different loci in the pathogenic mycobacteria named 
ESX-1 to ESX-5 secretion system. The ESX-5 T7SS is unique to the pathogenic mycobacteria and re-
sponsible for the secretion of PE-PGRS and PPE-MPTR proteins.
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PE/PPE proteins can be further divided into sub-families which are characterised by 
the C-terminal domain.
There are six possible configurations of the PE/PPE proteins, three for PE and three for 
PPE, where each configuration represents a sub-family. Both the PE and PPE proteins 
can have a unique variable C-terminal with no clear repeats. The PE proteins can also 
have a polymorphic GC rich sequence (PGRS) domain which is characterised by repeat-
ing GGA/GGN motifs. An N-terminal PE domain can occur as a stand-alone protein 
without a variable C-terminal. In addition to the unique C-terminal, PPE proteins may 
present with one of two types of variable C-terminal domains. The SVP C-terminal do-
main is characterised by the presence of a GGXSVPXXW motif. The major polymorphic 
tandem repeat domains (MPTR) are characterised by a repeating NXGXGNXG motif in 
the C-terminal (Figure 11). The secretion of both the MPTR and PGRS domains is medi-
ated by PPE38, a SVP protein which is close to the MPTR family in sequence homology 
(80).
The PE/PPE proteins are secreted in pairs, where a PE protein will pair with a PPE 
proteins, in a four helical bundle (81). The secretion signal for the PE/PPE proteins is 
located in the C-terminal of the PE proteins and is characterised by a YxxxD/E domain 
following a helix-turn-helix (82,83). This YxxxD/E domain is not found in the PPE pro-
figure 11: The PE/PPE proteins and the associated sub-families. The PE proteins are sub-divided 
into proteins that contain either a PE domain, a unique C-terminal or a PGRS domain. The PPE 
proteins are sub-divided into members that contain a SVP domain, a unique C-terminal or a MPTR 
domain. The amino acid repeats are depicted within the image. Figure adapted from Sampson et al, 
2011 (reference 35)
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teins, instead a WxD domain is located between the second and third alpha helix in the 
PE/PPE dimer (83). It has been proposed that the WxD and YxxxD/E domain interact 
to form a singular signal that mediates secretion through the ESX-5 system (83,84). 
In addition the PPE proteins has a chaperone interacting domain that binds the EspG 
protein associated with the specific secretion system (70,85). Together these proteins 
from a secretion complex that is further facilitated by PPE38 and secreted to the cell 
surface. It has further been shown that the PE-PGRS proteins can be cleaved from the 
PE domain by a novel protease, PecA. This confirms that the PGRS proteins are not 
only able to interact with the host cytosol in its immediate proximity but also able to 
circulate independently from the bacterial cell.
M. tuberculosis has 4173 genes of which 169 are dedicated for PE/PPE production. From 
these 169 genes, a total of 64 proteins encode the PE-PGRS proteins and 22 PPE-MPTR 
proteins. Previous computational studies has suggested that 825 proteins are secreted 
in M. tuberculosis H37Rv (86). Thus the 86 PE-PGRS and PPE-MPTR proteins equate to 
approximately 10% of the total secreted profile and 4% of the total coding potential. 
In a specialised genome, this is a large number of genes dedicated to a single protein 
family. These proteins are clearly important for interacting with the environment 
and while multiple theories have been proposed, a unified function has not yet been 
discovered.
HosT PATHoGEN INTERAcTIoNs
Recognition and response of an infected mammalian cell to invaders is part of the 
innate immune response and conserved across all mammalian species. Specialised 
cells such as antigen presenting cells recognise pathogen associated molecular pat-
terns (PAMPs) through specialised receptors known as pathogen recognition receptors 
(PRR’s). In a facultative intracellular organism like M. tuberculosis the ESX-5 system and 
its effectors, the PE-PGRS and PPE-MPTR proteins, are obvious candidates as PAMPs as 
they are unique to pathogenic mycobacteria (79). However, by abolishing the secretion 
of these proteins through PPE38 or by blocking the ESX-5 system, a hypervirulence 
phenotype is observed (39,87).
In this thesis we also investigate the macrophage response to ppe38 and here we will 
briefly introduce the most important immune signalling pathways involved. The innate 
immune system acts as the first barrier to invading organisms such as pathogenic bac-
teria or viruses. After activation of the innate immune system, the adaptive immune 
system will initiate, which occurs approximately four to seven after infection (88). 
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The innate immune system consists of multiple specialised cells, of which each has 
their own dedicated process (Figure 12) (89). After inhalation of M. tuberculosis the 
first encounter between the bacilli and the innate immune system is engulfment of 
bacteria by specialised alveolar macrophages (90–92). These macrophages will attempt 
to eliminate the invading bacilli by reactive oxygen stress, nitrogen stress, nutrient 
depletion and acidification (93). M. tuberculosis has multiple mechanisms in place 
to survive these initial innate immune defences. During this process inflammatory 
chemokines and cytokines are released which attracts additional immune cells and 
subsequently activates these cells (94). This inflammatory environment can overwhelm 
the M. tuberculosis bacilli in some individuals and clear the infection, in others PAMPs 
from the invading pathogen will be presented to naïve T-cells via antigen presenting 
cells, such as dendritic cells (DC), through interaction with major histocompatibility 
complex (MHC) (95). These T-cells can activate and initiate adaptive immune responses 
which can either clear or contain the bacilli. During chronic M. tuberculosis infection 
the bacilli resides mainly in DC cells in the lung interstitium (96,97). This containment 
can either result in the formation of dormant M. tuberculosis, leaving an individual 
asymptomatic but still infected or the bacilli can continue aggressive infection result-
ing in cavitation of the lung (98). In this thesis we investigate the initial response to the 
figure 12: Immune cells associated with the innate immune system. Hematopoietic cells can give 
rise to either lymphoid (adaptive immunity) or myeloid progenitor cells (innate immunity). The my-
eloid cells can further differentiated into various cell types with diverse functions in combatting 
pathogens.
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PE-PGRS and PPE-MPTR proteins using a model human macrophage to stand in for 
alveolar macrophages. Therefore the potential signal recognition pathway and direct 
molecular response mediated by the macrophage in response to PE-PGRS and PPE-
MPTR proteins will be introduced here.
M. tuberculosis is recognised by the toll like receptors (TLR) present on the macrophage 
surface and within the cell (Figure 13). The TLR’s involved are likely TLR2, TLR4 or a 
combination of the two (99,100). The TLRs, as well as most other pathogen recognition 
receptors initiate a signalling cascade that signal through the nuclear factor kappa B 
(NF-kB) pathway (101). This pathway controls the transcription of pro- and anti-inflam-
matory genes and is thus tightly regulated to avoid over and-/or under stimulation of 
the innate immune response on a fundamental level. This is achieved with various 
combinations of stimulators, inhibitors and post-translational modifications (102). 
Ultimately the NF-kB pathway ends in the translocation of transcription factors to the 
nucleus and depending on the proteins translocated different inflammatory genes can 
be described. There are two multimeric NF-kB proteins, NF-kB1 and NF-kB2. These 
proteins can either be in an inhibitory dimer state or an activated cleaved state. When 
cleaved, the active NF-KB sub-units, NF-kB1 p50 or NF-kB2 p52, can bind to either the 
RelA, RelB or c-REL and upon phosphorylation this NF-kB/Rel dimer will translocate to 
figure 13: Simplified Illustration of the canonical Nuclear factor kappa B signalling pathway fol-
lowing either TLR2 or TLR4 MyD88 signalling pathway. This pathway results in inflammatory bursts 
when triggered by pathogens.
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the nucleus and initiate transcription of target genes. In the case of p50/RelA transloca-
tion, the canonical NF-KB pathway is stimulated and the major pro-inflammatory cy-
tokine, Interleukin 1 beta (IL-1B), is transcribed and translated to pro-IL1B. In the pro 
form IL-1B is still inactive and activation occurs upon cleaving by the inflammasome. 
IL-1B is subsequently activated and secreted to stimulate the activation of other im-
mune cells. This process can compound and create a cascading inflammatory response 
to control infection and has been reviewed in depth (102–106).
While the immune system is complex and multiple intertwined processes are in place 
to combat invading pathogens, it can still be overcome. How M. tuberculosis overcomes 
the immune system is still not well understood, it is however certain that the bacilli has 
evolved numerous strategies for this purpose.
scoPE of THE THEsIs
chapter 2 describes the testing of a variant of auxotrophic, severely attenuated mutant 
of M. tuberculosis (SAMMtb) as a substitute for virulent M. tuberculosis in laboratory 
study. This auxotroph is deficient in leucine and panthethonate biosynthesis as a result 
of disruption of the leuD and panCD genes. Part of this investigation involved the test-
ing of SAMMtb in response to acidic stress using label-free proteomics. This forms the 
basis of our investigation into M. tuberculosis systems biology. We further found that 
SAMMtb has a greater sensitivity to cellular stress than wild type M. tuberculosis.
chapter 3 directly follows on chapter 2 where SAMMtb proteome dynamics in re-
sponse to acid stress is characterised by taking advantage of the leucine auxotrophy. 
By exploiting the uptake of leucine, stable isotopes of leucine can be fed to the bacilli 
and incorporated into the proteome using a technique called stable isotope labelling 
of amino acid in cell culture (SILAC). Metabolic labelling has distinct advantages 
over label-free workflows and allows for accurate quantitative proteomics as well as 
advanced mass spectrometry analyses such as protein turnover and quantitative post 
translational modifications. We exposed SAMMtb to acidic stress over a 24h time pe-
riod and characterised the protein expression, phosphorylation and protein turnover 
to gain a high level understanding of the M. tuberculosis response to common stressors. 
This is the first systems level analysis of a typical M. tuberculosis stress response that 
integrates multiple levels of proteome in a fully quantitative manner. Here we found 
that SAMMtb is more prone to enter dormancy and shutdown amino acid transport in 
response to acid stress. We further see an upregulation of type VII secretion compo-
nents as well as effectors of the ESX-1 being dynamically phosphorylated.
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chapter 4 investigates the evolution of M. tuberculosis by using genomics and pro-
teomics in a cross-platform omics approach. The M. tuberculosis genome is highly 
specialised due to genomic decay, the lack of horizontal gene transfer and competitive 
co-evolution. This chapter further investigates type VII secretion and introduces the 
ppe38-ppe71 mutation in M. tuberculosis. This mutation abolishes PE-PGRS secretion and 
has been found in the highly virulent lineage two isolates of M. tuberculosis. Initially we 
aimed to develop a genome processing pipeline that is able to identify deletions in the 
pe/ppe regions in clinical isolates of M. tuberculosis and to ultimately use this pipeline to 
identify the ppe38-ppe71 deletions. In the development of this software we could resolve 
the breakpoints with some accuracy and noticed that open reading frames can fuse and 
reform proteins. We subsequently demonstrated that fused and unfused versions of the 
ppe38-ppe71 mutation can be found in clinical isolates of M. tuberculosis and the fused 
genes complement PE-PGRS secretion. The protein products of these gene fusions are 
known as chimeric proteins and have an evolutionary implication for M. tuberculosis. 
We therefore further developed our genomics pipeline to discover more gene fusions 
specifically by combining reference assembly to identify multigene deletions and de 
novo assembly to find the breakpoints automatically. The consensus sequence from 
the de novo assembly was used in six frame translations and the amino acid sequences 
was added to a proteomics reference database if the N – and C-terminal of the chi-
mera correspond to the two parent proteins. Using this methodology we could identify 
multiple known chimeras and one unknown chimeric protein. The presence of gene 
fusions in the mycobacterial genome is especially intriguing as there is no horizontal 
gene transfer. By forming gene fusions the bacilli is able to create new proteins from 
existing genetic material instead of relying on environmental DNA like other bacteria.
chapter 5 investigates the ppe38-ppe71 deletion and the lack of PE-PGRS secretion in 
vitro and in human macrophages in an unbiased discovery based shotgun proteomics 
approach. In chapter 4 it became apparent that there is a vast difference between 
clinical isolates of M. tuberculosis and that each sub-lineage is different in their expres-
sion as well. Thus to accurately investigate the ppe38-ppe71 deletion we determined 
the spatial protein expression patterns between wild type and mutant versions of the 
bacilli in a clean genetic background. We found no differences in the protein abun-
dance in the cytoplasm, however this was not the case for the cell wall fraction and 
the secretomes as expected. We could identify a cluster of PE-PGRS and PPE-MPTR 
proteins that will likely drive the macrophage response to infection by each strain. We 
subsequently infected THP-1 macrophages and characterised the changes in protein 
abundance over time as well as the protein turnover using SILAC in response to PPE38 
controlled PE-PGRS and PPE-MPTR proteins. The main finding was the dampened M1 
response when macrophages were infected with ppe38 mutants compared to wild type. 
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We further show that this dampening is mediated by differential translocation of the 
NF-kB and Rel sub-units which in turn results in altered cytokine transcription. We 
finally demonstrate a decrease of either IL12p70 at 48 hours post infection in the super-
natant of THP-1 cells infected with either wild type and complement. Complementary 
to this observation, in the macrophages infected with ppe38-ppe71 mutant we found 
an increase of IL-13. As we found in chapter 4, this has an interesting consequence 
for the virulence for lineage 2 clinical isolates, as these contain a high frequency of 
ppe38-ppe71 deletions and known to mediate an anti-inflammatory response.
chapter 6 describes the use of quantitative proteomics to profile bronchiolar alveolar 
lavage (BAL) fluid from patients infected with tuberculosis. The samples obtained were 
from patients representing an active tuberculosis infection or the lung profile at the 
end of antibiotic treatment. In addition, the retention of live culturable M. tuberculosis 
was determined at the end of treatment and correlated with FDG-PET CT scans. We 
found that 12% of patients from a cohort of 41 retained culturable bacilli at the end 
of treatment and two of these patients eventually relapsed. Strikingly, within the BAL 
fluid proteome of the relapse patient at the end of treatment clustered closer to the 
active TB cohort. These types of clinical samples are rare and we could only procure 
one such sample. This study does however demonstrate the detection of an uncured 
patient by profiling the host immune response while other tests may suggest the indi-
vidual is cured. With more samples and experimentation a less evasive method can be 
developed to screen for individuals that pose such a risk.
chapter 7 describes creation of a cloud-based data analysis platform for proteomics 
and makes the data science and statistics techniques available to the end user without 
the need to rely on automated systems from a service provider. During our investiga-
tion and implementation of various standard and advanced proteomics techniques, 
a major bottleneck was the data analysis. In order to design follow up experiments 
and draw conclusions it was necessary to develop multiple tools and collate them into 
an in-house data analysis platform. In this chapter, we explain the data cleaning and 
statistical quality control methods that were used in this study and the creation of a dy-
namic and reactive dashboard to analyse labelled and label-free proteomics data. This 
dashboard is freely available for use online and contains in-application descriptions 
of the concepts described in this chapter. The aim of this dashboard is to facilitate the 
speed of analysis and without the need for data science, machine learning, statistics or 
programming knowledge required.
In chapter 8 we discuss the results obtained and the concepts investigated in this 
thesis.




 1. Hershkovitz I, Donoghue HD, Minnikin DE, May H, Lee OY-C, Feldman M, et al. Tuber-
culosis origin: The Neolithic scenario. Tuberculosis [Internet]. 2015 Jun [cited 2019 Jan 
15];95:S122–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25726364
 2. Grzybowski S, Allen EA. History and importance of scrofula. Lancet (London, England) 
[Internet]. 1995 Dec 2 [cited 2019 Jan 15];346(8988):1472–4. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/7490997
 3. Barberis I, Bragazzi NL, Galluzzo L, Martini M. The history of tuberculosis: from the 
first historical records to the isolation of Koch’s bacillus. J Prev Med Hyg [Internet]. 
2017 Mar [cited 2019 Jan 15];58(1):E9–12. Available from: http://www.ncbi.nlm.nih.gov/
pubmed/28515626
 4. Laennec RT. A treatise on the disease of the chest, translated by Forbes J [Internet]. New 
York: Hafner publishing company; 1962 [cited 2019 Jan 15]. Available from: https://archive.
org/details/tuberculosistrea00klebuoft/page/n5
 5. Zimmerman MR. Pulmonary and osseous tuberculosis in an Egyptian mummy. Bull New 
York Acad Med J Urban Heal. 1979;55(6):604–8.
 6. Cave AJE, Demonstrator A. The evidence for the incidence of tuberculosis in ancient 
Egypt. Br J Tuberc. 1939 Jul 1;33(3):142–52.
 7. The Story of Clinical Pulmonary Tuberculosis [Internet]. [cited 2020 Nov 24]. Available 
from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1527043/
 8. The Internet Classics Archive | Of the Epidemics by Hippocrates [Internet]. [cited 2020 Nov 
24]. Available from: http://classics.mit.edu/Hippocrates/epidemics.1.i.html
 9. Mason PH. Spitting blood: the history of tuberculosis. Anthropol Med [Internet]. 2014 
Sep 2 [cited 2020 Mar 5];21(3):357–8. Available from: http://www.ncbi.nlm.nih.gov/
pubmed/24963868
 10. Besciu M. THE BYZANTINE PHYSICIANS. Vol. 6, Bulletin of the Transilvania University of 
Braşov •.
 11. Eddy JJ. The ancient city of Rome, its empire, and the spread of tuberculosis in Europe. 
Tuberculosis. 2015 Jun 1;95(S1):S23–8.
 12. Sylvius F. Opera medica [Internet]. [cited 2020 Jul 10]. Available from: https://books.google.
nl/books?id=vqW3GAF2SuQC&printsec=frontcover&hl=nl&source=gbs_ge_summary_r&c
ad=0#v=onepage&q&f=false
 13. de la boe F. Sylvii Praxeos medicae idea nova, liber primus: de affectibus naturales 
hominis functiones laesas vel constituentibus, vel producentibus, vel consequentibus 
[Internet]. Elsevier. 1671 [cited 2020 Jul 10]. p. 1001. Available from: https://books.google.
nl/books?id=JWYQjnS-f2UC&hl=nl&source=gbs_similarbooks
 14. Roguin A. Rene theophile hyacinthe laënnec (1781-1826): The man behind the stethoscope. 
Vol. 4, Clinical Medicine and Research. Marshfield Clinic; 2006. p. 230–5.
 15. Doetsch RN. Benjamin Marten and his “New Theory of Consumptions.” Microbiol Rev 
[Internet]. 1978 Sep [cited 2019 Jan 15];42(3):521–8. Available from: http://www.ncbi.nlm.
nih.gov/pubmed/362148
 16. Daniel TMT. Jean-Antoine Villemin and the infectious nature of tuberculosis. Int J Tuberc 
Lung Dis [Internet]. 2015 Mar 1 [cited 2019 Jan 15];19(3):267–8. Available from: https://
www.ncbi.nlm.nih.gov/pmc/articles/PMC536441/
40
 17. Budd W. MEMORANDUM ON THE NATURE AND THE MODE OF PROPAGATION OF PHTHI-
SIS. Lancet [Internet]. 1867 Oct 12 [cited 2019 Jan 15];90(2302):451–2. Available from: 
https://www.sciencedirect.com/science/article/pii/S0140673602559559
 18. Opal SM. A Brief History of Microbiology and Immunology. In: Vaccines: A Biography 
[Internet]. Springer New York; 2010 [cited 2020 Nov 24]. p. 31–56. Available from: /pmc/
articles/PMC7176178/?report=abstract
 19. Koch R. Die Ätiologie der Tuberkulose. [Internet]. Berlin; 1882 [cited 2019 Jan 15]. Available 
from: https://edoc.rki.de/bitstream/handle/176904/5163/428-445.pdf?sequence=1
 20. Calmette A. L’Infection bacillaire et la tuberculose chez l’homme et chez les animaux, 
processus d’infection et de défense, étude biologique et expérimentale. 1922 [cited 2019 
Jan 17]; Available from: https://gallica.bnf.fr/ark:/12148/bpt6k5746709s.texteImage
 21. Schatz A, Bugie E, Waksman SA. Streptomycin, a substance exhibiting antibiotic activ-
ity against gram-positive and gram-negative bacteria. 1944. Clin Orthop Relat Res. 
2005;437(437):3–6.
 22. Comroe JH. Pay dirt - The story of Streptomycin. Part 1. From Waksman to Waksman. Am 
Rev Respir Dis. 1978;117(4 I):773–81.
 23. Comroe JH. Pay dirt: the story of streptomycin. II. Am Rev Respir Dis. 1978;117(5):957–68.
 24. FELDMAN WH, KARLSON AG, HINSHAW HC. Streptomycin in experimental tuberculosis: 
the effects in guinea pigs following infection in intravenous inoculation. Am Rev Tuberc 
[Internet]. 1947 Oct [cited 2020 Mar 5];56(4):346–59. Available from: http://www.ncbi.nlm.
nih.gov/pubmed/20270482
 25. HOLM J. How can elimination of tuberculosis as a public health problem be achieved. Am 
Rev Tuberc. 1959 May 23;79(5):690–4.
 26. A Timeline of HIV and AIDS | HIV.gov [Internet]. [cited 2020 Nov 24]. Available from: 
https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline
 27. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case 
Definition for AIDS Among Adolescents and Adults [Internet]. [cited 2020 Mar 5]. Available 
from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm
 28. Lawn SD, Bekker L-G, Wood R. How effectively does HAART restore immune responses to 
Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS [Internet]. 2005 
Jul 22 [cited 2020 Mar 5];19(11):1113–24. Available from: http://journals.lww.com/00002030-
200507220-00005
 29. Suchindran S, Brouwer ES, Van Rie A. Is HIV infection a risk factor for multi-drug resistant 
tuberculosis? A systematic review. Vol. 4, PLoS ONE. Public Library of Science; 2009.
 30. Gillespie SH. Evolution of drug resistance in Mycobacterium tuberculosis: Clinical and 
molecular perspective [Internet]. Vol. 46, Antimicrobial Agents and Chemotherapy. Ameri-
can Society for Microbiology Journals; 2002 [cited 2020 Nov 24]. p. 267–74. Available from: 
http://aac.asm.org/
 31. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, 
Gas S, Barry CE III, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, 
Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jage BB. Deci-
phering the biology of Mycobacterium tuberculosis from the complete genome sequence. 
Nature. 1998;393(6685):537–544.
 32. Bitter W, Houben ENG, Bottai D, Brodin P, Brown EJ, Cox JS, et al. Systematic genetic 
nomenclature for type VII secretion systems. PLoS Pathog. 2009;5(10):8–13.
chapter 1  |  General introduction
41
1
 33. Abdallah AM, Verboom T, Weerdenburg EM, Gey van Pittius NC, Mahasha PW, Jiménez 
C, et al. PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the 
type VII secretion system ESX-5. Mol Microbiol [Internet]. 2009 Aug 1 [cited 2019 Apr 
18];73(3):329–40. Available from: http://doi.wiley.com/10.1111/j.1365-2958.2009.06783.x
 34. Houben ENGG, Korotkov K V., Bitter W. Take five - Type VII secretion systems of Mycobac-
teria. Biochim Biophys Acta [Internet]. 2014 Aug;1843(8):1707–16. Available from: http://
dx.doi.org/10.1016/j.bbamcr.2013.11.003
 35. Sampson SL. Mycobacterial PE/PPE proteins at the host-pathogen interface. Clin 
Dev Immunol [Internet]. 2011;2011(Figure 1):497203. Available from: http://dx.doi.
org/10.1155/2011/497203
 36. L. Ramakrishnan, N. A. Federspiel and SF, Ramakrishnan L, Federspiel NA, Falkow S. 
Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich 
PE-PGRS family. Science. 2000 May;288(5470):1436–1439.
 37. Basu S, Pathak SK, Banerjee A, Pathak S, Bhattacharyya A, Yang Z, et al. Execution of mac-
rophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by toll-like 
receptor 2-dependent release of tumor necrosis factor-α. J Biol Chem [Internet]. 2007 Jan 
12 [cited 2020 Jul 10];282(2):1039–50. Available from: http://www.jbc.org/
 38. Dheenadhayalan V, Delogu G, Brennan MJ. Expression of the PE_PGRS 33 protein in My-
cobacterium smegmatis triggers necrosis in macrophages and enhanced mycobacterial 
survival. Microbes Infect [Internet]. 2006 Jan [cited 2015 Jun 23];8(1):262–72. Available 
from: http://www.sciencedirect.com/science/article/pii/S1286457905002595
 39. Ates LS, Dippenaar A, Ummels R, Piersma SR, van der Woude AD, van der Kuij K, et al. 
Mutations in ppe38 block PE_PGRS secretion and increase virulence of Mycobacterium 
tuberculosis. Nat Microbiol [Internet]. 2018 Feb 15 [cited 2018 Mar 6];3(2):181–8. Available 
from: http://www.nature.com/articles/s41564-017-0090-6
 40. Heunis T, Dippenaar A, Warren RM, van Helden PD, van der Merwe RG, Gey van Pittius NC, 
et al. Proteogenomic Investigation of Strain Variation in Clinical Mycobacterium tuberculosis 
Isolates. J Proteome Res [Internet]. 2017 Oct 6 [cited 2018 Feb 27];16(10):3841–51. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/28820946
 41. Fedrizzi T, Meehan CJ, Grottola A, Giacobazzi E, Fregni Serpini G, Tagliazucchi S, et al. 
Genomic characterization of Nontuberculous Mycobacteria. Sci Rep [Internet]. 2017 Mar 
27 [cited 2020 Jul 10];7. Available from: https://pubmed.ncbi.nlm.nih.gov/28345639/
 42. Supply P, Marceau M, Mangenot S, Roche D, Rouanet C, Khanna V, et al. Genomic analysis 
of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Myco-
bacterium tuberculosis. Nat Genet [Internet]. 2013 Feb 6 [cited 2020 Jul 10];45(2):172–9. 
Available from: https://www.nature.com/articles/ng.2517
 43. Gagneux S. Ecology and evolution of Mycobacterium tuberculosis [Internet]. Vol. 16, 
Nature Reviews Microbiology. Nature Publishing Group; 2018 [cited 2020 Jul 10]. p. 202–13. 
Available from: https://www.nature.com/articles/nrmicro.2018.8
 44. Jang J, Becq J, Gicquel B, Deschavanne P, Neyrolles O. Horizontally acquired genomic 
islands in the tubercle bacilli. Trends Microbiol [Internet]. 2008 Jul [cited 2020 Jul 
10];16(7):303–8. Available from: https://pubmed.ncbi.nlm.nih.gov/18515114/
 45. Cirillo JD, Falkow S, Tompkins LS, Bermudez LE. Interaction of Mycobacterium avium with 
environmental amoebae enhances virulence. Infect Immun. 1997;65(9).
 46. Danelishvili L, Wu M, Stang B, Harriff M, Cirillo S, Cirillo J, et al. Identification of Mycobac-
terium avium pathogenicity island important for macrophage and amoeba infection. Proc 
42
Natl Acad Sci U S A [Internet]. 2007 Jun 26 [cited 2020 Jul 10];104(26):11038–43. Available 
from: www.pnas.org/cgi/content/full/
 47. Von Wintersdorff CJH, Penders J, Van Niekerk JM, Mills ND, Majumder S, Van Alphen LB, et 
al. Dissemination of antimicrobial resistance in microbial ecosystems through horizontal 
gene transfer [Internet]. Vol. 7, Frontiers in Microbiology. Frontiers Media S.A.; 2016 [cited 
2020 Jul 10]. p. 173. Available from: www.frontiersin.org
 48. Marri PR, Bannantine JP, Golding GB. Comparative genomics of metabolic pathways in 
Mycobacterium species: Gene duplication, gene decay and lateral gene transfer. FEMS 
Microbiol Rev [Internet]. 2006 Nov [cited 2020 Jul 10];30(6):906–25. Available from: https://
pubmed.ncbi.nlm.nih.gov/17064286/
 49. Juhas M, Van Der Meer JR, Gaillard M, Harding RM, Hood DW, Crook DW. Genomic islands: 
Tools of bacterial horizontal gene transfer and evolution [Internet]. Vol. 33, FEMS Microbi-
ology Reviews. Oxford Academic; 2009 [cited 2020 Jul 10]. p. 376–93. Available from: https://
academic.oup.com/femsre/article-abstract/33/2/376/589749
 50. Tuller T, Girshovich Y, Sella Y, Kreimer A, Freilich S, Kupiec M, et al. Association between 
translation efficiency and horizontal gene transfer within microbial communities. Nucleic 
Acids Res [Internet]. 2011 Feb 22;39(11):4743–55. Available from: https://doi.org/10.1093/
nar/gkr054
 51. Coros A, Callahan B, Battaglioli E, Derbyshire KM. The specialized secretory apparatus 
ESX-1 is essential for DNA transfer in Mycobacterium smegmatis. Mol Microbiol [Internet]. 
2008 Jul 1 [cited 2017 Oct 12];69(4):???-??? Available from: http://doi.wiley.com/10.1111/
j.1365-2958.2008.06299.x
 52. Gray TA, Clark RR, Boucher N, Lapierre P, Smith C, Derbyshire KM. Intercellular commu-
nication and conjugation are mediated by ESX secretion systems in mycobacteria. Science 
[Internet]. 2016 Oct 21 [cited 2017 Oct 12];354(6310):347–50. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/27846571
 53. Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE, et al. Genomic 
analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the 
emergence and spread of multidrug resistance. Nat Genet [Internet]. 2017 Mar 1 [cited 2020 
Jul 10];49(3):395–402. Available from: https://www.nature.com/articles/ng.3767
 54. Coll F, Phelan J, Hill-Cawthorne GA, Nair MB, Mallard K, Ali S, et al. Genome-wide analysis 
of multi- and extensively drug-resistant Mycobacterium tuberculosis. Nat Genet [Internet]. 
2018 Feb 1 [cited 2020 Jul 10];50(2):307–16. Available from: https://www.nature.com/
articles/s41588-017-0029-0
 55. Farhat MR, Freschi L, Calderon R, Ioerger T, Snyder M, Meehan CJ, et al. GWAS for quan-
titative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes 
and regulatory regions. Nat Commun [Internet]. 2019 Dec 1 [cited 2020 Jul 10];10(1):1–11. 
Available from: https://doi.org/10.1038/s41467-019-10110-6
 56. Coll F, McNerney R, Preston MD, Guerra-Assunção JA, Warry A, Hill-Cawthorne G, et al. 
Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. 
Genome Med [Internet]. 2015 Dec 27 [cited 2018 Apr 25];7(1):51. Available from: http://
genomemedicine.com/content/7/1/51
 57. Boshoff HIM, Reed MB, Barry CE, Mizrahi V. DnaE2 polymerase contributes to in vivo sur-
vival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell [Internet]. 
2003 Apr 18 [cited 2020 Jul 10];113(2):183–93. Available from: http://genolist.pasteur.fr/
Tuberculist
chapter 1  |  General introduction
43
1
 58. Identification of gene fusion events in Mycobacterium tuberculosis that encode chimeric 
proteinsGallant J, Mouton J, Ummels R, ten Hagen-Jongman C, Kriel N, Pain A, et al. 
Identification of gene fusion events in Mycobacterium tuberculosis that encode chimeric 
proteins. NAR Genomics Bioinforma. 2020 Jun 1;2(2).
 59. Beveridge TJ, Davies JA. Cellular responses of Bacillus subtilis and Escherichia coli to the 
Gram stain. J Bacteriol. 1983;156(2):846–58.
 60. Costa TRD, Felisberto-Rodrigues C, Meir A, Prevost MS, Redzej A, Trokter M, et al. Se-
cretion systems in Gram-negative bacteria: structural and mechanistic insights. Nat Rev 
Microbiol [Internet]. 2015 May 15 [cited 2018 Jan 9];13(6):343–59. Available from: http://
www.nature.com/doifinder/10.1038/nrmicro3456
 61. Barnhart MM, Chapman MR. Curli Biogenesis and Function. Annu Rev Microbiol [Inter-
net]. 2006 Oct 11 [cited 2020 Jul 10];60(1):131–47. Available from: https://www.annualre-
views.org/doi/abs/10.1146/annurev.micro.60.080805.142106
 62. Stathopoulos C, Hendrixson DR, Thanassi DG, Hultgren SJ, St. Geme JW, Curtiss R. Se-
cretion of virulence determinants by the general secretory pathway in Gram-negative 
pathogens: An evolving story [Internet]. Vol. 2, Microbes and Infection. Elsevier Masson 
SAS; 2000 [cited 2020 Jul 10]. p. 1061–72. Available from: https://pubmed.ncbi.nlm.nih.
gov/10967286/
 63. Sato K, Naito M, Yukitake H, Hirakawa H, Shoji M, McBride MJ, et al. A protein secretion 
system linked to bacteroidete gliding motility and pathogenesis. Proc Natl Acad Sci U S A 
[Internet]. 2010 Jan 5 [cited 2020 Jul 10];107(1):276–81. Available from: www.pnas.org/cgi/
doi/10.1073/pnas.0912010107
 64. Chiaradia L, Lefebvre C, Parra J, Marcoux J, Burlet-Schiltz O, Etienne G, et al. Dissecting the 
mycobacterial cell envelope and defining the composition of the native mycomembrane. 
Sci Rep [Internet]. 2017 Dec 1 [cited 2020 Nov 24];7(1). Available from: https://pubmed.ncbi.
nlm.nih.gov/28993692/
 65. Bottai D, Gröschel MI, Brosch R. Type VII secretion systems in gram-positive bacteria. In: 
Current Topics in Microbiology and Immunology [Internet]. Springer Verlag; 2017 [cited 2020 
Nov 24]. p. 235–65. Available from: https://link.springer.com/chapter/10.1007/82_2015_5015
 66. Abdallah AM, Gey van Pittius NC, DiGiuseppe Champion PA, Cox J, Luirink J, Vandenb-
roucke-Grauls CMJE, et al. Type VII secretion — mycobacteria show the way. Nat Rev Mi-
crobiol [Internet]. 2007 Nov 1;5:883. Available from: http://dx.doi.org/10.1038/nrmicro1773
 67. Beckham KSH, Ciccarelli L, Bunduc CM, Mertens HDT, Ummels R, Lugmayr W, et al. 
Structure of the mycobacterial ESX-5 type VII secretion system membrane complex by 
single-particle analysis. Nat Microbiol [Internet]. 2017;2:17047. Available from: http://
www.nature.com/articles/nmicrobiol201747
 68. Poweleit N, Czudnochowski N, Nakagawa R, Trinidad D, Murphy KC, Sassetti C, et al. Title: 
The structure of the endogenous ESX-3 secretion system. Elife [Internet]. 2019 Dec 1 [cited 
2020 Nov 24];8. Available from: /pmc/articles/PMC6986878/?report=abstract
 69. Bunduc CM, Fahrenkamp D, Wald J, Ummels R, Bitter W, Houben ENG, et al. Structure and 
dynamics of the ESX-5 type VII secretion system of Mycobacterium tuberculosis [Internet]. 
bioRxiv. bioRxiv; 2020 [cited 2021 Mar 8]. p. 2020.12.02.408906. Available from: https://doi.
org/10.1101/2020.12.02.408906
 70. Phan TH, van Leeuwen LM, Kuijl C, Ummels R, van Stempvoort G, Rubio-Canalejas A, 
et al. EspH is a hypervirulence factor for Mycobacterium marinum and essential for the 
44
secretion of the ESX-1 substrates EspE and EspF. PLoS Pathog [Internet]. 2018 Aug 1 [cited 
2020 Jul 10];14(8). Available from: https://pubmed.ncbi.nlm.nih.gov/30102741/
 71. Ma Y, Keil V, Sun J. Characterization of Mycobacterium tuberculosis EsxA membrane 
insertion: roles of N- and C-terminal flexible arms and central helix-turn-helix motif. J Biol 
Chem [Internet]. 2015 Mar 13 [cited 2018 Jan 15];290(11):7314–22. Available from: http://
www.ncbi.nlm.nih.gov/pubmed/25645924
 72. Van Der Wel N, Hava D, Houben D, Fluitsma D, Van Zon M, Pierson J, et al. M. tuberculosis 
and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 
[Internet]. 2007 Jun 29 [cited 2013 Feb 5];129(7):1287–98. Available from: http://www.ncbi.
nlm.nih.gov/pubmed/17604718
 73. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice - PubMed 
[Internet]. [cited 2020 Nov 24]. Available from: https://pubmed.ncbi.nlm.nih.gov/7897219/
 74. Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, Morin PM, et al. The primary 
mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function 
required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A [Internet]. 2003 
Oct 14 [cited 2018 Jan 15];100(21):12420–5. Available from: http://www.ncbi.nlm.nih.gov/
pubmed/14557547
 75. Smith J, Manoranjan J, Pan M, Bohsali A, Xu J, Liu J, et al. Evidence for pore formation in host 
cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape 
from the vacuole. Infect Immun [Internet]. 2008 Dec [cited 2020 Nov 24];76(12):5478–87. 
Available from: https://pubmed.ncbi.nlm.nih.gov/18852239/
 76. Tufariello JM, Chapman JR, Kerantzas CA, Wong K-W, Vilchèze C, Jones CM, et al. Separable 
roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence. Proc 
Natl Acad Sci [Internet]. 2016;201523321. Available from: http://www.pnas.org/lookup/
doi/10.1073/pnas.1523321113
 77. Sloan Siegrist M, Steigedal M, Ahmad R, Mehra A, Dragset MS, Schuster BM, et al. Myco-
bacterial Esx-3 requires multiple components for iron acquisition. MBio [Internet]. 2014 
May 6 [cited 2020 Nov 24];5(3). Available from: https://pubmed.ncbi.nlm.nih.gov/24803520/
 78. Ates LS, Ummels R, Commandeur S, van der Weerd R, Sparrius M, Weerdenburg E, et al. 
Essential Role of the ESX-5 Secretion System in Outer Membrane Permeability of Patho-
genic Mycobacteria. PLOS Genet [Internet]. 2015;11(5):e1005190. Available from: http://
www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4418733&tool=pmcentrez&renderty
pe=abstract
 79. Gey van Pittius NC, Sampson SL, Lee H, Kim Y, van Helden PD, Warren RM, et al. Evolu-
tion and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and 
their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol 
Biol [Internet]. 2006;6(95):1471–2148. Available from: http://dx.doi.org/10.1186/1471-2148-
6-95
 80. McEvoy CRE, van Helden PD, Warren RM, van Pittius N, Gey van Pittius NC. Evidence for a 
rapid rate of molecular evolution at the hypervariable and immunogenic Mycobacterium 
tuberculosis PPE38 gene region. BMC Evol Biol [Internet]. 2009 Jan;9(1):237. Available 
from: http://bmcevolbiol.biomedcentral.com/articles/10.1186/1471-2148-9-237
 81. Chen X, Cheng HF, Zhou J, Chan CY, Lau KF, Tsui SKW, et al. Structural basis of the PE–PPE 
protein interaction in Mycobacterium tuberculosis. J Biol Chem [Internet]. 2017 Oct 13 [cited 
2020 Jul 10];292(41):16880–90. Available from: /pmc/articles/PMC5641871/?report=abstract
chapter 1  |  General introduction
45
1
 82. DiGiuseppe Champion PA, Stanley SA, Champion MM, Brown EJ, Cox JS. C-terminal signal 
sequence promotes virulence factor secretion in Mycobacterium tuberculosis. Science 
(80- ) [Internet]. 2006 Sep 15 [cited 2020 Jul 10];313(5793):1632–6. Available from: https://
science.sciencemag.org/content/313/5793/1632
 83. Daleke MH, Ummels R, Bawono P, Heringa J, Vandenbroucke-Grauls CMJE, Luirink J, et 
al. General secretion signal for the mycobacterial type VII secretion pathway. Proc Natl 
Acad Sci [Internet]. 2012 Jul 10;109(28):11342–7. Available from: http://www.pnas.org/
content/109/28/11342.abstract
 84. Poweleit N, Czudnochowski N, Nakagawa R, Murphy K, Sassetti C, Rosenberg OS. A large 
inner membrane pore defines the ESX translocon. bioRxiv [Internet]. 2019 Oct 10 [cited 
2020 Jul 10];800169. Available from: https://doi.org/10.1101/800169
 85. Korotkova N, Freire D, Phan TH, Ummels R, Creekmore CC, Evans TJ, et al. Structure of the 
Mycobacterium tuberculosis type VII secretion system chaperone EspG5 in complex with 
PE25-PPE41 dimer. Mol Microbiol [Internet]. 2014 Oct 1 [cited 2020 Jul 10];94(2):367–82. 
Available from: https://pubmed.ncbi.nlm.nih.gov/25155747/
 86. Vizcaíno C, Restrepo-Montoya D, Rodríguez D, Niño LF, Ocampo M, Vanegas M, et al. 
Computational prediction and experimental assessment of secreted/surface proteins from 
Mycobacterium tuberculosis H37Rv. PLoS Comput Biol [Internet]. 2010 Jun [cited 2020 Jul 
10];6(6):1–14. Available from: /pmc/articles/PMC2891697/?report=abstract
 87. Weerdenburg EM, Abdallah AM, Mitra S, de Punder K, van der Wel NN, Bird S, et al. 
ESX-5-deficient Mycobacterium marinum is hypervirulent in adult zebrafish. Cell Micro-
biol [Internet]. 2012 May 1;14(5):728–39. Available from: http://dx.doi.org/10.1111/j.1462-
5822.2012.01755.x
 88. Charles A Janeway J, Travers P, Walport M, Shlomchik MJ. Principles of innate and adaptive 
immunity. 2001 [cited 2020 Jul 10]; Available from: https://www.ncbi.nlm.nih.gov/books/
NBK27090/
 89. Chaplin DD. Overview of the immune response. J Allergy Clin Immunol [Inter-
net]. 2010 Feb [cited 2020 Jul 10];125(2 SUPPL. 2):S3. Available from: /pmc/articles/
PMC2923430/?report=abstract
 90. Philips JA, Ernst JD. Tuberculosis Pathogenesis and Immunity. Annu Rev Pathol Mech Dis 
[Internet]. 2012 Feb 28 [cited 2020 Jul 10];7(1):353–84. Available from: https://pubmed.ncbi.
nlm.nih.gov/22054143/
 91. Srivastava S, Ernst JD, Desvignes L. Beyond macrophages: The diversity of mononuclear 
cells in tuberculosis. Immunol Rev [Internet]. 2014 Nov 1 [cited 2020 Jul 10];262(1):179–92. 
Available from: https://pubmed.ncbi.nlm.nih.gov/25319335/
 92. Cohen SB, Gern BH, Delahaye JL, Adams KN, Plumlee CR, Winkler JK, et al. Alveolar Mac-
rophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination. 
Cell Host Microbe [Internet]. 2018 Sep 12 [cited 2020 Jul 10];24(3):439-446.e4. Available 
from: https://pubmed.ncbi.nlm.nih.gov/30146391/
 93. Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Im-
munol Rev [Internet]. 2015 Mar 1 [cited 2020 Jul 10];264(1):182–203. Available from: /pmc/
articles/PMC4368383/?report=abstract
 94. Cambier CJ, O’Leary SM, O’Sullivan MP, Keane J, Ramakrishnan L. Phenolic Glycolipid Fa-
cilitates Mycobacterial Escape from Microbicidal Tissue-Resident Macrophages. Immunity 
[Internet]. 2017 Sep 19 [cited 2020 Jul 10];47(3):552-565.e4. Available from: http://dx.doi.
org/10.1016/j.immuni.2017.08.003
46
 95. Pennock ND, White JT, Cross EW, Cheney EE, Tamburini BA, Kedl RM. T cell responses: 
Naïve to memory and everything in between. Am J Physiol - Adv Physiol Educ [Internet]. 
2013 Dec 1 [cited 2020 Jul 10];37(4):273–83. Available from: https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC4089090/
 96. Gonzalez-Juarrero M, Orme IM. Characterization of murine lung dendritic cells in-
fected with Mycobacterium tuberculosis. Infect Immun [Internet]. 2001 [cited 2020 Jul 
10];69(2):1127–33. Available from: https://pubmed.ncbi.nlm.nih.gov/11160010/
 97. Wolf AJ, Linas B, Trevejo-Nuñez GJ, Kincaid E, Tamura T, Takatsu K, et al. Mycobacterium 
tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In 
Vivo . J Immunol [Internet]. 2007 Aug 15 [cited 2020 Jul 10];179(4):2509–19. Available from: 
https://pubmed.ncbi.nlm.nih.gov/17675513/
 98. Lin PL, Flynn JL. Understanding Latent Tuberculosis: A Moving Target. J Immunol 
[Internet]. 2010 Jul 1 [cited 2020 Jul 10];185(1):15–22. Available from: /pmc/articles/
PMC3311959/?report=abstract
 99. Faridgohar M, Nikoueinejad H. New findings of Toll-like receptors involved in Myco-
bacterium tuberculosis infection [Internet]. Vol. 111, Pathogens and Global Health. 
Taylor and Francis Ltd.; 2017 [cited 2020 Jul 10]. p. 256–64. Available from: /pmc/articles/
PMC5560203/?report=abstract
 100. Grover S, Sharma T, Singh Y, Kohli S, Manjunath P, Singh A, et al. The PGRS domain of My-
cobacterium tuberculosis PE_PGRS protein Rv0297 is involved in Endoplasmic reticulum 
stress-mediated apoptosis through toll-like receptor 4. MBio [Internet]. 2018 May 1 [cited 
2020 Jul 10];9(3). Available from: /pmc/articles/PMC6016250/?report=abstract
 101. Kawai T, Akira S. Signaling to NF-κB by Toll-like receptors [Internet]. Vol. 13, Trends in 
Molecular Medicine. Elsevier; 2007 [cited 2020 Jul 10]. p. 460–9. Available from: www.
sciencedirect.com
 102. Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target 
Ther [Internet]. 2017 Jul 14 [cited 2019 Mar 29];2:17023. Available from: http://www.nature.
com/articles/sigtrans201723
 103. Sun S-C. The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Im-
munol [Internet]. 2017 Jun 5 [cited 2019 Mar 26];17(9):545–58. Available from: http://www.
nature.com/doifinder/10.1038/nri.2017.52
 104. Zhang Q, Lenardo MJ, Baltimore D. 30 Years of NF-kB: A Blossoming of Relevance to Hu-
man Pathobiology. Cell [Internet]. 2017 [cited 2019 Sep 1];168:37–57. Available from: http://
dx.doi.org/10.1016/j.cell.2016.12.012
 105. Cildir G, Low KC, Tergaonkar V. Noncanonical NF-κB Signaling in Health and Disease 
[Internet]. Vol. 22, Trends in Molecular Medicine. Elsevier Ltd; 2016 [cited 2020 Jul 10]. p. 
414–29. Available from: http://www.cell.com/article/S147149141600054X/fulltext
 106. Dorrington MG, Fraser IDC. NF-κB signaling in macrophages: Dynamics, crosstalk, and 
signal integration [Internet]. Vol. 10, Frontiers in Immunology. Frontiers Media S.A.; 2019 




comprehensive characterization of 
the attenuated double auxotroph 
Mycobacterium tuberculosis ΔleuDΔpanCD 







1  DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/South African Medical Research 
Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of 
Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
2  Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, United Kingdom
3  Section of Molecular Microbiology, Amsterdam Institute of Molecules, Medicines, and Systems, Vrije 





Currently available model organisms such as Mycobacterium smegmatis and Myco-
bacterium bovis Bacillus Calmette-Guérin (BCG) have significantly contributed to our 
understanding of tuberculosis (TB) biology, these models have limitations such as 
differences in genome size, growth rates and virulence. However, attenuated Mycobac-
terium tuberculosis strains may provide more representative, safer models to study M. 
tuberculosis biology. For example, the M. tuberculosis ΔleuDΔpanCD double auxotroph, 
has undergone rigorous in vitro and in vivo safety testing. Like other auxotrophic 
strains, this has subsequently been approved for use in biosafety level (BSL) 2 facilities. 
Auxotrophic strains have been assessed as models for drug-resistant M. tuberculosis 
and for studying latent TB. These offer the potential as safe and useful models, but 
it is important to understand how well these recapitulate salient features of non-
attenuated M. tuberculosis. We therefore performed a comprehensive comparison of 
M. tuberculosis H37Rv and M. tuberculosis ΔleuDΔpanCD. These strains demonstrated 
similar in vitro and intra-macrophage replication rates, similar responses to anti-TB 
agents and whole genome sequence conservation. Shotgun proteomics analysis sug-
gested that M. tuberculosis ΔleuDΔpanCD has a heightened stress response that leads to 
reduced bacterial replication during exposure to acid stress, which has been verified 
using a dual-fluorescent replication reporter assay. Importantly, infection of human 
peripheral blood mononuclear cells with the 2 strains elicited comparable cytokine 
production, demonstrating the suitability of M. tuberculosis ΔleuDΔpanCD for immu-
nological assays. We provide comprehensive evidence to support the judicious use of 
M. tuberculosis ΔleuDΔpanCD as a safe and suitable model organism for M. tuberculosis 
research, without the need for a BSL3 facility.
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coNTRIbuTIoN To THE fIELD
Mycobacterium tuberculosis research requires access to biosafety level 3 facilities, 
emphasizing the need for mycobacterial model organisms to facilitate our understand-
ing of M. tuberculosis pathogenesis. Previous work demonstrated the use of auxotrophic 
strains as models for drug-resistant M. tuberculosis and for studying latent tuberculosis, 
however it is important to understand how well these represent non-attenuated M. 
tuberculosis. In this study, we determined the suitability of the double auxotrophic M. 
tuberculosis ΔleuDΔpanCD strain as a model for M. tuberculosis research by comparing it 
to the widely used M. tuberculosis H37Rv reference strain. We provide comprehensive 
comparative analyses between these two strains concerning in vitro and intra-mac-
rophage growth, genomic features, response to anti-tuberculosis agents, proteomic 
response to stress and host immune response. Our results suggest that M. tuberculosis 
ΔleuDΔpanCD is a suitable and safe alternative for M. tuberculosis research, which can 
be conducted in a biosafety level 2 laboratory.
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INTRoDucTIoN
In order to radically reduce TB deaths and incidence by 2030, as set out by the End 
TB Strategy (1), there is a need for improved TB therapies and more effective ways of 
studying the deadly pathogen Mycobacterium tuberculosis. Current research challenges 
include restricted access to Biosafety level 3 (BSL3) facilities and the slow growth of 
M. tuberculosis. This emphasises the need for mycobacterial model systems that can 
facilitate our understanding of M. tuberculosis pathogenesis. Despite studies showing 
the use of currently available model organisms such as Mycobacterium smegmatis and 
Mycobacterium bovis Bacillus Calmette-Guérin (BCG) to have significantly contributed 
to the understanding of M. tuberculosis, these models have limitations.
Apart from being non-pathogenic, M. smegmatis is also substantially different from 
M. tuberculosis in terms of its larger genome size and considerably shorter doubling 
time (2,3). The model organism BCG is known to contain a natural RD1 deletion (4), 
which encodes the known virulence factors early secreted antigenic target-6 kDa 
(ESAT-6) (5) and culture filtrate protein-10 kDa (CFP-10) (6–9), suggesting that the im-
mune response elicited by BCG will be altered in comparison to M. tuberculosis.
Several attenuated strains of M. tuberculosis have been developed (10–18) that have the 
potential to serve as model organisms to study M. tuberculosis biology. These include 
strains with a deletion in the bioA gene, disrupting biotin synthesis (17) or single muta-
tion in the eccCa1 gene, disrupting ESX-1 type VII secretion, resulting in reduced host 
immune responses and immunopathology (16). To improve safety, several M. tuberculo-
sis strains with two or more attenuating mutations have been developed. These include 
ΔRD1ΔpanCD (11,13), which similarly to BCG does not include the RD1 region. Doubly 
auxotrophic strains include ΔlysAΔpanCD (11,13) and ΔleuDΔpanCD (12). Recent work 
generated a drug-susceptible and drug-resistant triple auxotrophic stain of M. tuber-
culosis, which provides a safe model for studying drug-resistant M. tuberculosis under 
BSL2 conditions (11). Another interesting development is the use of a streptomycin-
dependent M. tuberculosis strain (M. tuberculosis 18b) as a model of latent TB (19). These 
strains offer potential as research models, but need comprehensive characterisation to 
assess their suitability to the research question at hand.
The severely attenuated double auxotrophic ΔleuDΔpanCD strain of M. tuberculosis 
(12,15) offers significant advantages over M. smegmatis and BCG such as similar genetic 
background, growth and antigenicity properties to the widely used laboratory strain M. 
tuberculosis H37Rv. For example, the growth rate of the ΔleuDΔpanCD strain in minimal 
medium supplemented with both leucine and pantothenate was shown to be similar 
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to that of wild-type M. tuberculosis in minimal medium (12). Importantly, although 
the strain is fully attenuated, it was shown to retain immunogenicity and protective 
capacity in a sensitive guinea pig TB aerosol challenge model (12,15). In addition, the 
severely attenuated mutant of M. tuberculosis has undergone rigorous in vitro and in 
vivo safety testing, since it was originally developed as a TB vaccine candidate (12,15). 
The ΔleuDΔpanCD strain proved to be highly attenuated in the severe combined im-
mune deficient mouse M. tuberculosis model (12). The safety of this strain was further 
supported by evidence that it does not cause disease in simian immunodeficiency virus 
(SIV)-co-infected Rhesus macaques (15). Collectively this data indicates that in the case 
of accidental infection with this strain in humans, it would be highly unlikely to cause 
disease, even in immune-compromised hosts. The ΔleuDΔpanCD strain, therefore, 
holds minimal risk to human health and environment and serves as an excellent alter-
native model organism for TB research. Currently, several international laboratories 
have been granted approval to work with this and similar strains, under BSL2 condi-
tions (20,21).
We therefore aimed to compare M. tuberculosis H37Rv and M. tuberculosis ΔleuDΔpanCD 
to assess the suitability of this auxotrophic strain as a model for M. tuberculosis research. 
We provide comprehensive comparative analyses between M. tuberculosis H37Rv and 
M. tuberculosis ΔleuDΔpanCD with regards to in vitro and intra-macrophage growth, 
genomic background, response to anti-TB agents, proteomic response to stress, and 
the host immune response.
MATERIALs AND METHoDs
bacterial strains and culture
All bacterial strains utilized in this study are listed and described in Table 1, along with 
relevant plasmid information. All reagents were purchased from Sigma-Aldrich unless 
otherwise specified. Liquid cultures of mycobacterial strains were grown in Middle-
brook 7H9 supplemented with 10% oleic acid-albumin-dextrose-catalase (OADC, Becton 
Dickinson, New Jersey, USA), 0.2% (v/v) glycerol and 0.05% (v/v) Tween 80 (7H9-OGT), 
with antibiotics as required for plasmid maintenance, at 37⁰C, with shaking at 180 rpm. 
M. tuberculosis ΔleuDΔpanCD liquid cultures were additionally supplemented with 50 
µg/ml leucine and 24 µg/ml pantothenate. Electro-competent mycobacteria were pre-
pared and transformed as described by (22). Solid media cultures of mycobacteria were 
grown on 7H10 agar supplemented with 10% OADC, 0.5% (v/v) glycerol and antibiotics 
at 37⁰C and in the case of M. tuberculosis ΔleuDΔpanCD, 50 µg/ml leucine and 24 µg/ml 
pantothenate. Mycobacterial strains expressing the bacterial luciferase operon from 
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plasmid pMV306hsp+LuxCDABE (23) do not require an exogenous substrate to produce 
light. Bioluminescence was used to measure the intracellular growth of both the refer-
ence strain M. tuberculosis H37Rv and M. tuberculosis ΔleuDΔpanCD. The number of 
generations were calculated based on either OD, luminescence or median fluorescence 
intensity as previously described (3).
For proteomic analysis, M. tuberculosis H37Rv and M. tuberculosis ΔleuDΔpanCD were 
cultured, separately, in Middlebrook 7H9 broth supplemented with dextrose-catalase 
(DC), 0.2% (v/v) glycerol and 0.05% (v/v) Tween 80 (7H9-DC) at 37⁰C. Mycobacterial cells 
were harvested (4000 rpm, 10 min, 4⁰C) at an OD600 of ~0.8, and the cells were washed 
twice with ice-cold phosphate-buffered saline (PBS) pH 7.4. Cells were washed with 
PBS to remove residual media before LC-MS/MS analyses. Cells were either stored at 
-20⁰C until further processing (control), or resuspended in 7H9-DC (pH 4.5) and incu-
bated for 48 hours at 37⁰C. Acid-stressed cultures were subsequently washed twice by 
centrifugation at 4000 rpm for 10 min at 4⁰C with ice-cold PBS pH7.4, and the pellets 
were stored at -20⁰C.
For testing the effect of acid stress on bacterial replication using a dual-fluorescent 
replication reporter previously developed by our group (3), bacteria were grown in 
7H9-DC containing 4 mM Theophylline, to induce the expression of TurboFP635, for 7 
days until an OD600 of ~0.8 before washing with PBS. The cultures were sub-cultured in 
7H9-DC without Theophylline at pH 6.5 and pH 4.5 and incubated for 48 hours at 37⁰C.
Genomic DNA extraction
Genomic DNA was extracted by pelleting 15 ml culture at OD600 of 0.8 for 10 minutes 
at 4000 rpm according to previously published methods (24).
Table 1. Plasmids and strains.
Plasmid/strain Description source
pTiGc hsp60(ribo)-turboFP635 hsp60-gfp, Kan
R, 
episomal Mouton et al. (2016)
pMV306hsp+LuxCDABE bacterial luciferase operon, KanR, episomal Andreu et al. (2010) Addgene plasmid number 26519
M. smegmatis mc2155 non-pathogenic, fast-growing model organism ATCC 700084
M. tuberculosis 
ΔleuDΔpanCD
Double leucine and pantothenate auxotroph Sampson et al. (2004)
M. tuberculosis H37Rv M. tuberculosis reference strain and progenitor of M. tuberculosis ΔleuDΔpanCD
ATCC 27294, gift from Prof. 
Barry Bloom
ATCC, American Type Culture Collection; HygR, hygromycin resistant; KanR, kanamycin resistant; Leu, leucine; 
Pan, pantothenate.
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whole genome sequencing (wGs)
Whole genome sequencing was done on an Illumina NextSeq 550 instrument (Illu-
mina, California, USA) using a paired-end approach with ~600 base fragment sizes. One 
microgram of DNA was used to prepare libraries for sequencing per the manufacturer’s 
instructions using the NEBNext Ultra DNA library preparation kit for Illumina (New 
England Biolabs, Massachusetts, USA).
wGs data analyses
The Illumina paired-end reads for all isolates were analysed with open source software 
as described previously (25,26). Identified variants were compared between M. tuber-
culosis H37Rv and M. tuberculosis ΔleuDΔpanCD. Deleted regions in the genomes with 
respect to the M. tuberculosis H37Rv NC000962.3 reference genome were detected with 
DELLY and alignments of these regions were visually inspected (27).
MIc determination using bAcTEc MGIT 960
Minimum inhibitory concentration (MIC) determinations were performed using the 
semi-automated liquid culture BACTEC MGIT 960 system (Becton Dickinson) and 
EpiCenter software equipped with a TB eXist module for drug susceptibility testing 
(28). Briefly, a bacterial suspension was prepared from MGIT subcultures according to 
the manufacturer’s instructions (BACTEC™ MGIT™ 960 System User’s Manual: Becton 
Dickinson Document Number MA-0117) and 0.5 ml of the suspension was added to 
each MGIT tube supplemented with 0.8 ml of OADC and 0.1 ml of the drug (dissolved 
in DMSO) at a concentration range of 0.06 to 9.0 µg/ml for rifampicin or 0.0015 to 
2.0 µg/ml for isoniazid. M. tuberculosis ΔleuDΔpanCD were supplemented with 50 µg/
ml leucine and 24 µg/ml pantothenate. The MIC was determined as the lowest drug 
concentration that tested susceptible (less than 100 growth units by automated reading 
when the control vial turned positive).
Mammalian cell culture
RAW264.7 cells (ATCC TIB-71) were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM), supplemented with 10% heat-inactivated fetal bovine serum (FBS) at 37⁰C 
in 5% CO2. Cells were passaged every 2-4 days. For infections, cells were seeded at 
5x104 cells per well in 96 well white plates. M. tuberculosis H37Rv and M. tuberculosis 
ΔleuDΔpanCD were prepared and infected into RAW264.7 macrophages as described 
before (3). Bacteria were added to macrophages at a 10:1 ratio, and incubated at 37⁰C in 
5% CO2 for 3 hours, prior to penicillin/streptomycin treatment and subsequent wash-
ing, to remove extracellular bacteria. Infected RAW264.7 macrophages were cultured 
in the presence of DMEM, supplemented with 10% FBS, 50 µg/ml leucine and 24 µg/ml 
pantothenate to allow growth of the auxotrophic strain inside macrophages. To assess 
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the uptake of bacteria by macrophages, cells were lysed with sterile distilled water 
and pipetting, followed by colony forming unit (CFU) determination by serial dilution 
plating of lysates onto 7H10 agar, with leucine and pantothenate supplementation 
where necessary. Macrophages infected with strains expressing the bacterial lucifer-
ase operon were assessed for bioluminescence expression using a microplate reader 
(POLARstar Omega, BMG Labtech). Intracellular growth was monitored by measuring 
bioluminescence every 24 hours for 3 days. Macrophages infected with mycobacteria 
that do not contain the luciferase operon were included as controls to subtract back-
ground luminescence expression from all samples.
Isolation and infection of peripheral blood mononuclear cells 
(PbMcs)
PBMCs were isolated from whole blood, of healthy TST negative donors (n = 12), using 
Ficoll-Paque PLUS (GE Healthcare Life Sciences, Massachusetts, USA) density (D>1.077 
g/ml) gradient centrifugation. Informed consent was obtained from all the subjects and 
the study was approved by the Ethical Review Committee of the Faculty of Health Sci-
ences at Stellenbosch University (N16/05/070). Cells were cultured in Roswell Park Me-
morial Institute (RPMI) media, supplemented with 10% FBS at a density of 5x105 cells 
per well in 48-well plates (Greiner Bio-one, Kremsmünster, Austria). PBMCs were then 
infected with M. tuberculosis H37Rv or M. tuberculosis ΔleuDΔpanCD at an MOI of 10:1, 
treated with penicillin/streptomycin, followed by washing as described above, before 
adding fresh RPMI, containing 10% FBS. Uninfected and Lipopolysaccharide- (LPS; 10 
µg/ml) stimulated cells were included as negative and positive controls, respectively. 
Supernatants were collected 24 hours post infection and stored at -80°C until cytokine 
analysis. To assess uptake, PBMCs were lysed with sterile distilled water and pipetting, 
followed by serial dilution plating and CFU determination as described above.
Quantification of cytokine and chemokine levels by multiplex bead 
array
A human ProcartaPlexTM Multiplex Immunoassay (Thermo Fisher Scientific, Mas-
sachusetts, USA) was used to simultaneously quantify the levels of the following ana-
lytes in the culture supernatants: interleukin (IL)-1B, IL-12p70, granulocyte monocyte 
stimulating factor (GM-CSF), growth-regulated oncogene (GRO)α, interferon (IFN)
γ, macrophage inflammatory protein (MIP)-1α (CCL3), tumor necrosis factor (TNF)α, 
RANTES, stromal cell-derived factor (SDF)-1α. The assays were performed according to 
the manufacturer’s instructions and samples were evaluated in triplicate. The cytokine 
concentrations were measured on a Bio-Plex platform (Bio PlexTM, Bio-Rad Laborato-
ries, California, USA). A standard curve ranging from 227 to 8 979.52 pg/ml for IL-1B, 
7.15 to 29 426.85 pg/ml for IL12-p70, 13.69 to 51 379.68 pg/ml for GM-CSF, 1.93 to 9993 
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pg/ml GROα, 11.67 to 49 632.42 pg/ml for IFNγ, 1.5 to 6755.47 pg/ml for MIP-1α, 7.85 to 
33 043.15 pg/ml for TNFα, 0.86 to 837.85 pg/ml for RANTES and 10.85 to 34 295.44 pg/
ml for SDF-1, was used in the assay. Correlation coefficients (r2>0.9) for the standard 
curves were determined from transformed mean fluorescent intensity values for each 
cytokine. Bio-Plex Manager Software, version 6.1, was used to determine the median 
fluorescent intensities.
Proteomic sample preparation and Lc-Ms/Ms analysis
Mycobacterial cells from 25 ml culture (performed in four independent replicates) were 
mechanically lysed and whole-cell lysates were processed for LC-MS/MS analysis using 
a modified version of the filter-aided sample preparation (FASP) approach (Wiśniewski 
et al., 2009). A total of 1 µg peptide mixture from each sample was analysed, indepen-
dently, on an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher Scientific), 
connected to a Thermo Scientific UltiMate 3000 RSLCnano System (Thermo Fisher 
Scientific) (Detailed information is provided in Text S1 in supplemental material).
flow cytometry sample preparation, acquisition and analyses
Samples were sonicated, fixed in 4% formaldehyde for 30 min and washed twice in PBS, 
containing 0.05% Tween as previously described (3). Samples not immediately analysed 
were then stored at 4⁰C. Immediately prior to flow cytometry analyses samples were 
pelleted, resuspended in PBS and filtered. Samples were analysed using a FACSJazz 
flow cytometer (Beckton Dickinson) for GFP fluorescent intensity using a 488 nm laser 
(530/40 filter) and TurboFP635 fluorescent intensity using a 561 laser (610/20 filter). 
For each sample, 30,000 events were captured and flow cytometry data were analysed 
using FlowJo vX.0.07r2 software. The number of generations were calculated based on 
fluorescence intensity data as described before (3). Generation times are expressed as 
mean ±SD.
Data analysis
We used an exploratory data analysis approach for the multiplex bead array assay. De-
tails are indicated in Text S1 in supplemental material. All tandem mass spectra were 
analysed using MaxQuant 1.5.5.1 (29), and searched against a customized M. tubercu-
losis proteome database. Custom database construction was performed as previously 
described (30) and are detailed in Text S1 in supplemental material. Exploratory data 




The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner 
repository with the data set identifier PXD013677. Raw genomic data for this study have 
been deposited in the European Nucleotide Archive (ENA) under the project accession 
PRJEB32340.
REsuLTs
Next-generation sequencing reveals sequence conservation between 
M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv
Whole genome sequencing of M. tuberculosis ΔleuDΔpanCD and M. tuberculosis 
H37Rv (the reference strain in use in our laboratory and progenitor of M. tuberculosis 
ΔleuDΔpanCD was used to confirm sequence conservation outside of the leuD and 
panCD regions. When comparing M. tuberculosis ΔleuDΔpanCD to our laboratory ref-
erence strain M. tuberculosis H37Rv, only one unique nonsynonymous variant (I131T 
A>G) was identified at position 392 in Rv2988 (leuC) in M. tuberculosis ΔleuDΔpanCD 
that was not found in M. tuberculosis H37Rv. However, no peptide covering this re-
gion was identified in either of the two strains. Importantly, the leuC gene is located 
upstream of the leuD deletion and no proteomic differences were observed in down-
stream proteins in the attenuated and wild type strains, suggesting an absence of polar 
effects on expression. In agreement with the findings of Ioerger et al, our analysis 
identified 33 variants in both the attenuated M. tuberculosis ΔleuDΔpanCD strain and 
M. tuberculosis H37Rv progenitor, with respect to the reference strain M. tuberculosis 
H37Rv, NC000962.3 (31). However, 32 of these variants were identical between the at-
tenuated M. tuberculosis ΔleuDΔpanCD and the M. tuberculosis H37Rv progenitor strain 
(Supplementary Table S1). Visual inspection of the alignment confirmed the expected 
1297 bp panCD locus deletion at position 4043882 – 4045179 (M. tuberculosis H37Rv gene 
Rv3602c and Rv3601c) and the leuD deletion at position 3344036 – 3344394 (M. tubercu-
losis H37Rv gene Rv2987C) in the attenuated M. tuberculosis ΔleuDΔpanCD, with respect 
to M. tuberculosis H37Rv, NC000962.3. At a genomic level, M. tuberculosis ΔleuDΔpanCD 
is therefore highly similar to M. tuberculosis H37Rv.
The in vitro and intra-macrophage growth of M. tuberculosis 
ΔleuDΔpanCD and M. tuberculosis H37Rv are comparable.
To confirm that the growth rates of M. tuberculosis ΔleuDΔpanCD and M. tuberculosis 
H37Rv were similar in vitro, samples were taken for OD measurements at predeter-
mined time points (Figure 1A). Strains containing the pTiGc plasmid were included 
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to determine whether plasmid carriage affected bacterial growth. One-way ANOVA 
with Tukey’s multiple comparisons test revealed no differences in growth rates be-
tween these strains (p > 0.05). To confirm the auxotrophic nature of the M. tuberculosis 
ΔleuDΔpanCD strain (12), OD measurements taken from strains supplemented exog-
enously with leucine and pantothenate showed normal growth, whereas restricted 
growth was observed in the absence of pantothenate (Figure 1B).
We next assessed replication of M. tuberculosis during macrophage infection. RAW264.7 
macrophages were infected with M. tuberculosis ΔleuDΔpanCD and M. tuberculosis 
H37Rv strains expressing the bacterial luciferase operon. Bioluminescence measure-
ments demonstrated no difference in the growth of these strains, suggesting similar 
intracellular replication of M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv 
(Figure 1C). Pearson correlation tests revealed a statistically significantly positive 
correlation between generations calculated using luminescence for M. tuberculosis 
ΔleuDΔpanCD and M. tuberculosis H37Rv (r=0.975, N=4, p=0.0250).
figure 1. comparable growth of M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv strains. 
(A) M. tuberculosis ΔleuDΔpanCD (grey solid line, closed symbols), M. tuberculosis ΔleuDΔpanCD con-
taining the dual reporter pTiGc (grey dotted line, open symbols), M. tuberculosis H37Rv (black solid 
line, closed symbols) and M. tuberculosis H37Rv containing pTiGc (black dotted line, open symbols) 
growth was monitored by OD. One-way ANOVA with Tukey’s multiple comparisons test indicated 
no significant difference (p > 0.05). (b) OD600-based M. tuberculosis ΔleuDΔpanCD growth with ex-
ogenous supplementation of leucine and pantothenate (grey line, open symbols) and without pan-
tothenate supplementation (black line, closed symbols). (c) RAW264.7 macrophages were infected 
with M. tuberculosis ΔleuDΔpanCD + LuxCDABE (grey line, open symbols) or M. tuberculosis H37Rv + 
LuxCDABE (black line, closed symbols), and intracellular mycobacterial replication was compared 
by monitoring bioluminescence. Data shown are depicted as mean±SD of three technical replicates 
and are representative of three independent biological replicates. Pearson correlation tests revealed 
a statistically significantly positive correlation between generations calculated using luminescence 
for M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv (r=0.975, N=4, p=0.0250).
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M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv respond 
similarly to anti-tuberculosis agents
One important potential application of the attenuated M. tuberculosis ΔleuDΔpanCD 
strain is to allow for anti-mycobacterial compound screening. Phenotypic drug 
susceptibility testing (DST) of the two first-line anti-tuberculosis drugs with differ-
ent mechanisms of action, rifampicin and isoniazid, confirmed similar minimum 
inhibitory concentrations (MICs) for M. tuberculosis ΔleuDΔpanCD and M. tuberculosis 
H37Rv. Specifically, the MIC for isoniazid was determined to be 0.06 µg/ml for both 
strains, and the MIC for rifampicin was determined to be 0.25 µg/ml for M. tuberculosis 
ΔleuDΔpanCD and 0.5 µg/ml for M. tuberculosis H37Rv.
Proteomic analysis reveals an increased stress response in M. 
tuberculosis ΔleuDΔpanCD.
We performed LC-MS/MS analysis on the proteomes of M. tuberculosis ΔleuDΔpanCD 
and M. tuberculosis H37Rv grown in media at pH 6.5 and pH 4.5. In total, we identi-
fied 21 779 unique peptides that mapped to 2 329 proteins, which contained ≥2 unique 
peptides at an empirical protein FDR of < 1% (Supplementary Table S2, S3). The pro-
teins identified in this study covered 58.33% of the predicted M. tuberculosis H37Rv 
proteome. Principle component analysis revealed distinct clustering of replicates 
and experimental groups (Figure 2A). The first principle component (Component 1) 
explained 25% of the variance in the data, which has an association with acid stress. 
The second principle component (Component 2) explained ~19% of the variance in 
the data and was associated with inherent strain differences between M. tuberculosis 
ΔleuDΔpanCD and M. tuberculosis H37Rv. Additionally, Pearson correlation coefficients 
were higher within biological replicates than between groups (Figure 2B), indicating 
high reproducibility between independent experiments. Hierarchical clustering re-
vealed two major clusters that separated acid stressed M. tuberculosis ΔleuDΔpanCD 
and M. tuberculosis H37Rv from the strains grown under control (pH 6.5) conditions. 
Sub-clusters separated M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv. Taken 
together this data indicates that exposure to acid stress induced more variance in the 
data than the inherent strain differences between M. tuberculosis ΔleuDΔpanCD and M. 
tuberculosis H37Rv, with the strains having similar protein expression profiles under 
the conditions tested. However, some proteome-level differences were observed be-
tween the two strains grown under control (pH 6.5) and acid stress (pH 4.5) conditions.
chapter 2  |  SAMMtb as an alternative to H37Rv
61
2
We performed pair-wise comparisons to identify differences in relative protein 
abundances between M. tuberculosis H37Rv and M. tuberculosis ΔleuDΔpanCD. 
Twenty differentially regulated proteins, with a 2-fold change and adjusted p-value 
< 0.05, were identified when both of these strains were grown at pH 6.5 (Figure 3A, 
Supplementary Table S4). We detected 28 proteins as differentially regulated in M. tu-
berculosis ΔleuDΔpanCD during acid stress, compared to M. tuberculosis H37Rv (Figure 
3B, Supplementary Table S5). Interestingly, we observed 8 proteins that were more 
abundant in acid-stressed M. tuberculosis ΔleuDΔpanCD cells that were also detected as 
more abundant in M. tuberculosis ΔleuDΔpanCD grown under physiological conditions, 
compared to M. tuberculosis H37Rv under the same conditions. These included proteins 
that play a role in dormancy, oxidative and/or nitrosative stress (AhpC, AhpD), pan-
tothenate metabolism (CoaX, PanB, Rv3603c), transcription (Rv2989), methyl transfer 
(Rv2003c) and lipid catabolism (Rv2037c). This, in addition to increased abundance of 
DevR in M. tuberculosis ΔleuDΔpanCD during growth at pH 6.5, may suggest that M. 
tuberculosis ΔleuDΔpanCD experiences a more pronounced baseline stress response 
than M. tuberculosis H37Rv, which could be exacerbated during exposure to stress and 
could lead to reduced bacterial replication. To test this hypothesis we exploited a previ-
ously described dual-fluorescent replication reporter and flow cytometry to assess the 
effect of stress on bacterial replication. In accordance with our proteomics analyses, 
M. tuberculosis ΔleuDΔpanCD demonstrated a more pronounced decrease in bacterial 
replication in response to acid stress, compared to M. tuberculosis H37Rv after 48 hours 
(Figure 4).
figure 2. Quality control analysis of proteomics data reveals distinct clustering of M. tuberculosis 
H37Rv and M. tuberculosis ΔleuDΔpanCD protein intensities. (A) Principle component analysis of 
z-scored MaxQuant LFQ intensities obtained from M. tuberculosis H37Rv (blue) and M. tuberculosis 
ΔleuDΔpanCD (red) during control (pH 6.5; square) and acid stress conditions (pH 4.5; circle). (b) 
Correlogram of Pearson correlation coefficients from MaxQuant LFQ intensities obtained for M. 
tuberculosis H37Rv and M. tuberculosis ΔleuDΔpanCD (SAMMtb) cultured at pH 6.5 and pH 4.5.
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M. tuberculosis ΔleuDΔpanCD induces similar or higher PbMc 
cytokine and chemokine responses compared to H37Rv
The concentration of 9 immune markers including cytokines, chemokines and growth 
factors were measured in the culture supernatant of PBMCs 24 hours after infection 
with M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv. No statistically significant 
differences were observed in RANTES, GROα, SDF-1 and IL-1B concentrations between 
M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv (Figure 5A-D). Despite demon-
strating similar trends, M. tuberculosis ΔleuDΔpanCD did induce higher concentrations 
of TNFα (p=0.0010), GM-CSF (p=0.009), MIP-1α (p=0.0021), IL-12p70 (p<0.0001) and 
IFNγ (p<0.0001) when compared to M. tuberculosis H37Rv (Figure 5E-I). M. tuberculosis 
H37Rv induced low concentrations of IL-12p70 and IFNγ. Interestingly, M. tuberculosis 
ΔleuDΔpanCD induced higher concentrations of these two cytokines (Figure 5H and I).
figure 3. Proteomic comparison of M. tuberculosis H37Rv and M. tuberculosis ΔleuDΔpanCD un-
der physiological in vitro growth conditions and in response to acid stress. Volcano plot show-
ing protein expression differences between M. tuberculosis H37Rv compared to M. tuberculosis 
ΔleuDΔpanCD when grown at pH 6.5 (A) and pH 4.5 (b). Blue corresponds to proteins with <-1 log2 
fold differential expression and adjusted p-value < 0.05. Red corresponds to proteins with >1 log2 
fold differential expression and adjusted p-value < 0.05. (c) Heatmap of log2 fold changes of pro-
teins showing statistically significant regulation between M. tuberculosis H37Rv and M. tuberculosis 
ΔleuDΔpanCD during growth at pH 6.5 and pH 4.5.




We report here the assessment of attenuated M. tuberculosis ΔleuDΔpanCD as a suit-
able and safe model organism for M. tuberculosis research, without the need for BSL3 
facilities. This strain was originally developed as a TB vaccine candidate (12,15) and 
deletions in the leucine and pantothenate biosynthesis pathways render it safe to work 
with under BSL2 conditions, since it does not replicate in the absence of exogenous 
supplementation with leucine and pantothenate. Importantly, we compared M. 
tuberculosis ΔleuDΔpanCD to M. tuberculosis H37Rv with regards to in vitro and intra-
macrophage growth, response to anti-tuberculosis (TB) agents, genetic background, 
proteomic response to acid stress and host immune response. Our data supports the 
suitability of the attenuated strain as a model for TB research.
figure 4. fluorescence dilution demonstrates reduced replication of M. tuberculosis 
ΔleuDΔpanCD under acid stress in comparison to M. tuberculosis H37Rv. M. tuberculosis H37Rv 
and M. tuberculosis ΔleuDΔpanCD containing pTiGc was cultured in the presence of 4 mM theophyl-
line (Theo), before removal of theophylline and exposure to pH 4.5 and pH 6.5 for 48 hours prior to 
analyses by flow cytometry. Flow cytometry histograms demonstrate increased TurboFP635 fluo-
rescence intensity in acidic media (pH 4.5, red), compared to normal media (pH 6.5, green) in M. 
tuberculosis ΔleuDΔpanCD (panel A) after 48 hours. In contrast, M. tuberculosis H37Rv demonstrated 
similar, reduced, TurboFP635 fluorescence intensity after 48 hours in acidic media (pH 4.5, red) and 
control media (pH 6.5, green) (panel b). Representative examples of three independent biological 
repeats are shown, M. tuberculosis ΔleuDΔpanCD demonstrated reduced bacterial replication (high 
TurboFP635 levels) in response to acid stress after 48 hours compared to M. tuberculosis H37R.
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M. tuberculosis H37Rv and M. tuberculosis ΔleuDΔpanCD replicated at similar rates in 
vitro and in murine macrophages; this replication was not influenced by carriage of an 
additional plasmid. In addition, the auxotrophic nature of M. tuberculosis ΔleuDΔpanCD 
allows for growth limitation, by removal of either pantothenate (as shown here), or 
leucine, or both supplements (12). This could provide a useful and tractable stress 
model as a complement to other commonly used dormancy models (32–36) for inves-
tigating latent TB in vitro.
A major goal in the field of TB drug development is shortening the course of therapy by 
identifying new drugs. Being able to do so without the need for a BLS3 facility would 
greatly decrease cost and increase accessibility to perform drug testing and screening. 
As proof-of-concept, we compared susceptibility to rifampicin and isoniazid, key first-
line TB drugs with different mechanisms of action. Our study shows similar MICs of 
rifampicin and isoniazid for M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv, 
although a slightly increased sensitivity was observed for rifampicin for M. tuberculosis 
ΔleuDΔpanCD compared to M. tuberculosis H37Rv. Differences in the observed rifampi-
cin sensitivity for M. tuberculosis ΔleuDΔpanCD could be attributed to the MICs being 
determined using serial two-fold dilutions according to the 1% proportion method; 
the actual MIC value may therefore be anywhere between the highest drug concentra-
tion that allows growth and the last dilution inhibiting growth. The MIC measured for 
figure 5. cytokine secretion in response to M. tuberculosis ΔleuDΔpanCD and M. tuberculosis 
H37Rv. Cytokine release was assessed by Luminex analyses of supernatants from PBMCs. Cells were 
seeded at 5x105 cells per well in a 48 well plate and infected with M. tuberculosis ΔleuDΔpanCD and 
M. tuberculosis H37Rv (MOI 10:1) for 24 hours. Lipopolysaccharides (LPS 10 µg/ml) and uninfected 
cells were included as controls. Supernatants were analysed by multiplex assays using the Bio-Plex 
platform. The log-transformed data were analysed using a one-way ANOVA with a Tukey Honest 
Significant Differences (HSD) post hoc test. A p-value of < 0.05 was regarded as significantly different. 
All experiments were performed in technical triplicates.
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H37Rv may therefore not be 2X the MIC obtained for the attenuated auxotrophic strain, 
since the precision of the method is considered to be approximately 1 two-fold concen-
tration. The observed difference in the MIC for rifampicin between the two strains is 
therefore within the expected variability of the assay (37,38). However, testing a wider 
range of anti-TB agents with different mechanisms of action would provide a more 
comprehensive overview of the inhibition of both strains.
Comprehensive proteomic analysis demonstrated a high level of similarity between 
M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv when grown under physiologi-
cal conditions in vitro. Only 20 differentially regulated proteins were identified when 
M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv were grown at pH 6.5, of which 
16 were more abundant and four were less abundant in M. tuberculosis ΔleuDΔpanCD. 
As expected, PanC were absent in M. tuberculosis ΔleuDΔpanCD, which corresponds 
with the deletion of the panCD region from the attenuated M. tuberculosis strain (12,15).
Potentially also linked to the panCD deletion, we observed an increase in relative 
abundance of a type III pantothenate kinase (CoaX) and a 3-methyl-2-oxobutanoate 
hydroxymethyltransferase (PanB) that play a role in pantothenate metabolism. PanB 
upregulation is likely as a result of altered pantothenate metabolism introduced dur-
ing construction of the M. tuberculosis ΔleuDΔpanCD strain. Supplementation with 
pantothenate in the culture medium rescues the growth defect incurred by deletion 
of panCD (as previously shown). Pantothenate is phosphorylated during Coenzyme A 
(CoA) biosynthesis, and CoaX could contribute to the phosphorylation of supplemented 
pantothenate (39).
An alkyl hydroperoxide reductase C, AhpC, and an alkyl hydroperoxide reductase, 
AhpD, were more abundant in M. tuberculosis ΔleuDΔpanCD during growth at pH6.5. 
AhpD reduces the active site cysteines in AhpC, an NADH-dependent thiol peroxidase, 
required for the detoxification of peroxides (40,41). Furthermore, a conserved protein 
(Rv1531) predicted to have peroxiredoxin activity was also more abundant in M. tuber-
culosis ΔleuDΔpanCD. This indicates that M. tuberculosis ΔleuDΔpanCD may experience 
increased oxidative and/or nitrosative stress during growth under physiological condi-
tions, as compared to M. tuberculosis H37Rv. The transcriptional regulatory protein 
DevR/DosR was also more abundant in this strain, further supporting a stress response 
in M. tuberculosis ΔleuDΔpanCD (Supplementary Figure S1). To assess the possibility 
that the increased DevR/DosR abundance could be caused by excess clumping of the at-
tenuated strain, we performed Ziehl-Neelsen staining of the 2 strains following culture 
in the presence and absence of Tween 80, as well as at pH4.5 or pH 6.5 (Supplementary 
Figure S2). This demonstrated no difference in clumping of the attenuated auxotrophic 
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strain compared to the M. tuberculosis H37Rv strain in any of these conditions, indicat-
ing that clumping did not influence the DevR/DosR abundance. DevR/DosR is involved 
in initiating the dormancy response in mycobacteria during exposure to a number of 
stresses (42–48). Taken together, these results indicate that the proteomic profile of 
M. tuberculosis ΔleuDΔpanCD in normal in vitro culture conditions largely recapitulates 
that of M. tuberculosis H37Rv. However, the attenuated strain may be skewed towards a 
stress response, which should be taken into account during experimental design.
We further probed the stress response of the attenuated strain by comparing pro-
teomic profiles of M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv following 
exposure to acid stress. Here, 28 differentially regulated proteins were identified when 
M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv were exposed to pH 4.5 for 48 
hours, of which 24 were more abundant and four were less abundant in M. tuberculosis 
ΔleuDΔpanCD. As expected, PanC was less abundant in acid-stressed M. tuberculosis 
ΔleuDΔpanCD when compared to acid-stressed M. tuberculosis H37Rv.
We observed several proteomic differences that indicate a possible increased propensi-
ty of M. tuberculosis ΔleuDΔpanCD to enter a heightened stress state over M. tuberculosis 
H37Rv. A dormancy-associated translation inhibitor (DATIN, Rv0079) that forms part 
of the DosR regulon was more abundant in acid-stressed M. tuberculosis ΔleuDΔpanCD 
(49,50). DATIN gene expression has previously been shown to be upregulated in hypoxic 
conditions (35) and to induce pro-inflammatory cytokine expression via interaction 
with Toll-like receptor 2 (51). A universal stress protein Rv3134c, also a member of the 
dormancy regulon, was more abundant in acid-stressed M. tuberculosis ΔleuDΔpanCD. 
This gene is the first member of the Rv3134c-devR-devS operon and has been shown 
to be upregulated during exposure to carbon monoxide (48,52), nitric oxide (35) and 
hypoxic conditions (42). Another member of the dormancy regulon, Rv1738, was also 
more abundant in acid-stressed M. tuberculosis ΔleuDΔpanCD . The Rv1738 gene has 
been shown to be upregulated during exposure to hypoxia (42), carbon monoxide (48) 
and nitric oxide (52).
LeuA is involved in leucine biosynthesis and could reflect leucine starvation in the 
auxotrophic M. tuberculosis ΔleuDΔpanCD strain under acidic conditions. It is highly 
likely that leucine import could be affected under acidic conditions, placing further 
stress (in addition to the acidic stress) on M. tuberculosis ΔleuDΔpanCD. Collectively, 
our proteomic results suggest that M. tuberculosis ΔleuDΔpanCD may exhibit a height-
ened stress response with associated metabolic changes. Specifically, exposure to an 
experimentally-induced stress (48 hours exposure to pH 4.5) exacerbated this stress 
response in M. tuberculosis ΔleuDΔpanCD. The M. tuberculosis ΔleuDΔpanCD strain can 
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thus serve as an ideal model to study stress responses in M. tuberculosis under BSL2 
conditions. Furthermore, exploiting a dual-fluorescent replication reporter and flow 
cytometry we demonstrated markedly slower M. tuberculosis ΔleuDΔpanCD replica-
tion in response to acid stress after 48 hours of exposure, compared to M. tuberculosis 
H37Rv. It is thus tempting to speculate that the M. tuberculosis ΔleuDΔpanCD strain 
will enter a viable, but non-replicating (“dormant” or “persister”) state more readily 
than M. tuberculosis H37Rv when exposed to unfavourable conditions. However, this 
hypothesis requires further validation.
Another important potential application of attenuated strains is for immunological 
assays. Although BCG has been widely used for this (53,54), it lacks the RD1 region and 
as a result it does not secrete many immunogenic proteins. Often cytokine production 
levels are a major concern with regards to host cells infected by attenuated strains, 
since many of them have essential immunogenic proteins missing. Here we show 
that cytokine and chemokine production by PBMCs from individuals infected with M. 
tuberculosis ΔleuDΔpanCD is not restricted and that several key cytokines (RANTES, 
GROα, SDF-1 and IL-1B) are produced at comparable levels by PBMCs infected with 
M. tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv. While the research question 
would need to be considered, M. tuberculosis ΔleuDΔpanCD would in many instances be 
a good representative strain to use as a BSL2-appropriate alternative to M. tuberculosis 
H37Rv for immunological assays. Interestingly, we observed a higher inflammatory 
phenotype for PBMCs infected with the attenuated M. tuberculosis strain in comparison 
to the laboratory strain, H37Rv. Specifically, TNFα, GM-CSF, MIP-1α, IL-12p70 and IFNγ 
were produced at higher levels by PBMCs infected with M. tuberculosis ΔleuDΔpanCD 
than those infected with M. tuberculosis H37Rv. IL-12 plays an important role in 
anti-tuberculosis cell-mediated immunity, and in addition to IL-18 are regarded as the 
primary inducers of IFNy production in inflammatory reactions (55–57). Several M. 
tuberculosis strains from different genetic backgrounds have demonstrated differences 
in the inflammatory response they elicit (58–60). More specifically, the response of hu-
man macrophages to evolutionarily modern strains (bearing the TbD1 deletion, such as 
Euro-American and Beijing strains) showed a lower cytokine and chemokine produc-
tion compared to ancestral strains (59). Also, macrophages infected with non-Beijing 
strains such as Haarlem and LAM, showed heterogeneous cytokine and chemokine 
production compared to the Beijing strains that tend to induce homogeneously low 
cytokine and chemokine production. A more recent study has specifically shown that 
modern Beijing strains show less induction of IL1-B, IFNγ and IL-22 in vitro, compared to 
ancient Beijing and Euro-American reactivation strains (60). Despite the highly similar 
genetic background, the attenuated M. tuberculosis ΔleuDΔpanCD strain elicited higher 
production of analysed cytokines, akin to the more ‘ancient’ M. tuberculosis lineages. 
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Our proteomic analysis indicated increased production of DATIN in acid-stressed M. 
tuberculosis ΔleuDΔpanCD, which have previously been implicated in increased proin-
flammatory cytokine expression (51). It is therefore tempting to speculate that this may 
contribute to increased inflammatory responses, but this remains to be experimentally 
determined.
coNcLusIoN
We provide comprehensive evidence to support the judicious application of M. tubercu-
losis ΔleuDΔpanCD as a model organism for TB research. The strain recapitulates many 
characteristics of non-attenuated M. tuberculosis H37Rv, and is especially suitable for 
researchers interested in working with M. tuberculosis where access to BSL3 facilities 
is restricted or unavailable, or where specific instrumentation may not be available 
in a BSL3 setting. M. tuberculosis ΔleuDΔpanCD may find application in growth-based 
assays, drug testing, studies of dormancy/persistence, omics analysis (transcriptomics, 
proteomics and lipidomics), depending on research needs. As with all other models, its 
suitability should be carefully considered in the context of the research question. How-
ever, findings reported here can assist researchers with making an informed choice 
when using model organisms for tuberculosis research.
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supplementary figure 1: Log2 LfQ intensities of DevR in M. tuberculosis ΔleuDΔpanCD and M. 
tuberculosis H37Rv during acid stress. No difference in DevR expression was observed between the 
two strains in acidic conditions (corrected p-value of 0.06), based on a Benjamin-Hochberg correc-
tion for multiple hypothesis testing. Differences in DevR expression levels are observed between M. 
tuberculosis ΔleuDΔpanCD and M. tuberculosis H37Rv during acid stress, when analyzing protein LFQ 
intensities without correction for multiple hypothesis testing.
supplementary figure 2: Ziehl-Neelsen staining demonstrated no difference in clumping of the at-
tenuated auxotrophic strain compared to the M. tuberculosis H37Rv strain in the presence and ab-
sence of Tween 80 (panel A) in media with pH 4.5 or pH 6.5 (panel B).
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AbsTRAcT
We previously reported on the characterisation of a leucine and pantothenate double 
auxotroph of M. tuberculosis. The leucine auxotrophy provides the opportunity to label 
the proteome of M. tuberculosis and quantitatively study various process within the 
proteome. We expand on the work presented previously by characterising temporal 
quantitative differences in protein abundance, early quantitative phosphorylation and 
protein homeostasis in response to acidic stress. We find that the majority of proteins 
are downregulated over time regardless of their importance to combat acidic stress, 
suggesting a metabolic shutdown. We find that the Type VII secretion system has a sug-
gested role in the response to acid stress as well. This system is upregulated at 24 hours 
post stress while most other proteins are downregulated. Furthermore, the system is 
active at 45 minutes of acid stress as evident through increased phosphorylation and 
is kept in a steady state during active growth. We also find that amino acid import or 
utilisation is almost completely abolished in the presence of low pH, an effect that 
is immediately visible. Our results provide deeper understanding into the proteome 
response of M. tuberculosis to an important intracellular stress and further displays the 
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INTRoDucTIoN
Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), a chronic granu-
lomatous lung disease. The complexity of this disease, coupled with increased drug 
resistance in M. tuberculosis, has ensured that TB remains one of the deadliest infec-
tious diseases worldwide. This is exemplified by the fact that 130 new TB cases per 100 
000 and 1.2 million TB-related deaths were reported globally to the WHO in 2020 (1).
M. tuberculosis is a highly specialized pathogen with a small genome specifically evolved 
to survive within human macrophages. This pathogen is equipped with numerous 
strategies to circumvent host-derived stresses and can persist for prolonged periods of 
time by entering a dormant state. One of the first host responses to phagocytosed ba-
cilli is exposure to acidic pH in the phagsomal compartment of activated macrophages 
(2). One of the key M. tuberculosis responses is to circumvent macrophage acidifica-
tion by the ESX-1 secretion system (3). Thus M. tuberculosis located within its natural 
environment can experience acidic stress. This is achieved by blocking acidification 
which maintains the phagosome within a relatively neutral pH range (4–7). However, 
when the macrophages are activated by other components such as interferon gamma 
the phagosomal pH can drop significantly (8,9). As acid stress is clearly an important 
queue for the response of M. tuberculosis, studying the response of the bacillus can 
provide insights into the mechanisms employed by this pathogen to survive adverse 
environments. Proteomics has a number of distinct advantages over approaches 
such as transcriptomics for gaining insights into cellular processes. Some of these 
advantages include information on mature functional proteins, post-translational 
modification and spatial activity of the protein, all of which are lost in the genome and 
transcriptome. Indeed, a major consideration to note when investigating a time course 
response of M. tuberculosis is that there is a low correlation between the transcriptome 
and the proteome (10,11). Stable isotope labelling of amino acids in cell culture (SILAC) 
is a powerful method to quantify relative protein abundance with high accuracy. This 
technique is based on the differences of masses between the natural or “light” atomic 
mass compared to a “heavy” isotope which is expressed as a ratio of heavy/light. Eu-
karyotic cells take up essential amino acids from the environment, thus any essential 
amino acids can theoretically be used for SILAC-based proteomics. However, bacteria 
are able to synthesize amino acids naturally and more likely to follow this approach 
instead of relying on environmental amino acids. Deleting key steps in the amino acid 
biosynthesis pathway forces the bacteria to take up amino acids from the environ-
ment. Previously we have reported on an auxotrophic mutant of M. tuberculosis which 
is deficient in leucine biosynthesis (12). This provides a unique opportunity to label 
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M. tuberculosis metabolically in a BSL-2 environment. This extends the auxotrophic M. 
tuberculosis strain as a powerful model for studying M. tuberculosis processes.
Here we used a SILAC-based approach to study a temporal M. tuberculosis response to 
acid stress by investigation protein expression, quantitative regulation of post-trans-
lational modifications and protein turnover. By using the aforementioned approaches 
we performed a system-wide characterization of M. tuberculosis response to acid stress 
by using auxotrophic M. tuberculosis as a close genetic model. We identified increased 
synthesis of multiple virulence related proteins and dynamic phosphorylation of target 
proteins within the ESX-1 secretion system in response to acid stress. We further report 
a global reduction in protein synthesis and a shutdown of amino acid transport, both of 
which indicate a shutdown in of cellular systems and priming of the bacteria to enter a 
dormant state. This is the first large-scale study of M. tuberculosis stress response which 
encompasses multiple levels of regulation using fully quantitative methods. We further 
argue for the continued use of auxotrophic M. tuberculosis as a model for quantitative 
proteomics experiments which can be easily extended to other conditions.
MATERIALs AND METHoDs
M. tuberculosis culture conditions.
M. tuberculosis H37Rv ΔleuDΔpanCD (13), a severely attenuated mutant of M. tuberculo-
sis (subsequently referred to as SAMMtb), was used in this study. SAMMtb was grown 
in modified Sauton’s broth (0.4% L-asparagine, 0.4% glucose, 0.2% citric acid, 0.05% 
monopotassium phosphate, 0.05% magnesium sulphate, 0.005% ferric ammonium 
citrate, 0.001% zinc sulphate and 0.05% Tween-80) supplemented with 50 µg/ml L-
leucine, 24 µg/ml pantothenate and 50 µg/ml hygromycin-B. Cultures were maintained 
at 37°C without shaking. The effect of pH on SAMMtb growth was assessed by moni-
toring growth at pH 7.0, 5.0 and 4.5 using optical density (OD600nm) measurements at 
predetermined intervals. All cultures were inoculated at an OD600nm of 0.05 during this 
study, except where stated otherwise.
M. tuberculosis culturing conditions for stable isotope labelling by 
amino acids in cell culture.
SAMMtb was cultured in modified Sauton’s broth as previously described, containing 
either 50 µg/ml “light” L-leucine (Leu0) or 50 µg/ml “heavy” L-leucine-5,5,5-d3 (LeuD3). 
SAMMtb was cultured for five weeks, with weekly sub-cultures in fresh media, to allow 
incorporation of LeuD3. Incorporation was verified by tandem mass spectrometry (as 
described below) and LeuD3 incorporation efficiency (%) was calculated using the 
83
3
chapter 3  |  M. tuberculosis during acid stress
formula = [H/L] median/(1 + [H/L] median)*100 (14). An incorporation efficiency of > 
98% of LeuD3 was achieved within five weeks.
Acid stress exposure of M. tuberculosis for phosphoproteome and 
proteome analysis.
Experiments were performed during mid-exponential phase (OD600nm of 0.8-1.0). SAM-
Mtb cultured in LeuD3 was exposed to pre-warmed modified Sauton’s broth without 
Tween-80 at pH 4.5, whereas M. tuberculosis cultured in Leu0 served as control samples 
(i.e. pre-warmed Sauton’s broth without Tween-80 at pH 7.0). A label swop was intro-
duced to account for possible metabolic changes during label incorporation. SAMMtb 
cells were exposed to acidic (pH 4.5) and control (pH 7.0) conditions for 45 min and 
24 hours. Experiments were performed in biological duplicate for phosphoproteomics 
analysis and biological triplicate for proteomics analysis. SAMMtb cells were pelleted 
(4 000 xg, 10 min, 4°C) at each time point and washed twice with ice-cold PBS pH 7.4. 
Cells were subsequently stored at -80°C until further use.
Pulse-chase in M. tuberculosis.
Experiments were performed in biological duplicate, and during the mid-exponential 
phase of growth (OD600nm of 0.8-1.0). SAMMtb was cultured in modified Sauton’s broth, 
containing 0.05% Tween-80, 24 µg/ml pantothenate and 50 µg/ml Leu0. Cells were cen-
trifuged (4 000g, 10 min, 25˚C) and washed twice with pre-warmed PBS pH 7.4 before 
exposure to pre-warmed modified Sauton’s broth, without Tween-80 but containing 50 
µg/ml LeuD3, at pH 7.0 and 4.5, respectively. Cultures were harvested by centrifugation 
(4 000g, 10 min, 4°C) at 0, 3, 6, 12, 24 and 48 hours. SAMMtb cells were washed twice 
with ice-cold PBS pH 7.4 and stored at -80°C until further use.
filter-aided sample preparation for phosphoproteome analysis.
Samples were processed using a modified version of the filter-aided sample prepara-
tion (FASP) method (15). Briefly, samples from each matched SILAC condition (i.e. 
control and acid stress) were mixed in a 1:1 ratio, and 2.6 mg total protein (1.3 mg from 
each SILAC state) was processed for phosphoproteome analysis. Combined samples 
were reduced with 5 mM tris-2-carboxyethyl-phosphine (TCEP) at 25°C for 1 hour, and 
subsequently alkylated with 5.5 mM iodoacetamide at 25°C for 1 hour in the dark. The 
reduced and alkylated samples were transferred to a 15 ml Amicon 30kDa cut-off spin 
filter (Millipore) and centrifuged (4 000 xg, 30 min, 25˚C). Two ml UA buffer (8 M urea 
in 50 mM TEAB) was added to the filter and the samples were centrifuged (4000 g, 30 
min, 25˚C). This process was repeated twice for a total of three UA washes. Two ml 50 
mM TEAB was added to the filter and the samples were centrifuged (4000g, 30 min, 
25˚C). This process was repeated twice for a total of three TEAB washes. Proteins were 
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on-filter digested for 24 h at 37 °C, using a 1:50 ratio of trypsin (Promega) to protein. 
The filter unit was placed in a new collection tube after overnight digestion, and the 
peptides were obtained in the flow-through by centrifugation (4000 xg, 30 min, 25 °C). 
Peptides were concentrated by lyophilisation.
Phosphopeptide enrichment.
Peptides were desalted using Sep-Pak C18 cartridges (Waters) and dried prior to 
phosphopeptide enrichment. Phosphopeptides were serially enriched from 2.5 mg 
starting material and the MagReSyn® Ti-IMAC microspheres (ReSyn Biosciences), 
the MagReSyn® TiO2 microspheres (ReSyn Biosciences) and the MagReSyn® ZrO2 mi-
crospheres (ReSyn Biosciences), respectively. Enrichments were performed as rec-
ommended by the manufacturer. Briefly, microspheres were resuspended by vortex 
mixing and placed in a magnetic separator. Microspheres were washed with 70% 
ethanol with gentle agitation for 5 minutes. This wash step was repeated once more. 
The microparticles were subsequently washed with 1% NH4OH and gentle agitation for 
10 minutes. Microparticles were equilibrated with loading buffer (1M glycolic acid in 
80% ACN, 5% Trifluoroacetic acid (TFA)), for 1 minute. This was followed by a total of 
three washes with loading buffer. For phosphopeptide enrichment, the equilibrated 
TiO2 microparticles were resuspended in peptide samples dissolved in loading buffer. 
The samples were incubated for 20 minutes at room temperature with continuous mix-
ing. Samples were placed in a magnetic separator, the supernatant was removed and 
sequentially added to pre-equilibrated ZrO2 and Ti-IMAC microparticles, respectively. 
Samples were incubated as described above. Unbound peptides were removed by 
washing with loading buffer and gentle agitation for 1 minute. Non-specifically bound 
peptides were removed by washing with wash buffer (80% ACN and 1% TFA), for 2 
minutes with gentle agitation. This step was repeated for a total of two washes. Two 
additional wash steps were performed using of 10% ACN and 0.2% TFA. The bound 
phosphopeptides were extracted using elution buffer (1% NH4OH) and incubated for 15 
minutes with continuous mixing. Three elution steps were performed. Samples were 
desalted using STAGE tips, prepared with Empore C18 SPE Disks (Sigma-Aldrich, St 
Louis, USA), and dried before storage at -20°C.
filter-aided sample preparation for proteome analysis.
One hundred micrograms of total protein (i.e. 50 µg per SILAC state) was processed 
for proteome analysis. Combined samples were reduced and alkylated, as described 
above. The reduced and alkylated samples were transferred to a 0.5 ml Amicon 30 kDa 
cut-off spin filter (Millipore), and centrifuged (14 000 xg, 15 min, 25 ˚C). Four hundred 
microliters UA buffer (8 M urea in 100 mM Tris-HCl, pH 8.5) was added to the filter 
and the samples were centrifuged (14 000g, 15 min, 25 ˚C). This process was repeated 
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twice for a total of three UA washes. Four hundred microlitres 50 mM TEAB was added 
to the filter and the samples were centrifuged (14 000g, 15 min, 25˚C). This process 
was repeated twice for a total of three TEAB washes. Proteins were on-filter digested 
for 24 h at 37°C, using a 1:50 ratio of trypsin to protein. The filter unit was placed in 
a new collection tube after overnight digestion and the peptides were obtained in the 
flow-through by centrifugation (14 000g, 15 min, 25˚C). The peptides were dried in a 
vacuum concentrator and stored at -80°C until further analysis.
Peptide desalting and fractionation.
Peptides (40 µg) from the 45 min and 24 h acid exposure experiments, as well as the 
0 h time point of the protein turnover experiment, were fractionated using STAGE-
tip-based fractionation. Peptides were sequentially eluted from STAGE-tips using an 
increasing gradient of ACN in 10 mM TEAB (5%, 7.5%, 10%, 12.5%, 15%, 17.5%, 25% 
and 50%). Non-consecutive fractions were concatenated to obtain 4 fractions. Frac-
tions were then vacuum dried and stored at -80°C.
Lc-Ms/Ms analysis.
Peptides were dissolved in 2% acetonitrile, containing 0.1% formic acid, and each 
sample was analysed, independently, on an Orbitrap Fusion Tribrid mass spectrometer 
(Thermo Fisher Scientific), connected to a Thermo Scientific UltiMate 3000 RSLCnano 
System (Thermo Fisher Scientific). Peptide separation was performed on a PepMap 300 
C18 LC pre-column (300 µm ID x 5 mm, 5 µm, 300 Å), followed by separation on an 
analytical column (75 µm ID x 350 mm) packed with C18 Aeris Peptide 3.6 µm beads 
(Phenomenex 04A-4507), at a flow rate of 300 nL/min. Solvent A was 2% acetonitrile in 
0.1% formic acid, and solvent B was 100% acetonitrile in 0.1% formic acid. The gradi-
ent used was as follows: solvent B was maintained at 2% for 5 min, followed by an 
increase from 2 to 10% B in 5 min, 10-35% B in 65 min, 35-50% B in 10 min, 50-80% 
B in 0.1 min, and maintained at 80% B for 10 min. The Orbitrap Fusion was operated 
in positive ion data-dependent mode for Orbitrap-MS and Orbitrap-MS2 data acquisi-
tion. Data were acquired using the Xcalibur software package. The precursor ion scan 
(full scan) was performed in the Orbitrap in the range of 350-1500 m/z with a nominal 
resolution of 120 000 at 200 m/z. The number of accumulated ions was set to 4 x 105. Ion 
filtering for Orbitrap-MS2 data acquisition was performed using the quadrupole with 
a transmission window of 1.5 m/z. The most intense ions above an intensity threshold 
of 5 × 103 were selected for high-energy collisional dissociation (HCD). For proteome 
samples, an HCD normalized collision energy of 32.5% was applied to the most intense 
ions, and fragment ions were analysed in the Orbitrap at a resolution of 30 000. The 
settings for phosphoproteome analysis were the same, except that an HCD normalized 
collision energy of 28% was used. The number of Orbitrap-MS2 events between full 
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scans was determined on-the-fly to maintain a 3s fixed duty cycle. Dynamic exclusion 
of ions within a ±10 ppm m/z window was implemented using a 30 s exclusion duration. 
An electrospray voltage of 1.9 kV and capillary temperature of 280°C, with no sheath 
and auxiliary gas flow, was used. The automatic gain control (AGC) settings were 4 × 105 
ions with a maximum ion accumulation time of 50 ms for Oribtrap-MS, and 5 × 104 ions 
with a maximum ion accumulation time of 50 ms for Orbitrap-MS2 scans, respectively. 
Ions with <2+ or undetermined charge state were excluded from MS2 selection
Mass spectrometry data analysis.
All tandem mass spectra were analysed using MaxQuant 1.6.0.16 (16) and searched 
against a customized M. tuberculosis proteome database using the built-in Andromeda 
search engine (17,18). Custom database construction was performed as previously de-
scribed (12). Briefly, proteins containing single amino acid variants, derived from WGS 
analysis, were concatenated to the M. tuberculosis reference proteome (downloaded 
from Uniprot on 26 September 2017, containing 3993 entries). The custom M. tuber-
culosis database contained 4012 entries. Peak list generation was performed within 
MaxQuant and searches were performed using default parameters. Strict criteria for 
peptide and protein identification was implemented to control the false discovery rate 
(FDR) at < 0.01. LeuD3 was specified as heavy label during SILAC data analysis. Carb-
amidomethylation of cysteine was set as fixed modification, and oxidized methionine 
and N-terminal acetylation was used as variable modifications in proteome searches. 
The same settings were used for phosphoproteome analysis with the addition of phos-
phorylation on serine, threonine, and tyrosine as variable modification. Two missed 
tryptic cleavages were allowed. The “match between runs” and “re-quantify” options 
were enabled during database searches. For the incorporation check and protein turn-
over analysis, both these settings were ommited. Proteins were considered confidently 
identified when they contained at least 2 unique tryptic peptides per protein. Proteins 
that contained similar peptides, that could not be differentiated based on tandem mass 
spectrometry analysis alone, were grouped to satisfy the principles of parsimony. All 
contaminants, reverse hits, and proteins only identified by site were removed before 
downstream data analysis. Phosphorylation sites in phosphorylated peptides were 
considered as high confidence sites when they had a posterior error probability (PEP) 
of <0.01 and a localization probability of >0.75.
Protein turnover data analysis.
SILAC ratios (non-normalized) obtained from MaxQuant were used for protein turn-
over analysis. The rate of light signal degradation and half-lives were calculated as pre-
viously described (19). Briefly, ratios were filtered for each protein to contain at least 
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three ratios across all five time points analysed, and were subsequently transformed 
using equation 1 to yield r, where r is the transformed ration and R is the raw ratio.
r = In (R + 1) (1)
The coefficient of determination (R2) was calculated after transformation of the data set 
and only values greater than 0.85 were used for further calculations. Next, we deter-
mined the slope (Kdeg) and corrected for signal dilution (Kdp) as a result of mycobacte-
rial doubling, which is represented in equation 2 and 3, where ti represents each time 






Using the slope, it is possible to derive a first order reaction equation and calculate 
half-life (T1/2) as shown in equation 4.
 (4)
From the degradation rate and half-life, certain classes were defined as previously 
described (20). Class I was defined as (Kdeg ≥ 2xKdill), class II as (0.5xKdill ≤ Kdeg ≥ 
2xKdill) and Class III as (Kdeg ≤ 2xKdill). This translates to proteins that have a degra-
dation rate twice as fast as the dilution rate (Class I), proteins that degrade faster than 
half the mycobacterial doubling time (Class III) and proteins that fall between these 
two definitions (Class II).
REsuLTs
Time-dependent proteome analysis of M. tuberculosis during acid 
stress
Acidification of the phagolysosome by macrophages is an important early strategy to 
kill and process phagocytosed pathogens for further immune response (21). The lack 
of macrophage acidification in M. tuberculosis can be tied to the absence of a vacuolar 
proton-ATPase (22,23). For continued growth, M. tuberculosis maintains the intracel-
lular pH at an approximate pH of 6.2 and a pH below 5 can arrest growth (24,25). Activa-
tion of the immune system by interferon gamma can overcome the acidification block 
imposed by M. tuberculosis and acidify the compartment to a pH range between 4.5 
and 5.0. In in vitro experiments the intracellular pH of M. tuberculosis is maintained at 
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neutral even in the presence of highly acidic environments (26). This indicates that M. 
tuberculosis is able to survive the pH drop and is also metabolically active and thus able 
to maintain the intracellular pH. Furthermore, studies have shown that M. tuberculosis 
can maintain this state for extended periods of time and rapidly restart transcription 
once optimal conditions are restored (27–29).
We sought to identify downstream proteome changes in SAMMtb during acid stress. 
Heavy labelled mycobacteria were exposed to acidic conditions (pH 4.5) or physiologi-
cal pH (pH 7.0) for 45 min and 24 h. The proteomes were harvested and the contents 
were analysed by tandem mass spectrometry. Principal component analysis revealed 
a clear separation in the first component between the two time points and little to 
no separation in the second component (Figure 1A). This indicates that there is little 
variation between replicates and the majority of variation is driven by the duration of 
the experiment. To find the source of this variation, we performed hypothesis testing 
on the 2093 protein groups, and found significant upregulation of 23 proteins while 322 
were significantly downregulated at 24 hours exposure (Figure 1B, Data S1, Table 1). As 
there is a large number of downregulated proteins, we used gene ontology enrichment 
analysis to extract the major processes involved using a hypergeometric test. To iden-
tify a common role for the downregulated proteins, we only considered the child terms 
from the biological processes. A total of 172 nodes from biological processes (2173 total 
nodes) were identified where the top 10 most enriched terms fell within this parent 
node all with an odds ratio above 1 and a mean odds ratio of 10 (Supplemental figure 1). 
These were mainly associated with DNA and processes surrounding its synthesis and 
degradation. DNA is susceptible to acidic stress and these processes are likely in place 
to prevent DNA damage from accumulating (30).
To gain more insight into this data, we extracted the top 20 most significantly up-
and-downregulated proteins as identified after 24 hour exposure and visualised the 
abundance change over time (Figure 1C). As predicted by the hypothesis testing, there 
was no difference in the protein expression of these proteins at 45 minutes of exposure. 
Interestingly, the majority of downregulated proteins formed part of the Dos regulon 
(31). Prominent members included Rv2623 and HspX which are both associated with 
the negative regulation of growth (32,33). In addition, a distinct cluster of upregulated 
proteins formed within the significantly regulated proteins (Figure 1C). These included 
TcrX (a member of the two component regulatory system), Rv2558 (involved in the cel-
lular response to starvation), PrpD (catabolism of fatty acid via TCA cycle) and Rv3174 
(a short chain dehydrogenase). Furthermore, Rv1425 (involved in the stress response 
to hypoxia and nitric oxide), and MymA (involved in to maintaining cell membrane 
permeability and mycolic acid composition during acid stress) was present as well. The 
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figure 1: Quantitative proteomics reveals major down regulation of proteins after 24 hours ex-
posure pH 4.5. A) Principle component analysis of SILAC ratio’s at 45 minutes and 24 hours. b) 
Volcano plot depicting the fold change and corrected p-value of all proteins at 24 hours post stress 
compared to 45 minutes post stress. Significance was determined by hypothesis testing using Lim-
ma and Benjamini-Hochberg FDR was applied to the p-values to yield q-values. Points are coloured 
based on this q-value where a q-value below 0.05 as well as a absolute log fold change greater than 
1 was considered significant. c) Heatmap depicting the top 20 up- and downregulated proteins by 
q-value and fold change. Data used for the generation of these graphs were obtained from three 
independent experiments.
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two component system is responsible for cellular signalling by phosphorylation as well 
as mediating cascades in response to environmental signals (34,35). The increase of 
fatty acid metabolism is likely to account for the removal of toxic propionyl co-enzyme 
A, which accumulates during the catabolism of cholesterol (36,37). Fatty acid metabo-
lism and cholesterol has been linked to M. tuberculosis carbon utilisation when grown 
in acidic conditions (38).
Taken together our results show that the bacilli is responding to the low pH by increas-
ing production of virulence factors, utilising alternative energy stores and mediating 
signalling cascades. We also see a global down regulation occurring, which is in line 
with other observations where the bacilli slows down metabolism in preparation to 
enter a dormant state (29). This trend is a general one, where the majority of the pro-
teins are downregulated, a process mediated by the Dos regulon (39–41). Interestingly, 
we found also found upregulated and thus active over time, although fewer in number 
compared to the downregulated profile. As M. tuberculosis is first and foremost an 
intracellular pathogen, it is thus unsurprising that the proteins produced in response 
to acidification are those needed to increase pathogenicity.
Early exposure to acid stress remodels the M. tuberculosis 
phosphoproteome without affecting the proteome.
Phosphorylation plays an important role in M. tuberculosis as evident by 11 protein 
kinases and 12 two component systems (42,43). Phosphorylation cascades are used 
to activate or deactivate proteins (44). This can result in any number of changes and 
has been demonstrated to affect processes such as gene expression in M. tuberculosis 
through PknB (45). To identify the protein phosphorylation patterns, we exposed SAM-
Mtb to acid stress (pH 4.5) and control (pH 7.0) for 45 minutes.
In total, we identified 512 phosphorylated peptides in SAMMtb during exposure to acid 
stress and control conditions. Two hundred and eighty-nine phosphorylation sites had 
a posterior error probability (PEP) score of <0.01 and a localization probability of >0.75, 
which were deemed to be high confidence identifications (46). These phosphorylation 
sites were mainly localised to serine and threonine residues (Supplementary figure 
2A). By comparing the protein abundance to the phosphorylation abundance we found 
that the majority coincide, indicating that the phosphorylation is proportionate to 
the protein content (Figure 2A). Thirty-five phosphorylation sites were regulated by ≥ 
2-fold change after normalising phosphorylation sites ratios to protein ratios (Figure 
2B, supplementary figure 2 B1 – B35). The 35 phosphorylation sites mapped to 33 phos-
phoproteins that are involved in diverse biological processes (Data SI, Table 2).
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Twenty out of the 35 regulated phosphorylation sites we identified, have previously 
been reported in mycobacteria (47–49). The protein with the most abundant phos-
phorylation relative to protein abundance was Rv3407 (VapB47). This protein is part 
of the toxin-antitoxin (TA) protein family and is expressed to counter the effects of the 
VapC47 toxin (50). The TA systems is closely linked to persisters and non-replicating 
states in bacteria (51–54). Previous studies have demonstrated that expression of a VapC 
M. tuberculosis homolog results in a lack of translation which is likely due to RNAse 
activity (50,55). As we do not detect VapC47 within our phosphorylation proteomics 
data it is likely that the increased phosphorylation is stabilising the anti-toxin which 
in turns neutralises the toxin counterpart. Indeed we do see that the majority of VapC 
proteins detected at 24 hours are downregulated compared to their counterparts at 
45 minutes (Figure 1B, Data S1, table 1). As acidic stress can induce DNA damage, this 
enzyme is likely detoxifying nucleotides to remain viable within the environment. Due 
to the low number of regulated phosphorylation sites, typical hypergeometric statistics 
would not identify any significantly enriched groups. As an alternative, we performed 
functional annotation using the definitions provided by Mycobrowser. From this we 
could deduce that a large proportion of the phosphoproteins were localised to the 
cell surface and are involved in protein secretion as well as translocation across the 
membrane (EccCb1, EccC3, EsxB, Rv0394c, TatB, Mmps3). Other phosphoproteins, 
with regulated phosphorylation sites, are associated with roles in signal transduction 
and transcriptional responses (SigH, PknD, RpsA, and GreA), carbohydrate metabolism 
(GlcB), cell wall and lipid metabolism (GlmM, Pks13, CmaA2), cellular homeostasis 
(MoeA1, Rv0688, TrxB),and regulation of cell growth (VapB46, VapB47) (figure 2C). 
While this is an early timepoint, the increased phosphorylation of target proteins likely 
indicate a cellular response to environmental change.
Here we find that increased phosphorylation is primarily associated with the membrane 
itself and regulated by protein kinases. In our results we find PknD has phosphorylation 
sites with more than two fold regulation and PknH has phosphorylation sites between 
1.5 and two fold. Both PknH and PknD have transmembrane sensory domains which 
transduce extracellular signals across the membrane to the cytoplasm (42,56). There is 
indication that PknH is involved in the negative regulation of growth, where deletion 
of this protein results in higher bacillary load in vivo (57), a phenotype we observe 
indirectly at 24 hours. We show widespread changes in the phosphoproteome of M. 
tuberculosis during early exposure to acid stress, while the proteome is yet to change 
during this initial exposure. Phosphorylation changes on S/T/Y residues, together 
with other signalling cascades such as histidine phosphorylation of two-component 
regulatory systems, will induce survival mechanisms in response to changes in the 
environment.
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figure 2: Phosphorylation is dynamic and can be upregulated regardless of protein abundance 
in response to environmental stress. A) Scatter plot depicting the phosphorylation abundance rela-
tive to the protein abundance of the phosphorylated peptides at 45 minutes post stress. The hori-
zontal line indicates the fold change cut off which was set to 2. The abundance of phosphorylated 
proteins is greater than their protein abundance to which they belong. This indicates increased 
phosphorylation relative to the protein abundance. b) Bar graph indicating the distribution of phos-
phorylated peptide abundance in relation to protein abundance. The greater this ratio the more 
phosphorylation is found on the phosphorylated peptides relative to their proteins to which they 
belong. c) Pie chart indicating the number of proteins with regulated phosphorylation sites at 45 
minutes post exposure and their corresponding Mycobrowser annotation. The majority of these 
proteins were associated with the mycobacterial cell wall. The data used to generate these graphs 
were obtained from two independent experiments.
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M. tuberculosis pulse-chase sILAc reveals steady state turnover of 
type VII secretion proteins and shutdown of amino acid transport 
upon acid stress.
Protein turnover is a balance between protein synthesis and degradation, which is 
responsible for maintaining protein homeostasis (proteostasis). Proteostasis is an 
important, and often overlooked, cellular function that maintains proteome integrity 
by recycling old or damaged proteins. Proteostasis can be shifted to accommodate cel-
lular needs in response to environmental stimuli. We used pulse SILAC labelling to 
investigate the rate of global protein turnover, i.e. measurement of newly synthesized 
proteins by tracking Leu0 signal decay over five distinct time points.
During growth at pH 7.0, leucine was increasingly incorporated, with 183 protein 
groups containing heavy leucine after 3h of incubation and 800 protein groups contain-
ing heavy leucine after 48h of incubation (Figure 3A). We could identify three distinct 
classes of proteins based on protein turnover during growth at pH 7.0. These classes 
were was first defined by a study investigating protein turnover in S. cerevisiae and S. 
pombe during growth at physiological pH (20). The three classes represent the rate of 
turnover as a function of protein dilution that occurs naturally due to growth. Briefly, 
class I represents short-lived proteins (half-lives less than 13h), class II represents 
proteins with intermediate half-lives (half-lives between 13 and 57 hours), and class III 
represents long-lived proteins (greater than 57 hours or incalculable). These classes are 
defined based on their half-life distribution which is calculated from the degradation 
rate. At pH 7.0, most proteins were associated with a low corrected degradation rate 
(Kdp) (class III turnover rate), while the least amount of proteins had a fast degradation 
rate (class I) (Figure 3B). In total, six proteins were identified with a rapid turnover, 
42 proteins had an intermediate turnover and 478 proteins were long lived at pH 7.0 
(Figure 3C). The proteins with rapid turnover were involved in lipid metabolism (Ino1 
and PapA1), fatty acid metabolism (AccD6), transcription (Rv1830), DNA replication 
(DnaE1) cell growth (VapB47) (Data SI, Table 3). This observation was unsurprising as 
the bacilli are actively growing and processes such as transcription and replication 
are of importance to cellular survival (58). M. tuberculosis DnaE1 is responsible for the 
proofreading activity and dysfunction of this protein drastically increases the mutation 
rate (59). The rapid turnover of this protein is likely required to maintain its fidelity and 
proofreading capabilities (59). Proteins that provide anti-toxin properties also require 
high maintenance as dysfunctional anti-toxin components can result in self toxicity. 
The class II and III turnover groups had many associated proteins and we therefore 
performed gene ontology enrichment analysis. From the class II enrichments, 3 of the 
top 10 most enriched terms were associated with protein secretion and 2 of these terms 
were associated with interspecies interactions. (Supplementary figure 3A). The class II 
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enrichments are indicative of proteins and the processes they collectively represent 
in steady state. This data thus demonstrates an active growth cycle for the type VII 
secretion system, where the components or effectors are actively maintained. As these 
proteins are membrane bound and the bacteria is not under stress that these proteins 
would undergo a slow turnover. However, M. tuberculosis is a specialized pathogen and a 
steady state of these proteins may indicate their importance as first response elements 
to outside stressors. There is a noticeable delay between transcription and translation 
in M. tuberculosis, it is thus important that the proteins associated with combatting host 
defences are not delayed in their synthesis (60). For the long-lived class III proteins, 
all the top 10 most enriched terms were associated with metabolism and growth of 
the organism, with growth and nitrogen metabolism representing the most enriched 
terms (Supplementary figure 3B). The long lived proteins can display a negative half-
life, due to the measured H/L ratio being smaller than expected for proteins that are 
not degraded within the first doubling. It is certain that the proteins which have nega-
tive half-lives are the most stable. While metabolism was highly enriched it was not 
informative as these processes were too general to draw conclusions from.
Surprisingly, there was very little incorporation of LeuD3 in the proteome of SAMMtb 
during exposure to pH 4.5 over 48 hours. A total of 19 protein groups contained signal 
indicative of heavy leucine incorporation (Figure 3D). From these, we could calculate 
the half-life of two proteins (Data SI, Table 4). The minimal leucine uptake under acidic 
stress indicates that SAMMtb is unable to efficiently import leucine from the growth 
media. Whether this inability is due to SAMMtb becoming metabolically inactive or 
caused by deprotonation and therefore affecting amino acid transporters remains to be 
determined. Therefore, protein synthesis that occurs during acidic stress in SAMMtb 
must rely on amino acids imported early during exposure to acid stress or before. The 
integrity of the proteome must thus be maintained by salvaging amino acids from other 
proteins or by biosynthesis only. As leucine biosynthesis is blocked in the SAMMtb 
strain the source of leucine to sustain expression is likely derived from the remaining 
free leucine available within the cell or through biosynthesis from another source. 
Previous studies by Gouzy et al demonstrated a role for asparagine transport during 
acidic stress. In this scenario asparaginase is released to the extracellular milieu which 
hydrolyses asparagine to aspartate and ammonia. The ammonia buffers the extracellu-
lar environment and aspartate can be imported by AnsP transporter (61). The imported 
aspartate can follow metabolic pathways to synthesise other amino acids and provide 
free nitrogen to the pool (62). It is likely that SAMMtb under stress follows a similar 
pathway and favouring aspartate uptake rather than leucine uptake.
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figure 3: Pulse chase sILAc reveals a shutdown of leucine import upon exposure to acid stress. 
A) Incorporation of leucine at neutral pH (pH 7) at 3 hours, 6 hours, 12 hours, 24 hours and 48 hours. 
Leucine is incorporated steadily within one cell cycle indicating amino acid take up from the envi-
ronment and active protein synthesis. Values atop the bar graph indicate the number of proteins 
with incorporated leucine. b) Density plot indicating the rate constant of each protein as well as the 
classes to which the various proteins belong. The rate constant is used to calculate the half-life of 
each protein. Class I was defined as (degradation rate ≥ 2 x dilution rate), class II as (0.5 x dilution 
rate ≤ degradation rate ≥ 2 x dilution rate) and Class III as (degradation rate ≤ 2 x dilution rate) where 
dilution rate was set to 28 hours. c) Bar graph depicting the number of proteins that correspond to 
each protein turnover class where the values are indicative of the protein count. The majority of pro-
teins are associated with a slow protein turnover during active growth. D) Incorporation of leucine 
at low pH (pH 4.5) at 3 hours, 6 hours, 12 hours, 24 hours and 48 hours. A maximum of 19 proteins 
had heavy leucine incorporated across all time points and thus protein turnover could not be calcu-
lated for bacteria exposed to stress. Ratio’s were calculated from two independent experiments, in 
the cases where one of the replicate had a missing value the corresponding value was used.
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The observations made in the protein turnover of SAMMtb provided important insights 
into the behaviour of M. tuberculosis during active growth as well as acidic stress. The 
most striking observation was almost immediate shutdown of leucine transport during 
acid stress. This has interesting implications for dormancy and how the cell functions 
to sustain protein synthesis. More direct observations in protein turnover were made 
at pH 7. At this pH, a notable result was the use of the type VII protein secretion sys-
tems which were in steady state during active growth. Thus this secretion system and 
interspecies interaction forms an important process for M. tuberculosis regardless of 
the level of stress. Finally the long lived proteins were responsible for cellular metabo-
lism during optimal growth. This is also to be expected as the processes required to 
maintain sustained growth and accumulation of biomass (20), which is the staple of 
active growth.
DIscussIoN
Here we have performed an exhaustive investigation into M. tuberculosis using 
metabolic labelling on a leucine and pantothenate auxotroph of M. tuberculosis (12,13). 
Auxotrophy allows for metabolic labelling of the total proteome using heavy isotopes of 
leucine from which various quantitative proteomics studies are possible. Here we were 
able to exploit this technique to determine the temporal proteome effects, dynamic 
quantitative phosphorylation sites as well as protein homeostasis. Acidification of the 
phagosome is an important innate immune process and necessary for bacterial clear-
ance. The enzymes involved in lysosomal degradation as well as production of reactive 
oxygen species and nitrogen species are optimal at low pH (63,64). M. tuberculosis is a 
facultative intracellular pathogen and has evolved to circumvent host defences such as 
acidification of the phagolysosome (21). Previous studies have also shown that block-
ing of the macrophage acidification is a prerequisite for ESX-1 dependent phagosomal 
escape (65). M. tuberculosis is also able to survive severe acidic conditions that is lethal 
to intracellular pathogens (66,67). Survival in low pH is clearly an important strategy 
employed in M. tuberculosis and a comprehensive overview of the various mechanisms 
has been reviewed previously (25). We investigated the mycobacterial response to low 
pH using the aforementioned techniques in order to understand how the pathogen 
reacts to this stress condition.
We have previously assessed the response of the auxotrophic M. tuberculosis strain 
to low pH and found upregulation of dormancy related proteins, indicating that the 
entrance into dormancy (12). Similar phenotypes have also been previously described 
and characterized by the upregulation of 48 genes (39–41,68). As the direct compari-
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son between acidic pH and neutral pH has been extensively studied, we opted to use 
SILAC to rather study the temporal effects directly. We find a global decrease in the 
cellular response over time, with multiple members of the top 20 downregulated 
proteins associated with the dormancy regulon. These members included proteins 
responsible for mediating the negative regulation of mycobacterial growth such as 
Rv2623, Rv2626c and HspX (32,33). At first glance, it is curious that downregulation 
of multiple dormancy related proteins occurs at 24 hours compared to 45 minutes in 
our SILAC data. However, in our SILAC experiments we measure the collective effect 
of both proteomes over time. Our results thus show that while there are changes oc-
curring due to the stress response, the temporal changes indicate a global decrease 
in protein abundance. The growth rate of M. tuberculosis is significantly retarded in 
response to acid stress and a global down regulation of proteins is thus an indication 
of metabolic shutdown, a known feature of the dormancy phenotype (69,70). Interest-
ingly, we find dormancy related proteins upregulated at the 24 h mark as well. Previous 
studies have demonstrated a low abundance of stable transcripts while in a dormant 
state (29). While only within the first 24 hours, we too observe a cluster of upregulated 
proteins likely involved in maintaining the viability of the bacilli while transitioning 
into dormancy. The most prominent upregulated proteins included a member of the 
two-component system, TcrX. Deletion of the TcrX/TcrY system was found to result in 
increased bacillary growth implying their role in suppressing growth (71). As there is 
a global downregulation of genes, including others involved in suppressing growth, 
the TcrX/TcrY system may be involved in sustaining the signal to suppress growth. In 
addition, fatty acid metabolism and features of cholesterol metabolism were detected 
as well. Previous studies have shown that M. tuberculosis metabolizes cholesterol and 
other lipoproteins within macrophages (72). This response indicates an attempt by M. 
tuberculosis to utilize a specific carbon source during acidic conditions. As there is a 
global shutdown in progress and growth arrest occurs at the pH where these experi-
ments are conducted, this may give indication that M. tuberculosis preferentially will 
utilize fatty acids when confronted with environments mimicking activated macro-
phages (24,25). Indeed, isocitrate lyase, an enzyme involved in metabolizing acetyl-CoA 
from fatty acids, is required for sustained infection (73).
We also detected multiple virulence factors albeit below the 2-fold change cut off. 
These included EccD2 and EccCa1 of the ESX secretion systems. The ESX-1 secretion 
system is well known for its role in combating acidification of host vacuoles (6,74–76). 
At 45 minutes, we found increased phosphorylation of EccCb1, the partner of EccCa1 
(77) . The EccC component of the Type VII secretion systems is an ATPase and in-
creased phosphorylation is a likely indicator of increased activity of the entire secre-
tion system. EsxB allosterically binds to the ATPase pocket domains of EccC which 
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results in an increased ATPase activity (78). It is thus likely that the free phosphates 
are subsequently binding to both EccC and EsxB and are as a result detected at greater 
propensity within the phosphoproteome. As EsxA has a role in controlling phagosomal 
acidification, the increased activity of the ESX-1 system is expected upon sensing envi-
ronmental pH change (65,79,80). Strikingly, this change is observed and implemented 
before any increases in the abundance of ESX components or effectors. It is tempting 
to speculate about the function that phosphorylation of ESX components may entail. 
Partial acidification is key for successful escape from the phagosome and phosphoryla-
tion may be the mechanism used to determine the optimal conditions for escape (81). 
Indeed there is a significant overlap in M. tuberculosis expression profiles in vivo and 
when subjected to pH fluctuation thereby indicating a substantial role for pH as an 
environmental signal (2). It is thus clear that this system plays an extremely important 
role in mediating the bacterial response to its environment. In addition, we found the 
protein turnover rate of type VII secretion components to be within steady state. This 
ensures that there is a steady supply of ESX components ready to increase or decrease 
in activity upon necessity by the bacilli and further demonstrates the importance of 
the type VII secretion system to the bacilli.
We were unable to calculate protein turnover rates in the acid stressed bacilli due to 
a lack of leucine uptake. As protein turnover was calculable at neutral pH, the acidic 
extracellular milieu must have an effect on leucine transport across the membrane. We 
previously speculated that acidic environments may impact leucine import, the reason 
behind the lack of leucine incorporation is however still unclear (12). In E. coli, leucine 
transport is mediated by a sodium symporter (82). Low pH results in an increase of 
protons in the extracellular milieu which may interfere with the amino acid import 
by abolishing a charge differential across the membrane. The mechanism of leucine 
transport is as of yet unknown in M. tuberculosis. It is therefore difficult to comment on 
the exact processes responsible for blocking leucine import in such a drastic manner. 
Previous studies have shown that aspartate is the favoured amino acid during infec-
tion and is produced by utilising an extracellular asparaginase to hydrolyse asparagine 
to aspartate and ammonia (61). It is likely that M. tuberculosis obtains nitrogen from 
this pathway which can be used to synthesize leucine instead of direct uptake from 
the environment and the ammonia to buffer the acidic pH. Whether M. tuberculosis 
simply does not import leucine during low pH compared to a more efficient system 
or is unable to do so remains unclear. Indeed, this model is reliant on the leucine bio-
synthesis pathway in vivo and not direct uptake (13). Another explanation to the lack 
of leucine incorporation may be the decreased protein synthesis as observed in Figure 
1B. Leucine import may be unimpaired but the isotopes my not be incorporated into 
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the proteome. This is however less likely as we do observe differential regulation even 
at late time points when comparing low pH to neutral pH directly (12).
Here we have studied multidimensional proteome dynamics in response to acid stress, 
encompassing changes in temporal abundance, dynamic phosphorylation and protein 
turnover. We find that M. tuberculosis undergoes a large scale protein remodelling 
when exposed to acidic stress, which is driven in part by early phosphorylation cas-
cades. We find the type VII secretion system to form a central role in early responses 
to an acidified environment and that this system is kept at a steady state during active 
growth. While we were unable to measure protein turnover comparatively to acidic 
stress, a shutdown of leucine transport was observed. This indicates a shift in major 
cellular processes when exposed to harsh environments. By investigating all aspects of 
the mycobacterial response to common stressors can we gain sufficient insight into the 
processes involved in infection. The SAMMtb strain certainly allows for such investiga-
tions, and has the potential to play a pivotal role in future mycobacterial research.
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suPPLEMENTARy fIGuREs
supplementary figure 1: Gene ontology enrichment analysis on the down regulated proteins related to figure 
1: Figure displays the odds ratio’s as well as the top 10 most enriched terms gene ontology terms. The description 
of each term can be found in the table below. Terms were enriched using a hypergeometric test from all proteins 
depicted in Figure 1B with a log fold change below -1 and a q-value below 0.05.
supplementary table 1: Top 10 GO terms, associated with supplementary figure 1
Rank Go ID Term
1 GO:0019359 nicotinamide nucleotide biosynthetic process
2 GO:0016717 oxidoreductase activity
3 GO:0046496 nicotinamide nucleotide metabolic process
4 GO:0019363 pyridine nucleotide biosynthetic process
5 GO:0019362 pyridine nucleotide metabolic process
6 GO:0009435 NAD biosynthetic process
7 GO:0006733 oxidoreductase activity
8 GO:0003700 DNA-binding transcription factor activity
9 GO:0070482 response to oxygen levels
10 GO:0072525 pyridine-containing compound biosynthetic process
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supplementary figure 3: Gene ontology enrichment analysis on the protein turnover classes, related to figure 
3. Figure displays the top 10 regulated terms as determined by hypergeometric tests from A) Class II or b) class III 



























supplementary figure 2: Metadata associated with 
differentially regulated phosphorylated proteins, 
related to figure 2. A) Bar plot displaying the number 
of phosphorylated serine’s, threonine’s or tyrosine’s 
across all phosphorylated proteins. b) Tandem mass 
spectra of all regulated phosphorylated peptides avail-
able in online supplementary material. Peptides were 
considered regulated if the ratio of phosphorylated 
peptide to protein abundance was two fold or greater. 
Peptides were considered confident if a posterior er-
ror probability score was less than 0.01 and the local-
ization probability was greater than 0.75.
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Mycobacterium tuberculosis is a facultative intracellular pathogen responsible for caus-
ing tuberculosis. The harsh environment in which M. tuberculosis survives requires 
this pathogen to continuously adapt in order to maintain an evolutionary advantage. 
However, the apparent absence of horizontal gene transfer in M. tuberculosis im-
poses restrictions in the ways by which evolution can occur. Large scale changes in 
the genome can be introduced through genome reduction, recombination events and 
structural variation. Here, we identify a functional chimeric protein in the ppe38-71 
locus, the absence of which is known to have an impact on protein secretion and 
virulence. To examine whether this approach was used more often by this pathogen, 
we further develop software that detects potential gene fusion events from multigene 
deletions using whole-genome sequencing data. With this software we could identify 
a number of other putative gene-fusion events within the genomes of M. tuberculosis 
isolates. We were able to demonstrate the expression of one of these gene fusions at 
the protein level using mass spectrometry. Therefore, gene fusions may provide an 
additional means of evolution for M. tuberculosis in its natural environment whereby 
novel chimeric proteins and functions can arise.




Mycobacterium tuberculosis, the causative agent of the disease tuberculosis, is a 
facultative intracellular pathogen. Adaptation to an intracellular niche is typically ac-
companied by reductive evolution, which favours the accumulation of pseudogenes 
and gene deletions. These events are prevalent in bacterial pathogens (1), mutualistic 
endosymbiotic bacteria (2) and are observed in obligate pathogenic mycobacteria 
(3–5). Reductive evolution is most commonly associated with the loss of redundant 
genetic material, as a pathogen or symbiont transitions towards an intracellular life-
style (4). As an intracellular species, M. tuberculosis experiences a constant selective 
pressure in competition with the host, even though genome reduction in this pathogen 
has been limited. In order to maintain a competitive advantage, evolutionary changes 
are required. Usually, lateral evolution (horizontal gene transfer) plays an important 
role in bacterial adaptation to specific environments (6). Horizontal gene transfer is 
crucial to asexually reproductive organisms as this process provides a mechanism for 
the incorporation of genetic diversity in response to a dynamic environment (7, 8). This 
phenomenon likely occurs due to isolation of the bacilli while residing within a spe-
cialised environment such as a human macrophage. It has previously been shown that 
horizontal gene transfer occurs at higher frequency between closely related organisms 
who share the same niche (9, 10). However, horizontal gene transfer is limited or even 
absent in intracellular pathogens, likely due to isolation of the bacilli while residing 
within a specialised intracellular environment. In line with this, M. tuberculosis displays 
minimal signs of recent horizontal gene transfer events in the genome (6). M. tubercu-
losis relies on mechanisms independent of lateral evolution to acquire new material 
that facilitates continued evolution, such as genome recombination, gene duplication 
events and single nucleotide variants (11). While the contribution of single nucleotide 
variants in M. tuberculosis evolution and adaptation has been well characterised (12), 
the functional contribution of large scale genomic variation is largely understudied.
It was recently reported that a multi-operon deletion in the ppe38-71 operon of M. 
tuberculosis had a major effect on the surface characteristics of this pathogen, as it re-
sulted in the loss of all secreted Proline-Glutamic acid Polymorphic GC Rich Sequence 
(PE-PGRS) and PPE-Major Polymorphic Tandem Repeats (MPTR) proteins (13). This 
was especially striking due to the deletion occurring naturally within members of 
the highly successful Beijing strain family of M. tuberculosis (13). Of interest was the 
specific nature of this deletion, where the breakpoints fell within the open reading 
frames of distally located genes. We thus hypothesised that this type of rearrangement 
can result in the formation of novel chimeric proteins. However, this process will only 
produce a functional chimeric protein if the frame is maintained when creating gene 
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fusions. This phenomenon has garnered much attention in the cancer research field, 
where cells are prone to large scale rearrangements in the genome (14–16) and similar 
mechanisms have recently been demonstrated in bacteria (17, 18). We reasoned that 
the formation of natural chimeric proteins provides a mechanism for functional large-
scale alterations in the genome in the absence of horizontal gene transfer.
We have previously used comparative genomics in conjunction with discovery-based 
proteomics to create custom proteome search databases for analysing strain-specific 
features in clinical M. tuberculosis isolates (19). Here, we expand on our approach and 
extend it to naturally occurring gene fusions by designing and implementing custom 
software to identify fusions in the genomes of M. tuberculosis clinical isolates. In ad-
dition, we were able to confirm the expression of fusion proteins using tandem mass 
spectrometry. We demonstrate an additional means for M. tuberculosis evolution, which 
is likely applicable to the adaptation of other intracellular pathogens as well.
MATERIALs AND METHoDs
bacterial culture
Mycobacterium tuberculosis CDC1551 and H37Rv were used as wild type strains; Δppe38-
71 and Δppe38-71::pMVHSP60-ppe38-71 (complemented strain) were generated previ-
ously from M. tuberculosis CDC1551 as the parental strain (13). Clinical isolates of M. 
tuberculosis used in this study were obtained from the South African Western Cape 
region. Procurement of clinical isolates were approved by the Stellenbosch University 
Health Research Ethics Committee (approval number: N10/04/126). Samples were de-
identified and not linked to any patient information. Samples obtained from patients 
were initially cultured in mycobacterial growth indicator tubes (MGIT) at 37°C until 
growth was detected by means of a BACTEC 960 broth culture system (BD Bioscience, 
NJ, USA). Positive MGIT cultures were centrifuged, stored as glycerol cryobead stocks 
in the Division of Molecular Biology and Human Genetics strain bank as bacterial seed 
lots or represented by genomic DNA.
For further experimentation, mycobacterial cultures were either cultured in modified 
Sauton’s media (0.4% L-asparagine, 0.4% glucose, 0.2% citric acid, 0.05% monopotas-
sium phosphate, 0.05% magnesium sulphate, 0.005% ferric ammonium citrate, 0.1 ml 
of 1% zinc sulphate and 0.05% Tween-80, pH 7.0) or Middlebrook 7H9 media supple-
mented with an oleic acid, albumin, dextrose and catalase (OADC) mix (BD bioscience, 
NJ, USA), 0.5% glycerol and 0.05% Tween-80. Mycobacterial cultures were grown 
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without shaking at 37°C until harvesting. Long-term storage of mycobacterial cultures 
were done at -80°C in 20% glycerol.
Escherichia coli Top10F’ cells were cultured in lysogeny broth (LB) (1% Bacto-tryptone, 
0.5% Bacto-yeast extract, 1% Sodium chloride) media with shaking at 37°C, or kept at 
-80°C in 20% glycerol until use.
Mycobacterial strain selection
Twenty-one M. tuberculosis strains were selected for initial analysis (Table S1); 17 of 
these were genotyped based on spoligotyping and restriction fragment length polymor-
phism (RFLP) was used to stratify whether the lineage 2 strains were typical or atypical 
as previously described (20, 21), while the remaining 4 strains (HN878, S1945, S2135, 
S2701) were genotyped in previous studies (13, 22). These specific strains were chosen 
based on their genetically diverse profile from two commonly occurring mycobacterial 
lineages in the South African Western Cape region and formed the basis of our study 
(Additional file 1: Fig. S1A). An additional 159 clinical isolates were chosen from an 
in-house mycobacterial genome sequence repository for a total of 180 M. tuberculosis 
clinical isolates (Additional file 1: Fig. S1B). In total, 90 independently isolated strains 
from each lineage was procured to gain greater statistical power during computational 
analysis. These samples have a genetic bottleneck due to the limited sites where M. 
tuberculosis isolates can be sampled. To account for this, the lineages were determined 
in silico using TBprofiler to avoid including multiple strains that represent a single sub-
lineages (23).
DNA extraction and whole genome sequencing
Genomic DNA was extracted as previously described (24). The DNA library was 
sequenced on an Illumina HiSeq2000 platform (Illumina, inc, CA, USA). Briefly, one 
microgram of DNA was used for library preparation using the Nextera DNA sample 
preparation kit according to the manufacturer’s instructions. Paired-end reads were 
sequenced using approximately 500 bp fragment sizes. FastQ files for previously 
sequenced clinical isolates used in this study were obtained from the Stellenbosch 
University mycobacterial genome sequence repository.
construction of genomics pipeline
We have developed an in-house automated data analysis pipeline using the bash script-
ing language on the Ubuntu distribution of Linux for the detection of large deletions 
and potential gene fusions. Illumina FastQ files were processed in accordance with the 
genome analysis toolkit (GATK) best practices guide using either M. tuberculosis H37Rv 
(NC_000962.3) or M. tuberculosis CDC1551 (AE000516.2 ) as the reference strain (25, 26). 
116
FastQ files were trimmed and aligned using BWA and NovoAlign software (27). The 
resulting binary alignment map (BAM) files were used for single nucleotide variation 
(SNV) detection using GATK and SAMtools (25, 28). Automatic in silico lineage typing 
was determined by piping raw FastQ files to TBprofiler (23). Detection of deletions by 
read-pair and split reads was done using Delly and Lumpy while Bedtools was used to 
detect deletions based on zero coverage (29–31).
construction of gene fusion identification pipeline
To identify gene fusions, we first extracted a list of all the structural variants (SVs) 
found within the genome. All SVs used for high throughput gene fusion detection 
were obtained from either Delly (29) or Lumpy (30). These include insertions, dele-
tions, duplications, inversions and translocations. This list of SVs was further filtered 
for deletions, as these had the highest likelihood of recombining into gene fusions. 
The breakpoints of these deletions are subsequently annotated against the reference 
database with either the affected gene or the intergenic region. Using this information, 
we applied a set of filtering parameters to identify a list of putative gene fusions.
Firstly, we excluded any deletions that did not span multiple genes. If this criterion was 
passed, the deletion breakpoints had to fall within open reading frames of genes on each 
side of the breakpoints, and these genes had to be in the same orientation. If all these 
criteria were met, 2000 bp flanking each side of the breakpoint was extracted from the 
BAM files and converted to FastQ format. This format was used to determine optimal 
kmers using kmergenie and de novo assembled using SOAPdenovo2 which allows for 
precise breakpoint detection (32, 33). The resulting contigs were ordered against the 
corresponding truncated reference sequence of M. tuberculosis H37Rv using ABACAS 
which results in a consensus sequence (34). Post-pipeline analysis included manually 
inspecting the potential fusion sequence for open reading frames by searching in six 
frames using NCBI ORF finder and translated to protein sequence (35). These amino 
acid sequence from each potential fusion protein was cross referenced to both parent 
amino acid sequences. If a match occurs, and no insertion sequences are present in 
the genomic region, the fusion amino acid sequences were added to a protein FASTA 
database. This database was ultimately used for downstream peptide identification by 
mass spectrometry.
Harvesting of whole cell lysates and supernatants
M. tuberculosis isolates were cultured in modified Sauton’s media supplemented with 
Tween-80 and allowed to propagate for seven days at 37°C until an OD600 of 1.0 without 
shaking. M. tuberculosis Δppe38-71 and the complemented strain strains were supple-
mented with either hygromycin (50 µg/ml) or kanamycin (25 µg/ml) and hygromycin 
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(50 µg/ml), respectively. Antibiotics were omitted during growth for all clinical isolates. 
Cultures were washed three times with phosphate-buffered saline (PBS) to remove 
residual Tween-80 and inoculated in modified Sauton’s media without Tween-80 at 
an OD600 of 0.05. Bacterial cultures were allowed to propagate for an additional seven 
days. Not all clinical isolates defined in supplementary table 1 were able to grow in 
the modified Sauton’s media, likely due to the lack of OADC, and were therefore omit-
ted when determining PE-PGRS secretion. The bacterial cells and supernatant were 
separated by centrifugation (4000 rpm, 10 minutes) followed by resuspension of the 
cell pellet in lysis buffer (8M urea in 100 mM tetraethylammonium bromide (TEAB), 5 
mM tris(2-carboxyethyl)phosphine (TCEP), Benzonase, Roche cOmplete™ EDTA free 
cocktail tablets). Cell-free supernatants were filter sterilised using a 0.22 µM steriflip 
filter unit (Merck Milipore, MA, USA). Whole-cell lysates were prepared by bead beat-
ing the resuspended cell pellet (20s cycles with 20 seconds on ice for a total of 8 cycles), 
followed by clarification (14 000 rpm, 10 minutes, 4°C). Sterilised cell-free supernatants 
were concentrated with Amicon ultra-15 kDa spin filters (Merck Milipore, MA, USA), 
to approximately 200µl by centrifugation (14 000 rpm, 4°C). Concentrated cell-free su-
pernatants were precipitated overnight at -20°C using four volumes of ice-cold acetone. 
Protein content was quantified using a modified version of the Bradford protein assay 
(36).
sample preparation and liquid chromatography tandem mass 
spectrometry
Whole-cell lysates of M. tuberculosis clinical isolates S507, S5527 and S5218 were 
prepared in biological triplicate as written above and processed for liquid chroma-
tography tandem mass spectrometry (LC-MS/MS). Whole cell lysates were digested to 
peptides for shotgun proteomics following an in-solution digestion protocol. Briefly, 
equal concentration of proteins resuspended in urea buffer (8M urea in 100 mM TEAB) 
(Sigma Aldrich, MO, USA) were reduced with 5 mM TCEP (Sigma-Aldrich, MO, USA) 
and alkylated with 5.5 mM iodoacetamide (Sigma-Aldrich, MO, USA) in the dark for 
1 hour respectively. The protein solution was diluted with four volumes 50 mM TEAB 
(Sigma-Aldrich, MO, USA) to contain a concentration of less than 2M urea. Proteins 
were digested to peptides by addition of a 1:50 ratio of sequencing grade modified 
trypsin (Promega, WI, USA) to total protein content and incubated in a humidified 
chamber at 37°C for 18 hours. The resulting peptide mix was dried using a desiccator 
and resuspended in 2% acetonitrile supplemented with 0.1% formic acid. Peptides 
were desalted using stop and go extraction (STAGE) tips as described previously (37). 
The desalted peptides were dried in a desiccator and resuspended in 2% acetonitrile 
supplemented with 0.1% formic acid before mass spectrometry analysis.
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A total of 1 µg of peptides from each sample was analysed, independently, on an Orbi-
trap Fusion Tribid mass spectrometer (Thermo Fisher Scientific, MA, USA) connected 
to a Thermo Scientific UltiMate 3000 RSLCnano system (Thermo Fisher Scientific, MA, 
USA). Peptides were injected on a PepMap C18 LC pre-column (300 µm ID x 5 mm, 5µm, 
300 Å) followed by separation on an analytical column packed with C18 Aeris peptide 
3.6 µM beads at a 500 nL/min flow rate. Solvent A was water containing 0.1% formic 
acid, and solvent B was 100% acetonitrile containing 0.1% formic acid. Peptides were 
separated as follows: solvent A was maintained at 2% followed by an increase to 7.5% 
in 5 minutes, 7.5% to 25% in 45 minutes, 25% to 45% in 15 minutes, 45% to 80% in 0.1 
minutes, maintained at 80% for 10 minutes, followed by a decrease to 2% in 0.1 min and 
equilibration at 2% for 10 min. The Orbitrap Fusion was operated in positive-ion data-
dependent mode and precursor ions (MS1) were detected in the Orbitrap with a nomi-
nal resolution of 120 000 at 200 m/z. An automatic gain control (AGC) target of 5 × 105 
and an ion injection time of 50 ms was used. The most intense ions above a threshold 
of 5 x 103 were selected for high-energy collision dissociation (HCD) at a normalised 
collision energy of 32.5%. The fragmented ions were analysed in the Orbitrap (MS2) at 
a resolution of 15 000 at 200 m/z. The AGC target was set to 1 × 104 and a 45 ms injection 
time was allowed during MS2 analysis. The number of MS2 events between MS1 scans 
was determined on-the-fly to maintain a 3 s fixed duty cycle. Dynamic exclusion of ions 
within a ± 10 ppm m/z window was implemented using a 30 s exclusion duration. An 
electrospray voltage of 2.0 kV and capillary temperature of 275°C, with no sheath and 
auxiliary gas flow, was used.
Processing of Lc-Ms/Ms data
A custom-made M. tuberculosis reference proteome was generated as described in the 
whole genome sequencing analysis section, specifically by addition of the putative 
chimeras to the reference proteome. Amino acid sequences representing potential 
gene fusions were added to the reference proteome (UniProt accession: UP000001584) 
from M. tuberculosis H37Rv (downloaded from UniProt 10 April 2018). This custom 
database was used for all mass spectrometry searches and contained for a total of 
4002 entries which includes the potential gene fusions. MaxQuant (version 1.6.3.4) was 
used to analyse raw files obtained from LC-MS/MS. The Andromeda search algorithm, 
integrated in MaxQuant, was used for peptide and protein identification, using default 
parameters (38, 39). Carbidomethylation of cysteine was chosen as fixed modification 
and oxidation of methionine as well as N-terminal acetylation was chosen as variable 
modifications. Enzyme specificity was set as Trypsin/P and a maximum of two missed 
cleavages was allowed.
chapter 4  |  Gene fusions in the mycobacteria
119
4
PPE38 c-terminal domain cloning, expression and purification
Genomic DNA was extracted from M. tuberculosis CDC1551 as described above and 
the region encoding the PPE38 C-terminal target was amplified using primers, PPE38_
AB_F; CCG CGA CGT GCT AGC ATG GCG GTG GAG GGG GTG CCG GC and PPE38_AB_R; 
TCA CAG GTC AAG CTT CTA CGC CGA CAT CCC CGC ACC CA with Phusion hotstart 2x 
master mix polymerase (NEB, MA, USA). The resulting amplicon was cloned into pIBA 
(40), using an In-Fusion cloning reaction as described by the manufacturer (Takara 
Bio, Japan), in E. coli Top10F’ cells. Transformed cells were cultured on LB-agar supple-
mented with ampicillin (100 µg/ml). The presence of the ppe38 insert was verified by 
restriction digest and Sanger sequencing. For recombinant protein expression, trans-
formed E. coli Top10F’ was cultured in LB broth supplemented with 100 µg/ml ampicil-
lin. Expression was induced with 0.2 µg/ml anhydrotetracycline (Sigma Aldrich, MO, 
USA) at 37°C with shaking at 200 rpm when E. coli cultures reached an OD600 of 0.3 for 
2 hours or until an OD600 of 1.5. Cultures at OD600 of 1.5 were subsequently harvested 
by centrifugation (14 000 rpm, 10 minutes, 4°C) and suspended in ice-cold lysis buffer 
(10 mM Tris–HCl pH 8.0, 1 mM EDTA, 5 µg/ml lysozyme), followed by incubation at 
37°C for 1 hour. Cells were further disrupted by sonication (Branson sonifier 250) and 
the lysate was centrifuged (12 000 rpm, 15 minutes, 4°C) to sediment inclusion bodies. 
Contaminating factors were removed by resuspending the pellet in sonication buffer 
(10 mM Tris–HCl pH8, 1 mM EDTA) and disrupted by sonication, followed by addition 
of an equal volume triton wash buffer (10 mM Tris–HCl pH 8.0, 1 mM EDTA, 2% Triton 
X-100) and incubation for 1 hour at room temperature. Inclusion bodies were collected 
by centrifugation (12 000 rpm, 15 minutes) and suspended in sonication buffer followed 
by another round of sonication. An equal volume of urea wash buffer (10 mM Tris–HCl 
pH 8.0, 2 M urea) was added followed by an hour incubation at 37°C. After incubation, 
the inclusion bodies were harvested by centrifugation (123 000 rpm, 15 minutes) fol-
lowed by resuspension (sonication buffer) and sonication. An equal volume of high salt 
wash buffer (10 mM Tris–HCl pH 8.0, 2 M NaCl) was added to the resulting suspension 
and inclusion bodies were harvested by centrifugation (12 000 rpm, 25 minutes). An-
other round of sonication and centrifugation followed this step and the final inclusion 
body-containing suspension was stored in PBS containing 15% glycerol.
Inclusion bodies were separated by 10% SDS-PAGE (1x TGS buffer, 100 volts, 1 hour) 
and visualised with coomassie brilliant blue. These inclusion bodies were used for im-
munisation in rabbits performed by Innovagen (Sweden) as detailed in their custom 
polyclonal rabbit IgG service. Briefly, initial immunisation was done with the inclusion 
body suspension containing the PPE38 antigen with Freund’s complete adjuvant. This 
was followed by booster immunisations at weeks 3, 5, 8 and 11 with Freund’s incom-
plete adjuvant. Immune serum used for this study was collected at 13 weeks after im-
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munisation. The resulting anti-serum from the immunised rabbit was used for western 
blotting.
western blotting
Concentrated supernatants from M. tuberculosis CDC1551, Δppe38-71, the ppe38-71 
complemented strain, S507, S3651, S1453, S3760, S4437, S3839, S5218, H37Rv, S4570, 
S1116, S2701 and S2135 were separated by SDS-PAGE (12% resolving gel, 100V, 1 hour) 
and transferred to a nitrocellulose membrane. The membrane was blocked with 1% 
milk powder (Sigma-Aldrich, MO, USA) for 1 hour and probed with either mouse 
monoclonal α-PGRS (1:5000) (41), and α-EsxA (1:500) (42) or rabbit polyclonal α-PPE38 
(1:1000) (this study) overnight at 4°C. Primary antibodies were removed by washing 
with Tris-buffered saline supplemented with Tween (20 mM Tris-HCL pH 7.5; 150 mM 
NaCl; 0.1% Tween-20) followed by probing with either goat anti-mouse or goat anti-
rabbit horse radish peroxidase conjugated secondary antibody for one hour. Probed 
nitrocellulose membranes were visualised using a ChemiDoc Gel Imaging System (Bio-
rad, CA, USA). When required, membranes were stripped using mild stripping buffer 
(1.5% glycine, 0.1% SDS, 1% Tween-20, pH 2.2).
PcR and sanger sequencing
Polymerase chain reaction of the Rv2623-Rv2628 region was performed using Phusion 
polymerase (New England Biolabs, MA,USA) as indicated by the manufacturer with 
the addition of 2% DMSO. Products from M. tuberculosis H37Rv and clinical isolate 
S507 were sequenced by capillary electrophoresis to identify and confirm the fusion 
junction using the following primers: Rv2623_F; CCA TTG TCG CGC ACA AAC and 
Rv2628_R; GTG GCA TGG CCA TGT CTT CTA.
statistical analysis
All statistical tests performed downstream using Delly and Lumpy-SV outputs were 
implemented in the R programming language version 3.6.2. The data presented in 
Figure 1A was analysed as a contingency table using Fisher’s exact test with a p-value 
cut off set at 0.05.
REsuLTs
ppe38-71 deletions are more prevalent in lineage 2 isolates of M. 
tuberculosis.
A previous study in our group has shown that deletions within the ppe38-71 locus in 
certain strains of M. tuberculosis can result in a block of PE-PGRS secretion and is as-
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sociated with increased in virulence (13). An earlier study already indicated that the 
ppe38-71 operon is prone to recombination with multiple variations (43). However, be-
cause of the highly repetitive nature and high GC content of this region, these deletions 
are difficult to identify. In this study, we further investigated the genetic relationship 
between ppe38-71 deletions in various lineages of M. tuberculosis and the effect of this 
mutation on PE-PGRS protein secretion. Twenty-one well characterised and genetically 
diverse clinical isolates representing lineage 2 and lineage 4 were used as the initial 
screening group (Additional file 1: Fig. S1A, Supplementary table 1).
A custom Illumina data analysis pipeline was constructed, which used two split read 
callers, a coverage-based approach and a targeted approach, to find both known and 
unknown deletions (Additional file 1: Fig S2). To address the variability within the 
region, two genes that fall between ppe38 and ppe71 (mt2420 and mt2421) were exam-
ined. These genes are unaffected by the insertions of IS6110 and reads mapping to 
this region were therefore used as an indicator for a full ppe38-71 operon (Additional 
file 1: Fig. S3). Using these criteria, ppe38-71 deletions were detected in both lineage 
2 and lineage 4. The majority of the lineage 2 strains (Fig. 1A) had ppe38-71 deletions 
while the converse was observed for lineage 4 strains (Fig. 1B). This suggested a greater 
prevalence of this deletion, and by association a predicted lack of PE-PGRS secretion, 
in lineage 2 isolates. However, the members of both lineages are sampled within the 
same local geographical region and thus provide a bias within each distinct lineage. To 
detect whether this deletion was indeed more prominent in M. tuberculosis lineage 2 as 
isolates compared to lineage 4, 90 members from each of the two lineages were further 
screened for a total of 180 genomes (Additional file 1: Fig. S1B, Fig. S4 A1-A6). Using the 
same metric to detect this deletion as described above, we found a 74% occurrence of 
the ppe38-71 deletion in lineage 2 and a 17% occurrence in lineage 4. Thus indicating a 
significantly higher prevalence (p-value < 2.2e-16) of ppe38-71 deletions in the lineage 
2 isolates. (Fig. 1C).
Previous publications demonstrated that breakpoints occur within ppe38 and ppe71 
coding regions, effectively truncating the coding sequences of these genes and abolish-
ing PE-PGRS secretion (13, 43). This phenotype was tested in selected lineage 2 and 
lineage 4 clinical isolates by immunoblotting with a monoclonal antibody that specifi-
cally recognises repeat domains (41). No PE-PGRS secretion was observed in members 
of lineage 2 that also had a ppe38-71 deletion, as determined by whole genome sequenc-
ing (Fig. 1D). Interestingly, PE-PGRS secretion was observed in S3651, which also has a 
ppe38-71 deletion as determined by whole genome sequencing (Fig. 1D).
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figure 1: Deletions in the ppe38-71 operon are more prevalent in M. tuberculosis lineage 2 iso-
lates. Deletions are represented as Circos plots displaying whole genome sequence alignment by 
genomic coordinates (outer track), strain (first track), read density (middle track) and average cover-
age (inner track) for clinical isolates of M. tuberculosis representing A) lineage 2 and b) lineage 4. Av-
erages were determined per strain and only within the genomic coordinates spanning the deletion. 
c) Occurrence of ppe38-71 deletion as a percent calculated from each sub-population of lineage 2 
and lineage 4 representing 90 clinical isolates, respectively. Deletions were determined by inspect-
ing coverage in the ppe38-71 operon. D) Western blot of cell-free supernatants obtained from M. 
tuberculosis clinical isolates, M. tuberculosis CDC1551 as well as control strains targeting PE-PGRS 
proteins. Red dots indicate clinical isolates that were predicted by whole genome sequencing to 
have a ppe38-71 deletion.
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In the ancestral operon, the ppe38 and ppe71 genes are nearly identical copies of one 
another separated by two esx genes (43). It has been suggested that deletion of the inter-
vening sequence can result in a fusion protein (43). We thus reasoned that the presence 
of PE-PGRS proteins in S3651 culture supernatants could be due to the internal deletion 
causing the open reading frames of ppe38 and ppe71 to form a chimeric protein with a 
similar function to PPE38.
PPE38-71 deletion creates a natural chimera in clinical isolate s3651
We investigated different configurations of the ppe38-71 operon in more detail to 
determine whether a functional ppe38/71 chimeric protein was indeed present in the 
lineage 4 isolate, S3651. For this, we compared S3651 to S507 as an example of a lineage 
2 isolate with a ppe38-71 deletion, S3388 as an example of a lineage 4 isolate with a full-
length ppe38-71 operon, and M. tuberculosis H37Rv which also has a full-length ppe38-71 
operon (Fig. 2A).
As transposon insertions have previously been found in the ppe38-71 operon (13), we 
reasoned that the presence of a transposon will disrupt the open reading frames in 
cases where PE-PGRS secretion is abolished. De novo assemblies were used to target 
the ppe38-71 operon in S507 and S3651, which represent a PE-PGRS secretion negative 
and positive phenotype, respectively. This was accomplished by extracting aligned 
reads for approximately 2000bp upstream and downstream of the ppe38 and ppe71 
break points. Targeted de novo assembly revealed that S507 (lineage 2) has an inser-
tion sequence present between ppe38 and ppe71, which disrupts the reading frames 
(Fig. 2B, Additional file 1: Fig. S5A). However, de novo assemblies of S3651 indicated 
breakpoints causing the open reading frames of ppe38 and ppe71 to fuse and create a 
ppe38/71 gene fusion (Fig. 2C). The ppe38/71 fusion is created through an out-of-frame 
deletion spanning the ppe38 and ppe71 operon, situated on the reverse strand, with 
breakpoints occurring within the open reading frame of each respective protein. Spe-
cifically, a cytosine-cytosine pair remaining on the ppe71 breakpoint combines with a 
thymine at the ppe38 breakpoint generating a cytosine-cytosine-thymine codon (Ad-
ditional file 1: Fig. S5B). This recombination reinstates the proline originally encoded 
by cytosine-cytosine-guanine in ppe71, thereby creating the amino acid sequence S G P 
I A S reading from the N-terminal of PPE71.
Taking into account the secretion of PE-PGRS proteins found in S3651 (Fig. 1D) as well as 
the predicted reformation of a distinct, yet functional equivalent of ppe38 in S3651 (Fig. 
2C) we reasoned that this gene fusion is likely responsible for the PE-PGRS secretion 
phenotype. To detect expression of ppe38, we generated a rabbit polyclonal antibody 
against the C-terminal domain of M. tuberculosis PPE38, which was used to immunise 
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rabbits. Rabbit anti-serum was first tested for reactivity against PPE38 (Additional file 
1: Fig. S6A, Fig. S6B). Western blots against M. tuberculosis supernatants revealed the 
presence of PPE38 epitopes in M. tuberculosis CDC1551, the ppe38-71 complemented 
strain as well as M. tuberculosis S3651. As expected, PPE38 was not detected in S507 and 
Δppe38-71 strains (Fig. 2D). Interestingly, two bands were detected when probing for 
PPE38, and both bands were absent in both S507 and M. tuberculosis Δppe38-71 (Fig. 1D, 
figure 2: M. tuberculosis lineage 4 strain with a ppe38-71 deletion produces a functional chime-
ric protein. A) Specific clinical isolates used for further investigation of the ppe38-71 operon. M. 
tuberculosis H37Rv was used as a control for the NGS and aligned to CDC1551, full length ppe38-71 
is detected in contrast to the published reference. S3651 and S507 represents clinical isolates with a 
ppe38 deletion and S3388 a clinical isolate without. b) Schematic representation of targeted de novo 
assembly and contig ordering of S507 indicating a transposon insertion between ppe71 and ppe38, 
thereby disrupting the ppe71 reading frame. c) Schematic representation of targeted de novo as-
sembly in the ppe38-71 operon of S3651. No transposon insertion was found and the reading frame 
of ppe71 is intact causing a gene fusion. D) Western blot of CDC1551 reference, Δppe38-71, ppe38-71 
complemented strain, S507 and S3651 cell-free supernatant probed for PE-PGRS proteins, PPE38 
and ESAT-6 as the loading control. S3651 secreted PE-PGRS proteins and expressed PPE38 similarly 
to the wild type
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Additional file 1: Fig. S6B). This may occur due to cleavage PPE38 through a protease, 
possibly PecA, which has been shown to cleave PE-PGRS proteins (44). Staining with 
anti-serum directed against PE-PGRS proteins resulted in a similar pattern, providing 
evidence that the production of PPE38 and secretion of PE-PGRS are linked and that the 
chimera formed in S3651 is associated with the PE-PGRS secretion.
Detecting multigene deletions in M. tuberculosis clinical isolates
The presence of functional gene fusions in M. tuberculosis is an intriguing finding, 
which in the absence of horizontal gene transfer, may provide an alternate method for 
evolutionary adaptation. To find additional chimeric proteins which has the potential 
to form gene fusions, we searched for genomic features likely to result in a gene fu-
sion event. This was automated and coupled with de novo assembly, which was used to 
generate consensus sequences surrounding multigene deletions (Additional file 1: Fig. 
S7). This approach served as a first-pass method to identify multigene deletions present 
within coding sequences and is thus a starting point to identify potential gene fusions. 
This algorithm was incorporated into our existing software and used to screen clinical 
M. tuberculosis isolates for possible gene fusions.
We screened the genomes of the same 180 clinical isolates mentioned above for mul-
tigene deletions that can form potential gene fusions and compared this to all the SVs 
detected. The occurrence of gene fusions represented a low proportion of the total 
structural variation (Fig. 3A). Furthermore, the SV count had more variability across 
the two lineages with some strains containing more than 100 SVs. This was observed 
in both lineages, however, this increase in the total number of SVs did not affect the 
distribution of potential gene fusions (Fig. 3A). Thus, formation of gene fusions seem 
to be a rare phenomenon likely due to the inherent randomness in genetic variation 
and the precise breakpoints required to maintain a reading frame. Once this process 
concludes and a chimeric protein is formed, the new protein has to be favoured by 
natural selection to allow for propagation of the new feature within the population. It 
therefore stands to reason that formation of fused genetic elements that yield proteins 
are less likely to occur compared to pseudogene formation, full gene formations or out-
of-frame deletions. The highest occurrence of multigene deletions was found in genes 
encoding PE/PPE proteins, however due problematic read alignment in these regions 
(very high GC content of more than 75% and multiple repeats) it is difficult to determine 
with confidence that these are indeed true gene fusion events (Fig. 3B). We therefore 
discarded multigene deletions occurring within genes annotated as PE/PPE proteins 
during further analysis. This resulted in the identification of 21 multigene deletions, 
two of which were found within both lineages. Multigene deletions that resulted in 
fused open reading frames from the genomic data were further manually inspected by 
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six-frame translation of the fusion gene. If the six-frame translation indicated a single 
protein with domains from both parent genes, we annotated this as fused (Fig. 3C). 
We could detect the RDRIO deletion which forms a fused reading frame in Rv3346c/55c 
(Fig. 3C) (45) . However, the most prevalent multigene deletion that has fused open 
reading frames in our sample set was represented by the RD105 deletion (Rv0071/74) 
that occurs in lineage 2 isolates (46) (Fig. 3C).
figure 3: systematic detection of potential fusion events from M. tuberculosis large sequence 
polymorphisms. A) The distribution of multigene deletions that fall within an open reading frame 
and have the same orientation as predicted by our software compared to the distribution of struc-
tural variants (SV) found across 180 isolates of lineage 2 and lineage 4. The numbers on the graph 
represent the mean of the distribution. b) Most abundant annotations associated with potential 
gene fusions across all clinical isolates and separated by lineage. Annotation terms were sourced 
from the Mycobrowser functional categories. PE/PPE proteins constituted the majority of identifi-
cations associated with gene fusions. Potential gene fusions falling in this category were removed 
from further consideration as alignment failures in these areas are highly prevalent. c) Occurrence 
of specific multigene deletions that fall within open reading frames. Each of these were manually 
inspected for closed reading frames and annotated as either fused or truncated.
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Genetic evidence for gene fusions in mycobacteria
Three candidate gene fusions were observed at relatively high frequency within the 
180 M. tuberculosis genomes, compared to the other gene fusions (Fig. 3C). We opted to 
focus on Rv0071/74 and Rv2623/28 for further investigation, while Rv3346c/55c was dis-
regarded as this specific deletion was not found within the 21 well characterised clini-
cal isolates and has been described before (45). The Rv2623-Rv2628 genomic region is 
part of the M. tuberculosis dormancy regulon and has not yet been reported as deleted 
within clinical isolates of M. tuberculosis. This region is deleted in lineage 2 members, 
S507 and S5527, where the deletion completely removes the genes Rv2624-Rv2627 and 
truncates Rv2623 at the 5’ end, coding for the C-terminal domain, and Rv2628 at the 3’ 
end (Fig. 4A). The RD105 deletion was also detected as a gene fusion using our pipeline 
and recently shown to indeed form a chimeric protein (Fig. 4B) (18). This deletion is 
prevalent in the lineage 2 isolates and is used as a marker for sub-lineage speciation 
within M. tuberculosis (46). The protein encoded by Rv0071 is annotated as a potential 
maturase and the Rv0074 gene product is of unknown function and is localized in the 
membrane of M. tuberculosis, as determined by mass spectrometry analysis (47).
The Rv2623/28 putative gene fusion, identified by our method, has not yet been re-
ported as a gene fusion or indeed a deletion in the mycobacteria. We therefore char-
acterised this feature further by verifying the presence of this deletion as well as the 
specific break points using polymerase chain reaction and capillary electrophoresis 
sequencing. First, the deletion was confirmed in S507 and S5527 identifying a band at 
the 700 bp range using primers flanking Rv2623 and Rv2628, compared to a band of 
~7000 bp in S5218 and H37Rv which have an intact operon (Fig. 4C). Next the 700 bp 
and ~7000 bp band corresponding to S507 and S5218 was sequenced, respectively. The 
base pair sequence corresponding to wild type Rv2623 and the Rv2623/28 fusion was 
discernible and corresponded to the sequence prediction from our de novo assemblies 
of this genomic region (Fig. 4D). Based on these observations, the Rv2623/28 remains 
intact and should transcribe a hybrid protein under the Rv2623 promoter.
Gene fusions form chimeric proteins.
M. tuberculosis follows a reductive evolutionary path and consequently has a number of 
pseudogenes (48). Although the candidates found in our genetic screens may have the 
genotypic characteristics of a chimeric protein, these may not lead directly to proteins. 
The genetic features may thus be present within the genome, not as functional chime-
ras but rather pseudogenes.
We used mass spectrometry analysis to investigate whether the putative gene fusions 
found in our genetic screens are expressed by M. tuberculosis to form stable chimeric 
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proteins. To identify chimeric proteins, the translated sequences obtained from the de 
novo assemblies of ppe38/71; Rv2623/28 and Rv0071/74 were added to the M. tuberculosis 
H37Rv protein database (UP000001584). The pks15/1 gene is found in W-Beijing strains 
of M. tuberculosis and is comprised of fused pks15 and pks1 genes (22, 49). This gene was 
not detected in our genetic screens of W-Beijing strains, likely due to the close proxim-
ity of the breakpoints causing discordant read pairs to be missed. We therefore added 
this chimeric protein sequence as well, as it has previously been shown to combine in 
a manner similar to what we predict for gene fusions (22, 49). This database was used 
to search tandem mass spectra from S507, S5527, S5218 generated in this study as well 
as S3651 which is publicly available and generated from a previous study (19).
figure 4: Rv2623/28 and Rv0071/74 are gene fusions which have formed as a result of large dele-
tions. A) Circos plot depicting the genomic region of Rv2623-Rv2628 (outer track) from clinical isolates 
S5218, S5527, S507 and H37Rv. Middle and inner tracks display read density in the region and average 
coverage respectively. b) Circos plot of Rv0071-Rv0074 (outer track) as well as the read density (middle 
track) and average coverage (inner track) in the region. c) Polymerase chain reaction of wild type and 
deleted Rv2623-Rv2628 regions. D) Chromatograms from capillary electrophoresis displaying the de-
letion breakpoints (red arrow) from clinical isolate S5218 (wild type Rv2623) and S507 (Rv2623/Rv2628 
fusion protein). In the circos tracks M. tuberculosis H37Rv is representative of the reference genotype.
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MS-Digest, a tool available with the ProteinProspector software (50), was used to model 
the tryptic peptides of the potential chimeric proteins surrounding the expected fu-
sion junctions of ppe38-71; Rv2623/8, Rv0071/74, and Pks15/1 as well as their wild type 
counterparts. Translation of the de novo assembly of the ppe38/71 operon predicts the 
fusion junction to have the amino acid sequence S G P I A S (Additional file 2, book 1). 
The fusion junction amino acid sequence corresponding to V I G R is expected if the 
Rv2623/8 fusion is present in S507 and S5527, while D M S K is expected in wild type 
S5218 (Additional file 2, book 2). If Rv0071/74 is produced in the lineage 2 strains the 
fusion junction V V G V G R should be detected. (Additional file 2, book 3). Lastly, if 
Pks15/1 is present an amino acid sequence corresponding to V P W V I S A R is expected 
(Additional file 2, book 4).
We used de novo assemblies to determine the fusion junctions of Rv2623/28 and 
Rv0071/74 genetically. The Rv2623-Rv2628 deletion results in a new fusion gene with a 
restored reading frame (Fig. 5A). The Rv0071-Rv0074 deletion has an in-frame break-
point at position 93 (gtc) of the Rv0071 gene, with a codon for alanine (31st amino acid) 
as well as position 289 (gtg) of Rv0074 which codes for valine (97th amino acid) and 
thus closing the frame to create a V V G V G R amino acid sequence (Fig. 5B). This 
fusion candidate has recently been demonstrated to indeed encode for a functional 
chimeric protein, demonstrating a functional phenotype associated with this genotype 
(18). Next, we used our custom gene fusion database as a reference for tandem mass 
spectra searches to detect Rv2623/28 and Rv0071/74 in clinical isolate S507 and S5527 
while using S5218 as a control. Tandem mass spectra from previously published S3651 
were also searched by using the same approach to probe for ppe38/71. We detected 
the presence of a peptide that spans the Rv2623/28 fusion junction, thereby providing 
evidence for the expression of another chimeric protein in M. tuberculosis (Fig. 5C). 
While figure 5C represents the most confident peptide identification by the Androm-
eda search engine, in this specific peptide, fragmentation did not cover the fusion 
event located in the y1-y7 ion range. We found seven peptide spectrum matches of 
fragmentation across the fusion junction, thereby supporting the identification of this 
peptide as spanning the fusion junction between Rv2623 and Rv2628 (Additional file 1: 
Fig. S8 A1-A7). In addition, we were able to detect peptides corresponding to wild type 
Rv2623 in clinical isolate S5218 (Fig. 5D). We could not detect a peptide corresponding 
to the wild type Rv2623 protein in S507 or S5527, and likewise no fusion peptide was 
detected in S5218 (Additional file 1: Fig S8B). In addition, peptides spanning the fusion 
junction for Pks15/1, previously reported as an insertion was also detected in our mass 
spectrometry analysis (Additional file 1: Fig. S9) (22).
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No peptides corresponding to PPE38/71 or Rv0071/74 fusion junctions were detected 
by mass spectrometry analysis. This may be due to several reasons such as low abun-
dance, low coverage of the proteome, or in the case of Rv0071/74 a large amount of 
proline repeats across the fusion junction. Nevertheless Rv0071/74 was recently shown 
to form a chimeric protein and to be involved in the remodelling of the bacterial cell 
wall and have been associated with increased drug resistance (18). Furthermore, using 
polyclonal antiserum directed against PPE38, we were able to show that a chimeric 
protein was produced in strains containing the PPE38/71 fusion. Taken together, it 
is evident that gene fusions are not only present within M. tuberculosis but can also 
encode functional proteins.
DIscussIoN
In this study we present a computational method to discover chimeric proteins us-
ing large scale omics data. By using unique features found in individual genomes in 
a proteogenomics approach, structures such as chimeric proteins can be identified in 
figure 5: Targeted de novo assemblies and tandem mass spectrometry identifies Rv2623/28 as 
chimeric protein. A) Schematic illustration of Rv2623-Rv2628 de novo assembly and contig ordering 
from clinical isolate S507. b) Schematic illustration of de novo assembly and contig ordering from 
S507 displaying the deletion region and in-frame translation of Rv0071/74. Black indicates out of 
bounds genes and grey indicates deleted genes. Tandem mass spectra of peptides representing the 
c) Rv2623/28 fusion junction from S507 and D) wild type Rv2623 of S5218 in the same location. False 
discovery rate cut-offs for assigning peptides was set at 0.01.
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the proteomes of clinical M. tuberculosis isolates. While similar methodology has been 
implemented in other biological fields, such as cancer research (51), studies have not 
yet been conducted in a high throughput fashion in bacteria. Using the same method-
ology proposed here, the same approach can be broadly applied to other bacteria as 
genomics and proteomics data becomes more prevalent.
It has been hypothesised that M. tuberculosis does not undergo horizontal gene transfer 
(11). This imposes a significant limitation on the evolutionary capabilities of the bacilli, 
especially when it is faced with constant evolutionary pressure due to the harsh envi-
ronment of the phagosome (52). Proteins that have two distinct domains likely arose 
from two ancestral genes through gene fusion formation. These can be detected by 
comparative genomics between two or more related organisms. Gene fusion forma-
tion compress the coding potential of the genome by creating multifunctional proteins 
through the combination of domains (53–55). This is especially effective if there is 
a clear evolutionary link between multiple species from which gene fusions can be 
found using tools such as MosaicFinder, DomainTeam or machine learning approaches 
(56–58). Therefore, the formation of gene fusions could provide interesting insights into 
the functional evolutionary biology of M. tuberculosis. This is especially useful under 
strictive environments where reductive evolution is present (4). This is of importance as 
the bulk of studies mainly focus on single nucleotide variants and their functional role 
while larger structural genomic variation is used for the purpose of strain typing (59, 
60). Interestingly, these large deletions are optimal for differentiation between lineages 
of M. tuberculosis as they are highly conserved according to a geographical origin (61). 
This is indicative of restrictive divergent evolution, where deletions occur frequently 
as a function of intracellular lifestyle yet are selected for by variable environmental 
conditions. The ppe38-71 operon is a hypervariable region which arises due to the 
prevalence of transposon insertions (43). Therefore the deletion can occur in both lin-
eages and not associated with a single event. However, the specific breaks in this region 
can have seemingly different consequences. Apart from loss of function, as a result of 
large-scale deletions, we demonstrate that these deletions can result in the formation 
of detectable chimeric proteins, which in turn likely has functional consequences. We 
could demonstrate such functionality for the ppe38/71 fusion protein in the form of 
PE-PGRS secretion. Previous reports have shed light on the increased ability of lineage 
2 M. tuberculosis to transmit and cause disease (62, 63). As the lack of ppe38-71 is also 
associated with increased virulence (13), it is likely compounding and contributing to 
the increased disease-causing capability observed in lineage 2 isolates (13). Further-
more, others have demonstrated functionality for Rv0071/74 (18), Rv3346c/55c (45) and 
PKS15/1 (22) chimeric proteins as well as the impact of large deletions on increased 
virulence (64). M. tuberculosis strains can be grouped into sub-lineages by occurrence 
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of large deletions which remove multiple genes in the process. This has the clear effect 
of abolishing the functions of the genes that have been lost, but also as seen in the case 
of RD107 and RDRIO can form new coding sequences in the process. Contrary to the 
ppe38-71 deletions, formation of the gene fusions are likely a result of selection and 
expanded to create sub-lineages and thus form a monophyletic group.
A new chimeric protein candidate, Rv2623/28, was identified in this study. The par-
ent proteins for this chimera have been associated with entrance into dormancy (65, 
66) and associated with latency (67). Overexpression of Rv2623 causes a decrease in 
proliferation of M. tuberculosis in vitro and increased pathology in mice thereby me-
diating entrance into dormancy (66). This protein is comprised of two ATP binding 
domains and the chimera Rv2623/28 has one of these domains followed by a Rv2628 
N-terminus. If this domain remains stabilised with the Rv2628 N-terminus, it could re-
sult in a less pronounced inhibition of growth than reported for the full length Rv2623 
(66). Furthermore, the gene at the 3’ end of the deletion, Rv2628 is associated with 
latent tuberculosis infection as shown by a stronger cumulative IFN-gamma response 
towards Rv2628 antigens, compared to tuberculosis positive individuals (68, 69). The 
Rv2623-Rv2628 gene fusion is therefore an interesting open reading frame potentially 
with aspects associated with both early and late stage dormancy.
Information on transcribed gene fusions can also be identified by RNA-sequencing 
by using split read transcripts with multiple tools available for this purpose (70–72). 
A powerful approach presented by RNA sequencing is the use of de novo transcript 
assembly to mitigate the requirement of the reference sample, however this suffers a 
penalty in the form of decreased accuracy (73). While RNA-sequencing provides a pow-
erful tool to identify gene fusions, the function of the resulting chimera is performed 
on the protein level. This is especially important as there have been reports on the poor 
correlation between RNA and protein content (74, 75). This general discrepancy exists 
due to the complex mechanisms governing mRNA and protein regulation, both post-
transcriptionally as well as post-translationally and likely has a significant temporal 
component (76). Therefore, the combination of genomics and proteomics provides 
a powerful, yet under developed, approach to high throughput identification of ex-
pressed gene fusions. The combination of these technologies does however bring with 
it limitations associated with each respective platform. These limitations influence the 
detection power of a combined approach. From a genomics perspective, detection of 
gene fusions is influenced by the choice of a reference strain, this could however be 
mitigated by using a known ancestor or a metagenome approach by combining various 
related genomes in order to cover a broad range of genes (77). Long read sequencing 
provides an alternative option to facilitate the process of resolving gene fusions in the 
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genome. This can be used as either a de novo assembly, reference based assembly or a 
hybrid approach to genetically detect gene fusions in a similar fashion as the short reads 
used here. With longer reads the exact breakpoints could be resolved with increased 
accuracy and thus result in the detection of more gene fusions. This is especially valu-
able as failure of alignments to pinpoint exact breakpoints can confound detection and 
either falsely call a gene fusion or miss potential gene fusions completely. Finally, a 
diverse library of sequences is necessary in order to effectively search for gene fusions 
using whole genome sequencing. In the Western Cape region of South Africa, where 
this study was conducted, the majority of M. tuberculosis strains are either members 
of lineage 2 or lineage 4. We therefore focussed on these lineages of M. tuberculosis to 
act as our library and M. tuberculosis H37Rv as the reference, thus limiting the amount 
of gene fusions we could detect. As there are other lineages, characterised by large 
sequence polymorphisms, it is likely that there are more gene fusions to be identified.
The use of data-dependent tandem mass spectrometry analysis also limits the gene 
fusion detection ability. As the mass spectrometer only selects the “topN” most intense 
precursor ions (78), a gene fusion would need to have a relatively high abundance to 
guarantee detection. In addition, proteins are not completely sequenced using shot-
gun proteomics, thus fusion peptides that do not contain trypsin cleavage sites will be 
missed by this approach (79). As the fusion junction, and thus the fusion protein, is re-
solved by a single peptide the likelihood for detection decreases as well. With arguably 
low genomic diversity in this cohort, where only two major lineages were screened, we 
still identified four candidate gene fusions using a genomics and proteomics approach. 
M. tuberculosis is subject to reductive evolution, which is a marked characteristic of an 
intracellular lifestyle (1, 80, 81). With this limited and decreasing coding potential of 
M. tuberculosis, even rare occurrences of gene fusions and resulting chimeric proteins 
could result in significant phenotypic consequences. Some of the limitations to detect 
chimeric proteins in M. tuberculosis proteomes can however be overcome using a 
targeted proteomics approach to identify fusion junction peptides or using dedicated 
spectral libraries in conjunction with large scale data independent approaches such as 
SWATH-MS (82, 83) .
In this study, we focussed on gene fusions and their detection. However, the use of 
similar methodology can be extended to other phenotypic features typically lost by 
reference-based assembly, such as identifying novel proteins from unmapped reads 
(19). Indeed, a significant number of tandem mass spectra remain unassigned after 
database searches (84), of which many display high quality spectra (85). Spectra 
remain unassigned due to a multitude of reasons such as charge state, fully tryptic 
searches, post-translational or chemical modifications and errors in mass to charge 
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measurements (50, 86). It is also reasonable to assume that incomplete databases and 
unrepresented proteins also contribute to the large number of unassigned spectra. 
By expanding methodologies presented here and with further exploration of cross-
platform omics technologies, previously hidden features can be extracted and provide 
a high throughput approach to identifying novel features. In this study M. tuberculosis 
was used, however the same methodology can be implemented for other bacteria as 
well.
In conclusion, here we demonstrated that additional and often overlooked features 
of the genome contribute to the physiology of M. tuberculosis. These features provide 
a means to utilise vertical evolution to gain functionality in the absence of horizontal 
gene transfer. Further study into the effects of structural variation along with the 
mechanism that allow these features to translate to functional phenotypes could be 
important to understanding M. tuberculosis disease-causing capabilities.
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supplementary figure 1: Phylogenetic tree of M. tuberculosis clinical isolates. A) Phylogenetic tree 
represents the clinical isolates typed in supplementary table 1 and b) represents all strains used in 
this study. The tree was constructed by aligning raw sequence data to M. tuberculosis H37Rv and 
identify single nucleotide variants from each isolate. The general time reversal model of nucleotide 
substitution was used to construct an axelerated maximum likelihood phylogeny of the isolates with 
1000 bootstrap pseudo replicates. Positions with gaps or missing replicates were not considered in 
this analysis.
146
supplementary figure 2 schematic diagram depicting the pipeline used to analyse M. tuberculo-
sis genomes. This software was constructed in Linux Ubuntu distribution using the Bourne again 
shell scripting language. Pre-processing and processing of Illumina raw files followed the Genome 
Analysis Toolkit best practises guidelines defined by the BROAD institute (https://software.broadin-
stitute.org/gatk/best-practices/workflow). Identification of deletions utilised both coverage based 
approaches as well as split read and read pair methods. Previously published software TBprofiler 
(dashed line) was used to determine M. tuberculosis lineages computationally and not created in this 
work. This software is available on GitHub (https://github.com/HostPathogenSU/Pegasus).
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supplementary figure 3: Reads in the ppe38-71 region depicting three alignment profiles ob-
served in this study. Each of the depicted strains display an alignment indicating a deletion (S2135), 
a wild type operon where reads fail, likely due to transposon insertion (S3388) and an example 
where reads are able to map across the operon (H37Rv). The presence of reads in mt2420 (20) and 
mt2421 (21) was considered a wild type operon which is able to secrete PE-PGRS proteins.
148
supplementary figure 5: schematic representation of the de novo assembly from s507 and s3651 
in the ppe38-71 region. De novo assembly was done by extracting paired end reads flanking the 
breakpoints of the ppe38-71 deletion on the 3’ and 5’ side from novoaligned BAM files from A) S507 
and b) S3651 using Samtools. SOAPdenovo2 and abacas was used to perform the assembly and re-
constitute the reads into a consensus sequence. Snapgene was used to visualise the assembly and 
annotations were based on cross comparison with the sequence known sequence information for 
ppe38 and ppe71. The unknown sequence separating ppe38 and ppe71 in the S507 was identified as a 
transposon sequence by BLASTx.
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supplementary figure 6: Isolation of ppe38 recombinant protein and testing of anti-ppe38 antise-
rum. A) SDS-PAGE and coomassie stain of inclusion bodies containing PPE38 protein isolated from 
E. coli top10F’ cells. This inclusion body extract was used for immunisation in rabbits. b) Western 
blot depicting anti-PPE38 rabbit antiserum at various dilutions. M. tuberculosis CDC1551 and Δppe38-
71 supernatant was for as the target for western blot. Three dilutions of antibody, 1:1000, 1:5000 and 
1:10 000 was used to determine the optimal concentration. Membranes were cut prior to addition of 
the various anti-serum dilutions, approximate positions depicted by dotted lines, and visualised at 
the same time for 20 second exposure. The 1:1000 dilution was used for further experimentations.
150
supplementary figure 7: schematic illustration of a sequence of events executed computational-
ly to filter structural variant files generated by our custom illumina pipeline (figure s2). The code 
for this algorithm is written as an I/O operation in the bourne again shell language and implemented 
in the source code and can be executed from the main pipeline repository as an additional resource.
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supplementary figure 9: Tandem mass spectra assigned to a PKS15/1 fusion junction. Spectra was 
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It was previously shown that secretion of PE-PGRS and PPE-MPTR proteins is abol-
ished in clinical M. tuberculosis isolates with a deletion in the ppe38-71 operon, which 
is associated with increased virulence. Here we investigate the proteins dependent on 
PPE38 for their secretion and their role in the innate immune response using tem-
poral proteomics and protein turnover analysis in a macrophage infection model. A 
decreased pro-inflammatory response was observed in macrophages infected with 
PPE38-deficient M. tuberculosis CDC1551 as compared to wild type bacteria. We could 
show that dampening of the pro-inflammatory response is associated with activation 
of a RelB/p50 pathway, while the canonical inflammatory pathway is active during 
infection with wild type M. tuberculosis CDC1551. These results indicate a molecular 
mechanism by which M. tuberculosis PE/PPE proteins controlled by PPE38 have an ef-
fect on modulating macrophage responses through NF-kB signalling.
Keywords: Mycobacterium tuberculosis, Proteomics, NF-KB signalling, PE/PPE, Macro-
phage




Mycobacterium tuberculosis is an important human pathogen that has adapted to survive 
and replicate within human macrophages (1). This lifestyle requires the presence of 
virulence factors that have evolved to enable intracellular growth. One strategy to iden-
tify virulence factors is by comparing the genomes of pathogenic and non-pathogenic 
mycobacteria. The most striking result of such an analysis is a large number of genes 
encoding PE and PPE proteins in M. tuberculosis compared to M. smegmatis (2). The 
PE and PPE proteins belong to two unique but related protein families and are known 
to be secreted to the cell surface or extracellular milieu through the type VII secre-
tion system (3). The type VII secretion system is further represented by five loci in 
M. tuberculosis, named ESX-1 to ESX-5 (4). Of these five loci, ESX-2 and ESX-5 are the 
most recent, with ESX-5 being associated with the evolutionary split of the fast- and 
slow-growing mycobacteria (5). The PE/PPE proteins are characterised by the pres-
ence of a conserved N-terminal domain, including a Proline-Glutamic acid (PE) or a 
Proline-Proline-Glutamic acid (PPE) conserved motif (2). There are approximately 100 
genes in M. tuberculosis coding for PE proteins and the major sub-family is classified 
as the PE-PGRS proteins, due to a large number of GC repeats in the genes encoding 
them (Polymorphic GC-Rich Sequence). This sub-family is characterised by multiple 
Gly-Gly-Ala/Gly-Gly-Asn repeats in the C-terminal region (6,7). The PE-PGRS proteins 
are unique to slow growing mycobacteria, localised to the cell surface and secreted 
through the ESX-5 system (4,8–11). Furthermore, recent studies demonstrated that the 
C-terminal region of PE-PGRS proteins can be cleaved from the PE domain and can be 
released to interact with the host (12). The largest subfamily of PPE proteins are the 
PPE-MPTR proteins (Major Polymorphic Tandem Repeat), which are also specific to 
slow-growing mycobacteria and secreted via ESX-5 (3). Taken together, the PE-PGRS 
and PE-MPTR proteins are interesting candidates for studying host-pathogen interac-
tions considering their evolutionary history and extracellular localisation. However, 
elucidating the effects of PE-PGRS and PPE-MPTR proteins is hampered by the large 
number of proteins present in these groups. Recently, it has been shown that the ppe38-
71 operon, specifically the PPE38 protein, is involved in mediating secretion of both 
these important subfamilies and when deleted detectable secretion is abolished (13). 
More recent follow up studies conducted in M. africanum and M. microti demonstrated 
a lack of PE-PGRS secretion in the presence of an intact ppe38-71 operon and ESX-5 
secretion system (14,15). While it is clear that the ppe38-ppe71 operon is involved in 
PE-PGRS secretion, this phenotype can be present in other mycobacteria, driven by 
an independent and currently unknown mechanism. By utilising a ppe38-71 mutant 
in M. tuberculosis, the collective role of the PE-PGRS and PPE-MPTR proteins that are 
dependent on both ESX-5 and PPE38 can be studied in the context of host-pathogen 
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interactions. Interestingly, a hypervirulent phenotype was observed with increased 
bacillary growth of an M. tuberculosis ppe38-71 mutant in BALB/c mice (13). A similar 
phenotype was observed in zebrafish infected with a ppe38 transposon mutant of M. 
marinum (13,16). It was further demonstrated that an M. marinum ppe38 transposon 
mutant is able to modulate the innate immune response in murine macrophages and 
to alter antigen presentation (17). However, no differences were observed in TNF-α 
and CD40 levels in murine bone marrow-derived dendritic cells infected with an M. 
tuberculosis Δppe38-71 mutant compared to wild type (18). The dispensability of ppe38, 
and by association the secretion of PE-PGRS proteins, is an unexpected observation 
as these proteins are hypothesised to be important for adaptation to an intracellular 
lifestyle.
To further explore the role of PE-PGRS and PPE-MPTR proteins in host-pathogen inter-
actions, we characterised the temporal proteome profile of the THP-1 macrophage-like 
cell line in response to infection with M. tuberculosis CDC1551 and an isogenic ppe38-71 
mutant strain. We observed altered pro-inflammatory responses in macrophages in-
fected with M. tuberculosis Δppe38-71. We further used stable isotope labelling of amino 
acids in cell culture (SILAC)-based proteomics to investigate protein turnover rates in 
response to infection and could show an increased turnover of proteins involved in 
pro-inflammatory responses in macrophages infected with M. tuberculosis CDC1551. 
Finally, our results suggest a role for PPE38-controlled PE/PPE proteins of M. tuberculo-
sis in infection by modulating the inflammatory response through nuclear factor kappa 
B (NF-kB) signalling via the RelB pathway. By combining different approaches, we pro-
vide a deeper understanding of the molecular mechanisms exploited by M. tuberculosis 
to alter protective host responses during infection of macrophages.
MATERIALs AND METHoDs
bacterial strains
Mycobacterium tuberculosis CDC1551 Δppe38-(further referred to as Δppe38-71) and M. 
tuberculosis CDC1551 Δppe38-71::pMV_ppe38-71 (further referred to as complemented) 
were generated from M. tuberculosis CDC1551 as parental strain with an integrated 
ppe38-ppe71 serving as the complement under the constitutively expressed hsp60 pro-
motor. All three strains were obtained from a previous study (13). All bacterial strains 
were grown in modified Sauton’s medium (0.4% L-asparagine, 0.4% glucose, 0.2% citric 
acid, 0.05% monopotassium phosphate, 0.05% magnesium sulphate, 0.005% ferric am-
monium citrate and 0.001% zinc sulphate, pH 7.0), supplemented with 0.05% Tween-80 
at 37°C without shaking in 75 cm2 tissue culture flasks. M. tuberculosis Δppe38-71 was 
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cultured in the presence of 50 µg/ml hygromycin (ThermoFisher, MA, USA) and M. tu-
berculosis Δppe38-71::pMV_ppe38-71 was cultured in the presence of 25 µg/ml kanamy-
cin (Sigma-Aldrich, MO, USA) and 50 µg/ml hygromycin as indicated. Antibiotics were 
only used during pre-culture and were omitted during sub-culturing. In vitro growth 
was monitored by culturing M. tuberculosis CDC1551, Δppe38-71 and the complemented 
strain as stated above and measuring optical density at 600 nm over 20 days.
The mean was derived from four (n = 4) biologically independent experiments and 
error bars represent standard error of the mean (SEM). Statistical differences between 
strains at each time point was determined by two-way ANOVA followed by a Tukey HSD 
post-hoc test. The q-value used to infer statistically significant difference was set at 
0.05, thus only a q-value below this number was considered significant. The statistical 
tests were performed using the R statistical programming language version 3.8.1 using 
the standard library. See Fig. 1B and the corresponding legend for detailed statistical 
descriptions related to each figure.
cell lines
The THP-1 human monocytic cell line (ATCC®TIB-202©) available from the Ameri-
can Type Culture Collection (ATCC, VA, USA) was stored as frozen seed lots at -80°C 
suspended in cell freezing media (Merck, NJ, USA) until use. The THP-1 cells were 
cultured in RPMI (ThermoFisher, MA, USA) media supplemented with 10% fetal bovine 
serum (FBS) (ThermoFisher, MA, USA), further referred to as R10 media, at 37°C and 
in a 5% CO2 atmosphere for a maximum of three passages in either 25 or 75 cm2 tissue 
culture flasks. For pulse-chase SILAC (pSILAC) experiments, the THP-1 monocytes 
were grown as described above, however, the 10% FBS was substituted for 10% dialysed 
FBS (R10LIGHT). THP-1 monocytes were differentiated into macrophage-like cells using 
50 ng/ml phorbol myristate acetate (PMA) (Sigma-Aldrich, MO, USA) for three days. 
For experiments in ex vivo bacterial growth, 48-well tissue culture grade plates were 
used with 1 x 105 THP-1 seeding density. Proteomics experiments involving THP-1 cells 
used six well plates with a seeding density of 1 x 106 cells. The media was changed 
after three days, the cells washed twice with phosphate-buffered saline (PBS) pH 7.4 
(ThermoFisher, MA, USA) and the media replaced with either R10 or R10LIGHT. The 
THP-1 macrophage-like cells were subsequently rested for 24 hours at 37°C in a 5% CO2 
atmosphere before performing further experiments.
Macrophage infection
M. tuberculosis CDC1551, Δppe38-71 and the complemented strain were grown, sepa-
rately, as described above for 4 days or when an OD600 of 1.0 was reached. The cells 
were harvested by centrifugation (4 000 rpm, 10 min) and washed three times with 
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PBS pH 7.4 to remove Tween-80. Mycobacterial cells were subsequently resuspended 
in 5 ml PBS pH 7.4 and sonicated for 10 minutes in a water bath sonicator, followed 
by filtering through a 40 µm cell strainer to remove bacterial clumps. Optical density 
(OD) was measured, and suspensions were diluted to an OD600 of 0.1 (corresponding to 
approximately 1 x 107 cells/ml) in R10 medium.
The THP-1 macrophage-like cells were infected with the different M. tuberculosis strains 
at a multiplicity of infection (MOI) of 3:1 and incubated for 3 hours at 37°C in a 5% CO2 
atmosphere to allow for uptake of mycobacteria. For label-free proteomics, the infected 
macrophages were washed seven times with PBS pH 7.4 to remove extracellular bac-
teria and proteins were harvested at 4 hours and 18 hours post-infection, as described 
below. For colony forming unit (CFU) determination, the infected macrophages were 
treated with 100 U/ml pen-strep (penicillin/streptomycin) at 37°C for 1 hour, followed 
by three washes with PBS pH 7.4. Macrophages were lysed using deionised water at the 
indicated time points. The lysates were serially diluted to a maximum dilution of 1 x 10-6 
and plated on 7H11 agar, followed by incubation at 37°C for ~3 weeks or until colonies 
formed. To account for the presence of extracellular bacteria, THP-1 macrophage-like 
cells were washed seven times with PBS pH 7.4 to remove mycobacteria that were not 
internalised after three hours of infection. Bacteria remaining after the consecutive 
washes were determined by plating the final wash on 7H11 agar and incubated at 37°C 
for ~3 weeks or until colonies formed.
The bacterial viability and growth within macrophages were determined from three 
independent experiments described in Fig. 1C, Fig. 1D, Fig. 1E and the corresponding 
legend. Data was gathered by infecting THP-1 macrophage-like cells with mycobacterial 
strains and enumerated by colony forming unit (CFU) counts. The results were derived 
from three biologically independent experiments (n = 3) and error bars represent SEM. 
Hypothesis testing was performed in the R statistical programming language version 
3.8.1 using two-way ANOVA with a Tukey HSD post hoc test for data represented in 
supplementary Fig. 1C and 1E while a one-way ANOVA with a Tukey HSD post hoc test 
was used for Fig. 1D. Statistical significance was inferred using the resulting q-value 
and a cut-off was set at 0.05.
For pSILAC experiments, THP-1 macrophage-like cells were washed three times with 
PBS pH 7.4 and the media replaced with SILAC RPMI devoid of lysine and arginine 
(ThermoFisher, MA, USA). The cells were subsequently incubated for 3 hours at 37°C in 
a 5% CO2 atmosphere prior to infection to facilitate amino acid uptake upon exposure 
to mycobacteria. After the three-hour incubation, the SILAC RPMI was replaced with 
fresh SILAC RPMI supplemented with 10% dialysed FBS (ThermoFisher, MA, USA), 0.4 
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mg/ml 15N413C6-arginine and 0.08 mg/ml 15N213C6-lysine (R10HEAVY) and placed on ice until 
infection.
M. tuberculosis CDC1551, Δppe38-71 and the complemented strain were cultured and 
prepared for infection as previously described, with minor modifications. Briefly, the 
mycobacterial cells were harvested, sonicated and filtered as described above, how-
ever, the cells were diluted to an OD600 of 0.1 in R10HEAVY medium. Macrophage infec-
tions were further carried out as described above. Proteins were harvested at 4 hours, 
8 hours, 12 hours, 18 hours and 28 hours post-infection for protein turnover analysis, 
as described below.
MTT assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reagent was 
prepared in R10Light to a final concentration of 5 mg/ml. Supernatants of infected as well 
as uninfected macrophages were removed following infection at 18 hours and replaced 
with R10Light-MTT media. The macrophages were subsequently incubated at 37°C, 5% 
CO2 atmosphere for two hours. The media containing MTT was removed after this 
incubation step and replaced with DMSO and incubated at 37°C, 5% CO2 atmosphere 
for an additional 15 minutes. Macrophage viability was calculated by colorimetric shift 
measured at 540 nm using a plate reader.
The viability assay is described in Fig. 1G, the corresponding legend and details of the 
statistical test can be found in Data S1: Table S1. Results were gathered by infecting 
THP-1 macrophage-like cells with each mycobacterial strain as well as an uninfected 
control and measuring optical density at 18 hours post infection. The data in this ex-
periment was derived from three (n = 3) independent experiments and significant dif-
ferences were detected by one-way ANOVA following a Tukey HSD post hoc test. This 
test was performed in the R statistical programming language version 3.8.1 using the 
standard library and a q-value less than 0.05 was considered significant.
Protein extraction and proteomic sample preparation
At each time point, infected THP-1 macrophage-like cells were washed four times with 
PBS pH 7.4 on ice. Modified RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1mM 
EDTA, 1% IGEPAL CA-630, 0.1% sodium deoxycholate, Benzonase and Roche Complete 
EDTA-free protease inhibitor) was added to each well and placed on ice for 10 minutes 
to lyse cells. The lysates were subsequently centrifuged (14 000 rpm, 20 min) to remove 
cellular debris. Proteins were precipitated by the addition of four volumes ice-cold 
acetone and quantified by modified Bradford assay (19).
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All bacterial strains were grown in modified Sauton’s medium (0.4% L-asparagine, 
0.4% glucose, 0.2% citric acid, 0.05% monopotassium phosphate, 0.05% magnesium 
sulphate, 0.005% ferric ammonium citrate and 0.001% zinc sulphate, pH 7.0), supple-
mented with 0.05% Tween-80 at 37°C without shaking. For Tween-free supernatants, 
the bacteria was grown in tween until an OD of ~1 was reached and Tween-80 was 
removed by sequential washing through centrifugation (4 000 rpm, 20 minutes) for a 
total of 4 washes and sub-cultured in Sautons media without Tween-80. The bacteria 
was cultivated for an additional 5 days at 37°C before harvesting. Bacterial whole-cell 
lysates were produced by separating the cells from the supernatant by centrifugation (4 
000 rpm, 4°C, 10 minutes). The supernatant was filter sterilised using 0.22 µm low bind 
syringe filters (Merck Milipore, NJ, USA) and used for the Tween-80 supernatant frac-
tion. The pellet was resuspended in 1 ml ice cold protein extraction buffer (10 mM Tris-
HCl pH 7, 0.1% Tween-80, Complete Protease inhibitor cocktail table) and centrifuged 
once more (14 000 rpm, 4°C, 2 minutes). The pellet was suspended in 300 µl cold protein 
extraction buffer supplemented with RNase-free DNaseI and transferred to cryogenic 
vials containing an equal volume 0.1 mm acid washed glass beads. The suspension 
was mechanically lysed by bead-beating for 30 second intervals with 30 seconds on 
ice for a total of 8 cycles. The resulting lysate was clarified by centrifugation (14 000 
rpm, 4°C, 15 minutes) and filter sterilised through 0.22 µm pore acrodisks and syringes. 
Tween-free supernatants were harvested by separating the cells from the supernatant 
using 40 µm cell strainers (Corning, NY, USA) followed by centrifugation (4 000 rpm, 10 
minutes) and filter sterilised using 0.22 µm Steriflip® filters (Sigma-Aldrich, MI, USA). 
The supernatants were concentrated using Amicon Ultra 3 KDa spin columns and pre-
cipitated with ice cold acetone overnight. The precipitated proteins were resuspended 
in 8M urea, and all proteins were quantified using a modified Bradford assay and used 
for LC-MS/MS (19).
Equal amounts of protein (20 µg) were used for sample preparation for LC-MS/MS fol-
lowing a tube gel protocol (20). Briefly, proteins suspended in 8M urea were diluted 
in 1M tris-HCl pH 6.8 and cast in an acrylamide gel containing 10% SDS within an Ep-
pendorf tube. The samples were allowed to set overnight at room temperature. Protein-
containing gels were removed from the Eppendorf tubes and cut into ~1 mm x 1 mm 
gel pieces. Gel pieces were washed three times with 50 mM ammonium bicarbonate 
(Sigma-Aldrich), followed by reduction with 5 mM tris(2-carboxyethyl)phosphine (Sig-
ma-Aldrich, MO, USA) for 1 hour at 45°C. After reduction, the proteins were alkylated 
with 55 mM iodoacetamide (Sigma-Aldrich, MO, USA) for 1 hour at room temperature. 
The gel pieces were washed twice with 100% acetonitrile after alkylation. Sequencing 
grade modified trypsin (Promega, WI, USA) was added to the gel pieces at a 1:50 trypsin 
to protein ratio and incubated at 4°C for 1 hour, followed by an 18h proteolytic digestion 
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at 37°C in a humidified chamber. Peptides were eluted by sequential addition of 50%, 
70% and 100% acetonitrile until gel pieces turned opaque. The eluates were then dried 
in a vacuum desiccator (SpeedVac). Dried peptides were suspended in 5% acetonitrile 
(Sigma-Aldrich, MO, USA) containing 0.1% formic acid and desalted using C18 desalt-
ing columns (ThermoFisher, MA, USA) as recommended by the manufacturer.
Lc-Ms/Ms
Dried peptides were dissolved in 30 µl of solvent A (2% acetonitrile containing 0.1% 
formic acid in HPLC-grade water) and 500 ng peptides was analysed. All chromatog-
raphy was performed on a nanoAcquity UPLC system (Waters, MA, USA) using a 200 
cm uPAK™ column (Pharmafluidics, Gent, Belgium) coupled to a Thermo Q-Exactive 
Plus Orbitrap mass spectrometer (ThermoFisher, MA, USA) equipped with a Flex nano-
electrospray source. The spray voltage was set to 1.9 kV (Thermo Fisher, MA, USA) and 
the capillary temperature was 250°C. Peptide separation was performed using a linear 
gradient of solvent B (98% acetonitrile, 0.1% formic acid and 2% HPLC grade water), 
starting with 3% solvent B and increased to 40% solvent B over 80 minutes. Solvent 
B was increased to 100% in 5 minutes and subsequently decreased to 3% solvent B 
in 5 minutes. Solvent B was kept at 3% B for an additional 35 minutes at a flow rate 
of 750 nL/min, where a column temperature of 50°C was maintained with a heater. 
Mass spectrometry was performed in data-dependent acquisition mode using a full 
MS1 scan (350-1 850 m/z, resolution at 70 000, max injection time was 100 ms and ACG 
target was 3e6), and selecting precursor ions with a 2+ or greater charge state for MS/MS 
analysis. This was followed by HCD fragmentation with normalised collision energy set 
at 28% and MS/MS acquisition (200–2 000 m/z, resolution 17 500, max injection time of 
80 ms, AGC target was 1e5) of the top 20 most intense precursors from each full scan. 
Dynamic exclusion of ions was implemented using a 20s exclusion duration and only 
ions with an unassigned charge state were disregarded.
Mass spectrometry data analysis
All tandem mass spectra were analysed using MaxQuant version 1.6.10 (21) and 
searched against the human proteome (UP000005640, containing 74 349 entries) data-
base downloaded on 14/10/2017 from Uniprot and the M. tuberculosis CDC1551/Oshkosh 
proteome (UP000001020, containing 4 204 entries) downloaded on 17/4/2017. Peak list 
generation of label-free tandem mass spectra was performed within MaxQuant using 
default parameters and the built-in Andromeda search engine (22). Enzyme specific-
ity was set to consider fully tryptic peptides with two missed cleavages were allowed. 
Oxidation of methionine and N-terminal acetylation were allowed as variable modi-
fications. Carbamidomethylation of cysteine was allowed as a fixed modification. A 
protein and peptide false discovery rate of less than 1% was employed in MaxQuant 
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with match between runs enabled. Proteins that contained similar peptides that could 
not be differentiated on the basis of MS/MS analysis alone were grouped to satisfy the 
principles of parsimony. Data handling, statistical tests and figure generation was 
performed using ProVision, an online data analysis platform that uses the LIMMA 
package in R for statistical tests (23). Briefly, Reverse database hits, contaminants and 
proteins only identified by site modifications were removed. Precursor intensity values 
for each protein was obtained from MaxQuant using the MaxLFQ algorithm available 
internally (24). The file was further filtered for each protein group to contain at least 
two unique peptides. The assigned LFQ intensity values were subsequently log2 trans-
formed to gain a normal distribution and further filtered for two values in at least one 
group. This resulted in the high confidence expression dataset, and missing values 
were imputed from a truncated normal distribution of transformed LFQ intensities. 
Quantile of Quantile plots were used within the ProVision application to check for 
normality prior to statistical testing. Multiple hypothesis testing was corrected using 
the Benjamini-Hochberg FDR set at 0.05, and a two-fold cut-off was implemented. 
The statistical analysis and visualisations of label-free mass spectrometry data can be 
found in supplementary Fig. 1 and Fig. 2 with an extended analysis in supplementary 
Fig. S2. The mass spectrometry data pertaining to this experiment, which was used to 
generate these figures are available in Data S1, table S2. Differential expression of in 
vitro grown mycobacterial strains was as described in Fig. 5E, 5F, supplementary Fig. 
5A and supplementary Fig. 5B as well as Data S1: table S5, table S6 and table S7. The 
data used for hypothesis testing was derived from three (n = 3) biologically indepen-
dent experiments for each condition. Significant differences were accepted when the 
q-value was below 0.05 and a log2 fold change of 1.
Protein turnover
The search parameters for SILAC were largely similar to that of the label-free searches 
using MaxQuant version 1.6.10 and the same human proteome (UP000005640) as a 
reference database. For the pSILAC searches a multiplicity of 2 was chosen adding 
heavy arginine with a mass shift of 10 Da and heavy lysine with a mass shift of 8 Da. 
Furthermore, the re-quantify function was disabled and match between runs was 
enabled. Oxidation of methionine and N-terminal acetylation was chosen as variable 
modification and carbidomethylation of cysteine was set as the fixed modification 
and all FDR cut offs for peptide identification was set at 0.01. Under conditions with 
increased arginine cell lines can convert the excess arginine to proline which results 
in non-specific dilution in the stable isotope signal and can confound intensity values. 
We therefore tested this conversion in our differentiated THP-1 macrophage-like cell 
line with LPS stimulating with heavy lysine and arginine for 18 hours. Searching in the 
same manner as above with proline (6 Da shift) as a variable modification only iden-
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tified 5 proteins containing this amino acid. Thus, we continued with the 0.4 mg/ml 
15N413C6-arginine for the rest of our experiments. The resulting protein groups file was 
filtered in the same manner as detailed above for the label-free proteomics. Briefly, all 
contaminants; reverse database hits as well as proteins only identified by site modifica-
tions was removed from the SILAC dataset and we additionally filtered for a minimum 
of two unique peptides. The post-filtered raw ratios of each strain and each time point 
was used for further analysis.
As the heavy isotopes increase, the light isotopes decay providing a function to ex-
trapolate half-life for the population of proteins based on linear regression. Protein 
turnover was calculated from an average from the raw ratios using a similar approach 
as previously described (25). As the natural occurrence of 15N213C6-lysine is exceedingly 
rare we assumed a zero time point where the heavy fraction was set to zero for further 
handling in a manner as previously described (26). The raw ratios of each condition 
(i.e. THP-1 infected with CDC1551, Δppe38-71 etc.) were filtered to contain at least three 
ratios in the time course and with a coefficient of determination above 0.85. The half-
lives (T1/2) of each protein were determined using a first order reaction equation (eq 
1). This was subsequently derived for calculating the half life (eq 2), where half-life is 
equal to the natural log of two divided by the rate (Kdp)
 (1)
 (2)
The reaction rate (Kdp) was calculated using equation 3 without accounting for dilution 
by replication as THP-1 macrophage-like cells are terminally differentiated. Here r is 
representing the raw ratio at each time point and ti is each specific time point. For 
optimal handling the equation can be expressed using all variables for a direct calcula-
tion of half-life (eq 4).
 (3)
 (4)
Calculating the Kdp values were implemented using the Excel macro LinEstGap which 
implements equation 3 (see data availability for link to the macro) and the half-lives 
were calculated using equation 4. The average half-life was calculated after filtering for 
each replicate and was further processed in the R statistical programming language. 
Here the average half-life was calculated per condition which produced a log normal 
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distribution and missing values. This was followed by filtering the dataset where a 
protein should contain at least one half-life representing at least one of the four condi-
tions.
For further analysis we Z-scored the half-lives to obtain a dataset used to generate 
heatmaps where the row clustering was to gain a distance from the centroid metrics. 
These clusters were enriched for gene KEGG pathways using the WebgestaltR pack-
age available on the CRAN repository as shown in Fig. 3D (27). Hypothesis testing was 
used to determine differentially regulated half-lives from two biologically independent 
experiments (n = 2) across five time points namely 4 hours, 8 hours, 12 hours, 18 hours 
and 28 hours post infection. The difference in protein turnover between CDC1551 and 
Δppe38-71 infected THP-1 macrophage-like cells was determined using hypothesis test-
ing. This allowed for stringent filtering, i.e. contains ratios in both replicates in both 
conditions, without losing valuable data. The strict filtered dataset for each comparison 
was log2 transformed to obtain a normal distribution and the Limma package was used 
for hypothesis testing. The resulting p-values were corrected for using Benjamini-
Hotchberg FDR set at 0.05 and fold change was disregarded for these specific analyses. 
The results of these tests were visualised in Fig. 4A and Fig. 4B, the raw data used to 
generate these figures are available in Data S1: table S4. The differentially regulated 
proteins were further used to enrich for KEGG pathways using the WebGestaltR pack-
age as shown in Fig. 4D.
western blots
Macrophage whole-cell lysates and bacterial supernatants were either probed with 
a WesternBreeze anti-rabbit chemiluminescent kit (Thermo Fisher, MA, USA) or 
manually if primary antibodies required an anti-mouse secondary antibody. Briefly, 
whole-cell lysates were quantified using a modified Bradford assay and 50 µg total 
protein content was separated by SDS-PAGE. Proteins were subsequently transferred to 
nitrocellulose membranes for 1 h. The membranes were stained with Ponceau S (0.1%, 
w/v in 5% acetic acid) to inspect sample loading. Membranes were probed with anti-
GAPDH (CST, D16H11), anti-IL-1B (CST; D3U3E), anti-NF-kB1 (CST; D4P4D) anti-NF-kB2 
(CST,18D10), anti-ISG15 (CST; 22D2), anti-DDX58 (CST; D14G6), anti-PPE38 (custom, 
Innovagen, Sweden) or anti-PGRS (3) overnight at 4°C, as indicated in the text. This was 
followed by incubation with an alkaline phosphatase-conjugated secondary anti-rabbit 
antibody or a horseradish peroxidase-conjugated goat anti-mouse secondary antibody 
for 1 hour at room temperature. Blots were visualised using the chemiluminescent 
substrate provided by the WesternBreeze kit or with ECL detection reagent (Bio-Rad) 
and imaged on a ChemiDoc Imaging System (Bio-Rad).




M. tuberculosis CDC1551, Δppe38-71 and complemented strains were grown in Sauton’s 
media containing 0.05% Tween-80 for 5 days or until an OD600 of ~1 was reached. M. 
tuberculosis culture supernatants were harvested by centrifugation (4 000 rpm, 10 min) 
and concentrated using 4 kDa molecular weight cut off Amicon Ultra spin columns 
(Merck Millipore, MA, USA). Proteins in the cell-free supernatants were precipitated 
using ice-cold acetone and kept overnight at -20°C. The precipitated proteins were 
harvested by centrifugation (14 000 rpm, 30 min) and resuspended in 8M urea in 50 mM 
triethylammonium bicarbonate (urea buffer). Protein concentration was determined 
using a modified Bradford assay, as described previously (19).
THP-1 monocytes were seeded into 6-well plates at 1 x 106 cells/well and differentiated 
into macrophages, as described above. THP-1 macrophage-like cells were stimulated 
for 18h with lipopolysaccharide from E. coli (Sigma-Aldrich, MO, USA) at 100 ng/ml or 
proteins from cell-free supernatants of M. tuberculosis at 20 µg per well. Unstimulated 
cells served as baseline controls for IL-1B expression. Whole-cell lysates of the macro-
phages were harvested as described above and stored at -80°C until further use.
Expression was quantified by densitometry of western blots, where a represented blot 
is depicted in supplementary Fig. 5C. Relative quantification was determined from 
three independent biological experiments (n = 3) and depicted in supplementary Fig. 
5D. Significant differences were determined by one-way ANOVA followed by Tukey 
HSD and details are depicted in supplementary Fig. 5E. Significant differences were 
accepted when the q-value was below 0.05.
Immunofluorescent staining and microscopy
THP-1 monocytes were cultivated, differentiated and infected as described above. 
After 18 hours of infection, the medium was removed, the cells were fixed in 4% para-
formaldehyde (PFA) for 30 minutes at room temperature and washed three times in 
PBS pH 7.4 for 10 minutes. Cells were permeabilised using 0.1% Triton X-100 in PBS 
pH 7.4 for 10 minutes at room temperature and washed three times in PBS pH 7.4 for 
10 minutes. Cells were blocked with 1% bovine serum albumin (BSA) in PBS pH 7.4 
containing 0.1% Tween-80 and 0.1M glycine for 1 hour at room temperature, after 
which cells were incubated with corresponding primary antibodies diluted in 1% BSA 
in PBS pH 7.4 overnight at 4°C in a humidified chamber. Antibody dilutions were used 
as follows: RelA antibody (NF-kb p65 (D14E12) XP® Rabbit mAb, Cell Signalling Tech-
nology, MA, USA) was used at a 1:400 dilution; RelB (Recombinant Anti-Rel B antibody 
[EPR7076] - C-terminal (ab180127, Abcam, Cambridge, UK) was used at a 1:200 dilution; 
NF-kb1 p105/p50 (D4P4D, Rabbit mAb, Cell Signalling Technology, MA, USA) was used 
168
at a 1:200 dilution; NF-kb2 p100/p52 (D7AK9, Rabbit mAb, Cell Signalling Technology, 
MA, USA) was used at a 1:400 dilution. Cells were washed three times in PBS pH 7.4 
for 10 minutes and incubated with anti-rabbit Alexa Fluor 488 secondary antibody 
(Thermo Fisher, MA, USA) used at 1:500 dilution for 1 hour at room temperature in the 
dark. Cells were washed three times in PBS pH 7.4 for 10 minutes and subsequently 
stained with Phalloidin–Tetramethylrhodamine B isothiocyanate (Sigma Aldrich, MI, 
USA) to visualize F-actin. Nuclei were counterstained with Hoechst in PBS pH 7.4 for 10 
minutes at room temperature in the dark. Cells were washed a further three times in 
PBS pH 7.4 for 10 minutes before mounting upside down onto glass microscope slides 
using Dako fluorescent mounting medium and air drying overnight in the dark at room 
temperature. Slides were stored at 4°C in the dark until imaging. Unstained, single 
stained and secondary antibody only controls were prepared for each experiment to as-
sess background autofluorescence and signal specificity in each channel. Images were 
obtained using a Carl Zeiss LSM 780 confocal microscope (Plan-Apochromat x63/1.40 
oil DIC M27 objective lens). Images were acquired using the ZEN software (Carl Zeiss, 
Oberkochen, Germany). Acquisition settings for imaging were identically set for all 
treatment groups within each experiment. Analysis and quantification of images were 
done with the ZEN black software version 13.0.0.518 (Carl Zeiss, Oberkochen, Germany) 
and any manipulations done, such as min/max, were extended to all channels. No single 
channel enhancements were used during quantification and all changes were applied 
equally across the entire image. In addition, twenty cells were chosen from at least 
10 random fields per replicate to with a minimum of three independent experiments 
(n=3) to generate the results as depicted in Fig. 7J. For display images, channels were 
enhanced as appropriate to accurately demonstrate nuclear translocation of proteins.
ELIsA
Supernatants harvested from infected THP-1 macrophage-like cells at 18 hours and 48 
hours post-infection were sterilised using a 0.22 µm syringe filter. Sterilised superna-
tants were subsequently assayed for interleukin 12 p70 (IL-12p70) and interleukin 3 (IL-
13) levels using ELISA kits (Biosource, Invitrogen), as indicated by the manufacturer.
The data was derived from three independent biological experiments (n = 3) and is 
depicted in Fig. 8A, Fig. 8B and details of the statistical test can be found in Fig. 8 leg-
end and Data SI Table S8. Significant differences were determined by one-way ANOVA 
followed by Tukey HSD and accepted when the q-value was below 0.05.




PPE38 does not influence M. tuberculosis uptake or replication within 
macrophages
The cell surface of M. tuberculosis is covered with pathogen-associated molecular pat-
terns (PAMPs), which will be recognised by the host during infection to initiate immune 
responses. The PE-PGRS and PPE-MPTR proteins are groups of PAMPs localised on the 
cell surface of M. tuberculosis that have been implicated in host-pathogen interactions 
and virulence (28–30). Previous work has linked a Δppe38-71 deletion mutant to in-
creased virulence in M. tuberculosis by controlling a subset of PE-PGRS and PPE-MPTR 
secretion (13).
In the present study, we exploited a Δppe38-71 deletion mutant to test whether a lack of 
PPE38 and its effectors will result in altered macrophage responses during infection. 
Initially, we verified that the strains used in this study have the same phenotype of 
diminished PE-PGRS protein secretion previously observed (13), as well as verifying 
the presence and absence of PPE38 by western blot (Fig. 1A). Next, we measured the 
growth of M. tuberculosis CDC1551, the Δppe38-71 mutant and the complemented 
strain to determine if any growth differences exist. No significant differences were 
found between the strains over a 20-day growth period (Fig. 1B). To reduce variabil-
ity, 4-day old mycobacterial cultures were used for all infections. The growth of each 
strain was monitored within THP-1 macrophage-like cells for 28 hours by enumerat-
ing cell counts at various time points (4 hours, 18 hours and 28 hours) post-infection. 
No significant differences were found in mycobacterial proliferation or macrophage 
cell death associated with any of the strains over the 28-hour period (Fig. 1C). For the 
mass spectrometry experiments, we omitted antibiotic treatments for the killing of 
extracellular bacteria, which could result in confounding factors in this experimental 
design. Instead, extracellular bacteria were removed by multiple washes. The number 
of remaining bacteria was enumerated by CFU and a two log decrease of extracellular 
bacteria was observed (Fig. 1D). Mycobacterial uptake was measured by plating intra-
cellular bacteria at 4 hours, 18 hours and 28 hours to rule out uptake of the residual ex-
tracellular mycobacteria during the incubation period. The intracellular bacterial load 
remained steady across the time points and no significant differences were detected, 
thereby indicating little to no ongoing uptake within the time frame of this experiment 
(Fig. 1E). The percentage uptake from the original titre at 4 hours after infection was 
10-15% for all strains, with no significant difference between strains (Fig. 1F). Lastly, 
an MTT assay was used to determine macrophage viability at 18 hours post-infection. 
A decrease in THP-1 viability between infected and uninfected states was observed 
(Fig. 1G). However, no statistically significant differences in cell death were observed 
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figure 1: The absence of PPE38 controlled PE-PGRs proteins has no effect on bacterial survival or 
macrophage death in a 28 hour period.
A) PE-PGRS and PPE38 immunoblot of in vitro culture supernatants of M. tuberculosis CDC1551, Δppe38-71 and 
the complemented strain harvested at OD600 of ~1. b) In vitro growth curves of M. tuberculosis CDC1551, Δppe38-71 
and the complemented strain by optical density measurements for 20 days. Data is representative of four inde-
pendent experiments and error bars represent SEM. Two-way ANOVA with Tukey HSD post-hoc testing was used 
to determine a significant difference with a q-value cut-off at 0.05 c) Intracellular growth curve of M. tuberculosis 
CDC1551, Δppe38-71 and the complemented strain in THP-1 macrophage-like cells. Growth was monitored over 
28 hours and infected macrophages were harvested at 4 hours, 18 hours and 28 hours after exposure to mycobac-
teria. Mycobacterial load was measured by CFU enumeration. Data is representative of three independent experi-
ments and error bars represent SEM. D) Extracellular bacteria at 3 hours post-infection were determined by CFU 
enumeration after 7 consecutive washes. No significant difference was detected by one-way ANOVA between the 
different strains. Data is representative of three independent experiments and error bars are indicative of SEM. E) 
Differential uptake of mycobacteria by THP-1 macrophage-like cells during infection was measured by washing 
excess bacilli at 3 hours post-infection. Pen/Strep treatment for 1 hour was used directly before each harvesting 
time point, i.e. 4 hours; 18 hours and 28 hours; to remove any extracellular bacteria still present. The intracellular 
mycobacterial load was determined by CFU enumeration and data is representative of three independent experi-
ments, error bars represent SEM. f) Percent bacterial uptake calculated from the original inoculum at an MOI of 
3:1. Data is representative of three independent experiments where the percentage was calculated from the mean 
CFU of each strain obtained from 4 hours post-infection divided by the mean CFU of the original inoculum. G) 
THP-1 macrophage viability was measured by MTT assay at 18 hours post-infection. Data is representative of three 
independent experiments and error bars represent SEM. One-way ANOVA was used to determine significant dif-
ferences with a p-value cut off of 0.05.
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in macrophages infected with the different strains (Data S1, Table S1). These experi-
ments demonstrate similar growth of M. tuberculosis Δppe38-71 and wild type in vitro. 
The Δppe38-71 mutation does not alter macrophage viability compared to wild type, 
nor is intracellular survival of M. tuberculosis Δppe38-71 affected compared to wild type 
in our experimental conditions. These experiments indicated that abrogation of PE-
PGRS/PPE-MPTR secretion to the extracellular milieu does not cause the macrophage 
to clear the mycobacterial infection or succumb to it. However, given the immunogenic 
nature of the PE-PGRS and PPE-MPTR proteins some effect is to be expected upon loss 
of their secretion (28,29). We therefore investigated the proteome response of THP-1 
macrophage-like cells to infection with M. tuberculosis CDC1551, Δppe38-71 and the 
complemented strain.
Label-free proteomics reveals time-dependent differences in pro-
inflammatory responses in macrophages when exposed to M. 
tuberculosis strains lacking PPE38-and PPE38 controlled proteins.
Whole-cell lysates were harvested from infected macrophages at 4 hours and 18 hours 
post-infection and analysed by label-free mass spectrometry. A total of 2 052 confident 
protein groups (FDR < 1%) were identified after filtering for two unique peptides and a 
minimum of two values per replicate in at least one of the groups. The label-free quan-
tification (LFQ) algorithm in MaxQuant was used for relative protein quantification, 
and no differences in the mean distribution of intensity values were observed (Fig. 
S1A). Principal component analysis (PCA) of LFQ intensities was used to determine 
clustering within and between replicates of each test group at each time point. No 
distinct clustering was observed at the 4h time point (Fig. S1B), indicating that early 
innate immune responses are similar between macrophages infected with the different 
strains. However, a clear separation of the groups could be observed at the 18-hour 
time point in the first component, indicating that the majority of the variation is due 
to strain-specific features (Fig. S1C). The same analysis of the temporal macrophage 
responses within the groups at different time points also revealed separation in the 
first component (Fig. S1D, S1E, S1F).
Next, we determined the differentially regulated proteins in the infected THP-1 mac-
rophage-like cells. There was no significant difference in protein expression between 
M. tuberculosis CDC1551 and Δppe38-71 infected macrophages at 4 hours post-infection 
(Fig. 2A). At 18 hours post-infection, a total of 39 proteins were downregulated in mac-
rophages infected with M. tuberculosis Δppe38-71 compared to M. tuberculosis CDC1551, 
while 11 proteins were upregulated (Fig. 2B). Furthermore, macrophages infected with 
M. tuberculosis CDC1551 had an increased temporal cytokine expression profile, where 
the majority of the 39 upregulated proteins were involved in the expression of proteins 
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associated with a pro-inflammatory response (Fig. 2C, 2G). In contrast, M. tuberculosis 
Δppe38-71-infected macrophages had a remarkably low pro-inflammatory response 
to infection relative to wild type-infected macrophages (Fig. 2D, 2G). Macrophages 
infected with the complemented strain displayed largely a similar temporal profile as 
those infected with M. tuberculosis Δppe38-71 (Fig. 2E, 2F). This may be due a number 
of reasons, the most likely candidates involving the promotor or the physiological state 
of the bacteria upon infection. As the hsp60 promotor is constitutively expressed and 
at high amounts it is unlikely that the lack of complementation in the macrophage is 
due to a lack of protein products from the ppe38-71 operon (31). We do indeed observe 
greater variability within the replicates of the complement strain which likely results 
in reporting of non-significant results from hypothesis testing (Fig. S1C, S1F). Finally 
the PE-PGRS proteins are cell surface proteins and the presence of detergent is known 
to influence the mycobacterial capsule (9,32,33). Thus, the physiological state of the 
bacteria may be altered due to the presence of detergent in the culture media prior to 
infection. To gain more insight, we examined the expression of individual proteins and 
observed at least partial complementation in, among others, interleukin 1 Beta (IL-1B), 
nuclear factor kappa B (NF-kB) 2 and ‘-5’-oligoadenylate synthase 2 (OAS2) as indicated 
by individual fold change values (Fig. 2G, Data S1: Table S2). Lastly, gene set enrichment 
analysis of the differential response at 18 hours post infection between M. tuberculosis 
CDC1551 and Δppe38-71-infected macrophages indicated NF-kB signalling as the most 
enriched pathway (Fig. S2A). Furthermore, key proteins that were differentially regu-
lated during infection with these strains included IL-1B (Fig. S2B), NF-kB2 Fig. S2C), 
retinoic acid-inducible gene I (Rig-I/DDX58) (Fig. S2D) and Interferon stimulated gene 
15 (ISG15) (Fig. S2E), indicative of both altered interleukin and interferon responses, 
all of which can be controlled by NF-kB signalling.
figure 2. Label-free proteomic analysis reveals altered inflammatory responses in M. tuberculo-
sis-infected macrophages.
Volcano plots representing differential protein abundance in macrophages infected with M. tuberculosis CDC1551 
compared to infection with Δppe38-71 at A) 4 hours post-infection, b) 18 hours post-infection, c) infection with M. 
tuberculosis CDC1551 at 18 hours compared to 4 hours and D) infection with Δppe38-71 at 18 hours compared to 4 
hours post infections. Significance cut-offs were set at a q-value less than 0.05 and a log2 fold change greater than 
1. Numbers indicate the amount of significantly regulated proteins. E) Volcano plot representing regulated pro-
teins of THP-1 macrophage-like cells infected with the complemented strain compared to M. tuberculosis CDC1551 
at 18 hours post-infection. Significance cut-offs were set at a q-value less than 0.05 and a log2 fold change greater 
than 1. f) Volcano plot representing proteins of THP-1 macrophage-like cells infected with the complemented 
strain at 18 hours compared to 4 hours post infection. Significance cut-offs were set at a q-value less than 0.05 and 
a log2 fold change greater than 1. G) Heat map of the main regulated proteins between the groups, displaying the 
log2 fold changes between THP-1 macrophage-like cells infected with M. tuberculosis CDC1551, Δppe38-71 and the 
complemented strain at 18 hours post-infection. LFQ intensities were Z-scored and are from three independent 
biological replicates.
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While we could not definitively state that the major response observed here is driven by 
the ppe38-71 deletion, we do observe distinct trends in certain key proteins associated 
with an inflammatory response. These observations suggest a role for NF-kB signalling 
based on enrichment analysis of the significantly regulated proteins, which may shed 
light on the low inflammatory response of the macrophage to M. tuberculosis Δppe38-
71. Initiating an inflammatory response is an energy-intensive process and requires 
upregulation of multiple target proteins and thus increased transcription and transla-
tion. To maintain a balance in the proteome, proteins need to be degraded in relation 
to this increased synthesis (34–36). This phenomenon is known as protein turnover. To 
further corroborate our findings, the protein turnover of macrophages infected with 
the different strains, as well as an uninfected control was determined.
Proteostasis is affected by the presence of PPE38-controlled proteins.
Pulse-chase stable isotope labelling by amino acids in cell culture (pSILAC) can be 
used to determine protein turnover, and thus proteostasis, of an organism by mass 
spectrometry (25,37,38). Terminally differentiated THP-1 cells are unable to replicate 
and thus do not naturally dilute the proteins by division, providing a useful model for 
studying protein homeostasis. THP-1 macrophage-like cells infected with the M. tuber-
culosis CDC1551, Δppe38-71 and complemented strains, as well as control uninfected 
macrophages, were sampled at multiple time points to determine protein turnover 
in response to infection (Fig. S3A). A total of 1 257 protein half-lives were calculated 
across all four conditions, after filtering for two unique peptides, the presence of a 
heavy/light ratio in at least three time points and a coefficient of determination (R2) 
greater than 0.85 (Data S1 Table S3).
The percentage of heavy amino acid (lysine and arginine) incorporation increased 
linearly over time to a maximum of 30% incorporation in all conditions (Fig. S3B). 
Interestingly, no shift in the distribution of protein half-lives occurred between any 
of the conditions (Fig. S3C). Half-lives were highly correlated within the conditions 
with coefficients of determination (R2) values found to be 0.92 between M. tuberculosis 
Δppe38-71 and M. tuberculosis CDC1551-infected macrophages (Fig. S3D), and between 
macrophages infected with M. tuberculosis CDC1551 or the complemented strain (Fig. 
S3E). The R2 values of half-lives from uninfected macrophages compared to M. tubercu-
losis CDC1551 were only marginally less than that of the uninfected counterparts (Fig. 
S3F). This was surprising, as it was expected that less correlation would be observed 
between infected and uninfected macrophages due to increased protein synthesis dur-
ing infection.
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As no overall differences were observed when analysing global protein turnover 
rates, we used hierarchical clustering to assign proteins with correlated half-lives to 
distinct clusters. The protein turnover profiles between the uninfected cells and M. 
tuberculosis CDC1551-infected macrophages showed the greatest differences (Fig. 3A). 
The individual proteins grouped into two distinct clusters, where shifts in the marginal 
means were primarily driven by M. tuberculosis CDC1551 (Fig. 3B, 3C). Deviations of 
marginal means, the mean half-life of each protein from each group, in response to in-
fection reflect similar trends to those observed in the protein expression profiles. The 
response to infection with M. tuberculosis CDC1551 compared to the uninfected control 
acts as the driver that separates cluster 1 and 2. While infection by the M. tuberculosis 
Δppe38-71 strain has an effect on the protein half-lives compared to uninfected, it is 
not as pronounced as that observed for wild type. This is in line with our protein ex-
figure 3: Infection with M. tuberculosis cDc1551 and not M tuberculosis Δppe38-71 causes a shift 
in protein turnover associated with the IL-12 pro-inflammatory pathway.
A) Half-lives from THP-1 macrophage-like cells infected with M. tuberculosis CDC1551, M. tuberculosis Δppe38-71 and 
the complemented strain and uninfected control macrophages were assessed using hierarchical clustering with 
Euclidean distance. Two distinct clusters formed representing either an increase (cluster 1) or a decrease (cluster 2) 
in protein half-lives as depicted by profile plots. Protein groups from b) cluster 1 and c) cluster 2 are represented 
as a deviation in the estimated marginal mean of each protein half-life, after adjustment of covariates, across each 
factor. D) GO enrichment analysis of each cluster obtained in A and B. Protein turnover data is representative of two 
biological replicates.
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pression results where a modest change was observed during infection. Furthermore, 
these clusters represent either an increase (cluster 1) or decrease (cluster 2) in protein 
half-lives and these clusters were used for pathway enrichments. The enrichments 
indicate that half-lives associated with cluster 1 are involved in proteome integrity and 
maintenance, while those associated with cluster 2 are involved in the inflammatory 
response (Fig. 3D). Taken together, macrophages infected with M. tuberculosis CDC1551 
induce robust inflammatory responses, with dynamic shifts in both expression and 
half-life. However, these effects are less pronounced when challenged with M. tuber-
culosis Δppe38-71. As in our other proteomics experiments, the complemented strain 
clustered closer with M. tuberculosis Δppe38-71 infections than infection by CDC1551 
and all infections were distinct from the uninfected profile.
Protein half-life differences between M. tuberculosis cDc1551- 
and Δppe38-71-infected macrophages point to an altered pro-
inflammatory response.
To further investigate the effect of protein half-lives of infected macrophages, the dif-
ferential turnover of individual proteins was assessed using hypothesis testing. The 
protein half-lives were filtered prior to statistical testing to remove all missing values 
from the test groups. From these tests, we identified 24 proteins with differentially 
regulated half-lives between M. tuberculosis CDC1551 and M. tuberculosis Δppe38-71 (Fig. 
4A) as well as 10 differentially regulated half-lives between M. tuberculosis CDC1551 and 
macrophages infected with the complemented strain (Fig. 4B). Of these proteins, 17 
were unique to macrophages infected with M. tuberculosis Δppe38-71 compared to M. 
tuberculosis CDC1551-infected macrophages, and three were unique to macrophages 
infected with the complemented strain compared to M. tuberculosis CDC1551-infected 
macrophages. Seven proteins were shared between these conditions (Fig. 4C). While 
some proteins are complemented, a similar trend as with the label-free comparisons is 
observed (Data S1 Table S4).
The proteins displaying differential half-lives in the M. tuberculosis Δppe38-71 infected 
compared to M. tuberculosis CDC1551-infected macrophages were split into upregu-
lated (slower turnover than in M. tuberculosis CDC1551-infected macrophages) and 
downregulated proteins (faster turnover). These proteins were used for KEGG pathway 
analysis and showed enrichment of fatty acid degradation pathways in the slower 
protein turnover cluster. Interestingly, Th1/Th2 cell differentiation was enriched in the 
faster turnover cluster (Fig. 4D). From the hypothesis test, a number of immune-related 
proteins displayed differential half-lives. Proteins such as PSMA4, Stat-1 and Tapasin 
had a rapid turnover in M. tuberculosis CDC1551-infected macrophages compared to 
the other conditions (Fig. S4A). These proteins are involved in MHC class I presentation 
chapter 5  |  PPE38 dependent proteins alter inflammation
177
5
in the case of PSMA4 and Tapasin, or inflammatory cell signalling which is mediated 
by Stat-1. Interestingly, modulation of the MHC class I antigen presentation pathway 
by PPE38 has been demonstrated previously (39). Furthermore, proteins affecting in-
nate immunity with slow turnover in M. tuberculosis CDC1551-infected macrophages 
included Glyoxalase I and Leukosialin (Fig. S4B). The glyoxalases are used for the de-
toxification of α-oxaldehydes, in particular methylglyoxal, in eukaryotic cells (40–42). 
figure 4: Differential regulation of individual protein half-lives point towards changes in the in-
flammatory response.
Volcano plot depicting altered protein half-lives between A) M. tuberculosis CDC1551- and Δppe38-71-infected 
macrophages or b) M. tuberculosis CDC1551- and complement-infected macrophages. Significantly altered protein 
half-lives are highlighted based on q-value set at 0.05. Downregulated proteins are denoted as DR (purple), upregu-
lated as UR (orange) and non-significant as NS (grey) in the volcano plots. c) Venn diagram depicting the num-
ber of macrophage protein half-lives present either uniquely or commonly between the M. tuberculosis CDC1551 
infected and Δppe38-71 infected macrophage and between M. tuberculosis CDC1551 infected and complement-
infected macrophage comparisons. Data is representative of two biological replicates. D) Over-representation 
analysis of the proteins with differentially regulated half-lives against KEGG pathways, where up is indicative of 
rapid turnover and down indicative of slower turnover. Over-representation was calculated using the WebGestalt 
API using default parameters.
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Increased methylglyoxal can be produced by excess glucose or lack of phosphates by 
interfering with the glycolysis pathway and lead to the production of advanced glyca-
tion endproducts (AGE) (43). In turn AGE can stimulate the NF-kB pathway resulting 
in M1 polarization of the macrophage (44). As we see a clear inflammatory response 
in CDC1551-infected macrophages we expect an increase in the half-life of glyoxalase 
in order to cope with the detoxification of MG. Likewise, Leukosialin (CD43) is a cell 
surface protein that has been shown to interact with M. tuberculosis Cpn60.2 to induce 
TNF-α production (45), however, its expression can also commit T-cells to Th1 a re-
sponse (46,47).
Taken together, there is a robust macrophage response to infection with M. tuberculosis 
CDC1551 while little to no response is observed when challenged with Δppe38-71. 
Mixed results were observed for macrophages infected with the complemented strain 
thus obscuring the effect and requiring further investigation into the root cause of this 
differential phenotype. Based on our observations thus far it is certain that infection 
by the M. tuberculosis CDC1551 strain is stimulating the pro-inflammatory pathways of 
THP-1 macrophage-like cells. This is the expected response to infection by bacteria, 
however this result is not observed to the same extent when challenged with M. tuber-
culosis Δppe38-71. The loss of PPE38 controlled PE-PGRS proteins eliminate a number 
of PAMPs which may explain this observation, however the complementation does not 
fully restore the macrophage responses, which obscures the result.
M. tuberculosis Δppe38-71 is only partially complemented in vitro and 
complementation is detergent dependent.
The mixed response observed in the THP-1 macrophage-like cells infected with the 
complemented strain prompted us to further investigate possible differences between 
the bacilli under different growth conditions. For this, we analysed the proteome and 
secretome profiles of the different M. tuberculosis strains in vitro. As shown above, the 
PE-PGRS secretion phenotype is complemented at day four of in vitro growth (Fig. 1A) 
and there are no significant differences in optical density at this time point (Fig. 1B). 
We, therefore, sampled whole-cell lysates and supernatants from four-day-old cultures, 
which reflects the state of the strains used for infection. As PE-PGRS proteins are as-
sociated with the cell surface and thus susceptible to detergents, we removed Tween-80 
by sequential washing and allowed all three strains to grow for an additional four days 
to represent a detergent-free supernatant. We found no clear separation between 
strains from the whole-cell lysate fraction (Fig. 5A) in the first principal component, 
thus indicating minimal global variation between strains. However, separation in the 
first principal component could be observed in supernatant samples from mycobac-
teria cultured in Tween-80, and the complemented strain clusters with the Δppe38-71 
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strain (Fig. 5B). Interestingly, the secretome profile of the complemented strain 
clusters closer to M. tuberculosis CDC1551 when detergent is omitted from the culture 
supernatants (Fig. 5C). Western blots of all three fractions were used to determine the 
localisation and presence of PE-PGRS proteins in these samples. We found the majority 
of PE-PGRS proteins in the supernatants containing detergent (detergent fraction) and 
no PE-PGRS proteins in the detergent free supernatants (Fig. 5D).
Comparison of differential protein expression in the whole-cell lysates between M. tu-
berculosis CDC1551 and M. tuberculosis Δppe38-71 or the complemented strain revealed 
only two differentially regulated proteins below a q-value cut off set to 0.05, one of 
which was PPE71 (Data S1 Table S5). However, when comparing the detergent fraction 
of M. tuberculosis Δppe38-71 to M. tuberculosis CDC1551, downregulation of multiple 
PE/PPE proteins was observed (Fig. 5E, Data S1 Table S6). Complementation of this 
phenotype was observed, but partial, as many of the PE/PPE proteins still showed 
significantly different protein abundance relative to M. tuberculosis CDC1551 (Fig. 5F, 
Data S: Table S6). Finally, comparisons of the detergent-free fraction of M. tuberculosis 
Δppe38-71 to M. tuberculosis CDC1551 had a total of 142 differentially regulated proteins, 
22 of which were downregulated and 120 were upregulated (Fig. S5A, Data S1: Table 
S7). Complementation in the detergent-free fraction was much more pronounced with 
7 proteins significantly upregulated and 2 proteins significantly downregulated as 
compared to M. tuberculosis CDC1551 (Fig. S5B, Data S1: Table S7). However, the PE/
PPE proteins did not feature prominently within this fraction and are likely associated 
with the cell surface.
These results show that the PE-PGRS and PPE-MPTR proteins are indeed expressed 
in the complemented strain as indicated in Fig. 1A, however to a lesser extent than 
in wild type. As this represents the state used for infection, it is likely that the lack of 
full complementation stems from the culturing conditions prior to infection. To cor-
roborate our infection proteomics findings, cell-free supernatants from detergent-free 
cultures (Fig. 5E and Fig. 5F) were used to stimulate differentiated THP-1 macrophage-
like cells. As pro-IL-1B was the most differentially regulated protein, we probed for 
expression of this protein by Western blot 18 hours after stimulation and found similar 
differential regulation as observed in our infection proteomics data (Fig. S5C). Macro-
phages stimulated with M. tuberculosis CDC1551 supernatants displayed a significantly 
higher IL-1B expression compared to Δppe38-71, and this phenotype was partially 
complemented (Fig. S5D, S5E).
By analysing the spatial distribution of proteins in M. tuberculosis cultures at their 
metabolic state before infection, we could show that complementation of PE-PGRS 
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figure 5: In vitro proteomics of M. tuberculosis strains show partial complementation that can be 
restored by the omission of detergent.
Principal component analysis of A) whole-cell lysates, b) supernatant containing detergent and c) supernatant 
without detergent of each M. tuberculosis strain after four days of cultivation. D) Western blot of each fraction 
shows the PE-PGRS proteins in the supernatant only when there is detergent present in the growth media. Volcano 
plots of supernatants containing detergent from E) M. tuberculosis Δppe38-71 and f) the complemented strain com-
pared to M. tuberculosis CDC1551 when cultivated in detergent. The q-value was set to 0.05 and the log2 fold change 
was set to 1. The data is representative of three independent experiments.
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secretion was not fully restored prior to infection in the complemented strain (Fig. 5E, 
5F). However, the PE-PGRS secretion can be restored in the complemented strain when 
detergent is omitted, which is likely due to the surface localisation of PE/PPE proteins 
that are detached in the presence of detergent. By stimulating macrophages with 
cell-free supernatants, representing a high or low abundance of PE/PPE proteins, we 
could show differential regulation of IL-1B similar to infection with live M. tuberculosis 
CDC1551 and Δppe38-71 strains. As seen in Fig. 5, the composition of the M. tuberculosis 
Δppe38-71 secretome relative to M. tuberculosis CDC1551 is a complex mixture of dif-
ferentially secreted proteins not only limited to PE/PPE proteins. However, the most 
down-regulated proteins are indeed PE/PPE proteins, with members from both the 
PE-PGRS and PPE-MPTR sub-families (Fig 5E, Data S1: Table S6). It is thus likely that 
our observations are driven not by PPE38 alone but rather a physiological state, created 
by the absence of PPE38, where a group of PE/PPE proteins are acting as the effectors 
of PPE38 and mediating a response.
both Relb and Nf-kb p50 are translocated to the nucleus of M. 
tuberculosis Δppe38-71 infected macrophages.
NF-kB signalling regulates inflammatory responses in innate immune cells after 
receptor engagement with PAMPs. NF-kB subunits can be localised in the cytosol as 
inactive transcription factors or can be activated and translocated to the nucleus (Fig. 
6A) (48). We further investigated both NF-kB1 and NF-kB2, representing canonical and 
non-canonical NF-kB signalling pathways, respectively. The canonical NF-kB1 p105 
and p50 subunits were detected in all tested conditions (Fig. 6B, NF-kB1). Little to no 
cleavage of NF-kB2 was observed at 18 hours post-infection in any of the conditions 
(Fig. 6B, NF-kB2 p52). Upregulation of the p100 subunit and pro-IL-1B (Fig. 6B, NF-kB2 
p52; IL-1B) was observed for M. tuberculosis CDC1551-infected macrophages. This is 
congruent with our other observations and indicative of a pro-inflammatory response 
in CDC1551-infected macrophages (49). Furthermore, our proteomics results suggest 
an increased interferon signalling in M. tuberculosis CDC1551-infected macrophages. 
We used ISG15 as our downstream target to validate these results and indeed found 
upregulation of ISG15 in M. tuberculosis CDC1551-infected macrophages at 18 hours 
compared to other conditions. We did not directly observe the STING pathway in 
the proteomics results, but did observe evidence for RIG-I induction. However, the 
interferon pathway is reportedly stimulated by STING in macrophages infected with 
M. tuberculosis (50). We therefore used Western blotting to validate expression levels 
of this receptor and found no differences in RIG-I expression in any of the infection 
conditions (Fig. S6). This suggests that the RIG-I is not responsible for the differential 
ISG15 expression, which is in line with other observations (50).
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Based on these results, M. tuberculosis CDC1551 is triggering the canonical inflamma-
tory NF-kB pathway. Activation of NF-kB1 and/or NF-kB2 results in the translocation of 
either RelA or RelB, respectively. These Rel proteins act as the effectors of this pathway 
and initiate transcription of target genes, depending on the required immune response. 
Previous studies have shown increased NF-kB1 p50 levels in the nucleus of murine 
macrophages infected with wild type M. marinum compared to a ppe38 transposon 
mutant (17). While a different technique and model organism was used, this result 
is in line with our observations. However, it remains unclear whether M. tuberculosis 
Δppe38-71 reduces or entirely inhibits canonical NF-kB signalling or whether it induces 
an alternative signalling pathway.
To further investigate the activation of NF-kB signalling in infected macrophages, we 
used confocal microscopy to determine RelA and RelB nuclear translocation in infect-
ed macrophages. RelA translocation was observed in macrophages infected with M. 
tuberculosis CDC1551 and in macrophage infected with the complemented strain after 
18 hours of infection (Fig. 7A, Fig. 7C). However, in contrast, no RelA translocation was 
figure 6: THP-1 macrophage-like cells signal through the canonical Nf-kb pathway when infect-
ed with M. tuberculosis cDc1551.
A) Schematic representation of the canonical and non-canonical NF-kB pathways. b) Western blots for com-
ponents of the NF-kB pathway (α-NF-kB1 and α-NFkB2) and downstream effectors (α-pro-IL1β) as well as their 
respective sub-units. The Western blots were done on protein samples harvested at 4 hours and 18 hours post-
infection. α-GapDH was used as a loading control.
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observed for macrophages infected with the Δppe38-71 strain (Fig. 7B) or the uninfected 
control (Fig. S7A). This result was surprising as it was expected that the inflammatory 
response would be triggered by RelA translocation, although perhaps to a limited extent 
as compared to M. tuberculosis CDC1551-infected macrophages. The absence of RelA 
translocation in the M. tuberculosis Δppe38-71 infected macrophages prompted us to 
investigate RelB translocation. While no RelB translocation was observed for M. tuber-
culosis CDC1551- infected macrophages or uninfected control (Fig. 7D, Fig. S7B), RelB 
did indeed translocate to the nucleus in M. tuberculosis Δppe38-71 infected macrophages 
(Fig. 7E). We also observed translocation of RelB in the complemented strain-infected 
macrophages (Fig. 7F), however, to a lesser extent than in M. tuberculosis Δppe38-71 
infected macrophages (Fig. 7J). The duality of the translocation events observed for the 
figure 7: Infection with M. tuberculosis Δppe38-71 stimulates a Relb/p50 pathway in THP-1 mac-
rophage-like cells.
Confocal microscopy images showing individual fluorescent channels probing for F-actin (phalloidin), the nucleus 
(Hoechst) and A-c) RelA (Alexa Fluor 488) for A) M. tuberculosis CDC1551, b) Δppe38-71, c) complement-infected 
macrophages. Macrophages infected with D) M. tuberculosis CDC1551, E) Δppe38-71 and f) the complemented 
strain were also probed for translocation of RelB (Alexafluor 488). H) Confocal microscopy images showing p100/
p52 and I) p105/p50 nuclear translation in Δppe38-71 infected macrophages. White arrows indicate translocation 
events. J) Quantification of fluorescence intensity in the nucleus compared to that in the cytoplasm. Twenty cells 
were chosen from at least 10 random fields per replicate with a minimum of three independent experiments. The 
dashed line indicates a ratio of 1 for the cut off where translocation occurs.
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complemented strain was an interesting observation, which could give an additional 
explanation as to why partial restoration of the inflammatory phenotype is observed. 
Macrophages infected with the complemented strain seemingly mimic both the wild 
type, in RelA translocation, and the Δppe38-71 phenotype, in RelB translocation. This, 
in turn, may result in differential cytokine release on a per-cell basis. Finally, low 
transient levels of RelB translocation was observed in macrophages infected with the 
complemented strain (Fig. 7J). This phenomenon is consistent with other observations 
and likely due to poor binding of IkB-α allowing for transient movement to the nucleus 
for RelB complexes (51–53).
Translocation of RelB suggests that M. tuberculosis Δppe38-71 stimulates the non-
canonical NF-kB pathway, which can cause a slow, yet persistent, inflammatory 
response instead of a burst response (54). However, we did not observe upregulation 
of the p52 non-canonical partner in M. tuberculosis Δppe38-71 infected macrophages. 
Furthermore, slow and persistent inflammation should accumulate IL-1B over time, 
yet a downregulation of this cytokine was observed. Nonetheless, the p50 subunit 
was available as a potential partner for translocation. Based on our observations in 
both mass spectrometry, Western blots and microscopy, macrophages infected with 
M. tuberculosis CDC1551 are signalling through the canonical pathway characterised 
by RelA and p50 translocation. The translocation dynamics of macrophages infected 
with M. tuberculosis Δppe38-71 strain is however unclear. To rule out the non-canonical 
pathway, macrophages were infected with M. tuberculosis Δppe38-71 and probed for 
translocation of p50 and p52 at 18 hours post-infection. No translocation of the non-
canonical NF-kB2 p52 subunit was observed (Fig. 7H), while the canonical NF-kB1 p50 
subunit was found to localise to the nucleus (Fig. 7I). No noticeable translocation of 
either p50 or p52 was observed in the uninfected THP-1 macrophage-like cells (Fig S7C, 
Fig. S7D). This indicates that infection with M. tuberculosis Δppe38-71 causes transloca-
tion of RelB/p50 complexes (Fig. S7E), which has been shown to be associated with 
anti-inflammatory responses (55–57).
Less IL-12p70 is found in supernatants of M. tuberculosis Δppe38-71 
infected macrophages at 48h post-infection.
Pro- and anti-inflammatory macrophage responses are characterised by the secretion 
of specific cytokines. Examples include the secretion of IL-12p70 as a marker for the 
pro-inflammatory response and IL-13 to represent the anti-inflammatory response 
(58). Macrophages were incubated for 48 hours to examine the delayed inflammatory 
response during infection with M. tuberculosis Δppe38-71. We found a greater abun-
dance of IL-12p70 in M. tuberculosis CDC1551 and complement-infected macrophages 
relative to the M. tuberculosis Δppe38-71 infected, and uninfected control macrophages 
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(Fig. 8A). This differential secretion pattern indicates that 48 hours post-infection the 
macrophages have still not launched a strong inflammatory response to the M. tuber-
culosis Δppe38-71 strain as compared to M. tuberculosis CDC1551. There was also no 
significant difference in the secretion of IL-12p70 in M. tuberculosis Δppe38-71 infected 
macrophages when compared to the uninfected control (Fig. 8A, Data SI: Table S8). 
In contrast to this, IL-13 displayed the opposite pattern with less IL-13 present in the 
supernatant of M. tuberculosis CDC1551 and complement-infected macrophages com-
pared to macrophages infected with M. tuberculosis Δppe38-71 (Fig. 8B).
Taken together, these results indicate that the PE/PPE proteins controlled by PPE38 
have an effect on modulating macrophage responses through NF-kB signalling. THP-1 
macrophage-like cells infected with M. tuberculosis CDC1551 are exposed to substan-
tially more PAMPs as seen in Fig. 5E and thus a canonical RelA/NF-kB1 p50 pathway 
is initiated resulting in a strong pro-inflammatory response (Fig. 8C). However, in the 
absence of PPE38 and its effectors, RelB/p50 translocates to the nucleus and likely 
dampens this response, resulting in an anti-inflammatory phenotype over time (Fig. 
8D).
figure 8: Interleukin-12p70 and IL-13 are differentially secreted by THP-1 macrophage-like cells 
at 48h post-infection. The levels of IL-12p70 A) and IL-13 b) in supernatants of THP-1 macrophage-
like cells infected with either M. tuberculosis CDC1551, Δppe38-71 or complemented strains and un-
infected macrophages were determined by ELISA. Data is representative of three biological rep-
licates and significant differences were determined with one-way ANOVA as well as a Tukey HSD 
post-hoc test with a q-value set at 0.05. Schematic illustration of a proposed macrophage response 
upon infection with c) M. tuberculosis CDC1551 and D) M. tuberculosis Δppe38-71.
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DIscussIoN
M. tuberculosis can influence disease outcome by altering protective host innate im-
mune responses. However, the effector molecules involved in host-pathogen interac-
tions and altered host responses remain ill-defined. It was previously demonstrated 
that deletion of ppe38-71 in M. tuberculosis resulted in increased virulence in a murine 
infection model (13). In this study, we investigated the role of M. tuberculosis Δppe38-71 
in the context of host-pathogen interactions to identify the mechanisms associated 
with increased virulence. An important observation made here is that the PE-PGRS 
and PPE-MPTR proteins controlled by PPE38 are responsible for driving altered mac-
rophage responses. These proteins are unique to pathogenic mycobacteria and several 
authors have proposed a role for PE-PGRS and PPE-MPTR proteins in host-pathogen 
interactions (7).
Infection of macrophages with wild type M. tuberculosis CDC1551 results in increased 
expression of pro-inflammatory cytokines and chemokines, specifically, upregulation 
of pro-IL-1B, several interferon-inducible proteins (ISG15, IFIT1, IFIT2, IFIT3, IFIH1 
and MX1) and rapid recycling of components associated with IL-12 signalling. Con-
versely, deletion of ppe38-71 in M. tuberculosis resulted in a dampened innate immune 
response in infected macrophages, where IL-1B was found to be downregulated over 
time. This shift away from a pro-inflammatory response was observed in both temporal 
label-free proteomic analysis as well as protein turnover analysis using pulse SILAC 
labelling. However, there seems to be a disparity in the cytokine signalling of dendritic 
cells and macrophages when infected with ppe38 mutants in the current literature. 
After overnight stimulation of murine dendritic cells with M. tuberculosis CDC1551, M. 
tuberculosis Δppe38-71 and the complemented strain there was no significant difference 
observed in supernatant IL-12p40/70, IL-6 and TNF-α (18). In contrast, there is a stark 
difference in IL-6 and TNF-α levels found in macrophages infected with the M. mari-
num wild type and a ppe38 transposon mutant strain (16). In the latter case, TNF-α is 
lower in macrophages infected with a M. marinum ppe38 transposon mutant compared 
to wild type at both 24 and 48 hours post infection. We did not assay for IL-6 or TNF-α, 
however from our cytokine assay we find less IL-12p70 in the supernatant of macro-
phages infected with M. tuberculosis Δppe38-71. Notably the difference in abundance of 
IL-12p70 detected in this study could easily be influenced by various factors such as cell 
type, MOI and timeframe in comparison to the levels measured in dendritic cells (18).
Macrophages challenged with concentrated supernatants from each strain showed the 
same regulation of IL-1B as during live mycobacterial infections. Here it was demon-
strated that the deletion of the ppe38-71 operon has farther reaching consequences 
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to the cell than only this protein or even the PE-PGRS proteins. It is thus likely not 
one single protein is driving the macrophage response but a conglomerate of proteins 
representing a physiological state upon deletion of the ppe38-71 operon. Many of the 
PE/PPE proteins have unknown functions, however, multiple studies have shown that 
these proteins are upregulated during macrophage infection (59–61) and are highly im-
munogenic (62). In Fig. 5E several PE/PPE proteins were identified as being controlled 
by PPE38 and these are the likely candidates for intracellular effector proteins. Notably, 
PPE10 was represented in this cluster and has been implicated in the disruption of 
M. marinum capsule integrity, altering colony morphology and attenuation of viru-
lence in zebrafish (63). As PPE10 was one of the most downregulated proteins in the 
M. tuberculosis Δppe38-71 strain, it is likely similar phenotypes can be expected from 
PPE38 knock outs. However, no morphology differences were visible in M. tuberculosis 
Δppe38-71, although the upregulated proteins in Fig. 5E were associated with intracel-
lular proteins. While not definitive, this gives some indication of a damaged cell wall. 
Interestingly, M. marinum ppe38 transposon mutants demonstrate a visible change in 
colony morphology (16). It is as of yet unclear whether this is due to differential regula-
tion of PPE10 by proxy of PPE38. Nevertheless, drawing this conclusion seems likely 
given the evidence. Taken together, the in vitro profile of M. tuberculosis Δppe38-71 prior 
to infection indicates decreased levels of multiple virulence factors known to induce 
pro-inflammatory responses in macrophages. Based on these results it is likely not one 
protein that drives the effect but many proteins that are altered due to the loss of the 
ppe38-71 operon.
Functional enrichments revealed altered NF-kB signalling between macrophages in-
fected with M. tuberculosis CDC1551 and those infected with M. tuberculosis Δppe38-71. 
Canonical NF-kB signalling is partly responsible for the induction of pro-inflammatory 
responses and is characterised by the translocation of the RelA protein along with 
the NF-kB1 subunit in a RelA/p50 complex (49). This canonical signalling pathway is 
induced during infection with M. tuberculosis CDC1551. In contrast, infection by M. 
tuberculosis Δppe38-71 stimulated the signalling of a different NF-kB pathway where 
RelB and p50 are translocated to the nucleus. A multi-organ inflammatory response ob-
served in mice with a RelB(-/-) knock out was aggravated in a RelB(-/-)/p50(-/-) double knock 
out (55,64). This phenotype indicates that inflammation is controlled by the RelB/p50 
pathway and is likely used to limit excessive inflammation during activation of the ca-
nonical NF-kB pathway. Furthermore, a study investigating responses in dendritic cells 
and macrophages stimulated with LPS has shown that the RelB/p50 pathway inhibits 
TNF-α production by modulating the canonical pathway (57). We have shown that in 
the absence of PPE38, this pathway is activated in infected THP-1 macrophage-like 
cells, which provides a molecular mechanism that could be used by M. tuberculosis to 
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drive switching of inflammatory states in macrophages during infection. In addition, 
differential localisation of NF-kB subunits has also been previously reported for an M. 
marinum ppe38 transposon mutant as revealed by spatial proteomics (16,17).
Based on the results reported here and by others, the secretion of PPE38-dependent 
proteins to the extracellular milieu, where these proteins are able to interact with 
host proteins, can initiate a differential inflammatory cascade. In the absence of these 
effectors, immune dampening is observed mediated by RelB as the likely molecular 
switch. The ppe38-71 region is indeed a hotspot for evolutionary activity which includes 
recombination events, truncations, gene fusion formation and more recently a source 
for phenotype sharing as a donor for horizontal gene transfer (65–68). Thus, a natural 
deletion of the ppe38-71 operon can confer an evolutionary advantage by dampening 
the innate immune response and possibly by providing a downstream molecular 
mechanism for controlling macrophage polarisation states. A bacterial mechanism to 
dampen macrophage responses and switch the polarisation state has been shown to be 
mediated by effectors of the Spi-2 secretion system in Salmonella (69). Early investiga-
tions into M. tuberculosis HN878, a member of the lineage 2 isolates of M. tuberculosis, 
demonstrated increased virulence associated with the failure to stimulate Th1 respons-
es (70), similar to the observations made in this study. Interestingly, the same study 
found that a lack of a pro-inflammatory response was associated with an increased 
induction of type I interferons (70). In this study we observe increased ISG15 expres-
sion, which we speculate may be as a result of the induction of the STING pathway (50). 
The increased production of ISG15 may partly or wholly be caused by an increase in 
type I interferons elicited by the ppe38-71 mutant (71). It was further demonstrated that 
the decreased inflammatory response was associated with the presence of a phenolic 
glycolipid on the cell surface of M. tuberculosis HN878 (72). This phenolic glycolipid 
is synthesised by an intact copy of the pks15/1 gene found in a subset of lineage two 
isolates (72). Later studies investigated whether an intact pks15/1 gene confers the 
same hypervirulence, low inflammatory response phenotype regardless of the genetic 
background. The authors found that the phenolic glycolipid can act to modulate the 
host cytokine response but does not directly extend to a hypervirulent phenotype (73). 
The authors further speculate that the phenolic glycolipid forms a part of a greater 
genotypic and phenotypic profile of the lineage 2 strains to confer the dampened im-
mune response and hypervirulence (73). Interestingly, we have previously found that 
the ppe38-71 deletion occurs overwhelmingly within the lineage two isolates (13,68). 
Furthermore, other studies have demonstrated an increase in virulence of lineage 2 
isolates with a naturally occurring ppe38-71 deletion, this virulence was partially miti-
gated by the heterologous introduction of this operon (13). Taken together, it is likely 
that the ppe38-71 mutation, in part, plays a role in the increased virulence associated 
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with the lineage two isolates of M. tuberculosis by inducing a more permissive environ-
ment for bacterial growth during infection. This is supported by the observation that 
a ppe38-71 deletion mutant showed increased bacterial load at later stages of infection 
in mice compared to the wild type parental strain (13). Interestingly, a recent study 
demonstrated a similar response in IL-1B modulation, where clinical isolates that 
induce lower levels of IL-1B were able to successfully evade the macrophages response 
through decreased inflammasome activation (74). Furthermore, isolates that were as-
sociated with severe tuberculosis in patients presented with lower cytokine responses 
in infected peripheral blood monocytes (74). This shows that M. tuberculosis is capable 
of modulating the inflammatory response through multiple molecular mechanisms 
and does so by selecting for genomic variation that results in decreased inflammatory 
responses and increased pathogenicity.
In conclusion, we have used complementary mass spectrometry-based approaches 
along with follow-up validation to elucidate the role of PPE38-controlled proteins in 
host-pathogen interactions. Wild type M. tuberculosis CDC1551 strains induced the 
canonical NF-kB pathway to stimulate pro-inflammatory responses in infected human 
macrophages, whereas in the absence of PPE38-controlled PE-PGRS and PPE-MPTR 
proteins the alternative RelB/p50 NF-kB pathway is induced. This results in an anti-
inflammatory phenotype where the macrophages fail to launch an appreciable pro-in-
flammatory response. Future experiments will have to identify which PE-PGRS and/or 
PPE-MPTR protein plays a key role in the RelB-mediated switch between macrophage 
polarisation states that can influence the infectious process.
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suPPLEMENTARy fIGuREs
supplementary figure 1: Quality control of label -free mass spectrometry data, related to figure 2: A) 2 Boxplot 
representing LFQ intensities across all samples. Significant deviations from the mean 3 between samples were 
ruled out by hypothesis testing using one-way ANOVA and Tukey HSD 4 post-hoc testing, q-value was set at 0.05. b) 
Principle component analysis was used to assess 5 the clustering of groups and replicates. Little to no clear separa-
tion occurs at 4h post-infection 6 between all groups. c) Separation was observed between all three groups at 18h 
post-infection 7 and clustered based on strain genotype. Separation occurs between M. tuberculosis CDC1551- 8 
infected macrophages at 4h and 18h post -infection on the first component while replicates 9 separated on the 
second component in all three strains namely, D) M. tuberculosis CDC1551, 10 E) Δppe38-71 and f) complement-
infected macrophages. Data used for all samples is 11 represented by 3 biological replicates per sample.
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supplementary figure 2: Enrichment analysis indicates altered inflammatory responses in M. tuberculosis-in-
fected macrophages, related to figure 2. A) Gene ontology enrichment using the WebGestalt server. Significantly 
regulated proteins and their respective effect sizes, as determined in Figure 3, were used as the gene set input and 
enriched against the Kyoto Encyclopaedia of Genes and Genomes and scaled using the false-discovery rate (FDR). 
Log2 LFQ intensities for b) IL-1B, c) NFkB2, D) RIG-I and E) ISG15 identified from macrophages infected with the 
different strains at the indicated time points. Individual points in each group represent each biological replicate, 
while error bars represent the standard deviation.
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supplementary figure 3. Global protein turnover in THP-1 macrophages is not significantly altered during in-
fection, related to figure 3. A) A pulse SILAC labelling approach was used to obtain protein half-lives. Proteins 
were harvested at 4h, 8h, 12h, 18h and 28h post-infection from uninfected THP-1 macrophages as well as macro-
phages infected with M. tuberculosis CDC1551, M. tuberculosis Δppe38-71 and the complemented strain. b) In-
corporation of “heavy” arginine and lysine over time. Maximal incorporation of ~30% was achieved in all infected 
macrophages and in the uninfected control. c) Density plot representing the distribution of protein half-lives from 
both infected and uninfected macrophages. Half-lives were calculated from the mean raw H/L ratios of two inde-
pendent experiments. D-f). Multiple scatterplots of pairwise comparisons between conditions. The points of the 
scatter plot represent from log2 transformed half-lives, with Pearson correlation coefficients for each comparison.
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supplementary figure 4: Proteins involved in response to infection that have differentially regulated half-lives 
between THP-1 macrophages infected with M. tuberculosis cDc1551 and M. tuberculosis Δppe38-71, related 
to figure 4: From the differentially regulated half-lives, selected proteins with a A) rapid or b) slow turnover in 
THP-1 macrophages infected with M. tuberculosis CDC 1551 compared to other conditions are displayed. Values 
are representative of two independent pSILAC experiments.
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supplementary figure 5: Label-free mass spectrometry analysis of detergent free M. tuberculosis supernatants 
shows restored complementation but no PE/PPE proteins, related to figure 5. Volcano plots depicting differ-
ential expression of proteins found in the detergent-free supernatants from A) M. tuberculosis Δppe38-71 and 
b) complemented strain compared to M. tuberculosis CDC1551. A q-value cut-off was set to 0.05 and the log fold 
change was set to 1. Data is representative of three independent experiments. THP-1 macrophages were stimu-
lated with cell-free supernatants from M. tuberculosis CDC1551, Δppe38-71 or complemented strains. Stimula-
tion with lipopolysaccharides from E. coli served as a positive control and unstimulated macrophages as negative 
control. Macrophages were lysed and probed for IL-1B expression using c) Western blot, which was quantified by 
D) densitometry. The data is a representative of three independent experiments and statistical significance was 
determined using E) one-way ANOVA, followed by a Tukey HSD post-hoc test with a q-value set at 0.05
chapter 6  |  PPE38 dependent proteins alter inflammation
203
5supplementary figure 6: Expression of IsG15 and RIG-I at 18 hours post infection shows no differential regula-
tion in RIG-I but upregulation of IsG15 in M. tuberculosis cDc1551, related to figure 6. THP-1 macrophages 
were infected with M. tuberculosis CDC1551, M. tuberculosis Δppe38-71 and the complemented strain and probed 
for RIG-I and ISG15 at 4 hours and 18 hours post infection by Western blot. GapDH was used as a loading control 
and uninfected macrophages were used as a stimulus control.
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supplementary figure 7: confocal microscopy of RelA and Relb in control samples, related to figure 7. Rep-
resentative images of uninfected THP-1 macrophages used as control in for the experiment depicted in Figure 
7. Uninfected macrophages were labelled with phalloidin (F-actin), the nucleus was stained with Hoechst and 
A) RelA, b) RelB, c) p105/p50 and D) p100/p52 conjugated-Alexafluor 488 was used to detect NFkB proteins. E) 





Investigating non-sterilizing cure in  











Bavesh D. Kana1,6,7 
Gerhard Walzl1,2
1Department of Science and Technology/National Research Foundation, Centre of Excellence for Biomedical 
Tuberculosis Research and South African Medical Research Council Centre for Tuberculosis Research, Cape 
Town, South Africa
2Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Department of 
Biomedical Sciences, Stellenbosch University, Cape Town, South Africa
3Faculty of Medical Sciences, Biosciences Institute, Newcastle University, Newcastle upon Tyne, United 
Kingdom
4Section Molecular Microbiology, Amsterdam Institute for Molecules, Medicines and Systems, Vrije 
Universiteit Amsterdam, Amsterdam, The Netherlands
5Catalysis Foundation for Health, San Ramon, CA, USA
6 DST/NRF Centre of Excellence for Biomedical TB Research, Faculty of Health Sciences, School of Pathology, 
University of the Witwatersrand and the National Health Laboratory Service, Johannesburg, South Africa
7MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of 
Research in South Africa, CAPRISA, Durban, South Africa




Mycobacterium tuberculosis (Mtb) is extremely recalcitrant to antimicrobial chemother-
apy requiring 6 months to treat drug-sensitive tuberculosis (TB). Despite this, 4–10% 
of cured patients will develop recurrent disease within 12 months after completing 
therapy. Reasons for relapse in cured TB patients remains speculative, attributed to 
both pathogen and host factors. Populations of dormant bacilli are hypothesized to 
cause relapse in initially cured TB patients however, development of tests to convinc-
ingly demonstrate their presence at the end of anti-TB treatment has been challeng-
ing. Previous studies have indicated the utility of culture filtrate supplemented media 
(CFSM) to detect differentially culturable tubercle bacilli (DCTB). Here, we show that 
3/22 of clinically cured patients retained DCTB in induced sputum and bronchoalveolar 
lavage fluid (BALF), with one DCTB positive patient relapsing within the first year of 
completing therapy. We also show a correlation of DCTB status with “unresolved” end 
of treatment FDG PET-CT imaging. Additionally, 19 end of treatment induced sputum 
samples from patients not undergoing bronchoscopy were assessed for DCTB, identify-
ing a further relapse case with DCTB. We further show that induced sputum is a less 
reliable source for the DCTB assay at the end of treatment, limiting the utility of this 
assay in a clinical setting. We next investigated the host proteome at the site of disease 
(BALF) using multiplexed proteomic analysis and compared these to active TB cases 
to identify host-specific factors indicative of cure. Distinct signatures stratified active 
from cured TB patients into distinct groups, with a DCTB positive, subsequently relaps-
ing, end of treatment patient showing a proteomic signature closer to active TB disease 
than cure. This exploratory study offers evidence of live Mtb, undetectable with con-
ventional culture methods, at the end of clinically successful treatment and putative 
host protein biomarkers of active disease and cure. These findings have implications 
for the assessment of true sterilizing cure in TB patients and opens new avenues for 
targeted approaches to monitor treatment response.




Mycobacterium tuberculosis (Mtb) is a highly complex and well-adapted pathogen that 
causes tuberculosis (TB). The success of this pathogen can be attributed to its ability 
to evade the protective host immune response and its recalcitrance to antimicrobial 
chemotherapy. Although cure of the majority of patients treated with the standard 
6 month multidrug regimen indicates that treatment is highly effective, ~4–10% of 
clinically cured patients will develop recurrent disease within the first 12 months after 
completing therapy (1,2). Recurrence can fall into two categories; relapse due to the 
reactivation of the original infecting strain or reinfection due to exogenous infection 
with a strain of Mtb different from the original infecting strain (2). In high endemic 
countries, the line between reinfection and relapse is often blurred since patients are 
likely to be continually exposed to similar strains (3).
Current observed relapse rates indicate that a fraction of patients, whilst appearing 
clinically cured, still harbour a sub-clinical Mtb infection that failed to be sterilized 
by current treatment regimens. Indeed, there is growing evidence pointing to residual 
live Mtb in patients at the end of treatment (4,5). Previous work from our group has 
shown that most patients at the end of treatment retain 18F-fluorodyoxyglucose posi-
tron emission tomography (FDG-PET) avid lung lesions indicative of persisting inflam-
mation, even after sputum cultures are consistently negative. Furthermore, Mtb mRNA 
can be detected in sputum and bronchoalveolar lavage fluid (BALF) in a significant 
fraction of cured patients at the end of curative treatment, possibly indicating residual 
live Mtb (4). It is well-established that Mtb, amongst other bacteria, can form physi-
ologically heterogeneous populations both in-vitro and in-vivo (6–11). In patients, a 
sub-population of metabolically distinct bacilli, defined as differentially culturable tu-
bercle bacilli (DCTB) can be detected in sputa when grown in the presence of sterilized 
culture filtrate supplemented media (CFSM). This sub-population appears to become 
more prominent during early chemotherapy (12,13), yet is not directly detectable by 
conventional microbiological diagnostic methods. It remains to be conclusively deter-
mined whether the presence of DCTB cells correlates with clinical treatment response 
and relapse rates. Host-specific factors are likely to also be critical in determining 
favourable or unfavourable outcomes even in the presence of persistent bacteria.
Part of the complexity of the problem lies with the host itself, where, paradoxically, 
anatomic niches in the form of granulomas sequester infectious bacteria from the lung 
and favour the development and long-term survival of dormant Mtb, subsequently 
giving rise to actively replicating bacterial populations and dissemination (14–17). The 
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link between dormancy and reactivation of disease has been demonstrated in animal 
models for several bacterial species, including Mtb (18–21).
The aim of this study was to investigate whether patients at the end of successful anti-
TB treatment retain live, DCTB and to correlate this with FDG PET-CT activity. We used 
CFSM to culture mycobacteria from both BALF and induced sputum. We also analysed 
BALF supernatant from these same clinically cured patients and an equal number of 
active TB samples, using shotgun proteomics. The results provide a global picture of 
the host proteome at the site of disease and gives insight into host responses to active 
TB infection vs. clinical cure. The finding that DCTB and host biomarkers for active TB 
may be present in cured TB patients, albeit in a small proportion of patients, opens 
new avenues for targeted approaches to monitor treatment response.
MATERIALs AND METHoDs
A summary workflow diagram of the sample recruitment and methods is presented 
in Figure 1. Twenty-two patients were included for a full characterization at the end 
of treatment (EOT). Patients were scanned by FDG PET-CT imaging and had a spu-
tum induction by inhalation of hypertonic saline. These patients also underwent a 
bronchoscopy where a bronchoalveolar lavage fluid (BALF) and post-bronchoscopy 
sputum (PB sputum) was collected. The induced sputum, PB sputum and BALF pellet 
were assessed for DCTB at EOT and to correlate this with FDG PET-CT lesion activity. 
A subset of the BALF supernatant samples (n = 5) were used to develop a protocol that 
utilized proteomics analysis to provide insight into the global host proteomics changes 
at the site of disease. A further nineteen EOT patients were assessed for DCTB in their 
induced sputum, only.
Patient Recruitment
Ethical consent was obtained from the Medical Human Research Ethics committee 
(HREC) of Stellenbosch University (HREC references: N10/01/013 and N16/05/070). All 
methods were performed in accordance with the relevant guidelines and regulations. 
EOT patients were included in the study if they met the following criteria: willing to 
give consent, willing to have their HIV status tested, aged between 18 and 70 years, not 
taking any corticosteroid medication, having undergone successful anti-TB treatment 
(confirmed by two consecutive, negative sputum cultures). Detailed clinical medical 
history was taken at baseline (history of smoking, previous TB, other medication) and 
physical tests included chest X-rays and blood test for HbA1c level. All patients were 
given standard anti-TB treatment consisting of 2 months intensive phase [rifampicin 
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(RIF), isoniazid (INH), ethambutol and pyrazinamide] and 4 months of RIF and INH 
as continuation phase. Aft er informed consent, 41 EOT patients were recruited from 
studies that took place in primary health care clinics in Northern Cape Town. Patients 
were followed up to 1 year aft er the end of treatment (M18) to assess recurrence. Ten 
healthy house-hold contacts (negative controls) from the same community and two 
pre-treatment active TB cases (positive controls) were included as control subjects 
for the DCTB assay. A further fi ve pre-treatment active TB cases were recruited for 
proteomics analysis.
figure 1: Workfl ow diagram of the sample processing and analysis to investigate sterilizing cure in 
tuberculosis (TB) patients at the end of successful anti-TB therapy. Three sample types were anal-
ysed for resuscitation of M. tuberculosis; an induced sputum (n=41), bronchoscopy with bronchoal-
veolar lavage fl uid (BALF)(n=22) and post-bronchoscopy (PB) sputum (n=22) were collected. These 
patients were also scanned using FDG-PET CT to classify lesion activity at the end of treatment. The 
BALF supernatant from fi ve patients was used for multiplexed proteomics analysis using tandem 
mass tag (TMT 10 plex) and compared to the proteome of active TB cases. The resuscitation assay 
consisted of a series of confi rmatory tests once growth was detected including sub-culturing on 
blood agar, Mycobacterium Selectatab and Middlebrook 7H11 Agar. Colonies corresponding to typi-
cal growth of M. tuberculosis were subsequently picked and confi rmed for acid fast bacilli (AFB) 
using ZN staining before being strain typed using spoligotyping.
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End of Treatment Induced sputum
Sputum was induced with 20 mL of 3% hypertonic saline solution delivered through 
ultrasonic nebulizer and collected in a sterile sputum container. Sputum samples were 
stored at 4°C prior to processing (sputa were processed within 24 h of collection to 
minimize growth of commensal bacteria).
fDG PET-cT
Patients were scanned at the Western Cape Academic Positron Emission Tomography 
(PET) Centre, at Tygerberg Academic Hospital. All patients received between 5 and 7 
mCi of intravenous 18F FDG (18-F Fluorodeoxyglucose), which is taken up by meta-
bolically active cells and indicates inflammation. Patients were scanned 1 h after the 
injection using a Philips Gemini scanner. Whole lung analysis was performed on the 
scans to quantify the total glycolytic activity index (TGAI) on PET (indicating total 
inflammatory burden) using lesion-free lung as a background (4), the most intense 
residual lesion uptake on PET, (3) the total residual cavity volume on CT.
EoT bronchoscopy and bALf collection
One week following the FDG PET-CT scan and induced sputum visit, an experienced 
bronchoscopist conducted a bronchoscopy and bronchoalveolar lavage on patients at 
the Pulmonology Unit, Tygerberg Academic Hospital. Up to 200 mL of sterile physiologic 
saline solution were instilled (in divided aliquots of 20–60 mL each) and subsequently 
aspirated to obtain BALF from the lobe that showed the most residual infiltrates on an 
accompanying chest X-ray. BALF and the induced sputum samples were split into two 
volumes following collection and immediately processed. A post-bronchoscopy (PB) 
sputum was collected immediately after the bronchoscopy for the DCTB assay.
sputum and bALf Decontamination
BALF samples (50 mL) were concentrated by centrifugation at 4000 × g for 20 min at 
10°C, the supernatant transferred to a fresh tube and stored at −80°C for proteomics 
analysis, leaving ~5 mL pellet. The BALF pellets and sputa were decontaminated by 
adding equal volumes of N-acetyl-L-cysteine- 2% sodium hydroxide (NALC-NaOH) us-
ing the commercial MycoPrep™ kit (BD Biosciences, USA) and incubating for 15 min at 
room temperature (RT) with brief vortexing every 5 min. Specimens were neutralized 
with phosphate buffer saline (PBS) (33 mM Na2HPO4, 33 mM KH2PO4; pH 6.8) and 
concentrated by centrifugation at 4,000 × g for 20 min at 10°C. The pellets were resus-
pended in 300 µL PBS and used immediately for the DCTB assay.
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Preparation of culture filtrate supplemented Media
The laboratory strain of Mtb, H37Rv, was used to produce culture filtrate (CF), as de-
scribed previously (22). Briefly, Mtb cultures were grown in Middlebrook 7H9 medium 
containing 0.05% tween and supplemented with 10% OADC (oleic acid, albumin, dex-
trose, and catalase; BD Biosciences) in vented flasks and kept stationary at 37°C until 
mid-exponential phase was reached (OD600 nm 0.6–1.0). Cultures were centrifuged at 
4,000 × g for 15 min and supernatants were sterilized by double filtration using sterile, 
disposable Durapore Membrane Filters PVDF (0.22 µm pore size). CF was supplemented 
with fresh 7H9 media (at a 1:1 ratio) and polymyxin B, amphotericin B, nalidixic acid, 
trimethoprim, and azlocillin (PANTA™ antibiotic mixture, BD Biosciences) were added 
to increase subsequent selectivity for Mtb growth. A 450 µL aliquot of the CFSM was 
added to a 48-well cell culture plate (Nunc, Thermo Scientific). Sterility of the CF was 
verified by including neat aliquots in control wells of the cell culture plate.
Addition of sample to 48-well culture Plate
Decontaminated induced sputum and BALF samples (50 µL) were added in triplicate to 
each well containing CFSM. An additional three wells containing 7H9 media (without 
CFSM) were also included as a media control comparison and the same volume of 
samples was added to each of these wells (see DCTB assay for plate layout in Figure 1). 
For the blank controls, 50 µL of PBS was added to the CFSM. Culture plates were sealed 
with micropore tape and incubated without shaking at 37°C for a period of 8 weeks. 
Plates were checked for growth weekly.
confirmation of M. tuberculosis Growth
Confirmatory assays were conducted once growth was identified visually (through ob-
servation of turbidity), to confirm the presence of Mtb, as opposed to contamination by 
other microorganisms. Confirmatory testing included a combination of Ziehl-Neelsen 
(ZN) staining and sub-culturing onto; blood agar plates to check for contamination; 
Mycobacterium Selectatab media (Mast Group) to isolate single colonies and Middle-
brook 7H11 Agar (BD Life Sciences). Once colonies corresponding to typical growth 
of Mtb (non-pigmented, rough, dry colonies) were detected on Selectatab media and/
or 7H11 media, a colony was picked for ZN staining as well as resuspended in 500 µL 
ultrapure water (MilliQ, Merck) and heat inactivated at 100°C for 30 min to extract DNA 
for strain typing using spoligotyping. Replicate wells for both CFSM and media control 
were followed up independently. A negative culture well was defined as one in which 
neither Mtb grew, nor contamination was observed. Spoligotyping was conducted as 
previously described (23), and the recovered strain was matched to the original infect-




For the proteomics analysis of BALF supernatant, five EOT patients also analysed 
for DCTB (Figure 1), were chosen (including PID338 who subsequently relapsed) and 
BALF from five active TB (before treatment initiation) patients were included as a com-
parison. The active TB patients were recruited at their baseline visit and underwent 
a bronchoscopy, as described above. After cell collection, the BALF supernatants (15 
mL) were filter sterilized using 0.22 µm PVDF filters prior to processing. The filtered 
BALF samples were concentrated using Amicon ultra-15 kDa centrifugal filters (Merck) 
to ~2.5 mL and depleted using the ProteoPrep Blue Albumin and IgG Depletion kit 
(Sigma-Aldrich), as recommended by the supplier. Ice-cold acetone was added to the 
depleted samples and proteins were precipitated overnight at −20°C. Samples were 
centrifuged at 14 000 × g for 10 min and the supernatant removed. The protein pel-
lets were resuspended in 50 µL 8 M urea in 100 mM triethylammonium bicarbonate 
(TEAB) and sonicated on ice for 10 min to completely reconstitute the protein. Protein 
concentration was determined using a Bradford assay.
Proteolytic Digestion and TMT Labelling of Peptides
Aliquots corresponding to 50 µg protein from each sample were used for filter-aided 
sample preparation (FASP) (24). Samples were reduced with 5 mM tris(2-carboxyethyl) 
phosphine (TCEP) for 1 h at RT and alkylated with 5.5 mM iodoacetamide (IAA) for 1 h 
in the dark at RT. Samples were concentrated using Amicon 30 kDa Ultra 0.5 mL spin 
filters (Merck) at 14 000 × g for 15 min before adding 400 µL 50 mM TEAB to each spin 
filter, and further centrifugation at 14 000 × g for 15 min. This process was repeated a 
further three times, discarding the flow through between washes. Following the wash 
steps, 400 µL of 50 mM TEAB was added directly onto each filter and the samples centri-
fuged at 14 000 × g for 15 min. This process was repeated a further two times. Modified 
sequencing grade trypsin (Promega) was added at a 1:50 ratio of trypsin to protein to 
each filter and samples were incubated at 37°C for 18 h. Following trypsin digestion, 
filters were transferred to a new collection tube and centrifuged at 14 000 × g for 15 
min, collecting peptides in the flow through. Peptides were further eluted using 400 µL 
of 100 mM sodium chloride (NaCl) and centrifuged again. Peptide eluates were pooled 
and concentrated by vacuum drying. Peptides were subsequently desalted using in-
house packed C18 STAGE tips, vacuum dried, and stored until labelling with tandem 
mass tags. TMT 10 plex (Thermo Fisher Scientific) labelling was done according to 
manufacturer’s instructions. Briefly, peptide samples were reconstituted in 100 µL 100 
mM TEAB and the TMT labels were reconstituted in 41 µL anhydrous acetonitrile. The 
labelling reaction was quenched using 8 µL of 5% hydroxylamine and incubating for 15 
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min at RT. Approximately 15 µg from each sample was combined into a new tube and 
desalted and fractionated using a C18 STAGE tip. STAGE tip-based fractionation was 
done using increasing gradients of acetonitrile in 10 mM TEAB as follows; 7.5, 10, 12.5, 
15.5, 17.5, 20, 22.5, 25, 30, 50% and collecting the eluates between each gradient into 
individual tubes before vacuum drying.
Mass spectrometry
Peptides were dissolved in 2% acetonitrile containing 0.1% trifluoroacetic acid, and 
each sample was independently analysed on an Orbitrap Fusion Lumos Tribrid mass 
spectrometer (Thermo Fisher Scientific), connected to an UltiMate 3000 RSLCnano 
System (Thermo Fisher Scientific). Peptides were injected on an Acclaim PepMap 100 
C18 LC trap column (100 µm ID ×20 mm, 3 µm, 100 Å) followed by separation on an 
EASY-Spray nanoLC C18 column (75 µm ID ×500 mm, 2 µm, 100 Å) at a flow rate of 300 
nl.min−1. Solvent A was water containing 0.1% formic acid, and solvent B was 80% 
acetonitrile containing 0.1% formic acid. The gradient used for analysis was as follows: 
solvent B was maintained at 3% for 5 min, followed by an increase from 3 to 35% B in 90 
min, 35–90% B in 0.5 min, maintained at 90% B for 4 min, followed by a decrease to 3% 
in 0.5 min and equilibration at 3% for 10 min. The Orbitrap Fusion Lumos was operated 
in positive-ion data-dependent mode. Precursor ion (MS1) scans were performed in the 
Orbitrap mass analyser in the range of 375–1,500 m/z, with a resolution of 120 000 at 
200 m/z. An automatic gain control (AGC) target of 4 x 105 and an ion injection time of 
50 ms was allowed. Precursor ions were isolated using a quadrupole mass filter with an 
isolation width of 0.7 m/z, and fragmented using collision-induced dissociation (CID) 
with a collision energy of 35%. MS2 spectra were acquired in the linear ion (IT) trap 
using turbo mode. An AGC target of 1 × 104 and a maximum injection time of 50 ms was 
allowed. Ten MS2 fragment ions were co-selected for MS3 analysis using synchronous 
precursor selection (SPS), and underwent high-energy collisional dissociation (HCD) 
with collision energy set to 65% to ensure maximal TMT reporter ion yield. SPS-MS3 
fragment ions were analysed in the Orbitrap mass analyser at a resolution of 60 000 at 
200 m/z. An AGC target of 5 × 104 and maximum injection time of 120 ms was allowed. 
The number of MS2 and MS3 events between full scans was determined on-the-fly to 
maintain a 3 s fixed duty cycle. Dynamic exclusion of ions within a ±10 ppm m/z win-
dow was implemented using a 35 s exclusion duration. An electrospray voltage of 2.0 
kV and capillary temperature of 275°C, with no sheath and auxiliary gas flow, was used.
Mass spectrometry Data Analysis
All spectra were analysed using MaxQuant 1.6.2.6 (25), and searched against a combined 
Homo sapiens and Mtb database. Proteome databases were downloaded from Uniprot 
on 09 January 2019. The Homo sapiens database contained 42 410 entries while the Mtb 
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database contained 3 993 entries. Peak list generation was performed within MaxQuant 
and searches were performed using default parameters and the built-in Andromeda 
search engine (26). The enzyme specificity was set to consider fully tryptic peptides, 
and two missed cleavages were allowed. Oxidation of methionine and deamidation 
of asparagine and glutamine was allowed as variable modification, while carbamido-
methylation of cysteine was allowed as a fixed modification. TMT labelling (TMT 10 
plex) of peptide N-termini and lysine residues was enabled during the database search. 
A protein and peptide false discovery rate (FDR) of <1% was employed in MaxQuant. 
Proteins that contained similar peptides and that could not be differentiated based on 
MS/MS analysis alone were grouped to satisfy the principles of parsimony. Reporter 
ion quantification (TMT 10 plex) at MS3-level was enabled in MaxQuant and reporter 
ion intensities were used for relative quantification. Reverse hits, contaminants, and 
proteins only identified by site were removed before further analysis.
Samples were grouped in either end of treatment (EOT) or active tuberculosis (TB) 
groups in accordance with sampling for this study. The corrected reporter ion intensi-
ties were log2 transformed and centred around zero by median normalization. Protein 
groups were further filtered to contain at least two unique peptides and to contain 
intensities for all the TMT-10 plex reporter ions before downstream exploratory, statis-
tical, and bioinformatics analysis. Next, principal component analysis was performed 
to identify possible clusters in the data not based on any a priori knowledge. One of the 
EOT cases clustered with the active TB cases, indicating a protein signature similar to 
active TB. Follow up analysis revealed that this participant showed signs of active TB 
(modified culture confirmed) following successful anti-TB treatment and subsequently 
relapsed. Therefore, this EOT case was assigned as a TB case during statistical analysis. 
Hypothesis testing was performed using the Limma package (27), available in the R/Bio-
conductor repository (28), and p-values were corrected for multiple hypothesis testing 
using the Benjamini-Hochberg method (27,28). Proteins were considered significantly 
regulated when they had at least a two-fold change difference between groups and a 
corrected p-value <0.05. Enrichment analysis was performed using ClusterProfiler (29) 
and ReactomePA (30), and Gene Set Enrichment analysis (GSEA) was performed using 
WebGestalt (31).
REsuLTs
Differentially culturable Mtb Are Present at the End of Treatment
There were 22 clinically cured patients (negative sputum MGIT cultures after 20 and 
24 weeks of anti-tuberculous treatment) analysed for FDG PET-CT activity recruited 
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for assessment of DCTB in sputum and BALF (Table 1). Three patients (13.6%) had 
a positive DCTB status with one of the DCTB positive patients relapsing within the 
first year following treatment completion. FDG PET-CT scans indicated three main re-
sponse patterns at the end of treatment: A “resolved” PET response, seen in six (27.3%) 
patient scans, showing no residual increase in FDG uptake at the end of treatment. 
An “improved response” type shows residual uptake (but decreased in comparison 
to diagnosis) in 11 patients (50%). A “mixed response” (characterized by either new 
lesions or increased uptake in some lung lesions) in five patients (22.7%), including 
two of the three patients with DCTB (Table 1). Images of the M6 FDG PET-CT scan and 
chest X-rays at diagnosis (Dx), M6 and M18 follow up of the patients with DCTB are 
shown in Figure 2. In addition to the set of 22 patients with sputum and BALF samples, 
figure 2: (A) Representative chest X-rays at diagnosis (Dx) and month 6 (M6) and (b) corresponding 
FDG-PET CT scan at M6 for cured patients with differentially culturable Mtb. The FDG-PET CT scans 
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a further 19 clinically cured patients were recruited for assessment of DCTB in their 
induced sputum only, identifying a further two DCTB positive patients with one of 
these subsequently relapsing within a year of completing therapy (Table 2). The clinical 
and microbiological data for all 41 EOT patients is presented in Table S1. Treatment 
adherence was >96% for all patients and 75% of patients reached their first consecutive 
negative MGIT 8 weeks into treatment.
Table 2: Resuscitation results comparing growth in culture filtrate supplemented media (CFSM) and 
media only, when using three sample types (bronchoalveolar lavage fluid (BALF), post-bronchosco-
py (PB) sputum and induced sputum) in 22 EOT patients. Recovered Mtb strain type was determined 
using spoligotyping. The true positives row indicates how many of the positive cultures were con-
firmed to be Mtb using confirmatory assays.






cfsM Media cfsM Media cfsM Media
250 - - 3/3 1/3 2/3 1/3 NEG POS NEG NA
253 1/3 - 2/3 3/3 3/3 1/3 POS NEG NEG 1 BEIJING
267 3/3 - 3/3 3/3 3/3 1/3 POS NEG POS 373 T1
273 1/3 1/3 NEG NA NA NA
278 - - - - - - NA POS NEG NA
291 * * 1/3 1/3 3/3 1/3 NEG POS NEG NA
300 1/3 - 2/3 1/3 3/3 1/3 NEG POS NEG NA
306 - - 1/3 - 3/3 2/3 NEG POS NEG NA
314 1/3 - - 1/3 - - NEG POS NEG NA
315 1/3 1/3 1/3 1/3 3/3 3/3 NEG POS NEG NA
318 1/3 1/3 1/3 2/3 2/3 NEG POS NEG NA
334 - - - - 3/3 2/3 NEG POS NEG NA
332 - - - - - - NA NA NA NA
335 1/3 1/3 1/3 1/3 1/3 1/3 NEG POS NEG NA
338 3/3 1/3 2/3 3/3 1/3 2/3 POS NEG POS 1 BEIJING
351 - - - - 1/3 2/3 NEG POS NEG NA
357 - - - - - - NA NA NA NA
359 - - 1/3 - 1/3 - NEG POS NEG NA
365 1/3 - - 1/3 1/3 1/3 NEG POS NEG NA
375 - - - - 1/3 2/3 NEG POS NEG NA
382 - 1/3 2/3 1/3 1/3 1/3 NEG POS NEG NA
392 - - 1/3 - 1/3 - NEG POS NEG NA
% positive 41 22,7 54,5 54,5 81,8 72,7
% true positive 13,6 4,5 4,5 0 9 0
Growth is indicated as either positive in three of the replicate wells (3/3), two of the three replicates (2/3) or one 
of the three replicate wells (1/3) or no growth (-). Grey blocks indicate that a sample was not available. * Indicates 
the wells became contaminated with fungal growth and confirmatory assays could not be conducted. The green 
blocks indicate the samples that were confirmed positive for Mtb.
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bALf Is the optimal sample Type to Identify Differentially culturable 
Mtb at the End of Treatment
The DCTB assay indicated that a significant portion of culture wells were positive 
for growth in all samples analysed by visual inspection [induced sputum (81.8%), 
post-bronchoscopy sputum (54.5%) and BALF (41%)] (Table 3). However, the major-
ity of these did not contain Mtb, as determined by confirmatory assays. Only samples 
that could be sub-cultured onto selective media and subsequently strain typed were 
Table 3: Outcomes of patients assessed by FDG PET CT and the modified culture assay (resuscita-
tion) at month 6 after successful anti-TB therapy. PET CT responses were classified according to total 
glycolytic activity (TGAI), cavity, response pattern and intensity rank. Highlights in red show pa-
tients classified as higher risk according to PET CT cut offs (TGAI ≥600, cavity volume ≥7mL, mixed 
response and very high intensity rank).





338 YES Relapse Mixed Very high 43007,0 39,9
267 YES Cured Mixed Very high 38304,0 30,9
253 YES Cured Resolved Minimal 70,36 0,0
Median 38304,00 30.9
(range) (70.4-43007) (0-39.9)
332 Cured Mixed High 4598,2 0,0
351 Cured Mixed Moderate 2853,4 0,0
250 Cured Mixed Very high 620,0 62,9
334 Cured Improved Very high 9757,8 19,4
375 Cured Improved Very high 9562,6 1,8
291 Cured Improved Moderate 6349,8 5,9
392 Cured Improved Very high 6109,6 0,0
382 Cured Improved Very High 2795,4 2,8
335 Cured Improved High 2265,7 15,7
357 Cured Improved Moderate 634,9 0,0
278 Cured Improved Mild 585,6 0,0
315 Cured Improved Moderate 235,5 0,0
300 Cured Improved High 173,2 0,0
314 Cured Improved Mild 151,7 0,0
273 Cured Resolved None 1681,9 0,0
365 Cured Resolved Minimal 951,7 0,0
318 Cured Resolved Minimal 306,2 0,5
306 Cured Resolved Minimal 213,8 0,0







declared positive for DCTB. As shown in Table 3, the number of false positives was 
highest in the induced sputum and lowest in BALF. The relapse patients (in samples 
taken before relapse) showed pure Mtb growth, without obvious contamination by 
commensal bacteria, in all sample types tested (BALF, induced and post-bronchoscopy 
sputum for PID338 and induced sputum for PID404) (Figure S1) and these grew rap-
idly in the micro-well format (<5 days). BALF was also the sample in which we could 
consistently detect all DCTB positive patients when comparing to induced sputum and 
post-bronchoscopy sputum (Table S1). Differential cell staining showed that sputa is 
comprised primarily of epithelial cells, whereas the cell profile of BALF samples is 
comprised of macrophages, lymphocytes, and neutrophils (Figure S2).
An Altered Host Proteome can be Identified at the End of Treatment
Distinct FDG PET-CT responses at the end of treatment prompted us to investigate the 
host response at the site of disease using mass spectrometry-based proteomics. We 
analysed BALF supernatant collected from a subset of the patients recruited in this 
study, namely five EOT patients, with a mixture of FDG PET-CT responses (Table 4) 
and five pre-treatment active TB cases, using multiplexed proteomics with tandem 
mass tags (TMT 10 plex). This relative proteome comparison would enable us to gain 
fundamental insights into the host response at the site of disease during active TB and 
in clinically cured patients at the end of 6 month standard anti-TB therapy.
We identified a total of 1 565 high confidence proteins in BALF from EOT and active 
TB cases, which contained more than two unique peptides and were identified at a 1% 
empirical protein false discovery rate (FDR). These proteins spanned six orders of mag-
nitude in abundance (Figure S3). The most abundant protein was albumin, followed 
by several other proteins commonly identified in plasma, including serotransferrin, 
haptoglobin, alpha-1-acid glycoprotein, and alpha-2-macroglobulin. Importantly, we 
were able to probe the BALF proteome to a level where we could identify cytokines 
(interleukin-18, macrophage colony-stimulating factor 1 and macrophage inhibitory 
factor), chemokines (CXCL17), pulmonary surfactants (pulmonary surfactant-associ-
ated protein A, B, and D) and antimicrobial peptides (cathelicidin LL37 and neutrophil 
defensins) in these samples (Figure S3) identifying these low abundance proteins in 
clinical samples, especially biological fluids, is notoriously difficult. The proteins iden-
tified in BALF from EOT and active TB were mainly involved in processes associated 
with neutrophil activation, innate and adaptive immune responses, RNA metabolism 
and translation (Figure S4).
For quantitative analysis, the corrected reporter ion intensities for each sample was log 
2 transformed, resulting in a normal distribution (Figures S5A–J). The data was further 
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normalized by subtracting the median to centre all distributions around zero and 
thereby minimize inter sample variation (Figure S5K). This data was used for further 
analysis. We were able to reproducibly quantify 1 521 proteins in all patient samples 
analysed, after filtering out common contaminants such as albumin and keratin.
Principal component analysis was used to identify the major sources of variation be-
tween the BALF proteomes of active TB and EOT cases, and to identify clusters in our 
data driven by protein expression profiles. As hypothesized, a clear separation was ob-
served between the active TB and the EOT samples in the first component (Figure 3A). 
Interestingly, one EOT sample from this clinically cured set (PID 338) clustered with the 
active TB samples. During follow-up, this participant was subsequently diagnosed with 
recurrent TB disease (Figure 3A). Even though this participant completed 6 months 
of anti-TB treatment and was declared cured, a similar protein expression profile to 
that of an active TB case was observed 3 months before the participant returned to 
the clinic and was diagnosed as a relapse. To further confirm that the relapsed patient 
clusters with the TB cohort, we performed hypothesis testing by grouping the relapse 
as either active TB, EOT cure or removed from the sample set. We found that when 
relapse is added to the TB group there is an increase of 38 additional proteins (Figure 
S6) that distinguish active disease from cure. However, addition of the relapse case 
as an EOT cure resulted in little to no differential abundance of proteins due to the 
effects of the standard deviation which were introduced due to the active TB profile of 
the relapse distorting the EOT cured profiles. We therefore treated this sample as an 
active TB case for downstream analysis. We used hypothesis testing to determine the 
differentially regulated proteins between active TB and EOT cases. In total, 266 pro-
teins were differentially regulated (two-fold change and adjusted p-value <0.05), where 
138 proteins were significantly down regulated and 128 proteins were significantly up 
regulated during active TB disease (Figure 3B, Supplementary file 1). In the active TB 
cases, the top 15 regulated proteins by fold change included inflammatory and immune 
proteins such as CRP, BPIA2, and A1AG1 (ORM1) (Figure 3C). Furthermore, active TB 
was associated with increased levels of immunoglobulins, proteins associated with 
infiltration of neutrophils (MMP8, DEFA3, PRTN3), complement cascade members 
(C1QB, C1R, C1RL, C1S, C3, C4A, C5, C8A), and proteins playing a role in blood co-
agulation (F5, F13B, VWF, FGG, FGB, GP1BA). The top 15 down regulated proteins in 
the active TB cases were associated with translation as indicated by the presence of 
multiple ribosomal proteins (Figure 3D). To gain insights into the processes regulated 
between patients with active TB compared to those at the end of treatment (EOT), we 
performed gene set enrichment analysis on the differentially regulated proteins using 
non-redundant gene ontology terms. The greatest enrichment ratios were associated 
with proteins with increased abundance in the active TB cases, of which the humoral 
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figure 3: Unique proteome signatures exist in BALF from patients with active TB compared to pa-
tients with clinical cure. A) Principle component analysis of protein intensities obtained by mass 
spectrometry analysis of BALF obtained from active TB patients at baseline (TB) and patients suc-
cessfully completing 6 -months anti -TB therapy (EOT). Active TB cases could be distinguished from 
the majority of EOT cases in principle component 1, with the exception of one EOT case. Follow up 
analysis of this patient revealed this was the relapse case with differentially culturable M. tuberculo-
sis. b) Volcano plot representing the differentially regulated proteins in active TB compared to EOT. 
The relapse sample was considered as a TB case for the statistical test. Heatmaps of the c) top 15 
upregulated and D) downregulated proteins from the hypothesis testing. E) Gene enrichment analy-
sis (GSEA) of all significantly regulated proteins against gene ontology terms. GSEA was performed 
using the WebGestalt webserver.
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response and acute inflammatory response featured prominently (Figure 3E). On the 
other hand, proteins associated with RNA metabolic processes, protein synthesis and 
translation were more abundant in EOT cases.
DIscussIoN
Assessing true sterilization at the end of anti-TB therapy is paramount to reducing 
the global TB burden, especially since one of the highest priorities of the TB control 
programs is shortening treatment (1). A key area of contention is the presence or 
absence of “persistent” Mtb cells in patients and whether this quiescent population 
is responsible for subsequent relapse after therapy has ceased (32,33). Here, we have 
shown that although patients at the end of successful anti-TB therapy are cured by 
clinical standards, we were able to identify a fraction of patients retaining DCTB at the 
end of treatment, two of which subsequently relapsed within the first year after stop-
ping therapy. While the small sample size in this exploratory study does not have any 
statistical power, it is notable that Mtb growth was confirmed in CFSM from induced 
sputum of the two cases with the highest residual inflammatory burden on EOT FDG 
PET-CT, including the patient with subsequent relapse. This suggests that a correlation 
between the presence of DCTB and clinical outcome is plausible and that it should be 
further explored in prospective studies.
We decided to investigate both sputa and site of disease (BALF) for the presence of 
DCTB, as patients cannot always produce a sputum at the end of treatment. Using the 
DCTB assay at the end of treatment, most sputum sample types showed growth of com-
mensal bacteria, even with routine decontamination procedures. Unsurprisingly, BALF 
was the optimal sample type for recovering differentially culturable bacteria, since 
BALF represents a direct representation of the site of disease, and with less exposure 
to commensal organisms. This has implications for the routine use of the DCTB assay 
for monitoring sterilizing cure from sputum in a clinical setting. While the lengthy 
and laborious nature of the DCTB assay would make large-scale implementation of the 
technique impractical, these results indicate that these DCTB cells are an important 
consideration when monitoring treatment response, specifically for treatment short-
ening studies. Viability assays measuring Mtb rRNA as a marker of treatment response 
currently show the most promise as alternatives to measure bacterial viability in 
patient samples (34), and these should be tested in parallel to determine their ability to 
identify these differentially culturable bacilli.
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The relapse rate observed in this study is consistent with rates seen in other studies, 
although we acknowledge the small number of cases (35–38). Even though we cannot 
define the physiological state of the mycobacterial cells before recovery, this data shows 
that there remains a sub-population of cells that are undetectable by standard culture 
(MGIT), yet differentially culturable in the presence of CFSM. These results build on 
previous studies that have shown that DCTB can be detected in patient sputa from TB 
patients at baseline and early chemotherapy (12,13,39) and that bacterial persistence 
is likely the cause of EOT inflammation (4). The fact that many more patients retain 
FDG avid lesions at EOT than have demonstrable DCTB may be due to a low number 
of viable bacteria or relative insensitivity of the DCTB assay. Further work is needed to 
examine the link between inflammation on PET-CT imaging and DCTB. Multiple stud-
ies have been necessary to examine this question especially when trying to correlate 
with relapse since only 4–10% of patients relapse. This study confirms and extends 
the previous studies by modifying the DCTB assay and by thoroughly examining the 
patients (PET-CT, BALF proteomics) specifically at the end of successful treatment. To 
our knowledge, this is the first study to investigate the presence of differentially cultur-
able Mtb in sputum and BALF at the end of anti-TB therapy.
The patients that were identified as positive for DCTB yet have maintained cure indi-
cate how the host immune response plays a significant role to curtail the remaining 
infection and direct treatment outcome. Indeed, although the factors responsible for 
relapse and reactivation have not yet been completely elucidated, immune suppression 
has a clear impact on this phenomenon (9,40–42). As we have shown previously, a large 
proportion of patients at the end of successful therapy show ongoing inflammation 
as detected by FDG PET-CT indicating patterns consistent with active disease (4), yet 
not all these patients will go on to relapse. In this study, we found that FDG PET-CT 
responses consistent with active TB only partially correlated with differentially cul-
turable Mtb. One patient was positive for DCTB, yet FDG PET-CT indicated complete 
resolution of lesions. It must be noted that this patient sample was only positive for 
Mtb in the BALF sample in one of the triplicate wells, unlike the other patients, where 
Mtb was consistently detected in all samples analysed. It would also be beneficial to 
assess how long these DCTB cells can be detected, as it is possible that although they 
are present at month 6, later time points would show that these have been cleared by 
the immune response. The heterogeneity in patient FDG PET-CT responses highlights 
how different lesions, even within the same host, can progress differently. It remains 
to be determined what factors determine whether a patient achieves true sterilization.
We therefore analysed the global host proteome profiles of five end of treatment patients 
(consisting of one EOT patient that subsequently relapsed and four that had maintained 
chapter 6  |  Non sterilizing cure in TB.
227
6
cure with a mixture of FDG PET-CT responses) vs. active TB patients (before treatment) 
at the site of disease (BALF), to enhance our understanding of the lung microenviron-
ment. Principal component analysis indicated distinct proteomic signatures stratifying 
active and clinically cured TB patients into distinct groups. Additionally, the relapsed 
participant, although standard sputum MGIT negative and clinically defined as cured 
at M6, produced a M6 BALF protein expression profile that clustered more closely with 
the active TB group than with the clinically cured group. Taken together, it is likely 
that patients who are prone to relapse can be detected within the BAL fluid, however 
further investigation is required with greater study cohorts.
Gene set enrichment analysis revealed that the major upregulated responses in active 
TB (pre-treatment samples) correspond to important immune responses notably, the 
acute inflammatory response and protein activation cascades. The acute phase response 
serves various important functions within the immune system, one of which is the acti-
vation of the complement cascade by positive acute-phase proteins (APPs) (43). Several 
APPs that are involved in the complement cascade were identified as upregulated in 
the BALF of active TB cases including CRP, C3, C5, and C1qrs pointing to classical and 
lytic activation pathways. The complement system is a key component of the innate 
immune response and is initiated rapidly upon infection to promote inflammation, 
recruit leukocytes, form a membrane attack complex and ultimately destroy invading 
pathogens (44). Although there are limited BALF proteomics studies in the context 
of TB, a previous report showed that BALF from healthy patients contains classical 
complement activity which leads to C3b binding of Mtb in vitro (45). Our findings are 
also consistent with proteomic investigations of blood-based signatures for TB progres-
sion, showing a similar elevation of members of the complement cascade, infiltration 
of neutrophils and blood coagulation during early disease (46–48), whilst providing 
additional information on altered pathways of treatment response. It stands to reason 
that following treatment and sterilizing cure, these pathways would return to lower 
levels. Unsurprisingly, we observed these processes in actively infected TB patients 
and their decrease in the M6 EOT clinically cured patients. Further characterization in 
a larger cohort of patients would be beneficial in assessing whether these proteomic 
signatures are consistent, as these results show promise in identifying distinguishing 
signatures of treatment response. If these observations can be extended, emphasis 
should be placed on replacing the invasive BALF procedure with a more easily obtained 
sample. Analysis of serum samples by multiplexed ion mobility spectrometry similarly 
shows a similar decrease of acute phase proteins in response to antibiotic treatment 
and culture status (49). This supports the clinical translatability of identified BALF 
markers being applied for blood-based testing. To our knowledge, this is the first study 
to investigate host proteome changes at the site of disease during active TB and follow-
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ing anti-TB therapy. We were able to identify a large number of proteins spanning a 
broad dynamic range offering new avenues for targeted investigations.
coNcLusIoN
This study, although exploratory in nature, shows a comprehensive characterization of 
end of treatment patients from both a host and bacterial angle. We describe that DCTB 
can be detected at the end of successful anti-TB therapy and may represent a risk for 
relapse. Our methods were labour intensive and because of this they were limited in 
scope. Targeting dormant bacilli has been suggested as an important avenue to fight re-
activation of TB and shorten treatment (50), and this study defines a pathway to further 
explore biomarkers of persistence in patients at the end of therapy.
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suPPLEMENTARy fIGuREs
supplementary figure 1: Ziehl-Neelsen (ZN) stain of acid-fast bacilli showing purity of the recov-
ered culture using the resuscitation assay in induced sputum (PID 338 and 404) and bronchoalveo-
lar lavage fluid (BALF) and post-bronchoscopy sputum (PID338).
supplementary figure 2: Representative microscopy images of differential cell staining of an in-
duced sputum (100X) and BALF sample (40X) from the same EOT patient. Samples were concentrat-
ed by cytocentrifugation at 95rpm for 7 minutes with slow acceleration and stained using Rapid-Diff 
stain.
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supplementary figure 3: Dynamic range estimation showing combined log10 intensity of the pro-
teins identified in the study with functional plasma and tissue leakage proteins shown in orange and 
signaling proteins, surfactants and antimicrobial peptides shown in blue. The plot shows a dynamic 
range of 6 orders of magnitude.
236
supplementary figure 4. Dotplot showing enrichment results of the GO biological processes and 
Reactome pathways. The size of the circle signifies the count of the biological process or reactome 
pathway. The colour denotes the adjusted p-value.
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supplementary figure 5. Quality control of reporter ion intensities after normalization. A-J) His-
tograms depicting the distribution of reporter ion intensities for each normalized reporter ion. H) 
Box and whiskers plot depicting the distribution of data for each reporter. Each reporter has been 
normalized to center the data around zero by subtracting the median. K) Boxplot representing re-
porter ion intensities across all samples after log transformation and normalization by subtracting 
the median. No major shifts in mean intensity occurs between reporters.
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supplementary figure 6. Venn diagram showing the differential expression of proteins when ana-
lyzed with the EOT relapse (PID 338) case included as a TB case (with relapse), excluded from the 
analysis (without relapse) and included as an EOT case (relapse as EOT)
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Proteomics is a powerful tool for protein expression analysis and is becoming more 
readily available to researchers through core facilities or specialised collaborations. 
However, one major bottleneck for routine implementation and accessibility of this 
technology to the wider scientific community is the complexity of data analysis. To 
this end, we have created ProVision, a free open-source web-based analytics platform 
that allows users to analyse data from two common proteomics relative quantification 
workflows, namely label-free and tandem mass tag-based experiments. Furthermore, 
ProVision allows the freedom to interface with the data analysis pipeline while 
maintaining a user-friendly environment and providing default parameters for fast 
statistical and exploratory data analysis. Finally, multiple customisable quality control, 
differential expression plots as well as enrichments and protein-protein interaction 
prediction can be generated online in one platform.
Availability and implementation
Quick start and step-by-step tutorials as well as tutorial data is fully incorporated in the 
web application. This application is available online at https://provision.shinyapps.io/
provision/ for free use. The source code is available at https://github.com/JamesGal-
lant/ProVision under the GPL version 3.0 license.




Mass spectrometry-based shotgun proteomics is a powerful tool that allows researchers 
a means to investigate the proteome of an organism in an unbiased manner. However, 
the data analysis associated with proteomics often has a steep learning curve and thus 
presents a barrier for first-time users.
To address this, tools such as Perseus (1,2), LFQ-analyst (3) and various R packages (4–7) 
have been created. Perseus is currently a widely used companion tool for analysing 
data from the popular MaxQuant proteomics analysis platform (8). Perseus provides a 
wealth of functionality to interface with various label-free and label-based proteomics 
experiments. However, the proteomics data analysis pipeline can be daunting to 
newcomers and requires a significant time investment as it is not immediately evident 
which steps are required. Alternative R-based tools such as Proteus, LFQ-analyst, and 
MSstats (4) provide the usability of powerful open source tools from the R-language 
with a focus on allowing users to analyse data in an automated approach. However, 
either knowledge of the R-language is required or only data that incorporates the 
maxLFQ (9) algorithm is supported. Furthermore, automated data analysis provides an 
attractive option when data is routinely analysed, but may not be beneficial on a per-
use basis where altering key parameters can result in in various statistical outcomes.
Here we have created ProVision, a web-based and user-friendly proteomics data 
analysis platform for downstream analysis of MaxQuant output. The platform cur-
rently supports label-free data with and without the maxLFQ algorithm as well as 
tandem mass tag (TMT) data. Importantly, ProVision has been created to complement 
the reactive nature of the R-shiny web framework. Therefore, users can interact with 
important filtering and statistical parameters and view the effects in real time as the 
changes propagate through the platform. Default parameters are provided to guide 
unfamiliar users through the analytical steps, thereby addressing a potential learn-
ing curve for new users. In addition, ProVision aims to consolidate the proteomics 
data analysis workflow in one platform by providing built-in functionality to perform 
hypothesis tests, pathway and gene ontology enrichment using Webgestalt as well as 
protein-protein interactions using STRING (10–12). By use of this platform, the time 
spent learning and performing proteomics data analysis is reduced and biologically 
relevant conclusions can be reached within one platform. ProVision thus provides an 
exploratory data analysis platform where users can gain insight into their data and 
tweak parameters when needed, reach biologically relevant conclusions through hy-
pothesis testing and enrichment analysis as well as create custom figures with a high 
degree of control within the browser. This has the potential to dramatically decrease 
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the turnaround time for proteomics experiments, resulting in faster conclusions and 
accelerated discovery.
REsuLTs
ProVision was created with the use of the R-shiny web platform and styled with 
shinydashboard, shinyjs and shinywidgets as well as custom HTML/CSS and JavaScript 
to create a user-friendly experience.
The platform requires the proteingroups.txt file from MaxQuant and processes data by 
extracting relevant columns based on the experiment type, while removing identifica-
tions flagged as contaminants. From this point, the data is fully reactive and each filter-
ing parameter has a default value that can be changed based on user preference. With 
this feature it is possible to experiment with critical parameters that will effect the out-
come, while simultaneously retaining statistical rigour. Thereby providing end-users 
with a dynamic data analysis pipeline for specific use cases. Multiple quality control 
plots such as Q-Q plots (Fig. 1A), Histograms (Fig. 1B), Scatterplots (Fig. 1C), correlation 
heat maps (Fig. 1D), and principal component analysis (Fig. 1E) can be created.
Key figures that can be created include volcano plots (Fig. 1F) and heat maps (Fig. 1G) 
from statistically significant data. Analysis of the protein lists can be further extended 
by performing gene set enrichments and over-representation analysis using Webge-
stalt (10,11). Furthermore, both known and predicted protein-protein interactions 
can be done within the application using the STRING database (12). These analysis 
are done directly on the platform and automatically integrates with all upstream data 
analysis. The plots are created by ggplot2 and thus have multiple customisable options. 
Furthermore, all plots can be exported to major file formats and can be exported to 
PDF for vector graphics and downstream processing. The statistical analysis is done 
using the Limma (13) package and is fully reactive as well. This allows for any statistical 
changes made to propagate to the volcano plots, heatmaps, Webgestalt enrichments 
and STRING networks in real-time and update the display. The differential expression 
as well as the analysed data can be downloaded in either Excel or text format, with 
a choice of various delimiters, for downstream analysis. Finally, no uploaded data is 
stored within the server thus creating a safe environment with the caveat that progress 
can be lost if the browser window is closed. Both quick start and full tutorials are 
available online and embedded within the application for users to access. ProVision 
is under continuous development with source code available to advanced users who 
would like to contribute or request specific features.
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figure 1: Representation of the various graphs that can be created by Provision using the tutorial 
data. Quality control plots include A) Q-Q plots, b) histograms, c) scatterplots, D) correlation heat 
maps and E) principle component analysis. Main figures include f) volcano plots and G) heat maps. 
Multiple parameters of every plot can be customised to user preference.
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coNcLusIoNs AND ouTLooK
ProVision is an open source web application designed for ease of use and accessibility to 
newcomers for proteomics data analysis. ProVision aims to assist researchers to reach 
accurate conclusions based on their unique experimental designs, while providing 
high-quality customisable graphs and statistics in an intuitive environment. In addi-
tion, users can revisit their analysis and change parameters to gain the optimal output 
if necessary as well identify differentially regulated proteins, pathways and networks. 
This platform is deployed at https://provision.shinyapps.io/provision/ for general use 
and a development version is available at https://github.com/JamesGallant/ProVision 
for advanced users who would like to contribute to its development.
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This addendum acts as an extended report on the software presented in the manuscript 
titled: ProVision: A web based platform for rapid analysis of proteomics data processed 
by MaxQuant. Parts of this addendum will contain some of the tutorial explanations 
as well.
bAcKGRouND
The cloud-based application, ProVision, was written in the R-language using the 
Shiny web frame work to create a data analysis platform geared towards users that 
are unfamiliar in R as well as proteomics. This is achieved by providing a front end to 
multiple R functions and packages in an intuitive manner which further allows users 
to quickly run through an analysis while retaining the ability to tweak settings as de-
sired. The Shiny web frame work allows reactive functionality which forms the central 
functionality of ProVision, where data created upstream can propagate downstream 
and influence both the statistics and graphs created, allowing flexibility in analysis 
while still being limited in order to maintain statistical rigour. It is also possible to use 
the differential quantification data generated in the statistical tests and perform third 
party analysis such as Webgestalt (1) and STRING (2) enrichments by querying their 
respective public application programming interfaces (API). Finally, a tutorial system 
was developed and incorporated as well which aims to assist potential newcomers to 
the various steps associated with proteomics data analysis.
MAIN woRKfLow
ProVision uses a linear data analysis flow which is represented by tabs and constitutes 
the main workflow. Each tab is subsequently sub-divided into smaller units which gov-
ern the central functionality of ProVision. The main workflow consists of four sections, 
namely data handling, quality metrics, statistics and Figure construction (Figure 1). 
Each of these will be covered in detail in the following sections.
Data handling
uploading
ProVision currently accepts input from proteomics data searched with MaxQuant soft-
ware (3), thus the proteingroups.txt file. This application is further compatible with both 
label-free and tandem mass tagged proteomics experiments. The application will also 
restructure all the default values depending on which experiment was done by the user.
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filter and transform
In this section the raw intensity data is transformed to remove flagged false positives 
and potential false positives based on peptide counts. MaxQuant provides convenient 
filtering methods that are readily available for automatic processing, these include 
identifications that are only present due to site modifications; reverse database hits 
and potential contaminants. Proteins identified by their modifications alone, such 
as oxidation on methionine or N-terminal acetylation, have no peptides that indicate 
that this protein was specifically identified, therefore they are typically removed. The 
potential contaminants and reverse database hits are candidates that have been identi-
fied as common contaminating proteins, such as albumin or keratin, and proteins that 
have been identified in the reverse amino acid sequence. In both of these cases the 
figure 1: The complete 
ProVision workflow de-
tailing the various com-
ponents and steps in the 
application.
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proteins flagged as such are removed to reduce the noise within the dataset as well as 
the number of proteins contributing to the statistical test which is performed later in 
the pipeline. Another metric to consider as potential false positive is the number of 
unique peptides attributed to an individual protein. When performing peptide spec-
trum matching, proteins are either assigned unique peptides or razor peptides. The 
unique peptides are lengths of amino acids that can be matched to an specific protein 
and thus provides a level of confidence towards annotating the presence and abun-
dance of a specific protein. Razor peptides are named for the principles of Occam’s 
razor or the law of parsimony, where protein hits may be reported as the minimum set 
that accounts for all observable peptides. The unique peptides thus provide the most 
compelling evidence for the presence of a protein within the sample set. To add to this 
confidence, the protein groups with less than 2 unique peptides are filtered away as 
well. This parameter is changeable within ProVision, and increasing this number will 
yield more confident hits but at the cost of abundance and increases the risk for false 
negatives. By introducing these filtering steps the initial dataset has an increased con-
fidence and reduces the number of hypothesis tests which will be discussed later. By 
reducing the number of tests there is a lower chance for introducing false positives and 
the multiple hypothesis correction algorithm will have less tests to constrain resulting 
in a lower number of false negatives.
As part of the initial filtering it is also possible to transform data, which is standard 
and centre data around the mean intensity. In ProVision, parametric hypothesis testing 
is used which has a number of constraints. While these constrains are (at times) soft 
constrains, generally the test performs the best when they are met. The most impor-
tant is that data should be normally distributed. Typically, biological data follows a 
log-normal distribution which is not favoured by parametric statistical tests, as is done 
within ProVision, and would not contain additional distribution (i.e. not binomial). 
Thus by log transforming the intensities, a normal distribution is achieved and the 
data is suitable for parametric testing. Another option is to centre the median around 
zero which reduces variation between groups. This may be useful to reduce variation 
on the mass spectrometry itself and increases confidence in hypothesis tests without 
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As part of the initial filtering it is also possible to transform data, which is standard and 
centre data around the mean intensity. In ProVision, parametric hypothesis testing is 
used which has a number of constraints. While these constrains are (at times) soft 
constrains, generally the test performs the best when they are met. The most important 
is that data should be normally distributed. Typically, biological data follows a log-
normal distribution which is not favoured by parametric statistical tests, as is done 
within ProVision, and would not contain additional distribution (i.e. not binomial). Thus 
by log transforming the intensities, a normal distribution is achieved and the data is 
suitable for parametric testing. Another option is to centre the median around zero 
which reduces variation between groups. This may be useful to reduce variation on the 
mass spectrometry itself and increases confidence in hypothesis tests without 
significantly altering the intragroup variation. The function used to centre the median is 
shown below: 
 
1.  center_median = function(x) {     
2.    kolom_name <- as.data.frame(table(unlist(names(x))))     
3.    kolom_name <- as.character(kolom_name $Var1)     
4.      
5.  # Iterates the column name character list     
6.    x[, kolom_name] = lapply(kolom_name,      
7.                           function(i){     
8.                             LOG2 = x[[i]]     
9.                             LOG2[!is.finite(LOG2)] = NA     
10.                            gMedian = median(LOG2, na.rm = TRUE)     
11.                            LOG2 - gMedian     







This section is simply a user input section to define groups, which ProVision handles 
internally for a multitude of functions. The user provides the groups corresponding 
to each protein ID and also has an option to provide axis names as well. These groups 
are bound to the column and used to determine characteristics of an experiment au-
tomatically such as the number of groups present and which unique experiments map 
to which group.
filter valid values
This step is used to apply experiment specific logic and filter the data further and thus 
create an optimally reduced dataset for controlling the false discovery rate. Filtering 
for valid values simply means filtering for missing values, during log transformation 
these will be labelled as NA and thus register as non-valid. These values can occur due 
to two main factors, absent across replicates or absent due to experimental conditions.
Addressing the first case, it is completely possible that the spectra contributing to a 
specific protein are missed across different mass spectrometry runs or different repli-
cates of a condition. This does not mean that this protein is missing, it simply means 
that the mass spectrometer did not observe it in a specific run. To address this, it is 
possible to filter out proteins that were seen at least twice in a total of three replicate 
runs. Thus we are confident that this protein exists yet allow for some lenience with 
the knowledge of how the mass spectrometer operates. Changing the number to three 
(if you have three replicates) would only consider proteins that were observed in each 
replicate of a sample and thus be the strict case.
In the second case, it can be conceived that certain proteins will not be expressed in 
response to a condition, as per example addition of a drug in a cell line. This missing 
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data is thus important to keep in the calculations as it likely contains the proteins acti-
vated in response to the drug. To do this we choose in at least one group where groups 
were defined in the assigned groups section. By choosing the in each group option the 
minimum value filtering parameter will be applied to each group defined in the as-
signed groups section. To achieve the strictest possible filtering, assign the minimum 
values equal to your number of replicates and choose in each group. While it might 
be tempting to keep data as strict as possible, using this filtering parameter discards a 
large amount of usable data which could contribute to your phenotype. However, if you 
do decide to filter at the most strict level there will be no residual missing values and 
you are done with the section and imputation can be skipped.
Impute missing values
Missing values can be detrimental to statistical test, while it can be handled internally 
within an hypothesis test, it typically does not perform as well when the data is present. 
Depending on the type of filtering done there can be missing values present within 
the dataset prior to the statistical test and these can be filled in using imputation. 
Imputation refers to the process of including missing data within a given data set by 
extrapolating information from the data and making an “educated guess” of sorts. 
While many algorithms aim to do so, i.e. K-nearest neighbours, random forests or 
linear regression. These methods often assume that data is missing at random within 
the dataset, thus the missing data is imputed based on the current shapes and distribu-
tions of the data and not of the experimental setup that created the data. The simplest 
imputation method that follows this rule is by imputing missing values with the mean 
of the distribution. It should be immediately apparent that such an approach is not 
recommended for proteomics or any expression data as these values are not randomly 
missing and inclusion of missing values as a mean of the total distribution would skew 
data to the centre and no differences would be detected proteins who are perhaps low 
and mid abundant within a group if enough values are missing.
Missing values in a proteomics dataset can arise from two main methods, either the mass 
spec did not observe the spectra associated with a specific protein or the protein was sim-
ply not expressed. In both cases it is highly likely that the missing value falls within the 
low range of the distribution and not the mid-range. Thus one of the popular approaches 
is to extract the lower quantiles of the normal distribution in which the specific protein 
falls (Figure 2). The lower quantile represents the low abundant proteins. Regardless if 
it is not expressed or too low to be detected, the hypothesis is that the value would fall 
within the lowest quantile of the total distribution. Therefore by choosing a value at ran-
dom in the lower quantile, a low expression protein is simulated for every missing value. 
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There are limitations, such as not taking into account replicate values, however this 
approach performs well in combination with the filtering parameters described above.
After filtering and imputation the data is considered a high confidence data set and 
can be inspected in the QC tab or can be used for statistical tests directly. Any changes 
made within these critical steps will propagate throughout the analysis, therefore users 
can return to this section and change parameters as required.
Quality metrics
This section is used to evaluate metrics surrounding the proteomics data and checks 
prior to hypothesis testing can be done here. We focussed on metrics that has an 
influence on both the statistical test as well as the experimental setup. The available 
metrics are quantile of quantile plots, histograms, scatter plots, correlation heatmaps 
and principle component analysis. The following sections will provide an explanation 
on the interpretation of each plot.
figure 2: The lower quantile of a normal distribution. This quantile is used to infer missing values 
associated with low protein expression and other missing values.
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Quantile of quantile plots and histograms
Quantile of quantile (Q-Q) plots and histograms can be used to visualise a normal 
distribution. Ideally data should be normally distributed for imputation as well as sta-
tistical testing. Q-Q plots take the given data, in this case intensity data aft er processing 
and compares it to a known distribution using a scatter plot. The theoretical quantile 
represents a known normal distribution compares the quantiles of this distribution to 
the quantiles of each sample (Figure 3). The known normal distribution is calculated 
internally in the application. If a perfect straight line is formed then data is consid-
ered100% normally distributed. Typically tailing can be seen, either one or two tails 
and this is normal for proteomics data. Histograms function in a similar manner and 
plots the distribution curve. Tailing is not as easily spotted in histograms but a clear 
indication of normality can be observed using this method. If distributions are all you 
need then this should
figure 3: Example of the quantile of quantile plots as well as the associated histogram to demon-
strate the eff ect of log transformations on the data distribution. Quantile of Quantile plots are repre-




1.  NormalityPlot <- reactive({   
2.      # Defensive check   
3.      if (is.null(input$user_file)) {   
4.        return(NULL)   
5.      }   
6.       
7.      processed_data <- processed_data()   
8.         
9.      processed_data$GeneNames <- NULL   
10.    
11.     anno_data <- anno_data()   
12.     colnames(processed_data) <- anno_data$axisLabels   
13.     ylabname <- colnames(processed_data[Counter$normcounter])   
14.     index <- Counter$normcounter   
15.     qqplotList <- list()   
16.     histPlotList <- list()   
17.       
18.     #init plot cylce on render to save computing time   
19.     if (input$normRender > 0) {   
20.       #run for selected plots only   
21.       if (input$normPlotChoice == "qqPlot") {   
22.         for (i in 1:ncol(processed_data)) {   
23.           dat <- data.frame(qqnorm(processed_data[,i], plot.it = FALSE))   
24.           axisname <- colnames(processed_data[i])   
25.           p <- ggplot(dat, aes(x, y)) +    
26.             geom_point(pch = 21,   
27.                        alpha = input$qqPlotAlphaChannel,   
28.                        size = input$qqPointSize,   
29.                        colour = input$normPlotCol,    
30.                        fill = input$normPlotFill) +    
31.             geom_qq_line(aes(sample = y),    
32.                          lty = input$qqLinesType,    
33.                          lwd = input$qqLineWidth,    
34.                          colour = input$qqLineCol) +   
35.             ylab(axisname) +    
36.             xlab("Theoretical quantiles") +   
37.             ggtitle(input$qqPlotTitle) +   
38.             theme_classic(base_size = 14) +   
39.             theme(plot.title = element_text(hjust = input$normTitlePos,    
40.                                             face = input$normTitleFace,   
41.                                             size = input$normTitleSize),   
42.                   axis.title.x = element_text(size = input$normXsize),   
43.                   axis.title.y = element_text(size = input$normYsize))   
44.              
45.           qqplotList[[i]] = p   
46.         }   
47.            
48.         return(qqplotList)   
49.             
 
 








Drawing of the scatterplots: 
1.  scatterplot <- reactive({   
2.      if (is.null(input$user_file)) {   
3.        return(NULL)   
4.      }   
5.         
6.      processed_data <- processed_data()   
7.      anno_data <- anno_data()   
8.         
9.      anno_data$axisLabels <- sapply(anno_data$axisLabels, function(data){   
10.       data <- str_replace(pattern = "-
", replacement = ".", string = data)   
11.       return(data)   
12.     })   
13.        
14.     colnames(processed_data) <- as.character(anno_data$axisLabels)   
15.     index <- Counter$scatcounter   
16.     plot_list <- list()   
17.     plot.col <- input$scat_point_col   
18.     for(i in unique(anno_data$annotation)){   
19.       COLS=anno_data$axisLabels[anno_data$annotation ==i]   
20.       plot_combinations <- combn(COLS,   
21.                                  2,   
22.                                  simplify = FALSE)   
23.          
24.       for (a in 1:length(plot_combinations)) {   
25.         p = ggplot(processed_data,   
26.                    aes_string(x = plot_combinations[[a]][1],    
27.                               y = plot_combinations[[a]][2])) +   
28.           geom_point(pch = as.integer(input$scatCharcters),    
29.                      colour = input$scatPointBorder,    
30.                      size = input$scatPointSize,   
31.                      fill = plot.col,   
32.                      alpha = input$scatPlotAlphaChannel) +    
33.           ggtitle(input$scatTitle) +   
34.           theme_classic(base_size = 14) +   
35.           theme(plot.title = element_text(hjust = input$scatTitlePos,   
36.                                           face = input$scatTitleFace,   
37.                                           size = input$scatTitleSize),   
38.                 axis.title.x = element_text(size = input$scatXsize),   
39.                 axis.title.y = element_text(size = input$scatYsize))   
40.         out_name <- paste(i,a,sep = "_")   
41.         plot_list[[out_name]] = p   
42.       }   
43.     }   
44.        
45.     if (input$scatRender == 0) {   
46.       return(NULL)   
47.     } else {   
48.       dispPlot <- plot_list    
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Scatter plots are used to visualise comparisons of one sample to another. Ideally there 
should be a correlation between replicates and lower correlation within replicates, 
scatter plots are used to visualise this correlation (Figure 4). If there is a linear increase 
on the x and y axis, then samples are positively correlated as show in the Figure. Low 
correlation can be indicative of an outlier sample that should rather be left  out from 
further calculation as it will highly skew the standard deviation. These are the more 
likely sce-narios which are found within scatterplots. It is also possible to have a nega-
tive correlation, where there is a linear decrease of x and y. Scatterplots provide a good 
metric to evaluate a sample compared to another sample by visualising the proteins 
comparatively in each strain. Intragroup comparisons are not as informative using 
scatter plots and thus were restricted in ProVision, correlation heatmaps provide a 
better metric for inter- and intragroup comparisons.
correlation heatmaps
Correlation heatmaps are used to visualise the extent to which two variables change 
together, i.e. the correlation coeffi  cient. The correlation coeffi  cient is simply a numeri-
cal measure of correlation, in ProVision this correlation coeffi  cient can be calculated 
using either Pearson or Spearman methods. This value is tied to the scatter plots as 
displayed in the previous section and essentially measures the extent to which two 
variables change together. Correlation coeffi  cients describe both the strength and di-
rection of a given relationship. If a positive perfect correlation is achieved this number 
would be 1 or -1 for a perfect negative correlation and the associated scatter plot would 
present a perfect straight line. Instead of drawing scatter plots for each comparison, 
a correlation heatmap can visualise these relationships using a scaled values from -1 
figure 4: Scatter plots showing the correlation of proteins between samples. Straight lines represent 
correlated samples.
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to 1. In the context of proteomics, this relationship would typically be positive and in 
ProVision we have constricted this value to range from 0 to 1.
Pearson correlation coefficients measure the relationship between two continuous 
variables where the change in one variable leads to proportion-al change in another. 
Spearman correlation measures monotonic relationships between continuous vari-
ables. Thus Spearman is able to measure change where variables can change together 
but not at a constant rate and is based on ranking rather than raw values. In proteomics 
we hope to see high correlation within groups and low correlation between groups. 
figure 5: Correlation heatmap plotting the Pearson or Spearman correlation. This heatmap reduces 
the dimensionality of multiple scatter plots in order to gain higher order information on the inter-
sample relationships.
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This is a strong indication of a good experiment that will likely give statistical signifi-
cant difference when subjected to hypothesis test.
Drawing correlation heat maps:
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Drawing correlation heat maps: 
1.  correllation_heatmap <- reactive({   
2.       
3.      if (input$corrRender == 0) {   
4.        return(NULL)   
5.      } else {   
6.        cordata <- corrProcessing()   
7.        p = ggplot(cordata, aes(x=Var1, y=Var2, fill=value)) +   
8.          geom_tile() +    
9.          scale_fill_gradientn(colours = brewer.pal(input$corrColChoice,    
10.                                                   n = input$corrColourScal
e),    
11.                              name = "Pearson",   
12.                              limits = c(input$corrSlider, 1)) +   
13.         xlab(NULL) + ylab(NULL) + ggtitle(input$corrPlotTitle) +   
14.         theme_classic(base_size = 14) +   
15.         theme(plot.title = element_text(hjust = input$corrTitlePos,    
16.                                         face = input$corrTitleFace,   
17.                                         size = input$corrTitleSize),   
18.               axis.text.x = element_text(angle=90, hjust = 1, size = input
$corrXSize),   
19.               axis.text.y = element_text(size = input$corrYSize))    
20.          
21.       if (input$corrValDisp == TRUE) {   
22.         txtsize <- par('din')[2] / 2   
23.         p =  p + geom_text(label=cordata$value, size=txtsize * 0.8, color=
"grey9")   
24.            
25.         return(p)   
26.       } else {   
27.         return(p)   




Principle component analysis 
Principle component analysis is a test to determine the variation between principle 
components. These components represent the variation within a given dataset and is 
similar to correlation but uses stronger metrics by calculating variation directly. The first 
component represents the majority of variation and the second represents the second 
most variation and so on. For our purposes the first two components are of importance. 
ri i al co ponent analysis
Principal component analysis is a test to determine the variation between principle 
components. These components represent the variation within a given dataset and is 
similar to correlation but uses stronger metrics by calculating variation directly. The 
first component represents the majority of variation and the second represents the 
second most variation and so on. For our purposes the first two components are of 
importance. If we consider a differential expression experiment, the greatest amount 
of variation or the first principle component should occur between groups. There is 
always experimental variation, which often represents the second most variation in an 
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experiment and thus would cause separation on the second component. In an ideal ex-
perimental setup, treatment and control should separate in the first component while 
replicates of each should separate in the second. Ideally separation between replicates 
should be minimal and this indicates a good reproducibility of an experiment.
figure 6: Example of a principal component analysis that further reduces the dimensionality of data 
to represent differences in variation. The first component represents the largest variation and the 
second component represents the second largest variation.
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Drawing the PCA plot 
1.  pca_plots <- reactive({    
2.      pcaData <- pca()   
3.       
4.      anno_data <- anno_data()   
5.      cols <- pcaColNames()   
6.      if (is.null(pcaColNames())) {   
7.        cols <- rep("#000000", length(unique(anno_data$annotation)))   
8.      } else {   
9.        cols <- pcaColNames()   
10.     }   
11.     if (input$pcaRender > 0) {   
12.       p <- ggplot(pcaData, aes(pcaData$PC1, pcaData$PC2)) +   
13.         geom_point(pch = as.integer(input$pcaCharcters),    
14.                    size = input$pcaPlotPointSize,    
15.                    colour = "black",    
16.                    alpha = input$pcaAlphaChannel,   
17.                    aes(fill = pcaData$names)) +   
18.         scale_fill_manual(values = cols) +    
19.         theme_classic() +   
20.         ylab("Principle component 2") + xlab("Principle component 1") +    
21.         labs(fill = NULL) +   
22.         ggtitle(input$pcaPlotTitle) +   
23.         theme(legend.position = input$pcaLegendPostition,   
24.               plot.title = element_text(hjust = input$pcaTitlePos,   
25.                                         face = input$pcaTitleFace,   
26.                                         size = input$pcaTitleSize),   
27.               axis.title.x = element_text(size = input$pcaXSize),   
28.               axis.title.y = element_text(size = input$pcaYSize))   
29.       return(p)   
30.     }   




The PCA analysis provides the option to Z-score the data as the default. This transfor-
mation centres the data around zero with a minimal value of -3 standard deviations 
from the mean and a maximum of +3 standard deviations from the mean. The trans-
formation is done by subtracting each the mean of the total distribution from each 
observation (protein) and dividing that value by the standard deviation of the distribu-
tion. Changing the point size changes the size of the characters, circles by default and 
can also be changed to other characters. The colour input is generated dynamically 
based on the input from the assign groups page and can be accessed in a sub menu.
statistics and hypothesis testing
The statistical testing parameters can be seen as a research project on its own with 
many different experiments that can be performed to estimate what the best way would 
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be to analyse the specific data at hand. Using multiple different methods, we have 
found Limma (4) to be the best generalized approach for intensity data such as those 
used in proteomics. The other side is spectral counting which has its own assumptions 
and we have not tested ProVision for spectral counts nor do we extract spectral counts. 
As with all other data, the calculations are generalisable and will change if something 
upstream is changed such as the filtering parameters and so forth. The only thing not 
fully supported is the removal of samples. The calculation will display the significance 
counts of each comparison at a time and if more than two groups are present these 
comparisons can be accessed using the previous and next buttons. In certain cases it 
may not be beneficial to compare each group to every other group, a time course ex-
periment is a good example of this. Removing unnecessary comparisons is beneficial 
to the correction algorithms and also the computing time.
Intensities vs spectral counts
As mentioned, in ProVision Intensities is favoured and the statistical tests used reflect 
this. For spectral counts, different statistical tests are required. Here we will briefly 
provide an explanation on why intensities are favoured above spectral counts.
Intensities are based on the precursor intensity or MS1 based measurement by calcu-
lating the area under the MS peak or in some cases the maximum intensity of the peak. 
The sum of these measurements takes into account all the features of the comprised 
proteins. The precursor ion represents the total intensity of the peptide, but no infor-
mation on amino acid sequence of the peptide. Thus MS1 is used for quantification and 
MS2 is used for identification in this model.
Spectral counting is based on MS2 or fragment based measurements where quantifica-
tion is done by summing the number of identified MS2 spectra and matched against 
its peptides. The value obtained will depend on the intensity of the protein’s precursor 
peptide ions, as in DDA analyses more abundant features will be sampled more often 
than lower abundance ones (5).
Spectral counting infers quantification in the same process that identifies the peptides, 
allows for comparison between samples that are have a high degree of difference and is 
easy to implement computational. However spectral counting suffers from deficiencies 
in the method of quantification. The MS1 quantification is much more accurate and has 
a greater linear dynamic range due to the inherent limitations of spectral counting. 
With spectral counting the information on the precursor ion is not accounted for which 
discards potential important characteristics associated with the peak responsible for 
the peptide as a whole. In spectral counting there is chance for the introduction of 
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increased internal variation that arises from the fragmentation process as well. Statisti-
cally, spectral counting methods typically cannot be used with parametric tests because 
this type of data rarely follows a normal distribution and suitable transformations need 
to be tested first. With intensity data, these distributions are typically log normal and 
the normal distribution can be created by log transformation across all samples. The 
option for count data is to use non-parametric tests, however statistical power will be 
lost compared to parametric tests. In proteomics experiments, data is skewed to the 
most abundant peptides and thus it is important to maximize the statistical power in 
order to detect small differences within samples. While spectral counting works and 
can be used to quantify proteins, in ProVision we prefer MS1 based quantification for 
these reasons.
Limma and linear models
ProVision uses Limma or linear models for microarray data to calculate significant 
differences between groups. For in depth information on how Limma works, please 
refer to their publication (4). Briefly, moderated F-statistics (similar to ANOVA) that 
combine t-statistics for all comparisons is used as a test for significance in an empiri-
cal Bayes approach. Through this process the power of both t-tests as well as F-tests 
can be utilised and performs exceptionally well with matrix type data. Thus making 
Limma a powerful choice for proteomics data as well. When comparing Limma to 
more traditional methods such as ANOVA, the big differences should come from the 
genes with large variance, and moderate differential expression. This is because the 
variance estimate is shrunk towards the mean in Limma, while ANOVA uses the sample 
variance. Since the t or F test uses the variance estimate in the denominator, genes 
with very small sample variance will be less significant with shrinkage, whereas genes 
with high variance will be more significant. Finally, powerful correction tools such as 
Benjamini-Hochberg FDR can be used in conjunction with Limma, which has been 
shown to work well with proteomics data.
P-values, Q-values and effect size
The q-value is derived from the p-value by use of a correction algorithm. For proteomics 
data we have a large amount of observations (i.e. proteins) and thus conducting statisti-
cal tests over however many proteins are present within the data set. A typical label 
free proteomics experiment has around 3000 protein identifications which means an 
iteration of about 3000 hypothesis tests across multiple groups. If we take into account 
that a p-value represents a probability value and we set that probability arbitrarily 
to a value of 0.05 we accept that 95% of a distribution is different and 5% is similar 
to another distribution. By including more tests this effect is compounded and false 
positives accumulate. In order to mitigate this effect the p-values are modified by using 
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correction in order to control the false discovery rate. This correction is known as the 
q-value and is what we base the call of significance on. The value works similar to 
p-value and two options are available, either 0.05 for leniency or 0.01 if a stricter cut off 
is desired. The effect size simply means fold change and is exported as a logarithmic 
value. The default fold change cut off is set at a log fold change of 1, meaning that there 
is a one log difference of a protein between two groups. It is wise to include fold change 
in the cut off metrics when deciding which proteins are significant, especially consid-
ering that we work with biological data. Hypothesis tests simply evaluate whether two 
values and their standard deviations deviate significantly from one another regardless 
of the magnitude of that difference. However, consider the expression of two proteins. 
If the absolute concentration of protein A is 1 nM and protein B is 1.5 nM would this 
be biologically relevant or would a difference of protein A at 1nM and protein B at 
1uM represent a stronger biological significance. For this reason we give the option 
to change the cut-off for fold change significance in a wide range as it is subjective 
towards a study, the default of one is a good starting point.
correction algorithms
To obtain a p-value corrected for performing multiple tests we use correction 
algorithms. The best performing for the purpose of a proteomics experiment is the 
Benjamini-Hochberg FDR which provides a good control over the false discovery rate 
while not being as strict. Benjamini-Hochberg uses a step up method and calculates the 
correction by ranking each p-value according to its value. Another older, and perhaps 
more familiar algorithm is the Bonferroni correction. This is strict and increases in 
stringency as the number of input p-values (proteins) increases because every p-value 
is only compared to the total number of p-values. With small datasets it is good practice 
to use Bonferroni as all p-values are treated equally however as we increase the size it 
is better to control the false discovery rate instead. Thus at high numbers Bonferroni 
correction would swing the other way and leave false negatives. That being said, for 
some cases it may be better to have false negative calls than controlling the amount 
of false positives in the data set. For a more concrete look at p-value correcting within 
proteomics, a description has been provided by Diz et al in their manuscript (6). The 
Hommel method is very similar to the Benjamini-Hochberg method in that step-up 
methods are used to control the false discovery rate. The Hommel method is more 
powerful than Benjamini-Hochberg, however the differences in results is small and 
the Hommel method is computationally more intensive. The Benjamini-Yekutieli 
method is the most recent adaptation of the correction methods and is an addition 
to its predecessor, the Benjamini-Hochberg FDR method. While Benjamini-Hochberg 
calculates the corrected p-values under certain dependencies (such as positive re-
gression) the Benjamini-Yekutieli method assumes a general dependency. Thus this 
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method is more generalisable over different data types but it sacrifices power to do so. 
Probability values corrected with this method would need to be much lower compared 
to Benjamini-Hochberg FDR to be considered significant yet nowhere close to the 
strictness of Bonferronni method.
Performing the statistical tests
To perform the statistical test in ProVision, some key information is required. This 
includes 1) knowledge of the groups and their replicates, 2) performing the test and 3) 
extracting the relevant data from the linear models generated.
To identify the groups a matrix is required that displays the comparisons, replicates are 
mapped to each comparison as defined in the assign groups section. To visualise this 
simply consider an experiment where there are three groups, namely wild type, mu-
tant and complement The first step is to find all the potential combinations based on 
the replicates and assigned groups. In our example these combinations are `wild type 
vs mutant`, `wild type vs complement` and `mutant vs complement`, which has to be 
calculated without prior knowledge of the number of groups present. This is achieved 
in the function below by finding the names of the groups form the data defined in 
the assign groups section and calculating the number of unique annotation names 
provided by the user. From this information a list of lists can be generated where the 
second list contains a tuple of each potential comparison.
These comparisons will be used to generate a contrast matrix used by Limma to calcu-
late differences. This matrix is fed to the front end and displayed to the user and by de-
fault selects all comparisons. The inclusion of this choice was to allow sensible choices 
surrounding the statistical test as more tests equate to more error. Thus if there is a test 
that is non-sensical it can be removed at this step. The cost of permutation is however 
set at O(N!) and large comparisons may cause a significant increase in runtime.




Example table of permutations done by ProVision





2.  statComb <- reactive({   
3.      anno_data <- anno_data()   
4.      comb <- combn(unique(anno_data$annotation), 2, simplify = FALSE)   
5.      contrast <- lapply(comb, function(i) {   
6.        if (input$ComparisonSwitch == 1) {   
7.          compare <- paste(i[1], i[2], sep = "-")   
8.        } else {   
9.          compare <- paste(i[2], i[1], sep = "-")   
10.       }   
11.       return(compare)   
12.     })   
13.   })   
14.   
15. #Send to the front end   
16.  output$statComparisonMat <- renderUI({   
17.     pickerInput(inputId = "hypoTestMat",    
18.                 label = "Choose conditions to compare",   
19.                 choices = unlist(statComb()),    
20.                 multiple = TRUE,    
21.                 selected = unlist(statComb()),   
22.                 options = list(`actions-box` = TRUE,    
23.                                `selected-text-
format` = "count > 0"), choicesOpt = list(   
24.                                  style = rep(("color: black;"),length(stat
Comb())))   
25.     )   




Performing the statistical test is relatively straight forward and can be found in the 
documentation of Limma. Briefly a matrix is required containing the data to be tested 
and the column names as well as the group names are provided to helper functions. 
The statistical test is done in two steps, where the first step fits a model and the second 
step uses an Empirical Bayes approach to apply the statistical test to the comparisons 








Performing the statistical test is relatively straight forward and can be found in the 
documentation of Limma. Briefly a matrix is required containing the data to be tested 
and the column names as well as the group names are provided to helper functions. 
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step uses an Empirical Bayes approach to apply the statistical test to the comparisons 




1.  statsTestedData <- reactive({   
2.      processed_data <- processed_data()   
3.      rownames(processed_data) <- paste(rownames(processed_data),    
4.                                        processed_data$GeneNames,   
5.                                        sep = "_")   
6.      processed_data$GeneNames <- NULL   
7.      anno_data <- anno_data()   
8.         
9.      validate(   
10.       need(!is.null(anno_data),   
11.            message = "No groups assigned")   
12.     )   
13.        
14.     colnames(processed_data) <- anno_data$ID   
15.     anno_data$axisLabels <- NULL   
16.     if (input$calculateStats > 0) {   
17.       f.df <- factor(anno_data$annotation)   
18.       design <- model.matrix(~0+f.df)   
19.       colnames(design) <- levels(f.df)   
20.       fit <- lmFit(processed_data, design)   
21.       f.df <- factor(anno_data$annotation)   
22.       design <- model.matrix(~0+f.df)   
23.       colnames(design) <- levels(f.df)   
24.       fit <- lmFit(processed_data, design)   
25.        
26.       cont.matrix <- makeContrasts(contrasts = input$hypoTestMat, levels =
 design)   
27.          
28.       fit2 <- contrasts.fit(fit, cont.matrix)   
29.       fit2 <- eBayes(fit2)   
30.          
31.       return(fit2)   
32.          
33.     } else {   
34.       return(NULL)   
35.     }   




To use the data from the statistical test automatically only one data frame is required 
from the output of limma, namely the coefficients data frame. By mapping the total 
comparisons to a value it is possible to allow users to traverse the different 
comparisons within the coefficients data frame by its index. Data frames can be 
constructed using this method to contain the fold change and q-value statistics for each 
comparison without knowing the comparisons explicitly. The number of data frames 
To use the data from the statistical test automatically only one data frame is required 
from the output of limma, namely the coefficients data frame. By mapping the total 
comparisons to a value it is possible to allow users to traverse the different compari-
sons within the coefficients data frame by its index. Data frames can be constructed 
using this method to contain the fold change and q-value statistics for each comparison 
without knowing the comparisons explicitly. The number of data frames generated 
would be equal to the number of combinations calculated in the previous section and 
these data frames are stored in me ory and this output is used to generate the final 
output graphs available in ProVision
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uniprot ID p-value q-value effect size comparison significant Gene
Uniprot1 0.00001 0.001 3.5 Wt vs Mut Upreg Gene1
Uniprot2 0.00002 0.002 -5.6 Wt vs Mut Downreg Gene2
Uniprot3 0.06 0.1 -2.5 Wt vs Mut NS Gene3
Example of statisitical test output.
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1.  statsOut <- reactive({   
2.      fit2 <- statsTestedData()   
3.      statComb <- statComb()   
4.        
5.      #grab the data frame based on index   
6.      d.out <- data.frame(ID = names(fit2$coefficients[,statsCycler$counter]
),   
7.                          pValue = fit2$p.value[,statsCycler$counter],   
8.                          qValue = p.adjust(fit2$p.value[,statsCycler$counte
r],    
9.                                            input$pvalAdjust),   
10.                         EffectSize = fit2$coefficients[,statsCycler$counte
r],   
11.                         comparison = statComb[statsCycler$counter])   
12.       
13.     # Add significant column and calculate significance   
14.     d.out <- mutate(d.out,    
15.                     significant = ifelse(test = round(d.out$qValue,    
16.                                                       3) < input$UserSigCu
toff    
17.                                          & d.out$EffectSize > input$UserFC
Cutoff,   
18.                                          yes = "Upregulated",   
19.                                          ifelse(test =  round(d.out$qValue
,    
20.                                                               3) < input$U
serSigCutoff    
21.                                                 & d.out$EffectSize < (inpu
t$UserFCCutoff   
22.                                                                       * -
1),   
23.                                                 yes = "Downregulated",   
24.                                                 no = "Non significant"))) 
  
25.       
26.     # split the row names into uniprot and gene name   
27.     d2 <- data.frame(d.out,   
28.                      colsplit(string = d.out$ID,    
29.                               pattern = "_",    
30.                               names = c("UniprotID", "GeneName")))   
31.       
32.     # remove redundant info   
33.     rownames(d2) <- d2$UniprotID   
34.     d2$ID <- NULL   
35.     d2$UniprotID <- NULL   
36.        
37.     return(d2)   






Volcano plots are a variant of scatter plot and offer a rapid way to detect differences 
in data sets with replicates that have undergone statistical testing. It thus an effective 
method of visualising all the data found within a proteomics experiment both within 
comparisons and between comparisons. On such a plot, the effect size or fold change 
is plotted on the x-axis, a negative logarithm of the p-value is plotted on the y-axis 
and the points are coloured by q-value. Thus the greater the value on the y-axis the 
more significant and the greater absolute x value (can be either positive or negative) 
the greater the fold change. In ProVision the volcano plots are linked to the statistical 
test thus if there are two groups such as treatment control then you will only have one 
volcano plot. More than two conditions will create more volcano plots. The amount of 
volcano plots generated is the same as the amount of comparisons chosen during the 
statistical tests. Significant proteins can be labelled and are dependent on the statistical 
tests. Thus if there are no significant proteins it will not be possible to label something.
The volcano plot is constructed by determining the comparison first using the 
`statsComb` function and extracting the data from the statistical test performed. Ad-
dition of gene names is achieved by dynamically searching for the top N significant 
proteins provided by a slider on the front end and sorting the data frame based on this 
value. A new column is created for these genes and the altered data frame is used as 
the input data for the plotting system. The entire process is handled within memory. 
By keeping track of the index and the different comparisons users can change the plot 
that is displayed.
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figure 7: Example of a volcano plot representing the results of a statistical test. While p-values are 





1.  voclplot <- reactive({   
2.     d <- volcPlotData()[[volcCycler$counter]]   
3.        p <- ggplot(d, aes(x=EffectSize, y=-log10(pValue), fill = sig)) +   
4.          xlab("log2 fold change") + ylab("-log10 p-
value") + labs(fill = NULL) +   
5.          ggtitle(label = input$volcTitle) +   
6.          theme_classic(base_size = 14) +   
7.          geom_point(pch = 21, colour = "black", alpha = input$volcAlphaChan
nel,    
8.                     size = input$volcPlotPointSize) +   
9.          scale_fill_manual(values=c("Non significant" = input$volcNS,   
10.                                    "Downregulated" = input$volcDown,    
11.                                    "Upregulated" = input$volcUp)) +   
12.         theme(legend.position = input$volcLegendPostition,   
13.               plot.title = element_text(face  = input$VolcTitleFace,   
14.                                         hjust = input$volcTitlePos,   
15.                                         size = input$VolcTitleSize),   
16.               axis.title.x = element_text(size = input$VolcXSize),   
17.               axis.title.y = element_text(size = input$VolcYSize))   
18. return(p)   






Heatmaps can be used to visualise the magnitude of differential expression across 
replicates and across groups, a metric which is lacking in the volcano plots. It is also 
possible to view the expression globally across the proteome using heatmaps. The 
data for the heatmap is either extracted from the statistical test or from the data frame 
prior to the statistical test depending on the heatmap generated. If a zoomed in 
heatmap is visualised then the data frame from the statistical test is sorted and 
annotated based on q-value and subsequently extracted to create a new data frame. 
The new data frame is passed to the heatmap plotting function below to be rendered 
on the front end. As with all the other data remains reactive with the rest of the data 
analysis work flow. While the statistical tests are used to zoom in to the significant 




Heatmaps can be used to visualise the magnitude of differential expression across 
replicates and across groups, a metric which is lacking in the volcano plots. It is also 
possibl  to view the exp ession globally across the proteome using heatmaps. The data
for the heatmap is either extracted from the statistical test or from the dat  frame prior 
to the statistical test depending on the heatmap generated. If a zoomed in heatmap is 
visualised then the data frame from the statistical test is sorted and annotated based on 
q-value and subsequently extracted to create a new data frame. The new data frame is 
passed to the heatmap plotting function below to be rendered on the front end. As with 
all the other data remains reactive with the rest of the data analysis work flow. While 
the statistical tests are used to zoom in to the significant proteins, these tests are not 
plotted on the heatmap and only fold change is represented.





1.  UserHeatmap <- reactive({   
2.     anno_data <- anno_data()   
3.     if (input$generateHM > 0) {   
4.       if (input$HMAllorSig == "All") {   
5.         d1 <- allHeatMapData()   
6.       } else {   
7.         d1 <- HMPlotData()[[HMCycler$counter]]   
8.         #d1 <- SigheatmapData()   
9.       }   
10.      if (input$HMdata == "averages") {   
11.        colnames(d1) <- anno_data$annotation   
12.        d2 <- sapply(split.default(d1, names(d1)), rowSums, na.rm = TRUE)   
13.      } else {   
14.        colnames(d1) <- anno_data$axisLabels   
15.        d2 <- d1   
16.      }   
17.         
18.      validate(   
19.        need(dim(d2)[1] != 0, message = "This comparison has no significant
 proteins"),    
20.        errorClass = ".Shiny-output-error-validation {   
21.        color: red;}")   
22.      p <- pheatmap(d2, color = rev(brewer.pal(input$HMColChoice,    
23.                                           n = input$HMcolScale)),   
24.                    border_color = input$HMborderCol,   
25.                    fontsize_col = input$HMColFontSize,   
26.                    fontsize_row = input$HMRowFontSize,   
27.                    angle_col = input$HMcolAngle,   
28.                    cluster_cols = input$HMclustCols,   
29.                    cluster_rows = input$HMclustRows,   
30.                    clustering_method = input$HMClustMethod,   
31.                    show_colnames = input$HMDispCol,   
32.                    show_rownames = input$HMDispRow,    
33.                    treeheight_col = input$HMColTreeHeight,   
34.                    treeheight_row = input$HMColTreeHeight)   






ProVision uses Webgestalt for enrichment analysis, specifically the associated R 
package (1). As the analysis is targeted towards proteomics data a lot of the inherent 
Webgestalt functionality has been stripped to streamline analysis. Two main 
enrichment tests are supported namely, over representation analysis and gene set 
enrichment analysis. From these analysis, either pathway enrichment can be executed 
Enrichment analysis
ProVision uses Webgestalt for enrichment analysis, specifically the associated R pack-
age (1). As the analysis is targeted towards proteomics data a lot of the inherent Webge-
stalt functionality has been stripped to streamline analysis. Two main enrichment tests 
are supported namely, over representation analysis and gene set enrichment analysis. 
From these analysis, either pathway enrichment can be executed or gene ontology 
e t. The available pathw ys are KEGG, Reactome, wiki pathways and Panther 
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figure 8: Heatmap depicting the top x significantly up- and down regulated proteins.
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while the available gene ontologies are biological process, cellular component and 
molecular function.
Over representation analysis is a method that determines whether known biological 
processes are over-represented in a gene list (7). There are no values associated with 
over representation analysis and the enriched values represent either the up regulated 
or down regulated values as determined by an internal Fisher’s exact test. Thus this type 
of analysis will find enriched gene ontologies or pathways within the given data set. An 
example use case would be to find the most enriched pathway in either a upregulated 
or downregulated set of protein identifiers. In the case of no significant proteins, the 
same analysis can be used on the protein identifiers to find information such as the 
most common cellular component found in a given data set.
Gene set enrichment analysis is related to ORA in that underlying biological processes 
or pathways can be enriched but takes into account a direct comparison by including 
the fold changes between two states. This is done automatically by ProVision by taking 
the previous statistical test into account. The gene set enrichment analysis first calcu-
lates an enrichment score that represents a number associated with the enrichment of 
genes at the top or bottom spectrum, i.e. up or down regulated. A statistical significance 
of the enrichment score is determined by permutation to produce a null distribution 
for the enrichment score. The P-value is subsequently determined by comparison to 
the null distribution and this p-value is adjusted for multiple hypothesis testing. Gene 
set enrichment analysis is useful in cases where fold change cut offs are arbitrary and 
an example would be to use all significantly different proteins and the fold changes 
in the enrichment. This can also be done globally without an hypothesis test to gain 
insight into proteomics data without the need for a formal test.
Protein-protein interaction prediction.
STRING is a curated database with known and predicted protein-protein interactions 
and detailed description of their software can be found in their latest manuscript (8). 
The STRING database has information on over 5 000 organisms regarding the interac-
tion networks. In ProVision you can query the STRING database using either the up 
regulated or down regulated proteins that were determined by the statistical tests done 
previously. The data used to query the STRING database is reactive with the rest of 
the data in proVision, thus alterations that influence the statistical test will propagate 
to the STRING calls. It is possible that no information is displayed, this is due to no 
proteins being identified in the STRING network. In this case users can directly input 
Uniprot identifiers in ProVision to query the STRING database this way. It is important 
not to have any spaces between the Uniprot identifiers and each identifier must be 
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separated by a comma for the query to work. Users can also opt to change the sig-
nifi cant thresholds and the maximum nodes to fetch from the query. The signifi cance 
threshold ranges from 0 to 1 000 where larger numbers represent stricter results.
A request is sent via http using a URL that is dynamically constructed from user in-
put. Data is returned from the STRING API in JavaScript object notation and used to 
display data directly on ProVision without the user needing to navigate to the STRING 
website. To build the URL a list of protein identifi ers are extracted from the data frame 
generated from the previous statistical test. These identifi ers are fi ltered from most 
signifi cant and decreases in fold change depending on the number of proteins added. 
figure 9: Example of the data extracted from the string protein-protein interaction application pro-
gramming interface. Data is extracted automatically starting from the most upregulated – or down-
regulated proteins and submitted via an HTTP request.





tests done previously. The data used to query the STRING data base is reactive with 
the rest of the data in proVision, thus alterations that influence the statistical test will 
propagate to the STRING calls. It is possible that no information is displayed, this is 
due to no proteins being identified in the STRING network. In this case users can 
directly input Uniprot identifiers in ProVision to query the STRING database this way. 
It is important not to have any spaces between the Uniprot identifiers and each 
identifier must be separated by a comma for the query to work. Users can also opt to 
change the significant thresholds and the maximum nodes to fetch from the query. The 
significance threshold ranges from 0 to 1000 where larger numbers represent stricter 
results. 
 
Provision uses the STRING programming application interface based on RESTful 
principles. A request is sent via http using a URL that is dynamically constructed from 
user input. Data is returned from the STRING API in JavaScript object notation and 
used to display data directly on ProVision without the user needing to navigate to the 
STRING website. To build the URL a list of protein identifiers are extracted from the 
data frame generated from the previous statistical test. These identifiers are filtered 
from most significant and decreases in fold change depending on the number of 
proteins added. A few additional constraints are made available and th  URL is built. 
The base URL is built in the following way: 
1.  string_url_builder <- function(protein_query, sig_thresh, max_nodes) {   
2.    validate(need(protein_querry > 0,   
3.                  message = "No proteins available"))   
4.    if (protein_querry == 1) {   
5.      data <- "network?identifier="   
6.    } else {   
7.      data <- "networkList?identifiers="   
8.      protein_querry <- paste(protein_query,collapse=" ")}   
9.    URL <- paste0("http://string-db.org/api/image/",   
10.                 data,   
11.                 protein_query,   
12.                 "&required_score=",   
13.                 sig_thresh,   
14.                 "&limit=",   
15.                 max_nodes,   
16.                 "&network_flavor=evidence")   
17.   return(URL)   
18. }   
 
 
A few additional constraints are made available and the URL is built.
The base URL is built in the following way:
The protein_query parameter is built dynamically while sig_thresh and max_nodes are 
provided in the front end. To build the protein query the significant data is obtained 
first and dynamically handled based on user input:
Using the first function, the full URL can be constructed in an reactive expression to 
remain dynamic, there is also an option available to use custom inputs as well. In this 
case the data is not extracted from the statistics data generated earlier.
To render the image the URL is sent via HTML request and rendered using html tags 
in the application. As the URLis stored in a reactive STRING, the API call and rendered 
image will adapt to the user input.
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coNcLusIoN
By creating this application we hope to assist those that are not adept at statistics and 
omics data analysis to reach rapid conclusions in their proteomics data without the 
need to study the field. Based on Shiny, the application is functionally written and quite 
large, thus not all code could be displayed within this document. The code is available 
on github for anyone to use, browse or distribute under an open source license.
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APPLIcATIoNs AND LIMITATIoNs of MuLTI-PLATfoRM 
oMIcs.
There has been a major boom in the technological advancement of molecular biology. 
This allowed researchers to pursue the molecular make up of living organisms using 
“big data” techniques such as genomics and proteomics. M. tuberculosis has benefited 
highly from this boom and has a large number of genomes sequenced which results 
in insights into the pathogen evolution and biology of this organism. Throughout this 
thesis genomics, proteomics and data driven approaches form the core around the 
studies conducted, along with M. tuberculosis as the primary target of investigation.
The genomes of a wide array of related organisms allows for the in depth investigation 
around topics such as molecular epidemiology, evolution, population bottlenecks and 
retention of genetic features across generations. However genomics and proteomics 
suffer from a reference bias, where all new sequences are compared to an established 
sequence. The established sequence is not necessarily the best sequence for com-
parison, especially in the context of M. tuberculosis where lineages and sub-lineages 
of the same species can differ with large polymorphisms. While using a reference 
sequence is sufficient for detecting cross species variation in relation to one another 
the variation is inherently only detectable if present within the reference. This creates 
a situation where the only features that can be detected are features that already exist. 
Depending on the specific use case this may not be a problem, such as determining the 
variation in single nucleotide polymorphisms across species, detecting novel features 
are lost in the process. Furthermore, the existing tooling is not sufficient to explore 
these lost characteristics and has thus been named the “dark matter” of the genome 
or the “dark genome”. De novo assembly attempts to mitigate this loss by establishing 
a sequence in the absence of a reference through intra-contig alignment, using either 
De Bruijn graphs, overlap layout consensus or a combination of the two depending 
on the sequencing technology used (1,2). However, the use of short reads, such as 
those generated by the Illumina and Roche platforms, especially in highly repetitive 
genomes, is often unsuccessful or subpar. The de novo assemblies are often unfinished, 
especially in regions where De Bruijn graphs are prone to failure, such as the PE-PGRS 
and PPE-MPTR regions of M. tuberculosis. New technologies such as the PacBio long 
read sequencing can result in long contigs and often finish a small genome like M. tu-
berculosis but suffer from a higher error rate than the short read assemblers (2). As the 
genome of an organism forms the basis of genomics, transcriptomics and proteomics 
it is important to establish a sequence that is accurate to the organism of interest. An 
example where the reference of choice is of importance is seen with M. tuberculosis. 
Information regarding multiple large sequence regions will be lost in a transcriptomics 
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or proteomics experiment if the base reference was not from the same lineage as the 
subject. This is due to the large sequence polymorphisms that define each lineage 
which results in the inability to detect genes and in some cases full operons (3). The 
loss of this type of information is detrimental to the conclusions drawn, as these gain 
or loss mutations are themselves indicative of evolutionary adaptation to niche envi-
ronments (4). In ideal circumstances a reference sequence should be a known parent 
strain of the test organisms, especially in proteomics where the sequence database is 
highly dependent on accurate information from the translation of reference genes.
Proteomics and transcriptomics is the natural continuation of genomics technology 
which aims to identify the functionality of proteins and/or transcripts within the organ-
ism. Both approaches are concerned with identifying properties associated with genes 
and their expression. Transcriptomics focuses on the mRNA transcripts of genes while 
proteomics is the study of the total proteins present. As we did not study transcripts 
in this thesis, the focus will be on proteomics and its applications. Proteomics is the 
comprehensive study of the protein make up of a cell and aims to generate maps of 
the total proteome signature. The complexity of the proteome in comparison to the 
genome is much more expansive than originally hypothesised and as more studies 
are conducted it becomes increasingly apparent that the cytosol and its regulation is a 
highly dynamic and complex environment with many interacting parts. It has become 
increasingly clear that we have indeed come a long way from the one gene one protein 
hypothesis (5). Proteomics has its strengths in providing one platform for a variety 
of different techniques, of which each technique can give a different insight into the 
biological mechanisms at hand. Using this technique with variation in experimental 
design in this thesis we could apply the following techniques throughout the various 
studies; differential quantification, post-translational modifications, protein turnover, 
temporal proteome response, spatial organisation of proteins. These techniques were 
applicable to both prokaryotic and eukaryotic organisms (6). Many more applications 
exist and new techniques are constantly under development, thus demonstrating the 
versatility and power of proteomics. Proteomics has its main limitation in the sheer 
complexity of the proteomics pipeline, where many individual steps are prone to error. 
Researchers that wish to perform a proteomics experiment generally require knowl-
edge of the following: micro and/or cell biology to grow cells to usable quantities, 
molecular biology to extract proteins and perform quality checks, analytical chemistry 
to prepare and separate the samples, working knowledge of the concepts involved in 
tandem mass spectrometry and mass analysers for proper experimental design as well 
as working knowledge of statistics and programming capabilities to analyse the large 
amounts of data. For the best results in proteomics the one responsible for the project 
design and original hypothesis needs to keep all these steps in mind when designing 
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the experiment. Proteomics also suffers greatly from a reference bias, while genomics 
and transcriptomics have made major strides in de novo assembly (7–9), proteomics is 
still lacking in this regard (10). Database search algorithms used in matching real tan-
dem mass spectra with theoretical spectra assume that all spectra is present within the 
database and that the masses are correct for each spectra. This is however not the case 
when the theoretical database is obtained from the sequencing of a reference sequence 
that is dissimilar to the study organism. This also poses the additional challenge of post-
translational modifications, where these are lost if not explicitly added to the search 
parameter. These modifications can also occur after cell lysis, a common modification 
is oxidation. Thus many proteins that are present within the total protein content are 
not found due to unknown variable modifications on the proteins. In addition, peptides 
with trypsin missed cleavages will also be disregarded in the search unless specifically 
stated otherwise, which in turn significantly increases the database search time. With 
the knowledge of all possible post-translational modifications and including all pos-
sible missed cleavages as well as extreme computing power can mitigate these effects. 
This is however of no consequence if the protein and its theoretical spectra are not 
in the sequence database to begin with. The way to ensure that all real spectra have a 
theoretical counterpart is by ensuring that the correct reference sequence is used. To 
achieve this, researchers have merged the fields of genomics and proteomics to create 
proteogenomics (11).
Proteogenomics aims to address the reference bias and allows for a broad range of 
detection. Peptides may also be lost to database search algorithms due to mutations in 
the genome of even slightly unrelated organisms or due to complete lack of operons 
as mentioned earlier. Approaches to identify peptides with that may not be present 
is using sequence tag database searching or de novo peptide assembly, both of which 
are error prone and fail for large scale studies (12,13). Proteogenomics bypasses these 
restrictions by applying the established algorithms used to finish genomes to a specific 
organisms of interest. The proteins of the specific organisms are determined from the 
reading frames and this is used to establish the proteome database. Using this method, 
especially if the assembly of the target organisms is a complete or near complete ge-
nomic de novo assembly, all the mutations and coding regions are present and can be 
used for inference. This technique has allowed researchers to identify a large number 
of novel peptide variants and is further extended to identify chimeric proteins in M. 
tuberculosis as discussed in chapter 4 (14,15). Proteogenomics does have one obvious 
draw back when considering large amounts of data. As inference of a peptide is based 
on a statistical test and that statistical test is controlled by a false discovery rate, the 
larger the database becomes the stricter the test will become and thus real peptides 
and by extension proteins will be lost.
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As technologies become cheaper and advances are made in the software available 
to researchers, studies may incorporate genomics, proteomics and indeed proteoge-
nomics for targeted studies in organisms like M. tuberculosis. In chapter 4 we applied 
proteogenomics by using Illumina short read sequence data and proteomics to identify 
novel gene fusions as well as functional chimeras in M. tuberculosis clinical isolates. 
As mentioned a full genome is required but a reference introduces the reference bias 
and thus a de novo assembly is needed, however the de novo assembly produces an 
unfinished genome. In order to bypass this we used reference assembly to map the 
majority of reads and created custom software to extract regions around breakpoints 
that span multiple genes. These regions were subsequently used for de novo assembly 
for a more targeted approach and single base resolution of the breakpoints (see Chap-
ter 1, figure 2). The gene fusion resulting from the combination of two distally located 
genes was thus determined and translated to identify potential chimeras. While this 
approach was suitable for the identification of genomic elements that fit this criteria, 
the use of PacBio sequence data and long contigs or full de novo assemblies can greatly 
increase the discovery of novel genetic elements in important pathogens such as the 
M. tuberculosis. As the cost of long read sequencing decreases, the use of this type 
of sequencing in combination with proteomics would be highly beneficial and may 
become the mainstay and surpass Illumina as the default platform, especially with 
regard to M. tuberculosis.
GENETIc Loss IN THE MycobAcTERIA AND THE RoLE IT 
PLAys IN MycobAcTERIAL suRVIVAL.
As an intracellular pathogen, M. tuberculosis is prone to genomic decay (16). While 
there is relatively low genomic diversity in comparison to other organisms there is a 
high amount of recombination events, large scale polymorphisms and single nucleo-
tide polymorphisms to drive genomic change (17). One of the more striking features of 
M. tuberculosis is the lack of horizontal gene transfer to drive evolution (18,19). This is a 
unique position for an asexually reproductive organism as new DNA and by extension 
new functions need to be created from existing genetic material. This phenomenon ex-
plains the high prevalence of single nucleotide polymorphisms as the resistance caus-
ing mechanism used by M. tuberculosis to combat antibiotics, while other bacteria often 
transfer resistance genes via plasmids (20,21). The large sequence polymorphisms are 
of interest with regards to mycobacterial evolution. These large deletions are used to 
stratify species into various sub-lineages which are highly geographically restricted 
(Figure 1). Typically genetic decay occurs when a symbiont provides a function to the 
host and in turn the host assumes functions for the symbiont. As M. tuberculosis is 
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parasitic, the host is actively attempting to eliminate foreign the organism and thus the 
pathogen is under evolutionary pressure to survive. Therefore the fact that there is a 
geographically restricted signature is a strong indicator of direct competitive evolution 
through the loss of genetic material with each sub-group of hosts (Figure 1) (22) .
In chapter 4 we have demonstrated the functionality of genetic loss through the creation 
of gene fusions and that these genetic features are able to form functional proteins. 
This was achieved by use of proteogenomics and accurate break point prediction by 
combining reference and de novo assembly in regions with multi-gene deletions. This 
same phenomenon has been demonstrated for large sequence polymorphisms used for 
species stratification as well (chapter 4). The genetic loss is thus likely a major adaptive 
trait of M. tuberculosis to its specific niche and used for the de novo biosynthesis of genes 
from two related or unrelated parent genes, thereby greatly increasing the utility of a 
shrinking genome. As mentioned earlier, these features require at least lineage specific 
reference genomes to uncover but also provides a challenging aspect in the use of proxy 
organisms to study M. tuberculosis phenotypes observed across lineages or species. As 
an example, M. bovis BCG represents a sub-optimal model for M. tuberculosis study 
as it lacks the RD-1 region, which is responsible for a large subset of mycobacterial 
virulence (23). Another may be found in the lineage two strains of M. tuberculosis, these 
strains are more virulent and prone to higher transmission, which is interesting as 
their defining factor between lineage four strains is the loss of genetic material (24,25) 
. The deletions responsible for increased functionality may not necessarily be known 
figure 1: large sequence polymorphisms and global distribution of M. tuberculosis isolates adapted 
from Coscolla & Gagneux 2014. The figure demonstrates the differentiation of M. tuberculosis iso-
lates in isolated pockets across the globe, indicating competitive co-evolution with the host.
292
stratifying deletions but also more spontaneous variation. The loss of the ppe38-ppe71 
region blocks secretion of the PE-PGRS proteins and causes an increase in virulence 
over time (26). This region is intact in most, but not all lineage four strains, and can 
be reformed even after deletion as to once again secrete the PE-PGRS proteins (see 
Chapter 4). As mycobacterial research continues into the omics era, the large sequence 
polymorphisms and other less obvious changes in the genome may provide new and 
interesting information in the understanding of M. tuberculosis evolution.
coNsTRucTING A HIGHLy VERsATILE MoDEL foR M. 
TubERcuLosIs.
To control the variation in the different M. tuberculosis strains, M. tuberculosis H37Rv 
has become the standard reference strain. Often models for pathogenic mycobacteria 
are used for investigating the pathogen for safety and ease of use reasons. However, 
the main problem with using models for investigating a specific organism is that the 
genetic composition is naturally different to that of the target. This can be an issue for 
M. tuberculosis as the use of a non-pathogenic mycobacteria often defeats the purpose. 
In addition, a less pathogenic mycobacteria is while not deadly is still unsafe and 
genetically distinct from their pathogenic counterpart. Models are however necessary 
for the study of tuberculosis as a BSL-3 is a very restrictive environment that often is 
not capable of supporting advanced machinery or execution of advanced experimental 
techniques. Auxotrophic variants of M. tuberculosis provides a solution to this problem 
directly by creating minimal genomic variation while creating safe and widely appli-
cable proxy organisms. By creating a safe alternative to M. tuberculosis and decreasing 
the biosaftely level from three to two greatly increases the calibre of experimentation 
possible with such an pathogen (see chapter 2).
In chapter 2, we describe the characterisation of an auxotrophic M. tuberculosis strain, 
lacking leuD and panCD which renders this M. tuberculosis H37Rv strain incapable 
of growth in absence of leucine and pantothenate. We show that the auxotrophic M. 
tuberculosis provides the means to study diverse applications and has similar physi-
ological responses as M. tuberculosis H37Rv. The ΔleuD/panCD strain also has a defined 
genetic background with relation to the parent and by avoiding excessive passaging the 
genome remains stable. It is also possible to use such an organism to mimic the dele-
tions or single nucleotide polymorphisms present in other lineages of M. tuberculosis. 
This is particularly useful for testing drug resistance-conferring mutations directly in a 
M. tuberculosis background without creating a more dangerous version of the pathogen 
first.
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The leucine deficiency of the auxotrophic strain can be exploited and used for quantita-
tive whole proteome labelling experiments by use of stable isotopes of amino acids in 
cell culture (SILAC). SILAC is well established and typically involves total proteome la-
belling of Leucine and Arginine, as these are both essential amino acids and the targets 
of the trypsin protease. Thus the use of SILAC and proteomics is prevalent and used in 
this study to label human proteomes as well. By using heavy leucine we were able to 
label the proteome of M. tuberculosis. This extends the usability of the M. tuberculosis 
leuD/panCD mutant immensely and enables the use of advanced quantitative mass 
spectrometry techniques such as detection and quantification of post-translational 
modifications, highly accurate measurements of protein abundance, protein turnover 
measurements and more (see chapter 1). This greatly extends the reach of this specific 
auxotroph and is arguably a contender for the de facto model of M. tuberculosis when 
the pathogenic counterparts are out of the question.
AN EXTENsIVE QuANTITATIVE PRofILE of GLobAL M. 
TubERcuLosIs PRoTEoME REGuLATIoN DuRING AcID 
sTREss.
We used a SILAC labelled M. tuberculosis ΔleuD/ΔpanCD mutant for various quantitative 
proteomics experiments, including differential protein abundance, quantitative post 
translational modifications and protein turnover. A striking observation was made 
in the protein turnover experiments with the auxotrophic M. tuberculosis strain. This 
technique measures the differential protein content over time and is tracked by stable 
isotope labels. This is achieved by either growing the target organisms in a heavy 
isotope and fully incorporating this isotope and pulsing the organisms with the light 
or natural version. This technique can also function using the heavy isotope to pulse 
the organisms and this pulsing typically follows and physiological stressing event that 
will demand protein synthesis. In this example, the new proteins that are synthesised 
contains the light version of the amino acid as this theoretically the only amino acid 
present, there may however be some heavy amino acids present that are recycled from 
older proteins (see chapter 5, supplementary figure 3A). As the organisms equilibrates 
to the new environment the proteins will gradually be turned over until the organisms 
doubles and the proteins are diluted by half. All of these processes can be calculated 
using a first rate reaction equation that takes into account dilution.
In chapter 3 we used the auxotrophic M. tuberculosis strain characterised in chapter 2 
to investigate the mycobacterial response to acid stress. We specifically investigate the 
global proteome profile, including differential abundance, quantitative phosphoryla-
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tion and protein turnover using SILAC and proteomics. At the physiological pH, a num-
ber of proteins with the light version of leucine were present and the protein turnover 
was calculable. However, little to no light leucine was detected in the proteomes of 
the bacilli pulsed in acidic pH, thus rendering the calculation of half-lives void under 
these conditions. In retrospect, it is likely that the acidic pH depolarises the membrane 
enough to block the amino acid uptake from the environment. Thus during this condi-
tion, extracellular leucine is not incorporated into the proteome and not detectable by 
mass spectrometry. It is tempting to speculate whether the same lack of amino acid 
transport occurs when subjected to the acidified macrophage environment. However, 
all of the components associated with negating macrophage acidification are in place 
and thus the effect may be less pronounced. This is nonetheless an important observa-
tion to consider when using a model organism, while all genetic and phenotypic traits 
are controlled for there are still room for surprises with every experiment.
In the acid-free control sample the protein turnover of M. tuberculosis ΔleuD/ΔpanCD 
did provide information on the general state of proteome homeostasis during passive 
growth. By dividing the protein half-lives into categories, namely class I (fast) class II 
(intermediate) and Class III (long lived) we were able to elucidate the broader func-
tions of the proteins represented in each class using enrichments (see chapter 3). The 
intermediate class had the most interesting observations, with bacterial responses 
to the host and the type VII secretion featuring prominently. These included the 
ESX conserved components of ESX-1, ESX-3 and ESX-5. We also observed increased 
phosphorylation of type VII secretion factors during acidic stress. As has been shown 
with the sequencing of M. bovis BCG as well as routine passaging, the virulence of a 
pathogen is lost over time. It is however clear that the type VII secretion systems are 
active in optimal growth conditions without the need for stressors. Our results further 
indicate that culture filtrate protein 10 is phosphorylated at a greater propensity when 
upon exposure to acidic stress. The phosphorylation of a protein is associated with 
a form of signalling and it is tempting to speculate whether there is some form of 
signalling occurring with this virulence factor or whether phosphorylation mediates 
conformational changes to create an active CFP-10. Indeed, at least partial blockage 
of acidification is a pre-requisite for phagosomal escape and phosphorylation patterns 
on the effector molecules may be the method of interacting with the environment (27). 
It is however more likely that the increased phosphorylation is due to more EccA and 
EccC ATPase proteins releasing a free phosphate that binds to proteins like CFP-10 
when exposed to stress (28). This would have been confirmed if the protein turnover of 
the ESX secretion systems stayed constant during acid stress but unfortunately we were 
not able to measure this.
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THE PPE38-PPE71 DELETIoN IN cIRcuLATING M. 
tubERCulosIs sTRAINs AND ITs coNsEQuENcEs.
Since its discovery in the mycobacteria, the type VII secretion system has become a 
mainstay of mycobacterial research especially in the context of virulence. These sys-
tems are conserved in the mycobacteria and found in other gram positive bacteria as 
well. In the pathogenic mycobacteria there are a total of five type VII secretion systems 
designated ESX-1 to ESX-5, where ESX-2 and ESX-5 are the most recent and specifi-
cally of interest is ESX-5 which only present in slow growing mycobacteria, including 
most pathogens (see chapter 1 for more details). In the context of virulence and type 
VII secretion systems, arguably the ESX-1 and ESX-5 secretion systems are the most 
important for virulence. The ESX-1 secretion system is well documented in its role in 
virulence and is most notably involved in blocking phagolysosome maturation (29–31) 
and has been reviewed extensively (32–34).
The ESX-5 secretion system is unique to the pathogenic mycobacteria and responsible 
for the secretion of the PE-PGRS and PPE-MPTR proteins to the extracellular milieu. 
The ESX-5 system and the roles of the PE/PPE proteins have also been reviewed recently 
(35). The PE-PGRS and PPE-MPTR proteins provide an intriguing avenue of research 
in their own right. As M. tuberculosis is subject to reductive evolution as a result of 
an intracellular lifestyle, retaining certain coding regions above others should signify 
an evolutionary advantage due to the natural selection at play (16). The PE-PGRS and 
PPE-MPTR proteins are clonal expansions which contribute approximately 10 percent 
of the total coding potential in the M. tuberculosis genome. They are also unique to 
the pathogenic mycobacteria and secreted through the ESX-5 system, which is in its 
self also a unique type VII secretion system (34). Furthermore, the surface localisa-
tion of these proteins strongly suggest some form of interaction with the host cytosol 
and cellular processes (36). The PE-PGRS proteins are also highly immunogenic with 
individual members implicated in diverse roles most of which are related to survival 
in harsh environments such as in macrophages and/or granuloma’s (37–39). Taking the 
evolutionary context, the genetic features and the high immunogenicity factor into 
account, one of the first theories on the collective function of these proteins suggested 
a role in antigenic variation and thereby escape host responses to infection (40,41). 
This has however fell out of favour due a lack of recombination of these proteins within 
the host. There is also a general lack of evidence for this phenomenon and it is more 
likely that each of these proteins mediate a distinct function (39). The discovery of the 
ppe38-ppe71 operon and its role in modulating secretion of the PE-PGRS proteins to 
the extracellular milieu provided striking insights into the working of these proteins 
(26). Namely, that the PE-PGRS proteins are controlled in bulk by a single operon, the 
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deletions of this operon is found in clinical isolates of tuberculosis and this deletion 
results in increased bacillary load in mice (26).
In chapter 4 we used genomics and proteomics to investigate the prevalence of this 
deletion as one of our prominent examples of interesting multigene deletions in M. 
tuberculosis. We found a greater frequency of the ppe38-ppe71 deletion in the lineage 
two isolates of M. tuberculosis above lineage four strains. Interestingly, the lineage two 
strains are associated with an increased pathogenicity profile and higher mutation 
rates in comparison to the lineage four counterparts (42,43). It is tempting to add the 
ppe38-ppe71 deletion to the list of contributing factors. This is however ill advised with-
out more detailed investigations, given the complexity of any given organism and how 
little is actually consolidated about the molecular dynamics of even simple life forms. 
By changing perspective slightly, the correlation between the ppe38-ppe71 deletion 
and the lineage two strains is telling as the lack of PE-PGRS proteins does not seem to 
hinder these strains in the infectiveness and transmissibility. Our investigation into the 
lineage four ppe38-ppe71 showed that the breakpoints do not always form in the same 
manner, and in some cases the breakpoints can recreate ppe38 as a single gene from 
the original operon and thus forming a gene fusion. We further demonstrated that this 
gene fusion forms a functional protein able to secrete the PE-PGRS proteins once more 
(chapter 4). It would be interesting to investigate if the lineage four strains that have the 
reformed ppe38 compared to the full deletion have an increased virulence and muta-
tion rate or if the virulence remains stable, and vice versa for the lineage two strains 
that do not have the ppe38-ppe71 deletion. This may give indication into the role of this 
deletion within the circulating isolates and whether the lack PE-PGRS proteins rather 
promote a more aggressive phenotype. Highly immunogenic proteins also function to 
alert the immune system to the presence of the bacilli. The lack of these triggers can 
provide valuable time for the bacilli to establish an infection before being subject to 
the full force of the immune system. Additional time to response, especially for a slow 
growing organisms could mean the difference between eradication and persistence/
active infection. Indeed, the increased hypervirulence seen in mice was only evident 
at later time points through the presence of bacterial load (26). As bacterial growth 
is exponential, it is likely that additional doublings at an early stage can result in a 
greater overall population over a few generations compared to bacilli that were curbed 
by innate immune responses.
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INfLAMMAToRy REsPoNsEs To M. tubERCulosIs wITH AND 
wITHouT PPE38.
The presence of the ppe38-ppe71 deletion presents an anomaly with regard to M. tuber-
culosis physiology in the context of competitive co-evolution. Natural selection is a slow 
march towards an optimised state. Thus, as favourable mutations rise, the bacteria 
gain fitness and the mutation propagates through the population. Parasitic reductive 
evolution suggests that only the most favourable traits, which provide a competitive 
edge, would propagate in an organism that loses their genetic material over time. Thus 
the coding regions that are present should be beneficial as genetic “real estate” is at a 
prime rate within these organisms. The ppe38-ppe71 deletion challenges this dogma 
to an extent. While the genes themselves are present, their protein products and the 
effects they may have is functionally abolished. The most likely point of interaction 
between the PE-PGRS proteins and the host would be during early infection or active 
infection, as these proteins are secreted and the Type VII secretion system is active dur-
ing typical growth states (see chapter 5). During dormancy or persistence, the bacilli 
has a low metabolic state and thus using active transport is likely at a minimum (44). 
Furthermore, we speculated that an early advantage may result in increased bacterial 
growth over time which lends an explanation to the increased virulence observed (26) .
In chapter 5 we investigated the human macrophage response to infection by M. 
tuberculosis with and without the ppe38-ppe71 deletion. The PE-PGRS and PPE-MPTR 
proteins represent a broad category of proteins which have the potential to elicit a wide 
array of responses. To address this we used a discovery based proteomics approach to 
measure the differential abundance of proteins over time. We also used SILAC labelling 
of the THP-1 macrophages over time to calculate the protein turnover in response to in-
fection. The major findings observed in chapter 5 included a low response to infection 
with a marked decrease in inflammation when the macrophages were challenged by 
M. tuberculosis ppe38-ppe71 mutants. This was validated by Western blotting and we fur-
ther investigated the immune signalling pathways involved with immunofluorescence 
against the Nuclear factor kappa B (NF-kB) sub-units. We found that the signalling of 
this pathway is altered in macrophages infected with M. tuberculosis isolates deficient 
in PE-PGRS/PPE-MPTR secretion. Similar phenotypes have been observed using M. 
marinum ppe38 transposon mutants, while cytokine secretion using M. tuberculosis 
using dendritic cells as the host had only minimal differential regulation (45,46) (see 
chapter 5 for details).
At first glance a decrease in macrophage response seems intuitive, as fewer virulence 
factors are available to cause a stimulation of the immune receptors. Therefore less 
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signal is propagated and less immune responses are observed (figure 2). However, 
the inflammatory response decreased over time indicating that the macrophages are 
actively decreasing the response to infection, a phenotype that was reflected in both 
temporal proteome abundance and protein homeostasis. Enrichment of the major 
canonical pathways suggested a regulation in NF-kB signalling. This pathway is central 
to controlling fundamental immunological responses and controls critical processes 
such as inflammation. Alterations in NF-kB can lead to fatal disorders either through 
runaway inflammation or abolishing the innate immune response and thus resulting 
in a susceptibility to infection (47). At its core, the NF-kB pathway is a transcription 
factor pathway that is initiated by receiving signals from the environment and acts 
upon these signals by transcribing hormone like proteins, i.e. cytokines (48). These 
cytokines are the basal effectors of the immune system which can either stimulate 
the full activation of the immune system, decrease the immune response, cause cells 
to lyse or differentiate into other cell types (49). By modulating the NF-kB pathway, a 
pathogen can alter the host on a fundamental level and thus secure its survival indefi-
nitely. The mechanism of NF-kB translocation directs the type of response that can oc-
cur. This is typically split into the canonical and non-canonical pathways. Both of these 
can control inflammation by either rapid transcription of inflammatory cytokines or 
a delayed response if the non-canonical pathway is stimulated (50). We determined 
figure 2: Macrophages infected with wild type or ppe38-ppe71 knock out tuberculosis. The ppe38-
ppe71 mutant stimulates a lower overall immune response compared to wild type. Over time, this 
response may result in a greater intracellular bacterial load compared to wild type.
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the extracellular protein profile of M. tuberculosis ppe38-ppe71 mutants in comparison 
to wild type prior to infection in in vitro growth media. This gave indication on the 
PE-PGRS and PPE-MPTR proteins involved in PPE38 mediated transport across the 
cell. We found a clear cluster of highly regulated PE-PGRS and PPE-MPTR proteins 
which are likely the drivers of the phenotypes we observed ex vivo (see discussion of 
chapter 5 for more details). The components of NF-kB can combine in multiple ways 
and each permutation can have a major effect on the cytokines that are transcribed. 
This translocation was directly investigated and alternative NF-KB pathways associ-
ated with anti-inflammatory responses were found. Specifically, when infected with 
the ppe38 mutant, RelB translocation occurred instead of RelA, strongly indicating 
an anti-inflammatory phenotype (Figure 3). This discrepancy indicates a molecular 
switch controlled by M. tuberculosis through influencing translocation of Rel sub-units. 
This molecular switching of inflammatory pathways has been observed before, where 
Salmonella SPI-II systems mediate switching between M1 and M2 macrophages thereby 
reprogramming the macrophage signalling pathways (51). A similar mechanism may 
figure 3: Schematic illustration of the differential Nuclear factor kappa B signalling pathways iden-
tified in wild type and ppe38-ppe71 deficient mycobacteria. The lack of PPE38 dependent PE/PPE 
proteins stimulates a p50/RelB alternative pathway while the wild type signals through canonical 
NF-kB pathway. The canonical pathway stimulates secretion of IL1-B and creates an inflammatory 
response, the p50/RelB has been shown to dampen the inflammatory response.
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be at play with the use of ppe38 to modulate PE-PGRS and PPE-MPTR secretion which 
in turn can selectively stimulate the immune response thereby achieving a type of re-
programming. The lower immune response also provides the evolutionary imperative 
to remove the secretion of these proteins as discussed above. The lower the immune 
response to infection the more time to establish an infection. It is curious that the 
mechanism of secretion is lost but not the individual PE-PGRS proteins. Perhaps M. 
tuberculosis isolates with the ppe38-ppe71 deletion still synthesize these proteins and 
release them upon lysis to interact with other bacteria that are still intact. Thereby 
maintaining the overall functionality of these proteins, even in the absence of PPE38 to 
mediate the secretion. Recent findings of a protease, PecA, was shown to cleave the PE-
PGRS proteins with a possible cleavage site located in the PE region (52). This indicates 
that the variable PGRS part is free from the cell and able to function independently. 
While a rather extreme hypothesis, there is some imperative for a lysed mycobacterial 
cell to release the PE-PGRS proteins to the extracellular milieu and still interact with 
the host.
To summarise, there is evolutionary imperative for the deletion of the ppe38-ppe71 
operon in circulating clinical isolates (chapter 4) (26). These deletions likely contribute 
to a lower early immune response due to the lack of immunogenic proteins on the sur-
face, thereby providing a more favourable environment. The lack of immune response 
likely translates to increased bacterial load as the bacilli double over time as seen 
previously (26). Thus bacilli lacking the ppe38-ppe71 deletion and by association the se-
creted PE-PGRS and PPE-MPTR proteins allow these bacilli to trade an early virulence 
phenotype for a late virulence phenotype. The infection profile of M. tuberculosis is 
however complex and cannot only be categorised by the macrophage infection profile. 
Alveolar macrophages are for one more permissive than others and thus may have 
a more pronounced phenotype when infected with the ppe38-ppe71 deficient macro-
phages. Furthermore, M. tuberculosis is characterised by the formation of granulomas 
at the site of infection (53) and PE-PGRS proteins have been observed in M. tuberculosis 
granulomas (54,55). Many studies approach the PE-PGRS and PPE-MPTR proteins from 
the angle of the bacilli with the question focusing on the function of these proteins. 
It may however be more fruitful to shift focus towards the modulation of the immune 
system by these proteins in order to decipher more of this unique physiology.
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INVEsTIGATING M. tubERCulosIs RELAPsE THRouGH 
GLobAL LuNG PRofILEs usING MAss sPEcTRoMETRy.
In the Western and Eastern Cape provinces of South Africa, the lineage two strain is the 
most common strain infecting tuberculosis patients (56). As mentioned, this lineage 
presents the highest incidence of drug resistance and is the most aggressive (read 
pathogenic) (42,43). Unfortunately the completion of treatment is only at 53 % and 
among these there is a higher mortality rate associated with the drug resistant and 
aggressive tuberculosis isolates (57). Completion of treatment is of utmost importance, 
as M. tuberculosis can persist during the treatment process and later re-emerge to infect 
the individual once more. However, the mean relapse rate remains at ~8 % (58–60). 
The lung is the largest surface in contact with the outside environment and thus highly 
trafficked by immune cells to clear any particulates or organic agents inhaled by the 
individual (61). The lung profile and how the proteins present during infection with 
these isolates is a untapped resource.
In chapter 6 we procured sputum and bronchiolar alveolar lavage (BAL) fluid from pa-
tients at the start of tuberculosis treatment and at the end of treatment in the Western 
Cape regions of South Africa. These patients were predominantly infected with the 
M. tuberculosis lineage two strain (data not shown). The patients were also subjected to 
fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/
CT) scans to classify lung lesion activity. We found that approximately 10 % of patients 
retained live M. tuberculosis at the end of treatment and two patients relapsed. Pro-
teome analysis of the BAL fluid could differentiate between active tuberculosis cases 
and end of treatment cases. We also found that the relapse case demonstrated a BAL 
fluid proteome signal similar to the active tuberculosis cases at the end of treatment. 
The sample set is however too small to draw any real conclusions and this specific 
relapse sample without further investigation and may not represent a total population. 
The rarity of relapse cases and the invasiveness of extracting BAL makes investigating 
the in lung relapse profile extremely challenging. If this can be overcome, a greater 
proteomics BAL study with sufficient numbers in active, end of treatment and relapse 
cases has great potential. Identification of target profiles or circulating molecules 
within these patients can indicate the effectiveness of treatment, whether treatment 
can be stopped early or should be extended.
creating an open source proteomics data analysis platform.
Throughout the studies presented within this thesis, proteomics forms a central point. 
The analysis of proteomics data, and indeed other large dataset manipulations is still 
an open field with active development and there is no one-fits-all method. Certain para-
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digms may be followed but this can result in sub-optimal results that stem from the 
data handling rather than the actual biological experiment. In many ways the analysis 
of the data should be decided in the context of the research question but is often dis-
regarded up until the raw data is generated. The major steps in the data analysis of a 
proteomics experiment includes filtering of unwanted data, transformation, filtering 
of biologically non-sensical data, imputation, statistical testing and visualisation. Each 
of these steps require user input to some extent and may be of use in certain cases 
but irrelevant in others. It is up to the researcher to determine these factors, but the 
sheer volume of data often causes traditional methods such as spread sheets to be cum-
bersome. There are software packages available, with the de facto analysis platforms 
being Perseus, which is free, and Proteome Discoverer (62). Perseus attempts to create 
methods for the general analysis of proteomics data but without prior knowledge in the 
workflows a potential newcomer is bombarded with many hours of tutorials resulting 
in a high skill ceiling. Furthermore, the graphics quality is lower than other platforms 
and limited in its customisability within Perseus. The R programming language offers 
the most flexibility but the skill ceiling is even higher as it requires users to be knowl-
edgeable in software engineering paradigms as well as implementation of the various 
steps. The power of R is however unparalleled and any analysis can be easily tailored 
to a research question retrospectively and quality graphics can be generated, speeding 
up the analysis. The Bioconductor and CRAN libraries of R also provide a strong com-
munity with many developments in proteomics to facilitate the analysis (63,64).
In chapter 7, we created a cloud based proteomics data analysis platform in the R 
language for the analysis of common proteomics experiments which we called ProVi-
sion (Proteome Vision). The main driver behind creating this software was to rapidly 
analyse common proteomics data with the freedom to tailor the analysis to the re-
search problem while retaining the full functionality provided by R. As we performed 
many different types of analysis it was imperative that we created a flexible working 
environment. The alternative was to create a R library that performs similar operations 
as discussed here, this was however not as user friendly as using a R back end with 
a graphical front end for quick analysis. We achieved the low skill ceiling and rapid 
prototyping by creating a clear and intuitive workflow with control over each section. 
An important feature implemented is how the data flows through the platform, where 
changes created in the first step are propagated downstream to the figures. This allows 
for rapid experimentation of data analytics techniques to achieve the most optimal 
biologically relevant results. Proteomics data analysed with ProVision makes use of 
MS1 based normalised intensity values obtained from MaxQuant and is compatible 
with label free or TMT-tagged data (65). While spectral counts can be used for inferring 
protein abundance, we only focussed on the MS1 based methods largely to take advan-
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tage of parametric statistical testing. As biological data is log normal for the most part, 
a log transformation can be applied to obtain normally distributed data which can be 
verified with histograms or quantile of quantile plots within the application. Common 
contaminants are filtered out from the dataset and groups are designated for further 
filtering. A few options are available such as filtering for valid values in one group, in 
each group or filtering all values. The latter is particularly useful for TMT-tagged data 
where the presence of a tag guarantees detection and very few values are missing. 
This becomes more nuanced in label-free proteomics experiments where it may be 
sensible to follow one of the other filtering approaches. As a mass spectrometer usually 
analyses the most abundant peptides in a given cycle the peptides corresponding to a 
protein may be seen in one instance but not another. Thus filtering for two occurrences 
of a protein out of three may be a valid approach to retain biologically relevant data. 
In an experiment such as treatment compared to control, the lack of a protein across 
all replicates in the control and the presence of the same protein in the treatment is 
likely of importance. In this case it is sensible to filter for valid values in one group 
and not each group. This does however cause a missing value problem which will have 
implications on hypothesis testing and corrections. To combat this ProVision uses a 
truncated normal distribution to impute the missing values, a method popularised by 
Perseus (62). The reasoning is that missing proteins are not missing at random, which 
is the assumption for other popular imputation methods such as K-nearest neighbours. 
Expression values for proteins in the filtered dataset are either missing because they 
were not expressed or expressed at a very low level compared to the other condition. 
Therefore, by estimating the lower quantile of the normal distribution associated with 
that sample a low expression value can be assigned (chapter 7, addendum A). After this 
step a hypothesis test can be conducted, ProVision uses LIMMA to run the statistical 
tests as this has been specifically developed for expression type data (66). Statistical 
tests without corrections are not allowed within the platform. The reasoning behind 
this was to avoid type I errors (false positives) at all costs, at the expense of type II 
errors (false negatives). The correction is however set to the most lenient to combat 
the number of type II errors that can occur. While a balance between type I and type 
II errors is an important consideration to any study, for the majority of cases one may 
want to avoid false positives as much as possible. This does however mean that critical 
information regarding the ground truth of an experiment may be lost in the process, 
especially if there is little difference between experiments. The data from the statisti-
cal tests is passed to the figure generator where ProVision provides volcano plots and 
heatmaps for direct visualisation of the differentially regulated proteins. This is further 
complemented by the use of the Webgestalt and STRING application programming 
interfaces to perform enrichments from the statistical tests as well as protein-protein 
interaction networks respectively (67,68). Detailed explanations of each analysis step 
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as well as each graph is recorded in tutorials located within the application to assist 
users at any step.
While ProVision is powerful in its own right, it still lacks key aspects that requires in-
corporation to be competitive. These include support for SILAC based applications as 
well as analysis for protein-protein interactions. Additional developments incorporat-
ing more advanced imputation techniques, especially in machine learning, would also 
greatly benefit the application. We released this application as an open source project 
for active development by community members who would like to assist in its growth. 
At the time of writing, ProVision has been accepted by members of the proteomics 
community and continues to grow, with the largest user base existing in Germany, USA 
and the Netherlands.
fuTuRE PERsPEcTIVE AND coNcLuDING REMARKs
The work presented in this thesis has addressed questions in M. tuberculosis physiol-
ogy, evolution, host-pathogen interactions and provided new tools to the broader com-
munity. There is however many unresolved questions that still remain as well as scope 
for improvement on current studies presented here. The current adoption of PacBio 
long read sequencing for M. tuberculosis genomes has the potential to add immense 
value to M. tuberculosis genomics. The widescale adoption of this technology will create 
robust genomes which will likely add to the current understanding of M. tuberculosis 
evolution. Long read sequencing technology also has the potential to generate lineage 
specific reference sequences to form the basis of other high throughput studies such 
as transcriptomics, proteomics among others. The discovery of gene fusions was 
done using a sub-optimal technique, albeit one that works for this specific chimera 
formation in M. tuberculosis. With the combination of long read instead of short read 
sequence data, many more genetic features can be detected including but not limited 
to the gene fusions. It is likely that there are other structural variations that create 
novel genetic features which M. tuberculosis is able to utilise. The genome is the basis of 
all functionality within any organism. By increasing efforts to investigate these hidden 
features within the genome may uncover factors with profound effects across other 
systems within the pathogen.
Proteomics is undoubtedly a powerful tool for the study of system wide changes to an 
organism in response to stimuli. We attempted SILAC based proteomics in auxotro-
phic M. tuberculosis and while we were able to label the proteome of M. tuberculosis, 
the detection of peptides were limited by the use of heavy leucine. While this strain 
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provides a large impact on the research capabilities of M. tuberculosis, especially in the 
proteomics space, it is still limited. Trypsin is commonly used to cut peptides and the 
recognition sites are either at lysine or arginine. This guarantees one of these amino 
acids are located on the peptide when sequenced and can be accurately quantified. 
Thus if a peptide does not contain leucine, it will not be sequenced and does not con-
tribute to the quantification. Future studies in M. tuberculosis proteomics would benefit 
by creating a lysine/arginine double auxotroph. This may negate the safety of this 
organism outside a biosafety level three facility which would require additional investi-
gation. However, if successful the creation of such a strain has the potential to become 
a mainstay in M. tuberculosis proteomics and other stable isotope based research.
We also investigated the proteome response of M. tuberculosis ppe38-ppe71 mutants 
both in vitro as well as the macrophage temporal response to this strain (see chapter 5). 
It was known that PPE38 is associated with the secretion of a number of PE-PGRS pro-
teins, but the exact state of the bacteria was unknown. We could show the presence of 
specific PE/PPE proteins, including PPE-MPTR proteins that were clearly controlled by 
PPE38, however the cell membrane also demonstrated a large number of intracellular 
proteins differentially regulated. This is likely caused by instability of the cell mem-
brane in the absence of PE-PGRS and PPE-MPTR proteins on the surface. In addition, 
while PPE38 is clearly a chaperone for the PE-PGRS and PPE-MPTR proteins the exact 
mechanism is still unknown. There was no differential regulation in the cytoplasm of 
M. tuberculosis wild type and mutant strains, indicating that the secretion mechanism 
likely occurs within the membrane. The compromised cell wall and mechanism of 
secretion still remains unresolved. Understanding how the PE/PPE proteins interact 
and influence the mycomembrane and/or capsule could yield interesting observations 
regarding the fluidity and integrity of this structure.
With regards to the innate immune response to ppe38-ppe71 deficient mycobacteria, 
we demonstrated the signalling pathway involved and could show that the inflamma-
tion is mediated by a p50/RelB pathway. This indicates a possible molecular switching 
mechanism between inflammatory states, which has been demonstrated before using 
other intracellular pathogens (51). It may be of interest to investigate the accessibility 
of this switching mechanism to wild type M. tuberculosis. If PPE38 expression is modu-
lated during the course of infection this may indicate that the pathogen has the ability 
to influence macrophage polarisation indirectly. By further investigating the role of 
PPE38 in the innate immune response, especially in the context of polarisation states 
has potential in understanding not only how immune responses can be modulated but 
also how this pertains to bacterial survival in vivo. We however did not definitively 
show that a switch to M2 polarisation state occurs when infected with M. tuberculosis 
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ppe38-ppe71 mutants. It would be important to understand whether inflammation is 
reduced or a full switch occurs, which could link the PE/PPE proteins with persistence 
in vivo.
In conclusion, the adoption of high throughput technologies and establishing stan-
dardised workflows is ushering a new era of biological research. When used correctly, 
these technologies provide insight into cellular dynamics that was not previously 
possible. By using these techniques we have the potential to investigate major cellular 
systems directly. Here we found that even simple bacterial organisms has a high degree 
of complexity. Often as molecular biologists we focus on a single protein, decipher its 
functionality and infer it on the greater system. There is however a homeostasis within 
the cell with many inter-dependent processes. It is thus highly likely that alterations 
in this homeostasis, be it genetically or phenotypically can reverberate throughout the 
cellular processes. While we have come a long way in understanding the physiology 
of M. tuberculosis there is still a long way to go. With the increased availability of data 
and data generating techniques we are now more than ever equipped to tackle major 
problems such as infectious disease. In the case of M. tuberculosis, it still has a presence 
among the top causes of death from an infectious agent and has held the title since an-
tiquity. With technological advances we are increasing the resolution at which we are 
able to interrogate this pathogen. New techniques become available and new insights 
can be gained. By understanding fundamental processes as well as entire systems in 
context of infection we slowly build our understanding of M. tuberculosis. With the 
work presented in this thesis we have explored some of these processes, built upon 
others and created tools to assist future researchers in the fight against tuberculosis. 
With continued research and innovation we take strides in effectively combatting the 
spread and mortality of this pathogen.
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PoRTRET VAN EEN PATHoGEEN: EEN DIEPGAANDE 
KARAKTERIsERING VAN M. tubERCulosIs EN ZIJN GAsTHEER 
MET bEHuLP VAN MuLTIDIMENsIoNALE PRoTEoMIcs.
Inleiding en doel van dit onderzoek.
Mycobacterium tuberculosis is de oorzaak van de infectieziekte tuberculose bij de mens 
en is een van de dodelijkste infectieziektes wereldwijd. In het jaar 2020 waren er 130 
nieuwe tuberculose gevallen per 100.000 mensen en 1.2 miljoen doden (WHO tuber-
culosis report 2020). Ongeacht aanzienlijke inspanningen om de verspreiding van de 
ziekte te stoppen, is er nog steeds een wereldwijd probleem. Landen met een hoge 
incidentie van resistente bacteriën, zoals Zuid-Afrika, zijn kwetsbaar, dus is het belan-
grijk om verder onderzoek te doen.
M. tuberculosis is een gevaarlijke gespecialiseerde bacterie die voornamelijk longziekte 
veroorzaakt. Het heeft een zeer klein genoom dat speciaal is ontwikkeld om in een 
menselijke macrofaag, een afweercel, te leven. M. tuberculosis wordt vaak gevonden 
in het midden van meerdere immuuncellen, waarbij de cellen en bacterien samen 
een granuloom vormen. Het granuloom is een kenmerk van klinische tuberculose en 
meerdere granulomen worden gevonden in het infectiegebied. De gelijktijdige evolutie 
van de bacteriën en de menselijke cellen zorgt voor een hoge specialisatie in beide. Die 
bacteriële specialisatie is terug te zien in het kleine genoom en de eiwitten. De eiwitten 
zijn verantwoordelijk voor zowel de structuur als de metabole functie van de bacterie. 
Door de bijzondere evolutie van M. tuberculosis zijn de unieke kenmerken van het ge-
noom en het proteoom zeer belangrijk voor het onderscheid tussen mycobacteriën die 
wel en geen ziekte veroorzaken. Dit verschil kan ons aanwijzingen geven voor de juiste 
behandeling van de ziekte tuberculose. Het type VII secretiesysteem, met name het 
ESX-5 systeem, is een uniek kenmerk van de ziekte veroorzakende mycobacteriën. Dit 
systeem is essentieel voor de groei van M. tuberculosis en is verantwoordelijk voor de 
secretie van unieke eiwitten, namelijk de PE-PGRS en PPE-MPTR eiwitten. Deze eiwit-
ten worden in grote aantallen buiten de cel aangetroffen, zijn uniek voor langzaam 
groeiende mycobacteriën en hebben het vermogen om het immuunsysteem van de 
gastheer te beïnvloeden. Er is zeer weinig bekend over de samenwerking van de PE-
PGRS en PPE-MPTR als een eenheid en of er werkelijk een samenwerking is. In dit 
proefschrift wordt een mutant van het ppe38 gen bestudeerd. In een eerdere studie 
is gevonden dat het eiwit PPE38 de secretie van de PE-PGRS eiwitten uitschakelt. Een 
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mutant van ppe38, waarbij dit eiwit dus niet meer functioneert, heeft een groot effect 
op de interactie tussen M. tuberculose en zijn gastheer. Het is bekend dat een verlies van 
PPE38 zorgt voor meer virulente of agressieve M. tuberculosis en deze vorm komt voor 
in de natuur. De effecten van deze mutant op het cellulaire vlak zijn een onderdeel van 
het werk beschreven in dit proefschrift.
Het doel van het onderzoek beschreven in dit proefschrift is om meer inzicht te 
krijgen in de systeem biologie van zowel M. tuberculosis als zijn gastheer. Hiermee 
kunnen diverse hulpmiddelen en technieken voor verder onderzoek worden opgezet 
en toegepast. In dit proefschrift wordt gebruik gemaakt van een auxotrofe stam van 
M. tuberculosis voor onder andere geavanceerde massaspectrometrie, inzicht in de 
evolutiebiologie van M. tuberculosis, effecten van M. tuberculosis op de macrofaag en 
directe observaties van de effecten van de infectie op longweefsel. Tot slot hebben we 
de analyse van proteomics data verbeterd door een online platform te creëren.
Gebruikte onderzoeksmethoden.
In dit proefschrift gebruiken we in ieder hoofdstuk proteomics in zowel M. tuberculosis 
als zijn gastheer. In hoofdstukken 2 en 3 gebruiken we een auxotrofe variant van M. 
tuberculosis, welke een specifieke toevoeging nodig heeft om te groeien, waardoor het 
veel veiliger is om de stam in een ML-2 laboratorium te gebruiken voor complexe pro-
teomics experimenten. Deze hoofstukken zijn essentieel voor de opzet van proteomics 
technieken die worden gebruikt in andere hoofstukken. Onder andere wordt in deze 
hoofdstukken laten zien dat het van belang is de bacteriën op een specifieke manier te 
laten groeien, namelijk zonder abumine of polymeren.
Naast de auxotrofe M. tuberculosis, gebruiken we natuurlijke stammen van M. tuber-
culosis die zijn geïsoleerd uit een geïnfecteerd individu. Voor gecontroleerde experi-
menten waar de genetische achtergrond belangrijk is, gebruiken we de M. tuberculosis 
H37Rv of CDC1551 laboratoriumstammen of een ppe38 knock-out mutant. In hoofdstuk 
5 worden laboratoriumvarianten van menselijke macrofagen gebruikt en in hoofdstuk 
6 maken we gebruik van patiëntmateriaal. Het patiëntmateriaal is afkomstig van alveo-
laire bronchiale spoelsels uit de longen van mensen tijdens M. tuberculosis besmetting 
en na behandeling.
Proteomics wordt vaak gebruik voor het bepalen van het verschil in hoeveelheid eiwit 
tussen verschillende condities. Er zijn echter veel meer toepassingen en manieren om 
de nauwkeurigheid van een proteomics experiment te verbeteren. In dit proefschrift 
gebruiken we labelvrije proteomics voor het merendeel van de studies, evenals zoge-
naamde “tandem mass tagged” (TMT) en “stable isotopes of aminoacids in cell culture” 
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(SILAC) gebaseerde proteomics. Met deze technieken in combinatie met goede data 
analyse en statistiek is het mogelijk om betrouwbare data te verwerven. Daarnaast kun-
nen deze technieken worden toegepast op elk organisme en wordt het daarom vaak 
gebruikt, onder andere in bijna elk hoofdstuk van dit proefschrift. Het gebruik van 
SILAC en TMT-labels wordt toegepast in de hoofdstukken 3, 5 en 6. Met SILAC is het 
mogelijk om meer complexe experimenten met hoge nauwkeurigheid uit te voeren. We 
gebruiken SILAC om post-translationale modificaties te bepalen in hoofdstuk 3 en om 
eiwitvernieuwing te bepalen in zowel hoofdstuk 3 als 5.
Resultaten in dit proefschrift.
In hoofdstuk 2 wordt de auxotrofe mutant van M. tuberculosis gekarakteriseerd in 
vergelijking met de M. tuberculosis H37Rv laboratorium stam. De boodschap van dit 
hoofdstuk is dat de auxotrofe stam veilig is en als model voor M. tuberculosis kan wor-
den gebruikt. Het is wel zo dat levende organismen een hoge mate van complexiteit 
hebben, dus het is mogelijk dat zelfs een kleine verandering op het genoom vlak een 
groot effect heeft. Daarom is het essentieel om te bepalen of er effecten zijn van de 
auxotrofe stam ten opzichte van de normale M. tuberculosis stam. We bestuderen de 
verschillen op het genoom vlak, verschillen in groei zowel in vitro als ex vivo, effecten 
van antibiotica, proteoomreactie op zuur stress en macrofaagreactie op infectie met de 
auxotrofe stam. Dit hoofdstuk laat zien dat er weinig verschillen zijn, behalve welke al 
werden verwacht. Het grootste verschil is de reacties op zuurstress, de auxotroof is iets 
gevoeliger voor deze stress wat leidt tot een matig effect op groei.
Hoofdstuk 3 is het vervolg op hoofdstuk 2. De auxotrofe stam is een leucine auxotroof 
en heeft daarom geen vermogen om zelf leucine te produceren. De enige optie is om het 
leucine vanuit de omgeving op te nemen. Het is daarom mogelijk om de leucine in het 
groeimedium te vervangen met leucine dat atomair zwaarder is. Het zware leucine is 
een stabiele variant en kan met gemak worden teruggevonden in een massaspectrom-
eter. We kunnen SILAC gebruiken om meer inzicht te krijgen in de auxotrofe stam en 
zijn reactie op zuur stress. Naast verschillen in hoeveelheid in verloop van tijd, hebben 
we ook de post-translationele modificaties en eiwitomzet bestudeert. We vinden dat na 
verloop van tijd een groot deel van de eiwit concentraties verlaagd zijn, behalve enkele 
eiwitten die gerelateerd zijn aan pathogenese, o.a die type VII secretie systeem. We 
vonden ook dat de type VII secretie een belangrijke rol speelt in de post-translationale 
modificaties, met name bij fosforylering om die ESX-1 componenten en effectoren. Tot 
slot was de eiwitomzet een grote verrassing, er was namelijk tijdens stress bijna geen 
opname van leucine. Daarom konden we niet bepalen wat het verschil in omzet was 
tussen de stressreacties. Het is interessant dat dit gebeurt en het betekent dat de bacte-
riën snel iets belangrijks zoals aminozuur opname afsluiten. Wij kunnen niet verklaren 
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waarom dit proces zo snel gestopt wordt. Het was wel duidelijk dat tijdens meerdere 
stress reacties het secretie systemen een grote rol had in het beïnvloeden hiervan.
In hoofdstuk 4 gebruiken we genoom data van klinische M. tuberculosis stammen die 
afkomstig zijn van patiënten uit die West-Kaapse regio van Zuid-Afrika. Allereerst heb-
ben we bestudeerd hoe vaak een mutatie in de ppe38 regio in verschillende geslachtsli-
jnen van M. tuberculosis voorkomt. Uit deze experimenten ontdekten we dat de meeste 
ppe38 knock-out mutant voorkomen in lijn 2 en in een mindere mate in lijn 4. Met 
nadere inspectie van de DNA breekpunten vonden wij een verschil in de DNA volgorde 
tussen de twee lijnen. Zo bleek dat in een aantal gevallen lijn 4 een nieuw ppe38 gen 
maakt die functioneel is, wat zorgt voor het maken van een ‘fusie-eiwit’. We hebben 
dit opgevolgd door een software programma te schijven dat dit soort breekpunten in 
de DNA-volgorde kon identificeren. Met deze informatie konden we meer breuken 
vinden die leiden tot een hervorming van genen in het genoom. Dit werd vervolgens 
ook gebruikt om een proteomics-database op te zetten voor het vinden van meer 
fusie-eiwitten. Een opmerkelijk voorbeeld was de hervorming van Rv2623-Rv2628 in 
lijn 2 wat mogelijk een invloed op groei hebben. We konden hier dus bewijzen dat M. 
tuberculosis bij afwezigheid van horizontale gen-overdracht nog steeds nieuw genetisch 
materiaal kan aanmaken door gebruik te maken van bestaand materiaal.
In hoofdstuk 5 wordt onderzoek gedaan naar de ppe38 mutant en het effect ervan op 
het aangeboren immuunsysteem, specifiek met betrekking tot de macrofaag. Met 
behulp van massaspectrometrie zagen we dat de macrofaag een veel lagere response 
vertoont tijdens infectie met de ppe38 mutant. Verder wordt aangetoond dat deze reac-
ties optreden als gevolg van een dysbalans in het Nuclear Factor kappa B (NK-kB) eiwit. 
Met behulp van confocale microscopie hebben we het signalering pad bestudeerd en 
het verschil in translocatie van Rel eiwitten naar de celkern kunnen vinden. Het levert 
interestante resultaten op over de mogelijke invloed van deze mutant op de respons 
van het immuunsysteem. Vervolgwerk met ELISA tests bevestigde inderdaad dat er 
factoren worden geproduceerd en uitgescheiden door cellen geinfecteerd met de ppe38 
mutant welke inflammatie kunnen afremmen. Het is daarom mogelijk dat een verlies 
in secretie van de PE-PGRS eiwitten leidt tot een lagere initiële immuunrespons die na 
verloop van tijd bijdraagt aan een groter aantal geinfecteerde cellen bij geïnfecteerde 
individuen. Dit is een kenmerk is van infectie met lijn 2 mycobacterien.
Hoofdstuk 6 beschrijft een eiwitprofiel in longweefsel van patiënten met actieve 
tuberculose en van patiënten na afloop van behandeling. We gebruiken een aantal met-
ingen, o.a. het aantal bacteriën, FDG PET-CT scans en alveolaire bronchiale spoelsel/
lavage (BAL) van de patiënt. We vinden hier dat de meerderheid van patiënten na de 
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behandeling geen aantoonbare bacteriën meer heeft. Er waren echter ook patiënten 
met aantoonbare bacteriën alleen in de BAL maar niet in hun speeksel. Deze patiënten 
worden op basis van de uitslag van de speekselkweektest als gezond beschouwd, maar 
het is met tekenen van bacteriën in de long en op FDG PET-CT een ander verhaal. Daar-
naast konden we voorspellen met proteomics dat een van de patiënten enkele maan-
den na het bezoek aan het ziekenhuis opnieuw ziek zou worden van de mycobacteriele 
besmetting. Het is daarom mogelijk dat patiënten zich gezond presenteren maar dat 
dit niet de juiste conclusie is. Dit is belangrijk omdat het potentiaal dodelijk is, al is het 
in een klein deel van de gevallen. Met proteomics is het ook mogelijk om te ontcijferen 
welke patiënten een risico op heractivatie van de ziekte hebben. Het gebruik van pro-
teomics voor dit doel is op dit moment helaas niet mogelijk in de dagelijkse praktijk 
vanwege de complexiteit van deze techniek, maar met verder onderzoek in het veld 
kan dit op andere manieren mogelijk wel.
Hoofdstuk 7 is de afronding van alle proteomics-kennis die in dit proefschrift wordt 
gebruikt. Hoewel veel biologische vragen kunnen worden beantwoord, hangt het alle-
maal af van de data analyse erachter. Proteomics genereert een grote hoeveelheid data, 
waardoor het bijna onmogelijk is om op meer traditionele manieren te analyseren. 
De analyse hangt daarnaast ook af van het soort experimenten dat wordt uitgevoerd. 
Programmeren is nodig om goed inzicht te krijgen in de onderliggende data. Dit levert 
voor veel onderzoekers een probleem op, omdat het programmeren en geavanceerde 
statistiek bijna geen deel uitmaken van standaard opleiding. Om dit te verbeteren en 
te delen met collega’s in het veld hebben we alles wat we op dit gebied hebben geleerd 
gebundeld in een web gebaseerd data-analyseplatform. Dit hoofdstuk en het bijbe-
horende addendum zijn de beschrijvingen van dit platform. Vanaf de releasedatum 
wordt het platform veel gebruikt door meerdere mensen met het grootste gebruikers-
bestand in de VS, Duitsland, Nederland en het VK.
conclusie
Ten slotte luiden de aanpassing van technologieën zoals proteomics en genomics, en 
de standaardisatie van werk, een nieuw tijdperk in voor biologisch onderzoek. Met 
het juiste gebruik van deze technologie kunnen nieuwe inzichten worden opgedaan 
in cellulaire dynamiek die voorheen niet mogelijk waren. De technologie maakt het 
mogelijk om grootschalige systemen direct te bestuderen. Met deze technologie heb-
ben we ontdekt dat zelfs eenvoudige organismen zoals bacteriën een hoog niveau van 
complexiteit hebben waarin veel geheimen verborgen liggen. Wat betreft de fysiologie 
en evolutionaire kenmerken van M. tuberculosis en zijn varianten, moeten we nog veel 
leren. In dit proefschrift hebben we meer inzicht gekregen in belangrijke systemen van 
de mycobacteriën. Het is vooral duidelijk dat de bacterie moet worden bestudeerd in 
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de context van zijn omgeving of gastheer voor het beste inzicht in zijn gedrag. Met de 
combinatie van systeembrede karakterisering en begrip van de fundamentele proces-
sen waardoor M. tuberculosis zich onderscheidt van andere pathogenen, kunnen we 
hopen effectief te zijn in de strijd tegen deze ziektewekker.




PoRTRET VAN ‘N PAToGEEN: ‘N KARAKTERIsERING VAN 
M. tubERCulosIs AsooK sy GAsHEER MET bEHuLP VAN 
MuLTIDIMENsIoNELE PRoTEoMIKA
Inleiding tot hierdie navorsing en die doel.
Mycobacterium tuberculosis is die bakteriese agent wat die aansteeklike siekte tuber-
kulose veroorsaak in mense. Tuberkulose is nog steeds een van die dodelikste siektes 
in die konteks van infeksie siektes. In 2020, was daar 130 nuwe tuberkulose gevalle 
per 100 000 mense en 1.2 miljoen mense is dood as ‘n direk gevolg van tuberkulose. 
Ongeag noemenswaardige pogings om die verspreiding van die siekte te stop is daar 
wêreld wyd ‘n probleem. Dit is veral opvallend in lande soos Suid Afrika, waar daar hoë 
voorkoms is van dwelm weerstandbare mikobacterieë, dus is dit van uiters belang om 
verder navorsing te doen.
M. tuberculosis is ‘n gevaarlike gespesialiseerde bakterie wat hoofsaaklik long infeksies 
veroorsaak. Die bakterie het ‘n klein genoom wat spesifiek ontwikkel het om te lewe in 
‘n mens makrofaag sel. M. tuberculosis is dikwels omsingel deur meerdere immuun selle 
wat ‘n granuloom vorm. Inderdaad is die granuloom ‘n spesifieke kliniese kenmerk van 
M. tuberculosis infeksie. Hierdie gelyktydige ontwikkeling van M. tuberculosis en mens 
selle lei tot ‘n so genaamd wapen wedloop waar die bakterieë hoog gespesialiseerd 
word in beide sy genoom en uitdrukking van sy gene. In alle lewendige organismes 
vorm die proteïene die funksionele onderdele van die sel. Dus beide die struktuur van 
die sel en die metaboliese funksies word verrig deur sy proteïene. Omdat die miko-
bakterieë so ‘n besondere evolusionêre ontwikkeling gehad het, is die studie van die 
unieke kenmerke van die genoom en die proteoom van belang. Veral kenmerke wat 
siekte veroorsakende mikrobakterie skei van die wat nie-patogenies is, is dus moontlik 
die sleutel tot ‘n optimale antibiotika. Die tipe VII sekresie sisteem van M. tuberculosis 
is naamlik so ‘n kenmerk. Hierdie stelsel is uniek tot die patogeniese mikobacterieë, 
veral die ESX-5 sisteem het onlangs ontwikkel in die evolusionêre tydlyn. Dié sisteem is 
verantwoordelik vir die sekresie van die PE/PPE proteïene, ‘n groot aantal unieke pro-
teïene wat byna 10 persent van die genoom uitdrukkings potensiaal is. Dit is voor die 
hand liggend en voorheen bewys dat hierdie proteïene die vermoë het om in te meng 
met die immuun prosesse van die gasheer selle. Die manier waarby dit gehandhaaf 
word op so ‘n groot skaal is nog steeds onbekend. In hierdie tesis word veral ‘n uitslaan 
mutant van ppe38 in diepte bestudeer. Dit is juis omdat hierdie mutant die sekresie van 
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‘n groot aantal ander PE-PGRS (‘n sub-familie van pe/ppe) proteïene uitskakel. Met so 
‘n groot verlies is die ppe38 mutant ‘n aantreklike teiken vir studie, veral siende dat 
hierdie mutasie ook natuurlik voorkom.
Die doel van die navorsing wat hier verrig word is dus om uit te brei op die ope vrae 
wat in die sisteem biologie van beide M. tuberculosis asook sy gasheer van toepassing 
is. Deur so ‘n studie is dit moontlik om beide die nodige gereedskap en tegnieke op te 
stel vir verdere navorsing asook duidelike riglyne van hoe om die tegnieke toe te pas. 
Dit het gelei tot die opstel van ‘n auxotrofiese stam van M. tuberculosis wat gebruik kan 
word vir gevorderde massa spektrometrie, aanvullende insig in die evolusionêre biolo-
gie van M. tuberculosis, die biologie van M. tuberculosis in makrofage en die reaksie van 
die long tot infeksie. Om meerdere van die vrae te beantwoord het ons gebruik gemaak 
van proteomika, en daarom ook veel geleer in die veld, wat ons in staat gestel het om 
verder bydrae gelewer tot die breër gemeenskap deur ‘n analitiese platform vry te stel.
Navorsing metodes
Die navorsing in hierdie tesis draai om die sentrale toepassing van proteomika tot 
M. tuberculosis asook sy gasheer selle. In hoofstukke twee en drie gebruik ons ‘n 
auxotrofiese variant wat veiliger is en in bioveiligheidsvlak 2 kondisies gebruik kan 
word. Dit laat ook toe vir meer komplekse eksperimente, veral in proteomika. Die 
studies vorm ook die fondasie vir die proteomika tegnieke wat toegepas word in ander 
hoofstukke. Onder andere is dit ook die spesifieke manier van bakteriese groei wat 
belangrik is, naamlik in media sonder albumien of polimere. Ons gebruik natuurlike 
stamme van M. tuberculosis wat vanuit geïnfekteerde individu geïsoleer was. Vir gekon-
troleerde eksperimente waar die genetiese agtergrond van belang is, gebruik ons die 
M. tuberculosis H37Rv of CDC1551 laboratorium stamme of ‘n ppe38 uitslaan mutant. 
Ons maak ook gebruik van laboratorium variante van mens makrofage in hoofstuk 5 
asook pasiënt materiaal in hoofstuk 6. Die pasiënt materiaal is afkomstig van alveolêre 
brongiale spoel uit die longe van mense besmet met tuberkulose en na die afloop van 
behandeling.
Die mees algemene gebruik van proteomika is om die verskil in hoeveelheid proteïen 
te bepaal tussen toestande. Daar is wel veel meer toepassinge asook maniere om 
akkuraatheid van proteomika te verbeter. In hierdie tesis word ook gebruik gemaak 
van etiket vrye proteomika, so genaamd label-free proteomics in Engels, vir die 
meerderheid van studies, asook so genaamd “tandem mass tagged” (TMT) en “stable 
isotopes of amino acids in cell culture” (SILAC) gebaseerde proteomika. Al is etiket 
vrye proteomika minder akkuraat, is dit nogmaals moontlik om met data analise en 
eksperimentele praktyk goeie data te werf met hierdie tegniek. Die tegniek is toepaslik 
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op enige organisme en word daarom in amper al die hoofstukke van hierdie tesis 
gebruik, veral vir verskil in hoeveelheid bepaling. Die gebruik van stabiele aminosure 
en TMT etikette word in hoofstuk 3, 5 en 6 toegepas. Met stabiele swaar aminosure is 
dit verder moontlik om meer komplekse hoë akkurate eksperimente uit te voer. Ons 
maak gebruik van hierdie aminosure om in hoofstuk 3 na-translasionele modifikasies 
te bepaal en in beide hoofstuk 3 en 5 proteïen omset te bepaal.
Resultate in die tesis
In hoofstuk 2 word die auxotrofiese mutant van M. tuberculosis gekarakteriseer in 
vergelyking met die M. tuberculosis H37Rv wilde tipe laboratorium stam. Die auxotro-
fiese stam is veiliger dan die wilde tipe en kan gebruik word as ‘n model vir die wilde 
tipe in bioveiligheidsvlak 2 laboratoriums. Siende dat lewende organismes ‘n groot 
mate van kompleksiteit het, is dit moontlik dat matige veranderinge ‘n groot effek kan 
hê. Daarom is dit noodsaaklik om te bepaal of daar enige newe effekte is op die auxotro-
fiese stam. Ons bestudeer die verskille in genoom, verskille in groei beide in vitro en 
ex vivo, effekte van teenmiddels, proteoom reaksie tot suur en die makrofaag reaksie 
tot die auxotrofiese stam. Ons vind dat daar nie soveel verskille is in die meerderheid 
van gevalle nie, behalwe wat al verwag was. Ons vind wel dat die auxotrofiese stam ‘n 
groter verskil toon in sy response tot suur stres. Dié stam is meer gevoelig vir die stres 
response en daarom is daar matige verskil in sel verdeling ook.
Hoofstuk 3 is die opvolg van hoofstuk twee. Die auxotrofiese stam is naamlik ‘n leusien 
auxotroof en het nie die vermoë om leusien self te produseer nie. Dit is dus moontlik 
om die leusien in die groei media te vervang met leusien wat atomies swaarder is. Die 
swaar leusien is stabiel en kan maklik terug gevind word in massa spektrometrie. Ons 
het dus SILAC gebruik om meer insig te kry oor die auxotrofiese M. tuberculosis stam en 
sy response tot suur stres. Behalwe vir verskille in hoeveelheid oor tyd, het ons ook die 
na-translasionele modifikasies en proteïen omset. Ons vind dat daar oor tyd ‘n daling 
van proteïen hoeveelheid was, met die uitsondering van ‘n paar wat te maak het met 
patogenese. Wat interessant was, was dat die dormant reaksie proteïene oor tyd ook 
gedaal het in vergelyking met pH 7. Dit wys dat die grotendeels die reaksie tot stres ‘n 
daling is van die sel se proteoom reaksie. Dit was ook voor die hand liggend dat die tipe 
VII sekresie sisteem ‘n groot rol speel in die stres response. Dit was moontlik om te 
sien in beide die proteïen hoeveelheid en na-translasionele modifikasies. Die proteïen 
omset bepaling in M. tuberculosis was ‘n groot verrassing. Daar was byna geen opname 
van leusien tydens die stres nie. Daarom kon ons nie bepaal wat die verskil in omset 
tussen die stres reaksies was nie. Terwyl dit jammer was dat ons die geleentheid mis 
geloop het om verskille in suur stres te bepaal met betrekking tot omset was dit interes-
sant dat dit die uitkoms was. Dit beteken dus dat die bakterieë vinnig iets belangrik 
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soos aminosuur opname afsluit wat naamlik vra stel oor die rol van dié sisteem tydens 
infeksie.
In hoofstuk 4 gebruik ons genoom data van kliniese M. tuberculosis stamme wat vanuit 
pasiënte afkomstig is. Ons het begin deur om te kyk hoe volop die ppe38 mutant is in 
verskillende geslagslyne van M. tuberculosis is. In hierdie eksperimente het ons gevind 
dat die meerderheid van ppe38 uitslaan mutante in geslagslyn twee voorkom en tot ‘n 
minder mate in geslagslyn vier. Met verdere inspeksie in die breekpunte van die ppe38 
mutant kon ons ‘n verskil in die DNS volgorde vind. So was dit duidelik dat in sekere 
gevalle in die geslagslyn 4 stamme die mutant kon hervorm. Ons het dit opgevolg deur 
om ‘n program te skryf wat hierdie tipe breekpunte in die DNS volgorde kon identifi-
seer. Met hierdie informasie kon ons meer breuke vind wat lei tot ‘n hervorming van 
gene in die genoom. Dit was verder gebruik om ‘n proteomika databasis op te stel en 
sodoende kon ons die proteïene vind wat ooreenstem met die hervormde gene. ‘n 
Noemenswaardige voorbeeld was die Rv2323-Rv2628 hervorming in geslagslyn twee. 
Ons kon dus hier bewys dat in die afwesigheid van horisontale geen deling, kan M. 
tuberculosis nog steeds nuwe genetiese materiaal skep deur om bestaande genetiese 
materiaal te gebruik.
In hoofstuk 5 word die ondersoek in M. tuberculosis ppe38 verder gevat. Hierdie hoofs-
tuk behels die ondersoek van die ppe38 mutant en die effek op die aangebore immuun 
sisteem, spesifiek die makrofaag. Met die gebruik van massa spektrometrie het ons 
ontleed dat die makrofaag ‘n laer reaksie toon tydens infeksie van die ppe38 uitslaan 
mutant. Daar word verder gewys dat dié response gebeur as gevolg van ‘n wanbalans 
in die Kernfactor kappa B proteïne. Met konfokale mikroskopie het ons die pad in 
diepte bestudeer en kon ‘n verskil in translokasie van Rel proteïene vind. Dit lewer in-
teressante resultate wat die inflammatoriese kapasiteit van die immuun sel beïnvloed. 
Opvolg werk met ELISA toetse het ook bevestig dat anti-inflammatoriese faktore meer 
volop is in die supernatant van selle geïnfekteer met die uitslaan mutant. Dit is dus 
moontlik dat ‘n verlies in sekresie van die PE-PGRS proteïene lei tot ‘n laer aanvanklike 
immuun reaksie wat oor tyd bydrae tot ‘n groter bakteriese sel telling in geïnfekteerde 
individu. Dit is inderdaad ‘n kenmerk van geslagslyn 2 mikobakterieë.
In Hoofstuk 6 word pasiënte wat tydens aktiewe tuberkulose asook na die afloop van 
behandeling met antibiotika gevolg. Verskillende mates word geneem, onder andere 
die bakteriese telling, FDG PET-CT skanderings, asook alveolêre brongiale spoel (BAL) 
afkomstig van die pasiënt long. Ons vind hier dat die meerderheid van pasiënte geen 
telbare bakteria na die afloop van behandeling het nie. Daar was ook ongelukkig pa-
siënte met telbare bakterieë wat slegs in die BAL voorkom maar nie in hul spoeg nie. 
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Hierdie pasiënte word gesien as gesond in die konteks van ‘n speeksel kweek toets, 
maar in die long met bewys van bakterieë en FDG PET-CT is dit ‘n ander verhaal. Ons 
kon ook verder met proteomika sien dat een van die pasiënte sou herbesmet word 
met mikobakterieë maande na die besoek aan die hospitaal. Dit is dus moontlik dat 
pasiënte kan presenteer as gesond maar eintlik nie is nie, al is dit in ‘n klein proporsie 
van gevalle is dit noodsaaklik om dit na te volg. Met behulp van proteomika is dit ook 
moontlik om te ontsyfer watter pasiënte eintlik toon met ‘n gevaar van herbesmet-
ting. Met verdere ondersoek is dit dus moontlik om hierdie pasiënte uit te ken voor hul 
herbesmetting en in te gryp as dit nodig is met antibiotika.
Hoofstuk 7 is die afronding van al die proteomika kennis wat in hierdie tesis gebruik 
word. Terwyl daar baie biologiese vra beantwoord kan word, is dit alles afhanklik van 
die data analise wat daar agter sit. Proteomika genereer ‘n groot aantal data, wat dit 
amper onmoontlik maak om met meer tradisionele maniere te analiseer. Die analise 
is ook afhangend van die tipe eksperimente wat gedoen word. Dit is vir die rede dat 
programmering nodig is om goeie insig te kry in die agterliggende data. Hierdie skep 
‘n probleem vir vele ondersoekers, want programmering vir data analise en gevorderde 
statistiek vorm nie deel van enige tradisionele opleiding nie. Om dit te voorkom en 
terug te gee aan die proteomika gemeenskap het ons alles wat ons van dié veld geleer 
het gekonsolideer in ‘n internet gebaseerde data analise platform. Hierdie hoofstuk en 
sy addendum is die beskryf van hierdie platform. Vanaf die publikasie datum word die 
platform veel gebruik deur meerdere mense met die grootste gebruikers basis in die 
VSA, Duitsland, Nederland en VK.
Afsluiting
Ten slot, die aanname van tegnologie soos proteomika en genomika asook die stan-
daardisering van die werk is besig om ‘n nuwe era te bring in biologiese navorsing. 
Met die korrekte gebruik van hierdie tegnologie kan daar nuwe insigte kom in sellulêre 
dinamika wat nog niet voorheen moontlik was nie. Die tegnologie maak dit naamlik 
moontlik om grootskaalse sisteme direk te bestudeer. Met hierdie tegnologie het ons 
gevind dat tot eenvoudige organismes soos bakterie wel ‘n hoë gehalte van komplek-
siteit besit waarin nog veel geheime verberg sit. Met betrekking tot die fisiologie en 
evolusionêre eienskappe van M. tuberculosis en sy variante het ons nog baie om te leer. 
In hierdie studie het ons meer insig gekry in belangrike sisteme van die mikobakterieë. 
Dit is veral duidelik dat die bakterie in die konteks van sy omgewing of gasheer gestu-
deer moet word vir die beste insig in sy gedrag. Met die kombinasie van sisteem wye 
karakterisering en verstand van die fundamentele prosesse wat M. tuberculosis laat 
uitstaan bo ander patogene kan ons hoop om effektief te wees in die stryd teen die 
patogeen.





Dit is die grote, meer dan die einde van ’n studie maar die einde van ’n tien jaar lange 
reis, of sal ek sê stryd. Wat ‘n sprong was dit vanaf my meesters tot my PhD, seker het 
ek in die tyd gegroei as wetenskaplike maar ek sou my bemis as ek nie erken dat ek ook 
veel gegroei het as ‘n mens nie. Hierdie vlak van opleiding kom nie sonder hulp nie, 
en hulp het ek in stukke gehad. Vir die allerlaaste keer het ek die voorreg om in so ‘n 
dokument die mense wat my gehelp het tot by hierdie punt te bedank en te eer.
Starting a PhD study is a team effort, I would like to thank my promotors who have 
started me on this path and stuck with me to the end. This says something about their 
character if I do dare say so myself. As I have abruptly switched to English, I think it is 
safe to say I will start with samantha sampson. Sam I remember when you joined, or 
shall I say re-joined, the department (as an associate professor?) back then. I was very 
much in awe of the new group leader who will be joining us from prestigious places as 
Imperial College London and Harvard. As a young researcher I had the singular goal of 
somehow joining your group. This is why I will never forget the day when you entered 
my old office, in an old building, and spoke to me about a potential PhD project with 
you. Who could say no to working in the top group of the department, it would be crazy 
to turn you down. With your leadership and care for your students I can surely say that 
I made the right decision in joining your group. Thank you for your support throughout 
my PhD and for creating a wonderful group. Mijn promotoren komen als een duo, dus 
wil ik ook graag een woord van dank richten aan wilbert bitter. Wilbert, jij bent een 
van de slimste personen die ik ooit heb ontmoet en ik voel me vereerd dat ik zoveel 
van jou heb mogen leren. Al heb ik de meerderheid van mijn tijd als promovendus in 
Zuid-Afrika gespendeerd, voelde ik mij altijd welkom in jouw lab. Jij hebt mij zowel bin-
nen als buiten het lab geholpen in meerdere manieren dan alleen wetenschappelijk. 
Ik moet zeggen dat je grootste geschenk, al was dat niet de bedoeling, de introductie 
was tot de persoon met wie ik de rest van mijn leven zal doorbrengen. Het was een 
groot plezier om onderdeel te zijn van jouw team en de vele interessante projecten de 
afgelopen jaren.
Jy dink ek het jou vergeet né ou Heunis. My co-supervisor, Tiaan Heunis kry naamlik sy 
eie deel. Jis dude, daar is regtig nie woorde nie. Sonder jou was daar maar baie min wat 
sou werk in die werk wat hier gepresenteer is. Jy is meer dan ‘n co-supervisor, jy is ‘n 
goeie vriend. Toe ek jou eers ontmoet, jare gelede in die Department van Mikrobiologie 
by Stellenbosch het ek nooit gedink dat die perd wat sit en speel met sy kar battery jare 
later so ‘n belangrike persoon sal word in my persoonlike en professionele lewe nie. 
Dankie vir jou bydrae en dankie vir al die koffies, vakansies, praatjies, intellektuele 
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terugvoer en mal eksperimente wat ons saam gedoen het. Wie sou dink dat ‘n paar 
manne uit Tygerberg nou hier sou staan. Ek sien uit om te luister na al die mal goed wat 
jy gaan doen in jou loopbaan. Hartlik dank vir jou bydrae en jou vriendskap, wie weet 
miskien doen ons nog cool dinge saam in die toekoms.
Ek will ook my vriende wat ek in die werkplek gemaak het, maar vriende geword het 
buite ook, hartelik bedank. Bonjour caroline (GG), c’est l’étendue de mon français. Vos 
leçons ont vraiment aidé même si j’ai abandonné à mi-chemin. Number three of the 
golden trio and co-founder of the Tiaan Institute for Technology and science. Thanks 
for going out of your way to be such an awesome friend, colleague and collaborator. Es-
pecially thanks for the beautiful images in this thesis. Jomien, mevrou vloeisitometrie 
in lewende lywe. Dankie vir al die kere wat ek kon bydra tot jou navorsing en dat jy daar 
was om te luister as ek dit nodig gehad het. Dankie vir al jou insig in die werk ook. Dit 
word opreg waardeur. Alex and suus, my very first office mates when I joined the VU. 
Thanks for helping me navigate things at the start and making me feel very welcome 
in the laboratory. I enjoyed working alongside both of you and my only complaint was 
that it was too short.
I would also like to thank my past and present Host-Pathogen Mycobactomics lab 
mates: Nastassja, Trisha, caitlyn, su-Marie, Lesedi, Pamela, bahar, Julian, Zimvo, 
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